data_2ki2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ki2 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.86 0.362 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -89.02 175.28 7.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.952 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.409 ' HB3' ' CE2' ' A' ' 47' ' ' PHE . 32.3 m-20 -121.95 129.49 52.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.865 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.6 mt -100.57 146.53 9.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.158 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -125.52 116.36 21.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.899 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 p -120.84 134.18 65.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.084 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.99 -168.64 14.49 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.429 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 59.99 33.23 21.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.844 0.354 . . . . 0.0 110.875 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.401 ' CD1' ' CD2' ' A' ' 33' ' ' LEU . 53.7 mt -87.67 136.39 32.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.4 p -105.89 179.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.778 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -46.43 -53.37 11.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.871 0.367 . . . . 0.0 111.138 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.43 68.11 1.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.569 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.38 -76.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.381 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.49 -23.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.867 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.7 p -47.29 -58.16 4.43 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.728 0.299 . . . . 0.0 111.459 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.24 -12.83 61.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.832 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -90.52 -29.86 17.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.152 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.419 HG23 ' CD1' ' A' ' 22' ' ' PHE . 12.3 p -87.5 -25.48 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.75 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.72 -26.84 6.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.74 0.305 . . . . 0.0 111.22 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -75.0 -34.64 61.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.8 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.5 tp -89.58 -30.18 18.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.995 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.419 ' CD1' HG23 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -58.08 -21.83 47.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.083 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.3 p -82.56 -24.38 34.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.19 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -85.44 -26.48 26.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.222 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.67 -29.27 7.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.256 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.5 -26.78 3.83 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.712 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.0 tttt 64.05 51.1 2.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.369 . . . . 0.0 110.837 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.3 p -54.76 135.76 17.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.235 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -90.96 -42.47 10.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.938 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -138.82 124.92 20.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.9 p -136.15 121.46 28.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -138.4 178.83 6.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.011 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.401 ' CD2' ' CD1' ' A' ' 9' ' ' LEU . 7.4 mt -145.43 173.8 11.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 pp -110.31 179.0 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.144 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -121.61 173.22 7.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.037 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.73 -11.06 60.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.349 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.97 33.2 5.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.948 0.404 . . . . 0.0 110.848 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -165.34 -43.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.856 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.59 -1.51 16.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.346 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.15 33.03 14.78 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.885 0.374 . . . . 0.0 110.856 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.07 148.13 38.78 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.802 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.67 113.19 2.65 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.52 2.147 . . . . 0.0 112.231 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.2 109.19 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.52 -71.58 0.3 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.541 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -165.55 179.07 6.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.351 . . . . 0.0 110.946 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.17 -175.78 16.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.548 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.409 ' CE2' ' HB3' ' A' ' 3' ' ' ASN . 1.2 t80 -140.68 155.09 46.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.801 0.334 . . . . 0.0 110.926 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.1 t -151.36 131.36 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.08 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.88 116.46 31.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.419 ' HE3' ' CD2' ' A' ' 22' ' ' PHE . 4.0 mtt -142.29 168.24 20.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.963 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.0 179.75 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -96.2 35.52 1.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.996 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -123.86 -41.1 2.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.923 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.9 p -87.79 -24.77 23.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.171 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.7 t -65.38 -28.79 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.319 . . . . 0.0 111.319 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.4 m -65.4 -47.33 76.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.111 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -90.24 -25.0 20.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.226 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -50.42 -45.27 55.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.536 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.407 ' O ' HG23 ' A' ' 59' ' ' ILE . 3.9 mp -90.44 -28.31 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.078 0.466 . . . . 0.0 110.929 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.32 -58.84 5.43 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -90.36 -12.46 37.57 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 33.5 mt -90.04 -75.11 0.46 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.888 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.402 ' HB3' ' CG2' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -46.69 132.62 11.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.942 0.401 . . . . 0.0 111.632 -179.185 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 179.96 -67.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.742 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.17 -167.1 1.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.72 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -107.64 111.34 23.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.885 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.05 -167.17 1.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.951 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 3.5 mmt -86.9 56.19 3.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.69 32.67 40.51 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.503 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.7 -29.23 8.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.801 0.334 . . . . 0.0 110.966 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.94 -65.21 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.98 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.2 mt 59.74 159.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.979 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.32 78.58 9.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.698 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.0 p -101.71 153.84 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.206 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.4 t -169.1 161.65 10.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.958 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.45 130.83 47.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.089 179.979 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 120.883 0.373 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.29 169.35 8.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.838 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -104.13 133.55 48.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.6 mt -98.99 111.33 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.099 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -90.54 119.39 30.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.828 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.7 p -131.86 139.05 51.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.044 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.64 -163.6 14.45 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.399 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 55.67 36.26 26.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.788 0.328 . . . . 0.0 110.981 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.1 mt -100.73 109.81 21.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.066 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -78.33 -175.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.653 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -46.79 -48.96 20.57 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.894 0.378 . . . . 0.0 111.098 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -142.3 62.01 1.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.652 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.46 -70.85 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.424 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 175.23 -28.43 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.34 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 26.8 t -48.33 -55.83 9.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.77 0.319 . . . . 0.0 111.345 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.86 -14.7 60.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.912 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -90.48 -41.12 11.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.04 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.7 p -76.57 -14.21 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.759 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -51.77 -40.59 60.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.773 0.32 . . . . 0.0 111.193 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -61.06 -33.25 73.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.818 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.4 tt -88.65 -28.65 20.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.853 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.47 -26.37 61.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.019 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.6 t -73.12 -34.57 66.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.923 0.392 . . . . 0.0 110.867 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -90.15 -4.98 56.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.245 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -114.47 -33.86 5.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.732 0.301 . . . . 0.0 111.238 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.0 -2.46 6.08 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.293 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? 59.63 40.85 19.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.944 0.402 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.6 p -57.52 139.45 17.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.207 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -75.78 -39.09 57.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.933 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -168.83 154.9 6.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.007 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.7 t -138.72 118.79 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.983 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.53 132.27 17.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.108 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.405 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -106.98 174.53 5.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.558 179.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.449 ' CD1' ' CZ ' ' A' ' 45' ' ' PHE . 2.1 pp -105.19 152.12 7.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.263 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 2.7 m-85 -117.73 -173.07 2.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.962 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.1 -168.66 1.9 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.864 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.7 ttt-85 -127.65 36.27 4.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -157.02 -54.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.72 -2.14 26.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.379 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.3 mttm 60.84 36.97 18.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.815 0.341 . . . . 0.0 110.925 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -105.64 141.29 22.34 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.903 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.19 118.28 4.67 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.479 2.119 . . . . 0.0 112.276 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -58.35 -69.11 0.2 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.839 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 173.9 35.11 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.562 -0.828 . . . . 0.0 113.012 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.449 ' CZ ' ' CD1' ' A' ' 34' ' ' ILE . 28.4 p90 -178.5 155.82 0.88 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.077 0.465 . . . . 0.0 111.333 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -141.09 -166.18 10.62 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.388 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -144.08 143.74 31.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.88 0.371 . . . . 0.0 110.967 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.3 t -134.26 138.9 49.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.055 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.33 107.87 19.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.908 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 3.6 mtt -135.78 156.36 48.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.915 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -81.29 154.94 26.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.974 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -51.06 -29.58 13.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.198 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -71.24 -35.09 71.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.95 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.9 p -87.07 -43.65 12.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.938 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.2 t -58.21 -31.11 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.145 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.51 -51.32 70.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.098 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -88.64 -23.51 23.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.157 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -55.04 -41.48 71.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.408 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.434 HG21 ' HB3' ' A' ' 63' ' ' ASP . 4.5 mt -90.25 -24.81 5.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.067 0.46 . . . . 0.0 110.917 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.49 -55.66 30.97 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.29 -19.71 23.78 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 64.9 mt -85.4 -75.15 0.38 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.763 0.316 . . . . 0.0 111.65 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.434 ' HB3' HG21 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -55.97 137.17 51.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.147 -179.522 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 178.78 -61.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.813 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.89 -173.6 3.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -105.78 118.58 36.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.419 ' CD2' ' HD3' ' A' ' 70' ' ' ARG . 0.2 OUTLIER -135.2 -165.52 1.69 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.83 32.27 2.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.026 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.57 33.29 2.11 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.585 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.419 ' HD3' ' CD2' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -113.52 -34.48 5.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 0.0 110.934 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.92 -61.55 0.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.843 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.1 mp 59.94 162.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.908 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.5 mmm-85 -87.75 75.78 8.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.84 156.12 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.9 t -167.23 161.26 14.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.961 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -81.76 107.56 14.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.907 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.167 -0.921 . . . . 0.0 111.089 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.825 0.345 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -135.77 173.32 11.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 -102.61 139.44 38.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.935 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.1 mt -109.8 136.95 44.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.044 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -114.73 122.76 47.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.913 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.3 p -129.06 134.19 64.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.142 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -118.47 -168.3 14.22 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.468 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 59.64 33.9 22.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.858 0.361 . . . . 0.0 110.957 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.4 mt -98.74 -175.03 2.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.909 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.405 ' CG1' ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -167.97 -167.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.733 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.405 ' N ' ' CG1' ' A' ' 10' ' ' VAL . 77.4 m-85 -47.58 -46.76 28.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.798 0.333 . . . . 0.0 111.195 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.44 53.26 0.79 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.824 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.14 -55.32 22.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.184 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 177.07 -33.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.081 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.39 -52.39 53.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.803 0.335 . . . . 0.0 111.103 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -66.62 -15.52 63.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.772 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -90.55 -29.81 17.63 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.308 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.4 p -89.74 -20.94 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.811 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.3 pttp -57.29 -30.47 64.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.693 0.282 . . . . 0.0 111.12 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -72.77 -35.98 67.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.885 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.4 tp -87.56 -27.76 22.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.449 ' CD1' ' CE ' ' A' ' 50' ' ' MET . 0.1 OUTLIER -57.06 -21.96 35.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.211 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 t -83.25 -21.12 33.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.22 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -89.17 -43.65 10.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.125 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -100.05 -29.86 12.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.148 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.34 -21.96 20.82 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.597 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.66 31.69 16.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.911 0.386 . . . . 0.0 110.918 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.0 p -55.2 141.87 10.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.167 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -84.07 -42.63 15.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.62 160.36 40.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 p -149.09 151.15 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.928 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.21 131.92 0.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.088 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.28 -174.31 2.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.603 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.432 HG12 ' CZ ' ' A' ' 45' ' ' PHE . 1.3 pp -107.27 167.71 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.288 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -147.34 157.66 43.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.01 154.25 23.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.872 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -94.71 46.52 1.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -176.52 -40.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.801 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.71 -18.7 16.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.084 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.49 34.84 12.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.871 0.367 . . . . 0.0 110.911 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -113.39 142.13 27.01 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.782 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.24 117.58 4.07 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.443 2.095 . . . . 0.0 112.297 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -60.63 -70.11 0.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.762 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 176.22 35.55 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.737 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.432 ' CZ ' HG12 ' A' ' 34' ' ' ILE . 28.2 p90 -178.66 172.82 1.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.901 0.382 . . . . 0.0 111.082 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -162.58 -164.31 17.27 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.418 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -138.3 164.3 29.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.915 0.388 . . . . 0.0 111.05 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.7 t -149.91 151.55 12.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.926 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.31 110.92 21.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.904 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.449 ' CE ' ' CD1' ' A' ' 22' ' ' PHE . 18.1 mtp -147.3 -176.64 5.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -86.23 148.44 25.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.902 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -57.75 -35.1 70.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.062 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.22 -44.46 92.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.914 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.4 m -77.1 -32.1 56.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.906 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.17 -36.11 71.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.189 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.4 m -60.0 -43.48 95.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.189 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -90.0 -27.82 19.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.283 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -56.88 -41.83 78.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.396 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.421 ' CG2' ' HB3' ' A' ' 63' ' ' ASP . 2.7 mp -90.22 -27.35 5.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.041 0.448 . . . . 0.0 110.966 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.56 -58.35 7.07 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -90.35 -13.0 36.01 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 41.3 mt -89.99 -75.18 0.46 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.775 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.421 ' HB3' ' CG2' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -49.65 129.88 20.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.521 -179.324 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -176.98 -43.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.914 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.39 -175.13 4.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -106.89 99.8 9.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.962 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.69 -168.95 1.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.899 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.38 52.25 2.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.959 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.63 27.93 20.64 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.579 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 ttp180 -107.82 -31.16 8.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.796 0.331 . . . . 0.0 110.868 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.31 -59.2 0.53 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 63' ' ' ASP . 15.5 mt 59.38 161.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.012 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -86.63 56.27 3.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.796 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.0 p -76.81 158.96 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.294 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.2 t -167.76 165.79 13.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -96.76 110.55 22.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.31 -0.852 . . . . 0.0 111.17 179.971 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 ttt . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.788 0.328 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -130.46 161.07 32.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.855 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -103.19 119.24 38.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.891 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.406 ' O ' ' CD1' ' A' ' 47' ' ' PHE . 17.2 mt -92.97 131.83 38.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.18 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -111.17 126.01 54.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.852 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.16 145.0 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.192 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.54 -174.29 14.74 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.474 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 60.48 41.81 15.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 110.875 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.8 mt -103.88 -179.16 3.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 13' ' ' ALA . 5.7 p -173.36 169.76 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.799 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -40.23 -37.73 0.68 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.855 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.0 p -142.61 54.97 1.41 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.842 0.353 . . . . 0.0 111.1 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.483 ' N ' HG12 ' A' ' 10' ' ' VAL . . . -77.11 -69.99 0.49 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.189 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -179.8 -36.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.966 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.8 -51.26 61.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.893 0.378 . . . . 0.0 111.078 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -14.58 62.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -90.33 -31.72 16.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.144 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.8 p -87.76 -24.83 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.593 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -54.02 -28.53 38.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.812 0.339 . . . . 0.0 111.0 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -33.86 69.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.662 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.5 tt -90.13 -28.44 18.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.838 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.19 -26.55 51.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.004 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.1 p -76.23 -33.55 59.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.852 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -90.1 -9.62 47.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.337 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -111.77 -37.18 5.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.715 0.293 . . . . 0.0 111.077 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.03 -8.47 5.57 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.198 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.33 47.35 6.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.882 0.372 . . . . 0.0 110.755 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.7 p -54.28 155.56 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.29 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -93.15 -49.18 6.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.09 143.47 30.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.2 t -150.19 110.74 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.122 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.33 172.94 16.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.5 mt -104.13 156.62 17.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.828 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.439 HG12 ' CE2' ' A' ' 45' ' ' PHE . 2.7 pp -66.04 -35.51 75.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.127 0.489 . . . . 0.0 111.205 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 49.69 -175.97 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.196 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -109.47 141.02 42.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.8 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -90.13 52.43 2.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.942 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -177.49 -40.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.818 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -104.9 -18.35 14.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.167 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.8 mttp 63.32 33.67 13.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.909 0.385 . . . . 0.0 110.883 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -113.89 145.25 33.12 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.883 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.65 120.31 6.11 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.58 2.187 . . . . 0.0 112.352 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -75.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.878 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 175.9 37.11 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.65 -0.785 . . . . 0.0 112.684 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.439 ' CE2' HG12 ' A' ' 34' ' ' ILE . 32.7 p90 -177.14 132.95 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.905 0.383 . . . . 0.0 110.992 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -122.4 -159.3 10.55 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.533 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.406 ' CD1' ' O ' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -145.01 152.59 40.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.841 0.353 . . . . 0.0 111.057 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.7 t -141.75 124.75 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.856 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -95.39 108.4 20.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.2 mtp -136.79 158.96 43.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.54 155.53 25.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -77.75 69.15 3.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.027 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -149.98 -48.27 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.428 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.18 -20.07 23.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.014 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.0 t -59.5 -47.98 88.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.317 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 m -56.01 -56.13 24.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.149 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -69.65 -28.67 66.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.187 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -60.56 -41.72 95.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.281 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.415 HG23 ' HB3' ' A' ' 63' ' ' ASP . 3.3 mt -90.34 -27.28 5.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.045 0.45 . . . . 0.0 111.046 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.53 -57.26 12.09 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -90.45 -14.56 32.58 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 48.8 mt -90.08 -75.08 0.46 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.777 0.322 . . . . 0.0 111.826 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.415 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -48.96 140.58 8.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.979 0.419 . . . . 0.0 111.499 -179.291 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 174.19 -35.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.641 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.72 -170.25 2.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.744 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.2 109.2 17.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.911 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -139.2 -174.22 3.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -74.98 68.2 1.78 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.36 26.55 72.69 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.683 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.3 mtp85 -96.56 -36.36 10.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.898 0.38 . . . . 0.0 110.82 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -138.67 -51.66 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.776 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.0 mt 59.78 159.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.107 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.01 50.54 1.68 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.947 0.403 . . . . 0.0 110.845 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.8 p -72.65 158.81 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.2 t -176.77 157.82 1.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.895 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.18 108.64 14.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.828 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.156 -0.926 . . . . 0.0 111.105 179.976 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 mtt . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.827 0.346 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -109.18 -171.08 1.77 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -121.06 137.92 54.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.948 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.1 mt -109.48 141.05 25.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.103 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -110.23 124.2 51.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.908 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.5 p -129.37 138.16 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.108 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.19 -171.58 17.4 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.45 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.9 t30 58.73 30.22 19.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.831 0.348 . . . . 0.0 110.97 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -86.29 163.38 17.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.455 HG11 ' N ' ' A' ' 13' ' ' ALA . 3.6 p -147.36 172.4 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.853 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -42.58 -41.52 3.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.583 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.3 m -150.25 66.34 0.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.927 0.394 . . . . 0.0 110.953 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.455 ' N ' HG11 ' A' ' 10' ' ' VAL . . . -73.49 -77.38 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.323 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -173.11 -36.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.28 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.3 t -49.79 -52.53 31.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.351 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.81 -14.43 62.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.85 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -90.39 -46.23 8.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.959 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.91 -9.42 12.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.689 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -53.59 -31.03 45.26 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.799 0.333 . . . . 0.0 110.971 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -69.8 -33.15 71.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.828 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.4 tt -90.02 -29.97 18.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.882 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -26.04 61.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.01 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m -76.19 -30.19 57.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.062 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -90.07 -5.17 56.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.348 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -116.18 -36.98 3.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.71 0.29 . . . . 0.0 111.11 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.1 -0.18 3.88 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.32 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 mmtt 56.04 103.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.985 0.393 . . . . 0.0 111.071 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.454 ' CG2' ' CG2' ' A' ' 31' ' ' VAL . 7.1 p -117.17 169.06 7.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.793 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -129.9 -39.51 1.4 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -97.6 -96.3 0.21 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.454 ' CG2' ' CG2' ' A' ' 28' ' ' VAL . 45.4 t 66.58 88.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.734 0.302 . . . . 0.0 110.882 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.67 151.93 22.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.93 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.3 mt -101.47 153.55 19.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.43 HG12 ' CE2' ' A' ' 45' ' ' PHE . 2.7 pp -85.63 -179.36 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -137.9 -172.19 3.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.862 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -91.7 -175.59 4.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.974 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.23 31.71 6.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -160.25 -59.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.881 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 p -92.42 -17.02 25.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.195 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.6 mptt 66.91 30.17 7.85 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.86 0.362 . . . . 0.0 110.882 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.1 pttt -92.15 138.15 24.6 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.789 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.29 115.82 2.54 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.438 2.092 . . . . 0.0 112.302 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -59.64 -74.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.898 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.5 39.36 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.561 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.43 ' CE2' HG12 ' A' ' 34' ' ' ILE . 13.4 p90 -172.1 145.55 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.91 0.386 . . . . 0.0 110.934 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -125.97 -166.05 12.17 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.541 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -145.67 128.94 16.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 111.164 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 52.4 t -114.75 116.0 51.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.863 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -87.26 94.99 9.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.945 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 29.2 mtp -121.18 177.56 5.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.881 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -69.1 158.2 35.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -31.18 69.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.902 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -81.63 -31.17 32.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.012 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.61 -33.0 64.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.051 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.9 t -58.01 -47.6 86.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.395 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.1 m -57.74 -64.77 0.79 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.13 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.15 -26.99 63.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.149 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -68.34 -37.14 80.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.415 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.433 HG21 ' HB3' ' A' ' 63' ' ' ASP . 5.8 mt -90.36 -11.79 9.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.275 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.75 -49.6 12.77 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -90.64 -19.41 23.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.799 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.535 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 78.2 mt -90.07 -75.03 0.47 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.433 ' HB3' HG21 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -59.56 144.95 46.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.023 0.44 . . . . 0.0 111.059 -179.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 179.67 -38.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.803 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.79 -170.39 3.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.824 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -111.15 111.71 22.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.964 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.56 -172.02 2.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.815 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -95.49 39.77 1.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.037 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.17 31.2 3.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.563 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.35 -41.83 4.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.806 0.336 . . . . 0.0 110.881 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.93 -48.9 0.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.5 mt 59.28 165.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.793 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -99.19 48.9 0.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.925 0.393 . . . . 0.0 110.756 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.38 125.19 21.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.064 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.0 t -132.67 162.98 29.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.009 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.86 117.11 21.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.932 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.215 -0.897 . . . . 0.0 111.121 179.969 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.425 ' HG2' ' CZ ' ' A' ' 29' ' ' PHE . 20.9 mtp . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.816 0.341 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -108.22 -169.26 1.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.411 ' HB3' ' CE2' ' A' ' 47' ' ' PHE . 1.6 m120 -121.71 150.5 41.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.89 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.4 mt -116.74 119.15 61.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.126 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -96.16 129.73 43.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.993 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.415 ' CG2' HD21 ' A' ' 9' ' ' LEU . 7.6 p -123.01 136.99 58.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.974 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -124.3 174.92 17.02 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.502 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 62.23 25.6 15.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.613 0.244 . . . . 0.0 110.986 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.415 HD21 ' CG2' ' A' ' 6' ' ' VAL . 1.8 mm? -60.15 138.63 57.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.679 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.7 p -102.49 162.18 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.644 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -43.33 -30.02 0.48 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.162 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -100.57 -71.64 0.7 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.054 0.454 . . . . 0.0 110.057 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 76.39 141.43 0.07 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.411 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 m -106.01 -26.84 11.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.374 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.08 -46.49 80.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.047 0.451 . . . . 0.0 110.09 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -75.75 -12.94 60.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.037 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.46 -41.09 11.64 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.496 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.9 p -78.2 -4.91 7.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.618 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -53.12 -37.16 61.53 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.762 0.315 . . . . 0.0 110.962 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -60.17 -31.53 70.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.707 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.1 tt -89.95 -29.65 18.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.789 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.66 -25.81 60.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.97 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m -67.11 -38.59 85.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.964 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.15 -7.75 52.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.209 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -103.54 -27.51 12.31 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.314 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.85 19.77 0.58 Allowed Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.372 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.4 pttm 42.33 98.99 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.905 0.383 . . . . 0.0 111.925 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.8 p -103.77 133.95 46.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.992 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.425 ' CZ ' ' HG2' ' A' ' 1' ' ' MET . 92.1 m-85 -69.45 -46.13 67.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.012 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -166.95 157.52 11.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.002 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -147.34 129.33 6.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.107 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.67 138.57 13.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.012 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.407 ' HB3' ' CA ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -126.92 148.15 50.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.784 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.425 HG23 ' CZ ' ' A' ' 45' ' ' PHE . 2.9 pp -64.38 177.73 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.043 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -132.89 -177.03 4.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.986 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -60.93 -22.36 64.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.173 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 62.26 33.57 16.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.781 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.06 -46.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.788 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.49 -0.29 32.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.364 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.1 mttt 62.61 35.99 13.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.846 0.355 . . . . 0.0 111.016 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -116.53 128.07 26.28 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.78 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.66 115.71 3.54 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.407 2.071 . . . . 0.0 112.244 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.62 132.04 1.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.943 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 137.7 -72.89 0.44 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.506 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.425 ' CZ ' HG23 ' A' ' 34' ' ' ILE . 20.8 p90 -169.4 168.21 9.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.846 0.355 . . . . 0.0 110.833 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.407 ' CA ' ' HB3' ' A' ' 33' ' ' LEU . . . -137.75 -178.07 15.71 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.601 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.436 ' CZ ' ' CB ' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -150.96 129.61 12.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.82 0.343 . . . . 0.0 111.094 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 51.2 t -126.3 143.51 39.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -111.9 106.09 14.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.978 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 35.5 mtt -137.4 -177.36 4.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.994 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -67.21 168.05 11.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.965 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -66.81 -37.05 83.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.954 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -74.8 -32.5 62.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.963 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.87 -36.31 82.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.6 t -62.32 -44.97 99.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.227 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.4 m -55.94 -63.57 1.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.085 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -62.11 -28.18 69.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.968 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.528 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -61.18 -38.29 85.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.293 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 59' ' ' ILE . 3.5 mt -90.22 -16.9 8.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.23 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.87 -48.34 31.71 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.3 mmmt -90.41 -22.85 21.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.656 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.528 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 78.6 mt -89.96 -69.8 0.7 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.532 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.436 ' CB ' ' CG1' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -63.05 141.42 58.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.087 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -178.63 -38.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.872 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.79 -168.64 2.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.73 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -110.34 104.67 13.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.974 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.9 -167.95 1.83 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.893 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.6 ptm -95.16 43.8 1.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.078 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.54 26.61 8.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.628 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 44.7 mtp85 -103.94 -34.99 8.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.908 0.385 . . . . 0.0 110.74 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.1 t -141.07 -47.06 0.4 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.651 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 63' ' ' ASP . 2.2 mt 57.76 167.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.826 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.4 47.36 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.912 0.387 . . . . 0.0 110.833 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.436 ' CG1' ' CB ' ' A' ' 63' ' ' ASP . 13.2 p -61.93 153.25 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.12 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.0 t -159.97 165.97 30.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -80.25 126.01 30.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.826 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.436 ' CB ' ' CZ ' ' A' ' 47' ' ' PHE . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.173 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 ttm . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.843 0.354 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -123.67 132.54 53.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -76.43 140.43 41.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.881 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.1 mt -106.18 126.02 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.033 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -107.88 104.44 13.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.836 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.0 p -113.32 130.95 66.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.166 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -120.46 -174.01 15.1 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.424 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 59.37 39.19 22.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.901 0.381 . . . . 0.0 110.863 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.6 mt -82.46 178.41 8.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.417 HG13 ' N ' ' A' ' 13' ' ' ALA . 6.3 p -143.69 169.13 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -44.33 -31.49 1.05 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.505 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -170.99 76.3 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.934 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.417 ' N ' HG13 ' A' ' 10' ' ' VAL . . . -81.69 -59.68 2.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.153 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 176.35 -31.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.204 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.9 m -50.51 -53.74 27.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.783 0.325 . . . . 0.0 111.297 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -13.62 62.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.713 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.56 -38.56 13.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.231 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.0 p -84.06 -9.78 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.899 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -56.88 -44.36 82.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.775 0.321 . . . . 0.0 110.932 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -59.74 -33.04 71.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.705 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.7 tt -87.67 -27.46 22.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.836 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.46 ' CD1' ' CE ' ' A' ' 50' ' ' MET . 0.1 OUTLIER -55.76 -23.64 30.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.162 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.8 t -80.26 -26.83 38.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.082 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -90.09 -20.47 23.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.236 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -109.54 -33.59 6.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.208 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.62 -18.25 4.9 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.154 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm 65.64 42.61 3.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.89 0.376 . . . . 0.0 110.741 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.3 p -51.08 151.76 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.33 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -91.79 -43.05 9.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -153.48 157.18 39.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.075 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.9 t -150.83 121.85 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.889 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.58 163.04 33.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.081 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 76.9 mt -129.36 179.67 5.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.791 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.421 HD11 ' CD1' ' A' ' 45' ' ' PHE . 2.5 pp -126.92 171.75 14.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.349 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -115.63 -169.86 1.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.937 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.04 178.33 6.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.81 30.86 7.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.935 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -162.47 -48.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 p -91.92 -20.83 20.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.004 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.43 34.31 8.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.839 0.352 . . . . 0.0 110.96 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -101.69 151.02 37.81 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.851 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.71 97.8 0.92 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.618 2.212 . . . . 0.0 112.628 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.23 135.6 0.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.799 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.42 -59.96 0.44 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.457 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.421 ' CD1' HD11 ' A' ' 34' ' ' ILE . 40.8 p90 -171.52 167.91 6.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.849 0.356 . . . . 0.0 110.962 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.77 174.57 22.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.352 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.86 133.92 38.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.884 0.374 . . . . 0.0 111.017 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.7 t -129.22 151.57 35.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.956 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -125.14 120.31 31.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.914 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.46 ' CE ' ' CD1' ' A' ' 22' ' ' PHE . 32.5 mtp -151.88 166.79 30.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -68.88 159.85 31.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.794 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.51 61.7 3.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.984 0.421 . . . . 0.0 110.903 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.61 -47.79 0.51 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.578 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.8 m -90.18 -25.55 20.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.956 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.6 t -64.4 -35.1 73.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.826 0.346 . . . . 0.0 111.472 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.37 -46.89 88.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.204 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.63 -23.5 21.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.311 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -59.5 -41.54 90.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.458 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.3 mp -90.36 -27.91 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.075 0.464 . . . . 0.0 111.048 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.05 -60.29 3.37 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -90.51 -10.31 44.05 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 26.5 mt -90.06 -75.29 0.46 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.95 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -49.36 149.03 2.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.96 0.409 . . . . 0.0 111.526 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.14 -48.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.762 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -158.96 -173.81 4.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.784 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -95.2 104.48 16.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.888 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.41 ' CZ ' ' NH2' ' A' ' 70' ' ' ARG . 0.3 OUTLIER -126.63 170.04 12.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.953 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 4.9 mtt -83.17 58.81 4.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.07 33.54 11.96 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.511 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.41 ' NH2' ' CZ ' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -111.41 -42.25 3.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.797 0.332 . . . . 0.0 110.835 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.96 -47.96 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.796 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.8 mt 59.74 159.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.033 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.37 69.73 6.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.851 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.7 p -93.09 132.9 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.176 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.4 t -154.02 159.75 41.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -58.38 139.27 55.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.96 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.102 -179.974 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.808 0.337 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -109.36 146.15 34.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.416 ' HB3' ' CE2' ' A' ' 47' ' ' PHE . 4.6 m120 -85.36 129.94 34.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.9 mt -107.69 139.32 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.093 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -113.78 125.57 54.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.844 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.0 p -121.94 124.28 70.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.077 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -112.66 -168.45 17.48 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.531 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.8 32.44 20.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.818 0.342 . . . . 0.0 110.887 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.9 mt -88.35 -178.03 5.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.407 ' CG1' ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -160.68 -168.43 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.819 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.407 ' N ' ' CG1' ' A' ' 10' ' ' VAL . 0.7 OUTLIER -48.56 -45.51 37.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.836 0.351 . . . . 0.0 111.134 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.94 60.64 0.52 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.647 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.44 -77.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.37 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -166.19 -31.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.446 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.3 p -46.85 -55.41 8.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.646 0.26 . . . . 0.0 111.441 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.57 -14.32 62.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.777 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -90.5 -30.97 16.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.09 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.422 HG23 ' CD2' ' A' ' 22' ' ' PHE . 14.8 p -86.54 -29.19 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.495 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.9 pttt -48.93 -28.5 3.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.132 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.8 -34.88 69.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.66 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.4 tt -89.96 -18.89 25.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.037 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.422 ' CD2' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -71.12 -17.09 62.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.236 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.2 p -90.13 -26.23 20.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.438 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -87.4 -47.77 8.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.345 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.57 -11.25 10.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.63 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.9 -22.94 37.05 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.641 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.58 35.17 14.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.81 0.338 . . . . 0.0 110.86 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.9 p -76.81 141.79 15.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.119 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -77.31 -44.79 28.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.96 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -174.7 145.87 0.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.014 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.0 t -127.09 140.95 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.908 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.94 106.59 2.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.071 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.7 mt -85.91 175.16 8.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.634 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.446 HG12 ' CZ ' ' A' ' 45' ' ' PHE . 1.5 pp -107.9 154.53 8.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.22 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.413 ' CE1' ' HG3' ' A' ' 42' ' ' PRO . 83.2 m-85 -140.43 -176.21 4.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.92 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -84.93 -179.6 7.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.934 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -112.09 32.97 5.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -157.79 -54.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.037 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.01 5.65 20.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.415 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 57.85 29.68 17.9 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.839 0.352 . . . . 0.0 110.957 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -76.27 113.96 33.36 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.867 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.413 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 52.8 Cg_exo -52.91 121.73 9.82 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.452 2.101 . . . . 0.0 112.27 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -41.09 69.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.05 37.79 0.11 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.978 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.446 ' CZ ' HG12 ' A' ' 34' ' ' ILE . 31.6 p90 -178.95 165.83 1.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.982 0.42 . . . . 0.0 111.215 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -146.91 -167.69 13.2 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.524 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.416 ' CE2' ' HB3' ' A' ' 3' ' ' ASN . 0.1 OUTLIER -139.56 136.59 34.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.85 0.357 . . . . 0.0 111.021 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.1 t -129.03 136.09 60.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.899 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -105.21 113.13 26.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.885 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -150.38 152.03 33.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.919 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.52 173.06 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.718 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.69 -152.54 0.06 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.376 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 67.49 -68.69 0.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.209 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.2 m -67.63 -28.62 67.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.235 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.2 t -58.16 -25.05 25.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.401 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.2 p -72.22 -50.47 27.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.136 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -83.24 -26.11 31.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.296 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -56.55 -42.65 78.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.494 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.8 mp -90.39 -12.15 9.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.281 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.08 -47.39 13.6 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -90.46 -21.47 21.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.687 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.518 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 80.3 mt -90.03 -69.6 0.71 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.737 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -49.51 124.38 9.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.321 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -177.59 -49.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.857 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.02 -169.5 2.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.82 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -101.71 124.96 48.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.917 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.57 -173.16 4.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 8.5 mtp -72.13 66.09 0.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 59.32 28.94 65.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.509 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.36 -27.76 12.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.728 0.299 . . . . 0.0 110.968 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.57 -71.68 0.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.091 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.6 mt 59.78 159.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.8 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -81.78 74.02 8.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 110.789 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.0 p -90.13 155.23 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.4 t -167.47 152.65 7.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.93 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -68.5 124.78 24.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.911 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.143 179.965 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 tpp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.798 0.333 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -127.75 -177.65 4.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -122.58 153.74 38.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.2 mt -131.56 123.3 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.173 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.499 ' CE2' ' CD2' ' A' ' 45' ' ' PHE . 29.2 t80 -108.84 115.54 30.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 p -124.08 124.17 68.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.156 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.15 -170.17 29.55 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.535 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 59.05 40.89 21.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.917 0.389 . . . . 0.0 110.945 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.1 mt -98.45 -178.14 3.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.908 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -172.85 -168.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.743 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -50.29 -47.95 55.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.827 0.346 . . . . 0.0 111.128 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 p -143.35 55.14 1.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.675 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.91 -72.98 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.196 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -165.44 -41.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.056 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.15 -49.33 66.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.065 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -67.05 -15.59 63.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.718 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -90.41 -36.39 14.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.981 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.407 HG22 ' CD1' ' A' ' 22' ' ' PHE . 12.2 p -90.07 -23.44 6.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.66 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 42.3 pttt -52.58 -34.33 50.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.762 0.315 . . . . 0.0 111.209 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -65.18 -34.45 78.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.723 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 tp -89.86 -26.69 20.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.407 ' CD1' HG22 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -55.74 -23.19 27.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.166 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.6 t -82.91 -29.78 28.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.987 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -90.1 -21.54 22.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -112.82 -30.96 6.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.284 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -117.94 -1.39 16.95 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.113 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.3 pttt 44.92 43.77 7.38 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.85 0.357 . . . . 0.0 111.337 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.9 p -54.67 150.94 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.228 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -91.8 -51.24 5.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.039 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -139.46 158.04 44.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.022 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.0 t -151.48 98.19 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.977 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.84 166.48 11.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.002 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.4 mt -140.68 175.09 9.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.843 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 pp -119.51 -178.79 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.083 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -130.22 -179.13 5.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.054 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -20.29 55.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.17 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.09 36.05 2.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.902 0.382 . . . . 0.0 110.746 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -175.19 -40.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.743 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.3 -10.21 17.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.266 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 mptt 66.66 31.47 7.66 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.86 0.362 . . . . 0.0 110.686 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -111.82 131.04 22.61 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.22 111.17 0.6 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.467 2.112 . . . . 0.0 112.294 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -176.63 127.23 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.918 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.52 -79.09 0.27 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.617 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.499 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 50.3 p90 -168.01 -176.64 3.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.811 0.338 . . . . 0.0 111.032 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.68 169.25 26.09 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.539 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.09 131.35 47.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.802 0.334 . . . . 0.0 111.001 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.8 t -126.26 145.19 34.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.963 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -114.4 114.45 25.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 29.6 mtm -141.83 169.5 17.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -78.48 154.29 30.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -72.01 93.3 1.37 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.904 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -173.43 -49.41 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.466 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.14 -15.34 31.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.994 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.7 t -66.68 -39.51 83.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.825 0.345 . . . . 0.0 111.179 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.12 -24.67 58.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.216 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.26 -42.95 10.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.759 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.86 -67.78 0.33 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.892 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.7 mt -56.53 -29.4 29.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.144 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.75 -57.55 12.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.69 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -90.25 -26.08 20.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.646 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 84.4 mt -75.21 -72.9 0.27 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.81 0.338 . . . . 0.0 111.488 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.9 135.67 23.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.346 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -178.12 -67.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.761 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.76 -172.16 2.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.811 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.51 99.2 8.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.964 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.18 -172.52 2.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.842 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 23.9 mtt -100.22 36.42 1.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.66 32.7 1.4 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.505 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.12 -37.95 3.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.825 0.345 . . . . 0.0 110.953 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.56 -55.69 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.872 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mt 59.79 160.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.991 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.39 59.32 5.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.762 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.3 p -79.72 156.75 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.224 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.0 t -178.46 144.98 0.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.903 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.36 114.61 6.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.069 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.818 0.342 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.21 161.28 13.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -100.96 102.09 13.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.405 ' O ' ' CD1' ' A' ' 47' ' ' PHE . 29.6 mt -72.42 141.08 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.095 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -112.24 138.36 49.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.807 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 p -147.79 129.14 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.285 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.08 -175.79 25.49 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.329 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 58.45 37.83 25.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.816 0.341 . . . . 0.0 110.806 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -87.98 159.63 18.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.033 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -154.03 -167.41 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.78 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.423 ' CD1' ' HG2' ' A' ' 42' ' ' PRO . 80.0 m-85 -49.5 -46.09 47.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.833 0.349 . . . . 0.0 111.088 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -157.18 57.64 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.778 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.04 -52.01 65.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.259 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -177.61 -36.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.099 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.5 m -51.34 -51.88 50.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.223 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.86 -14.87 63.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.787 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -90.54 -36.27 14.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.089 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.424 HG21 ' CD1' ' A' ' 22' ' ' PHE . 10.7 p -86.23 -24.77 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.625 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -53.16 -32.04 45.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.889 0.376 . . . . 0.0 111.072 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.37 -39.28 94.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.632 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.3 tt -83.14 -31.23 27.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.705 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.424 ' CD1' HG21 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -61.2 -28.27 69.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.928 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.27 -26.9 26.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.088 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -85.36 -25.44 27.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.137 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -111.47 -29.57 7.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.195 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -114.15 -24.65 4.42 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.807 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.87 46.53 3.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.861 0.362 . . . . 0.0 110.776 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.1 p -52.02 147.4 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.295 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -73.81 -50.26 21.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.919 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -154.67 157.92 38.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.972 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.4 t -152.76 124.08 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.082 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -160.02 -178.6 7.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.981 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 34.0 mt -122.78 160.01 26.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.851 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.411 HG23 ' CE2' ' A' ' 45' ' ' PHE . 2.5 pp -81.63 -22.11 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.516 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 58.83 171.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.008 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -59.94 160.44 7.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.68 40.53 1.22 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.969 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -170.82 -44.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.763 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.98 -17.97 18.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.186 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp 64.12 33.17 12.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.894 0.378 . . . . 0.0 110.9 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.4 150.42 37.98 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.763 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.423 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 63.5 Cg_exo -51.45 99.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.581 2.188 . . . . 0.0 112.3 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.81 129.4 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 127.9 -76.45 0.4 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.643 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.411 ' CE2' HG23 ' A' ' 34' ' ' ILE . 24.4 p90 -176.09 171.61 2.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.754 0.312 . . . . 0.0 110.913 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.93 171.01 21.9 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.479 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.405 ' CD1' ' O ' ' A' ' 4' ' ' ILE . 2.7 m-85 -134.38 145.52 49.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.836 0.351 . . . . 0.0 110.87 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.8 t -131.59 97.47 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.092 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -68.3 86.91 0.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.973 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.7 mtp -125.42 179.6 5.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.905 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -67.89 173.84 4.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.02 -36.94 48.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.968 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -64.3 -36.04 82.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.02 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.7 t -71.03 -30.27 66.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.033 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.8 t -66.82 -36.37 77.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.267 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.9 t -77.87 -24.99 48.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.214 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.25 -44.9 9.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.753 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -57.48 -68.39 0.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.965 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.3 mt -54.85 -31.1 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.073 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.34 -59.8 4.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.602 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -90.32 -11.48 40.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.106 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 63.6 mt -89.93 -75.08 0.46 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.641 0.258 . . . . 0.0 111.623 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.72 150.33 5.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.035 0.445 . . . . 0.0 111.246 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -178.58 -40.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.847 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -162.85 -169.48 2.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.781 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -107.13 93.55 4.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.818 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.09 -176.28 2.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 15.0 mtm -94.16 46.44 1.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.81 32.99 4.86 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.494 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -113.77 -30.01 6.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.758 0.313 . . . . 0.0 111.152 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 t -152.37 -45.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.013 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 72' ' ' ILE . 20.3 mt 61.6 161.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.796 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.0 mtm180 -94.25 43.38 1.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.984 0.421 . . . . 0.0 111.011 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.2 p -61.81 147.51 11.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.981 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.1 t -158.76 171.83 19.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.918 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -85.03 121.07 27.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.785 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.162 179.916 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttt . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.847 0.356 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.13 -175.33 5.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.886 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -123.12 105.63 10.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.877 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.6 mt -65.16 145.44 13.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.987 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -125.13 115.65 20.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.922 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.6 p -109.66 141.52 24.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.951 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -120.93 62.92 0.5 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.582 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -177.5 62.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.875 0.369 . . . . 0.0 110.636 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.2 mt -109.73 161.61 15.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.061 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.5 p -178.96 161.46 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.723 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -47.23 -27.99 1.73 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.328 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 88.2 p -120.28 30.12 7.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.14 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.51 ' O ' ' CB ' ' A' ' 14' ' ' THR . . . -68.69 -31.42 70.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.235 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.51 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 1.3 m 90.61 5.64 0.1 Allowed 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.721 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.6 m -70.93 -52.74 18.17 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.927 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.78 -18.6 62.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.449 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.43 -39.17 12.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.978 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.9 p -81.87 -24.58 9.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.687 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -51.3 -37.05 45.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.802 0.334 . . . . 0.0 111.031 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.16 -32.59 70.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.007 0.432 . . . . 0.0 110.542 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.3 tt -83.6 -31.01 26.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.563 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -20.79 61.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.935 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.3 t -83.1 -29.24 28.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.954 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -81.64 -22.11 37.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.124 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -112.12 -31.64 6.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.149 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.59 -23.96 4.21 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.926 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? 62.48 50.14 3.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.858 0.361 . . . . 0.0 110.838 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.64 146.68 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.169 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -93.8 -31.05 14.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.968 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -150.71 145.85 26.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.107 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.7 t -147.1 106.43 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.772 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.24 155.7 49.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.186 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.94 155.17 29.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.58 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.455 ' CD1' ' CE1' ' A' ' 45' ' ' PHE . 2.6 pp -82.85 177.29 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.034 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.407 ' CG ' ' O ' ' A' ' 34' ' ' ILE . 70.7 m-85 -157.02 167.55 30.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.33 156.88 22.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.5 38.57 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.941 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -159.97 -45.29 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.927 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p -106.95 -16.27 14.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.206 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.7 mttp 62.39 37.25 13.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.915 0.388 . . . . 0.0 110.965 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -113.32 139.01 22.66 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.809 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.95 118.88 5.64 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.445 2.097 . . . . 0.0 112.402 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -70.2 -64.55 0.87 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.3 50.29 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.413 -0.898 . . . . 0.0 112.987 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.455 ' CE1' ' CD1' ' A' ' 34' ' ' ILE . 27.8 p90 -178.04 153.38 0.8 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.013 0.435 . . . . 0.0 111.081 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.61 -164.73 11.42 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.571 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -140.78 144.96 35.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.85 0.357 . . . . 0.0 111.169 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.9 t -141.97 115.61 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.867 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.65 101.52 13.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.02 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 29.8 mtm -130.58 154.86 47.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.918 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.76 149.45 46.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.892 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.21 -31.72 63.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.088 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -63.25 -34.71 78.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.006 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.5 t -90.0 -39.25 13.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.985 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -54.82 -47.81 74.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.372 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.7 m -52.15 -64.02 0.95 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.19 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -26.83 67.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.004 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -63.94 -39.53 94.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.267 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.445 HG22 ' HB3' ' A' ' 63' ' ' ASP . 5.4 mt -90.12 -7.28 10.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.303 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.7 -44.95 9.67 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.97 -25.0 19.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.451 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.571 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 66.0 mt -90.11 -74.23 0.49 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.901 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.445 ' HB3' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -50.96 142.1 12.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.932 0.396 . . . . 0.0 111.295 -179.395 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -178.83 -38.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.871 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -159.72 -175.05 4.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -104.35 108.66 20.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -124.71 -168.61 1.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.948 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.2 mmt -95.04 44.46 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.82 32.61 6.14 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.499 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.95 -34.62 6.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.83 0.347 . . . . 0.0 110.964 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.62 -53.93 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.992 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.3 mt 59.92 159.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.019 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 61.18 6.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.831 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.4 p -72.82 140.64 17.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.096 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.9 t -164.27 150.91 11.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.868 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -70.33 127.35 32.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.103 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.822 0.344 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -114.4 -178.53 3.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.866 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -110.73 142.5 42.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 mt -118.85 120.08 62.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.463 ' CD2' ' CE1' ' A' ' 47' ' ' PHE . 3.5 t80 -102.17 123.54 46.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.004 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 p -128.47 129.04 68.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.024 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -110.67 -168.84 19.31 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.51 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.38 33.68 23.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.751 0.31 . . . . 0.0 110.9 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.3 mt -85.97 -178.72 6.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.964 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.443 HG11 ' N ' ' A' ' 13' ' ' ALA . 2.5 p -163.98 174.42 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.824 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -43.19 -45.56 5.66 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.75 0.31 . . . . 0.0 111.563 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.9 t -140.78 61.94 1.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.888 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.443 ' N ' HG11 ' A' ' 10' ' ' VAL . . . -68.13 -78.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.327 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -177.43 -32.24 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.312 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.9 t -47.27 -54.95 9.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.76 0.314 . . . . 0.0 111.521 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -14.47 61.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.851 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -90.68 -27.95 18.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.274 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -90.14 -20.69 6.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.842 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.36 -28.01 4.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.778 0.323 . . . . 0.0 111.236 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -72.35 -32.14 66.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.82 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.6 tt -90.01 -30.26 17.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.955 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.85 -22.91 40.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.7 t -76.51 -31.93 57.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.985 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -90.19 -10.67 43.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.42 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.52 -37.77 5.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.645 0.26 . . . . 0.0 111.157 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -127.38 -5.65 5.48 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.516 -0.85 . . . . 0.0 113.265 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp 61.33 47.54 6.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.872 0.367 . . . . 0.0 110.938 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.6 p -53.97 116.05 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.188 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -59.77 -39.9 86.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.887 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -160.08 158.76 30.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 p -155.22 127.88 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.035 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.3 mtpt -160.04 123.23 3.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.973 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.0 mt -84.68 -169.04 2.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.572 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.44 HG12 ' CZ ' ' A' ' 45' ' ' PHE . 1.7 pp -111.93 155.18 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.902 0.382 . . . . 0.0 111.233 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -157.22 169.66 24.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.741 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.61 131.5 34.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -84.1 56.4 3.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.921 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 179.2 -40.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.795 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 p -111.88 -19.82 12.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.203 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.1 tttt 68.92 25.82 5.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.778 0.323 . . . . 0.0 110.904 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -90.73 121.3 68.37 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.831 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.3 125.81 20.27 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.408 2.072 . . . . 0.0 112.337 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.58 -35.47 80.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.745 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 130.11 32.64 0.53 Allowed Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.119 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.44 ' CZ ' HG12 ' A' ' 34' ' ' ILE . 27.8 p90 -178.49 -176.96 0.52 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.992 0.425 . . . . 0.0 111.223 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -161.97 -171.72 28.44 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.453 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.463 ' CE1' ' CD2' ' A' ' 5' ' ' TYR . 1.7 m-85 -144.8 141.17 28.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.938 0.399 . . . . 0.0 111.075 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.6 t -130.24 150.11 34.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.932 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -111.49 109.95 20.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.93 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.4 mtp -143.6 177.68 8.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -71.22 159.27 34.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -67.07 -30.77 70.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.824 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -75.9 -31.81 59.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.908 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.4 m -74.69 -29.46 61.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.063 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.402 ' CG1' ' CD1' ' A' ' 59' ' ' ILE . 21.6 t -65.12 -37.31 79.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.276 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.2 t -74.91 -24.39 58.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.09 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.21 -42.68 10.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.663 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.82 -67.99 0.31 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.818 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.402 ' CD1' ' CG1' ' A' ' 55' ' ' VAL . 3.3 mt -54.88 -30.57 23.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.056 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.04 -59.44 5.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.366 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.15 -9.14 49.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.904 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 71.5 mt -90.09 -74.95 0.47 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.838 0.351 . . . . 0.0 111.336 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.67 152.4 12.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.134 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.57 -40.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.775 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -166.43 -178.28 4.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.873 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.0 p-10 -98.14 102.81 14.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.843 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.22 -168.83 1.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.939 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 1.5 mmt -93.46 46.93 1.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.876 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.37 37.49 6.2 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.546 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.1 tpp85 -116.14 -42.36 3.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.837 0.351 . . . . 0.0 110.92 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.98 -48.77 1.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.914 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.3 mt 59.27 163.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.999 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -94.07 47.64 1.22 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.019 0.437 . . . . 0.0 110.74 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.6 p -62.0 144.29 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.095 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.3 t -149.27 175.88 11.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.986 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.69 133.07 35.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.967 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.131 179.958 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.842 0.353 . . . . 0.0 111.137 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -94.2 -8.57 38.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.503 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.5 m120 54.1 103.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.219 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.3 mt -94.42 158.51 2.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.219 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -139.79 143.47 36.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.682 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.9 p -142.52 146.63 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.268 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -130.29 -174.37 13.67 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.322 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 t30 56.01 33.18 21.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.931 0.396 . . . . 0.0 110.994 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.2 mt -89.43 99.91 12.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.096 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.402 HG13 ' N ' ' A' ' 13' ' ' ALA . 2.7 p -63.33 176.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.642 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -41.54 -35.35 0.7 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.865 0.364 . . . . 0.0 111.419 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 p -157.26 67.47 0.52 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.571 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.402 ' N ' HG13 ' A' ' 10' ' ' VAL . . . -71.62 -65.4 0.76 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.405 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -179.12 -24.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.578 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -46.07 -57.91 4.06 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.747 0.308 . . . . 0.0 111.509 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -66.49 -13.3 60.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.817 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -90.54 -28.3 18.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.291 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.9 p -87.07 -24.49 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.754 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.7 -27.67 12.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.744 0.307 . . . . 0.0 111.171 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -33.1 70.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.764 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.4 tt -88.9 -30.85 18.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.809 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -26.04 62.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.016 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.44 -24.17 24.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.237 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -88.66 -24.38 22.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.265 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -111.47 -30.68 7.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.225 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -117.62 -17.56 5.55 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.575 -0.822 . . . . 0.0 113.067 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm 61.98 43.98 8.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.944 0.402 . . . . 0.0 110.715 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.0 p -46.36 139.54 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.459 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -89.3 -39.1 13.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.835 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -139.29 149.19 43.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.955 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.2 p -172.11 120.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.063 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -157.11 167.3 30.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.949 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.61 160.26 32.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.683 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.435 HG12 ' CE2' ' A' ' 45' ' ' PHE . 1.0 OUTLIER -94.33 170.48 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.054 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -138.77 -174.23 3.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.009 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -101.55 -178.48 3.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -120.28 31.75 6.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.67 -58.25 0.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.876 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.03 -1.08 27.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.403 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt 60.2 36.21 20.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.88 0.371 . . . . 0.0 110.883 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -112.99 152.02 44.59 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.822 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.37 135.25 53.79 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.581 2.187 . . . . 0.0 112.282 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.75 -69.18 0.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.794 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.41 37.59 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.898 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.435 ' CE2' HG12 ' A' ' 34' ' ' ILE . 38.3 p90 -179.9 152.88 0.49 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.987 0.423 . . . . 0.0 111.124 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.28 -169.99 13.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.389 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.445 ' CZ ' ' CB ' ' A' ' 77' ' ' ALA . 1.9 t80 -133.13 156.3 47.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.884 0.373 . . . . 0.0 111.057 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.1 t -149.16 130.45 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.972 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.57 116.17 30.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.02 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.5 mtm -140.63 156.21 46.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.916 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.05 151.73 18.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.971 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -77.24 95.03 4.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.931 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -174.91 -53.44 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.261 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 m -90.02 -16.15 30.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.981 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.0 t -61.09 -43.87 97.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.832 0.348 . . . . 0.0 111.277 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.6 m -56.82 -54.22 48.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.165 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -74.98 -26.47 59.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.106 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -57.61 -39.36 76.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.338 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.2 mt -90.29 -8.94 10.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.181 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.51 -48.75 10.67 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.65 -19.11 24.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.785 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 83.3 mt -89.97 -75.12 0.46 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.93 147.42 15.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.842 0.353 . . . . 0.0 111.041 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -176.6 -41.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.941 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -154.62 -177.66 6.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -103.57 97.45 7.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.16 -169.33 1.46 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 16.9 ptm -98.38 31.57 2.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.92 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.09 33.55 1.49 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.474 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.77 -54.06 2.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.786 0.327 . . . . 0.0 110.883 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 t -119.73 -49.76 2.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.889 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.8 mt 60.15 159.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.212 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.71 51.6 2.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.819 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.0 p -67.18 125.51 24.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.072 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.5 t -141.9 160.22 40.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.02 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -59.82 140.88 56.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.875 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.445 ' CB ' ' CZ ' ' A' ' 47' ' ' PHE . . . . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.095 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mtp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.845 0.355 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -99.16 175.45 5.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.959 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.401 ' HB3' ' CE2' ' A' ' 47' ' ' PHE . 22.0 m-20 -122.07 120.13 33.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.862 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 mp -111.21 132.61 59.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.122 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -107.2 142.85 36.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.904 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.98 121.01 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.99 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.429 ' HA2' ' CD1' ' A' ' 45' ' ' PHE . . . -104.79 -169.53 24.38 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.767 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 63.46 29.66 15.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.715 0.293 . . . . 0.0 110.948 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.0 mt -101.24 159.8 14.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.919 0.39 . . . . 0.0 111.124 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.404 ' CG1' ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -155.07 -166.8 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.666 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.404 ' N ' ' CG1' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -48.77 -44.95 39.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.878 0.371 . . . . 0.0 111.051 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.06 49.04 1.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.593 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.8 -76.1 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.359 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -164.59 -37.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.304 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.94 -52.96 21.81 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.798 0.332 . . . . 0.0 111.36 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -65.43 -15.96 63.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.751 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -90.59 -36.92 14.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.073 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.9 p -90.04 -22.35 6.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.669 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 pttp -50.0 -29.48 8.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.799 0.333 . . . . 0.0 111.101 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -68.22 -35.69 78.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.66 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.3 tp -87.03 -30.36 21.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.899 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.15 -24.48 54.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.116 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.2 m -82.38 -25.9 33.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.158 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -90.02 -24.48 21.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.216 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -110.43 -30.9 7.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.156 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -112.06 -22.24 5.99 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.775 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp 62.98 45.07 5.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.944 0.402 . . . . 0.0 110.901 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.0 p -54.14 153.07 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.107 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -97.26 -36.37 10.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.015 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -166.15 140.87 4.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.124 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t -124.71 119.44 56.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.732 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -123.44 163.14 21.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.024 0.44 . . . . 0.0 111.26 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 mt -141.51 161.29 38.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.397 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.456 ' CD1' ' HA3' ' A' ' 44' ' ' GLY . 2.5 pp -123.62 155.41 30.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.981 0.419 . . . . 0.0 111.29 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -94.36 -165.58 1.34 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.92 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -73.66 -8.53 56.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.332 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 66.42 29.57 9.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.896 0.379 . . . . 0.0 110.743 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -165.61 -44.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.615 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 p -97.48 -13.71 21.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.184 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.29 25.94 2.77 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.803 0.335 . . . . 0.0 110.982 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -102.53 123.62 42.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.7 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.53 107.49 1.63 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.38 2.053 . . . . 0.0 112.101 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.32 42.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.29 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.456 ' HA3' ' CD1' ' A' ' 34' ' ' ILE . . . -132.05 42.02 1.43 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.619 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.429 ' CD1' ' HA2' ' A' ' 7' ' ' GLY . 0.9 OUTLIER 73.94 161.49 0.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.851 0.358 . . . . 0.0 111.033 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.94 -173.84 13.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.582 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 48' ' ' VAL . 46.0 t80 -128.34 159.32 35.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.761 0.315 . . . . 0.0 110.919 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.451 ' N ' ' CD1' ' A' ' 47' ' ' PHE . 31.7 t -144.81 127.7 10.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.06 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -105.3 113.33 26.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.931 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 35.4 mtm -142.26 147.87 37.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.6 155.83 14.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.881 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.07 95.18 4.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.037 0.446 . . . . 0.0 110.906 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -176.36 -49.37 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.263 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.1 m -90.02 -21.73 22.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.916 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.61 -31.62 49.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.379 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.0 m -60.98 -53.93 51.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.243 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.63 -22.93 27.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.292 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -55.47 -41.48 73.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.432 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.412 HG21 ' HB3' ' A' ' 63' ' ' ASP . 3.3 mp -90.32 -21.22 6.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.911 0.386 . . . . 0.0 111.301 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.13 -55.38 25.77 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.44 -14.3 33.13 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 51.0 mt -90.05 -75.27 0.46 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.943 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.412 ' HB3' HG21 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -55.52 150.7 11.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.07 0.462 . . . . 0.0 111.406 -179.114 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 175.1 -36.62 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.715 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.39 -173.89 3.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.81 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.5 96.68 6.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.955 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.407 ' CD2' ' HB2' ' A' ' 70' ' ' ARG . 0.6 OUTLIER -121.71 169.07 11.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 24.2 mmm -80.51 65.05 5.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.953 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.69 31.02 30.92 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.607 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.407 ' HB2' ' CD2' ' A' ' 67' ' ' PHE . 1.5 tmm_? -111.0 -30.1 7.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.793 0.33 . . . . 0.0 111.081 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 t -153.02 -51.09 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.942 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.1 mt 64.65 160.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.033 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.4 48.68 1.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.875 0.369 . . . . 0.0 110.913 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.0 p -72.17 114.58 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.182 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.6 t -135.25 153.85 51.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.042 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -57.13 131.62 50.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.312 -0.851 . . . . 0.0 111.077 179.873 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ptp . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.822 0.344 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.94 -6.11 22.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.496 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.5 t30 59.03 114.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.055 0.455 . . . . 0.0 110.993 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.7 mt -103.31 127.84 56.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.117 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -110.94 126.97 55.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.844 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.1 p -135.03 154.02 35.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.122 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.7 -166.11 12.01 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.394 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 58.98 31.43 21.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.757 0.313 . . . . 0.0 110.787 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.4 mt -93.9 -179.39 4.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.953 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.412 ' CG1' ' N ' ' A' ' 11' ' ' TYR . 0.6 OUTLIER -170.32 -165.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.697 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.412 ' N ' ' CG1' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -46.3 -40.55 11.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.95 0.405 . . . . 0.0 111.269 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -163.72 52.66 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.67 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.24 -46.89 75.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.307 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -177.65 -32.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.416 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.7 p -47.55 -55.09 9.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.779 0.323 . . . . 0.0 111.429 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.01 -12.78 61.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.949 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -90.77 -39.06 12.61 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.204 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.416 HG23 ' CD2' ' A' ' 22' ' ' PHE . 12.3 p -77.2 -27.93 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.865 -179.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.9 ptmm? -53.36 -28.52 29.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.779 0.323 . . . . 0.0 110.992 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -70.94 -35.36 72.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.576 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.7 tp -90.03 -27.27 19.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.721 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.416 ' CD2' HG23 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -54.87 -28.09 47.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.938 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.03 -24.27 47.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.97 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -90.12 -34.27 15.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.773 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -60.82 -41.51 95.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.746 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.07 27.27 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.577 -0.82 . . . . 0.0 113.045 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 57.01 110.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.909 0.385 . . . . 0.0 111.193 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.8 p -96.37 131.33 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -59.18 -43.6 92.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.971 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -171.46 166.48 6.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.953 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.2 p -146.59 123.4 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.03 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -132.53 174.48 10.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.121 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.8 158.98 43.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.757 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.45 ' CD1' ' CE1' ' A' ' 45' ' ' PHE . 2.5 pp -85.18 -178.91 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.14 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -158.17 168.91 25.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -86.71 152.15 22.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.951 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -96.94 41.36 1.11 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.878 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -162.56 -44.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.799 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.22 -11.12 15.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.262 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.71 30.65 16.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.821 0.343 . . . . 0.0 110.85 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.401 ' HG3' ' N ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -107.76 141.76 23.77 Favored Pre-proline 0 N--CA 1.451 -0.395 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.118 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.401 ' N ' ' HG3' ' A' ' 41' ' ' LYS . 37.4 Cg_endo -65.66 115.82 3.6 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.522 2.148 . . . . 0.0 112.332 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -56.69 -67.77 0.28 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.018 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.23 52.61 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.817 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.45 ' CE1' ' CD1' ' A' ' 34' ' ' ILE . 29.4 p90 -177.94 142.5 0.29 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.917 0.389 . . . . 0.0 111.061 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -134.86 -167.07 11.31 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.474 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.99 150.08 40.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.79 0.329 . . . . 0.0 110.934 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.6 t -133.2 152.31 35.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.003 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -117.45 105.14 11.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.929 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -140.72 144.26 35.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.848 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.1 pm0 -55.66 146.53 20.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.089 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -69.32 93.39 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.948 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -172.81 -49.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.431 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.23 -19.91 23.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.952 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.0 t -58.99 -48.24 87.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.845 0.355 . . . . 0.0 111.229 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 t -62.58 -23.73 67.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.035 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -90.2 -35.03 15.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.598 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.78 -65.61 0.66 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.751 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.9 mt -58.22 -29.56 37.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.005 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.32 -56.87 16.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.711 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -90.23 -25.98 20.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.708 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 84.2 mt -76.02 -72.14 0.34 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.763 0.316 . . . . 0.0 111.312 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.42 140.6 27.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.269 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -178.19 -39.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.956 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.57 -169.73 1.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.849 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -106.68 119.92 40.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -147.51 -175.95 5.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.82 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.67 49.41 1.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.017 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.59 35.18 5.26 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.627 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.97 -30.44 7.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.7 0.286 . . . . 0.0 111.001 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.2 t -155.27 -52.03 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.075 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.9 mt 60.76 159.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.031 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.11 53.88 2.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.841 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.3 p -73.92 159.32 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.05 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.1 t -161.15 179.05 8.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.897 0.38 . . . . 0.0 110.957 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.82 108.76 20.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.962 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.184 -0.912 . . . . 0.0 111.049 179.998 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.861 0.362 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.07 171.23 9.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.029 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -113.2 166.32 11.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.0 mp -132.59 125.32 52.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.033 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -99.05 124.05 43.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.012 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.5 p -131.14 142.6 43.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.961 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -136.59 179.81 17.52 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.535 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 62.89 30.6 16.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.785 0.326 . . . . 0.0 110.96 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.428 ' C ' ' CD1' ' A' ' 9' ' ' LEU . 0.8 OUTLIER -123.09 -177.51 3.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.045 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.59 -169.57 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.767 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.42 ' CD1' ' HG2' ' A' ' 42' ' ' PRO . 4.8 t80 -57.05 -52.25 66.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.806 0.336 . . . . 0.0 110.949 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 t -126.45 54.04 1.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.975 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.71 -54.93 3.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.111 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.65 -41.96 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.079 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.3 t -54.46 -48.59 71.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.058 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -69.36 -14.36 62.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.757 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -90.45 -37.52 13.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.084 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 p -83.7 -28.2 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.583 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -53.3 -34.38 57.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.789 0.328 . . . . 0.0 110.983 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.07 -38.36 90.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.752 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.9 tt -86.28 -28.79 23.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.79 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.27 -26.16 62.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.974 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.62 -26.83 55.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.077 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -90.06 -12.8 37.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.489 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -109.04 -36.82 5.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.645 0.26 . . . . 0.0 111.24 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.8 10.27 4.55 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.066 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.6 pttp 43.07 54.78 4.78 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.837 0.351 . . . . 0.0 111.454 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.9 p -47.11 131.56 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.368 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -60.19 -57.43 12.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.894 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -156.65 165.21 36.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.002 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.63 114.49 4.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.005 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -119.02 151.94 37.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.024 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mt -130.76 149.36 52.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.755 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.447 ' CG2' ' CE2' ' A' ' 45' ' ' PHE . 2.7 pp -72.69 -175.14 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.983 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -149.14 -176.2 5.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.999 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -80.83 -168.52 1.81 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.826 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -120.61 35.97 4.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.817 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -163.97 -59.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.964 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.37 -4.94 28.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.387 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.93 35.98 13.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.843 0.354 . . . . 0.0 110.901 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -77.25 116.28 56.27 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.42 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 32.0 Cg_exo -61.27 114.77 2.35 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.54 2.16 . . . . 0.0 112.311 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.411 ' O ' ' CD ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -177.61 137.03 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.976 0.417 . . . . 0.0 110.971 179.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.32 -72.09 0.48 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.633 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.447 ' CE2' ' CG2' ' A' ' 34' ' ' ILE . 1.7 p90 -152.25 -177.8 6.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.764 0.316 . . . . 0.0 110.851 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -154.59 -170.56 20.51 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.587 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.36 135.25 13.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.841 0.353 . . . . 0.0 110.92 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.8 t -123.98 156.7 31.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.015 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -119.74 112.18 18.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.871 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 21.9 mtp -144.96 168.97 18.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.956 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -71.85 160.53 32.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.824 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -82.04 59.38 4.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.76 -46.67 0.45 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.739 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.02 -20.08 23.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.041 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.9 t -64.7 -41.52 92.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.819 0.343 . . . . 0.0 111.166 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.4 m -57.71 -47.69 81.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.162 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -82.8 -28.32 30.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.118 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -58.4 -41.22 84.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.329 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.8 mp -90.32 -24.4 5.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.96 0.41 . . . . 0.0 111.166 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.37 -52.16 62.88 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.45 -19.1 24.27 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 75.8 mt -90.02 -71.21 0.63 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -46.37 136.0 7.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.559 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -177.18 -48.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.784 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -163.94 -175.15 3.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.968 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -91.0 113.62 25.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.941 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -130.25 -171.69 2.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.09 51.53 2.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.88 38.07 10.85 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.465 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.44 -51.53 2.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.348 . . . . 0.0 110.987 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.79 -53.89 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.441 HD11 HG21 ' A' ' 72' ' ' ILE . 5.0 mt 57.73 166.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.913 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.1 48.84 1.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.902 0.382 . . . . 0.0 110.836 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.1 p -66.89 156.03 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.162 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.5 t -166.66 157.94 12.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.65 127.93 34.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.249 -0.882 . . . . 0.0 111.093 179.985 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.885 0.374 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -88.44 175.19 7.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -118.55 129.88 55.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.868 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.6 mt -97.03 152.93 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.164 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -130.18 103.58 6.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.812 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.6 p -113.56 116.97 54.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.164 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.1 -175.11 30.38 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.336 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.3 26.67 10.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.673 0.273 . . . . 0.0 111.323 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.433 ' C ' ' CD1' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -102.76 -171.91 2.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.92 0.39 . . . . 0.0 111.17 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 13' ' ' ALA . 6.7 p -164.49 170.55 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.469 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -40.05 -31.64 0.13 Allowed 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 111.971 0.359 . . . . 0.0 111.971 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.04 50.55 1.33 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.798 0.332 . . . . 0.0 111.197 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.468 ' N ' HG13 ' A' ' 10' ' ' VAL . . . -78.58 -61.16 2.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.123 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 179.47 -36.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.123 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.93 -50.53 68.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.01 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -71.72 -12.66 61.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.669 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -90.71 -28.0 18.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.147 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.435 HG22 ' CD1' ' A' ' 22' ' ' PHE . 14.7 p -90.09 -24.2 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.833 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.3 pttp -48.95 -32.72 9.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.761 0.315 . . . . 0.0 111.207 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -66.1 -33.77 76.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.967 0.413 . . . . 0.0 110.479 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.2 tt -88.87 -27.12 21.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.662 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.435 ' CD1' HG22 ' A' ' 18' ' ' VAL . 2.0 m-30 -53.82 -24.86 16.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.049 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.6 m -61.41 -37.94 85.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.831 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.408 ' HG3' ' N ' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -90.35 -29.1 18.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.941 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.408 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -69.94 -40.4 75.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.936 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.57 21.26 0.16 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.434 -0.888 . . . . 0.0 113.264 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.2 tttm 56.17 111.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.959 0.409 . . . . 0.0 111.316 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.8 p -105.37 121.54 57.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.013 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -67.44 -53.17 31.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.976 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -158.35 159.95 36.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.977 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.3 t -127.93 130.45 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.973 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.65 145.97 51.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.028 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 34.6 mt -141.18 146.55 37.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.728 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.6 pp -82.22 175.65 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.161 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -134.01 175.69 9.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.003 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -75.2 166.39 23.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 mpp_? -105.24 36.61 2.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.911 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -174.18 -41.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.966 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.6 -10.54 19.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.332 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt 61.76 28.97 17.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.782 0.325 . . . . 0.0 110.834 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -105.95 137.05 19.24 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.706 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.25 109.46 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.43 2.087 . . . . 0.0 112.407 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.01 109.68 2.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.993 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 148.54 -63.92 0.41 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.726 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -177.25 170.72 2.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.875 0.369 . . . . 0.0 111.05 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -125.34 179.87 16.01 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.543 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -146.36 129.53 16.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.348 . . . . 0.0 110.917 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.3 t -122.46 148.67 26.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.045 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -117.69 104.76 11.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.927 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 32.0 mtp -138.09 159.73 41.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.7 158.51 34.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.722 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -68.24 93.31 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.096 0.474 . . . . 0.0 110.963 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -169.53 -60.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.999 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 t -90.3 -15.56 30.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.84 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.5 t -68.68 -49.0 68.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.843 0.354 . . . . 0.0 111.173 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.12 -22.36 63.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.157 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -90.28 -37.21 14.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 110.602 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.75 -65.05 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.86 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.6 mp -58.01 -30.63 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.031 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.43 -55.9 28.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.678 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -90.48 -28.07 18.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.684 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.1 mt -74.87 -72.26 0.3 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.782 0.325 . . . . 0.0 111.398 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.25 138.93 30.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.16 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -177.38 -46.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.891 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -158.22 -178.69 7.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.948 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -92.65 106.62 18.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.873 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.67 -164.87 1.0 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.743 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 3.1 mtm -96.86 34.93 1.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.784 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.0 31.03 4.57 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.513 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -112.45 -62.28 1.6 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.862 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.7 -50.14 3.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.843 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.0 mt 56.37 167.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.15 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.4 ttm105 -95.01 45.08 1.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.915 0.388 . . . . 0.0 110.637 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.57 159.29 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.236 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.1 t -157.8 -176.82 6.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.63 44.66 1.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.93 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.141 179.96 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mtm . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.839 0.352 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -107.81 172.52 6.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -111.18 129.68 55.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.2 mt -98.12 143.46 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.093 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.493 ' CE1' ' CD2' ' A' ' 45' ' ' PHE . 41.5 t80 -116.97 123.32 46.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.962 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.0 p -125.92 121.32 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.971 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -107.21 76.8 0.23 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.696 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -178.04 54.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.85 0.357 . . . . 0.0 110.758 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.7 mt -128.73 -168.82 1.97 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.179 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -178.55 -168.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.388 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -47.02 -41.76 17.03 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.859 0.361 . . . . 0.0 111.1 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -167.66 76.43 0.15 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.658 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -97.62 -63.3 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.547 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -163.61 -19.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.989 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.6 t -47.56 -59.16 3.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.821 0.343 . . . . 0.0 111.511 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -67.42 -11.73 58.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.88 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -90.36 -32.61 16.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.062 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.6 p -87.23 -25.96 6.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.748 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -55.62 -29.75 59.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.781 0.324 . . . . 0.0 111.036 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -67.71 -35.96 79.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.757 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.8 tt -85.01 -30.34 24.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.815 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -17.79 65.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.107 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.7 -24.28 41.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.257 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -88.3 -25.97 22.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.225 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -107.24 -32.37 7.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.231 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -114.46 -25.27 4.1 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.806 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.99 53.47 2.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.039 0.447 . . . . 0.0 110.748 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.4 p -57.34 143.63 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.195 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -100.92 -40.12 7.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.875 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -138.59 126.13 21.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.906 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 p -146.47 131.73 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.087 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.4 170.08 7.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 23.2 mt -96.63 154.29 17.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.816 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.429 HG12 ' CE2' ' A' ' 45' ' ' PHE . 2.6 pp -92.82 175.74 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.095 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -144.85 171.89 13.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.44 160.32 24.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.932 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.39 30.82 4.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.963 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -144.46 -57.41 0.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.43 -5.5 25.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.276 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 63.4 34.2 13.14 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.968 0.413 . . . . 0.0 110.934 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -110.72 143.17 27.67 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.831 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.47 133.66 54.3 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.532 2.155 . . . . 0.0 112.257 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 tptp -79.51 -69.02 0.61 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.848 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.99 45.07 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.532 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.493 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 27.0 p90 -177.75 169.31 2.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.904 0.383 . . . . 0.0 110.947 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.89 178.93 19.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.481 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -128.73 136.77 51.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.756 0.312 . . . . 0.0 110.915 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.8 t -127.74 141.62 45.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.093 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.26 113.83 25.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.7 mtp -145.96 -179.78 6.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.823 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -61.15 152.02 29.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.834 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -69.12 -32.6 72.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.016 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -77.13 -29.73 54.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.039 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.6 m -73.86 -32.42 63.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.015 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t -56.74 -49.18 79.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.309 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 m -53.16 -62.49 1.62 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.07 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -63.02 -29.65 70.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.997 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -66.57 -40.09 88.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.413 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.443 HG21 ' HB3' ' A' ' 63' ' ' ASP . 8.0 mt -90.12 -24.08 5.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.978 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.99 -52.8 63.47 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -90.47 -23.48 20.97 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.518 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 78.6 mt -85.39 -75.01 0.38 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.717 0.294 . . . . 0.0 111.702 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.443 ' HB3' HG21 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -52.46 134.04 34.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.875 0.369 . . . . 0.0 111.254 -179.439 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 179.1 -38.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.844 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.61 -165.8 2.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.768 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -119.92 96.95 5.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.921 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.2 -165.54 1.03 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.831 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 4.3 mmt -97.1 36.19 1.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.052 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.37 28.12 3.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.576 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -110.76 -31.15 7.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.815 0.341 . . . . 0.0 110.968 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.82 -56.38 0.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.949 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.0 mt 59.97 159.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.052 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.7 ttt85 -89.29 53.64 2.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.776 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.1 p -74.57 156.81 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.21 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.0 t -178.12 147.89 0.47 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.806 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -61.7 128.72 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.3 -0.857 . . . . 0.0 111.156 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpp? . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.813 0.339 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.4 mmt-85 -118.62 151.99 36.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.854 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.414 ' HB3' ' CE1' ' A' ' 47' ' ' PHE . 26.4 m-20 -89.72 115.74 27.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.5 mt -87.27 127.01 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.134 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -99.62 123.05 43.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.837 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.0 p -121.65 127.21 75.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.096 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.423 ' HA2' ' CD1' ' A' ' 45' ' ' PHE . . . -105.88 -171.98 23.51 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.414 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 59.48 30.49 20.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.809 0.337 . . . . 0.0 110.955 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.7 mt -82.83 166.72 18.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.982 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -162.23 -174.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.796 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.43 ' CZ ' ' HD2' ' A' ' 42' ' ' PRO . 6.9 m-85 -46.73 -52.99 12.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.95 0.405 . . . . 0.0 111.159 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -154.07 75.05 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.61 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.95 -56.72 2.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.429 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.5 m -165.5 -34.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.465 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.27 -54.4 11.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.715 0.293 . . . . 0.0 111.451 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -68.13 -13.08 61.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.96 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -90.62 -43.4 10.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.136 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.416 HG22 ' CD1' ' A' ' 22' ' ' PHE . 12.3 p -79.23 -30.79 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.683 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -52.43 -27.53 16.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.801 0.334 . . . . 0.0 111.15 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -71.95 -37.74 69.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.811 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.1 tp -88.38 -28.44 20.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.416 ' CD1' HG22 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -57.89 -21.67 44.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.163 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 85.8 p -84.57 -27.62 27.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.093 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -89.98 -34.2 16.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.289 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -105.21 -30.23 9.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.271 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.4 -14.95 22.66 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.895 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.75 35.01 24.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.85 0.357 . . . . 0.0 110.86 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.0 p -50.69 143.31 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.336 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -91.26 -34.46 14.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.927 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -167.79 158.18 10.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.918 0.39 . . . . 0.0 111.193 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t -143.48 150.34 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.898 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.0 ttpt -169.64 151.76 4.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.933 0.397 . . . . 0.0 111.288 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.95 -177.27 4.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.329 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.441 ' CD1' ' HA3' ' A' ' 44' ' ' GLY . 1.8 pp -129.57 179.83 3.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.821 0.343 . . . . 0.0 111.189 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.71 -168.59 2.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.952 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.77 -20.67 36.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.513 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.29 26.44 4.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.922 0.392 . . . . 0.0 110.81 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -156.44 -46.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.414 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.07 0.54 25.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.96 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.9 mttm 63.98 38.95 8.34 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.93 0.395 . . . . 0.0 111.044 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.5 mtmm -100.96 100.79 13.76 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.573 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.43 ' HD2' ' CZ ' ' A' ' 11' ' ' TYR . 33.3 Cg_endo -64.8 107.1 0.84 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.354 2.036 . . . . 0.0 112.216 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.5 37.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.195 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.441 ' HA3' ' CD1' ' A' ' 34' ' ' ILE . . . -129.25 32.64 3.2 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.473 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.423 ' CD1' ' HA2' ' A' ' 7' ' ' GLY . 0.5 OUTLIER 72.41 166.05 0.3 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.888 0.375 . . . . 0.0 110.905 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.31 -162.36 9.08 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.482 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.414 ' CE1' ' HB3' ' A' ' 3' ' ' ASN . 0.3 OUTLIER -139.81 160.91 38.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 0.0 111.039 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.7 t -147.91 142.22 19.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.955 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -107.75 114.58 28.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 21.4 mtm -145.54 -178.12 5.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.85 150.65 37.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -61.18 -36.96 81.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -63.47 -31.05 72.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.016 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.41 -35.42 21.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.987 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.7 t -57.69 -30.82 38.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.28 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.39 -23.43 27.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.269 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -90.21 -41.45 11.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.888 0.375 . . . . 0.0 110.84 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -58.34 -66.43 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.949 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.6 mt -58.07 -21.81 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.277 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.66 -54.3 17.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.584 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.19 -29.97 17.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.479 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 92.9 mt -73.2 -74.24 0.18 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.241 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.419 ' CB ' ' CG1' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -57.0 135.86 56.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.055 -179.78 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 t30 179.51 -38.78 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.789 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -159.49 -177.51 6.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.788 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.21 111.4 23.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.988 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -131.71 -171.07 2.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.947 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 21.5 mtp -93.12 45.68 1.18 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.98 39.5 3.8 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.516 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.08 -39.68 2.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.697 0.284 . . . . 0.0 111.075 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.37 -48.86 0.72 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.244 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.9 mt 55.26 174.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.637 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.78 66.16 0.77 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.969 0.414 . . . . 0.0 111.022 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.419 ' CG1' ' CB ' ' A' ' 63' ' ' ASP . 14.7 p -83.25 156.98 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.0 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.4 t -167.31 142.12 3.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.964 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -69.61 134.12 48.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.949 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.044 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mtm . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.783 0.325 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -96.48 167.0 11.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.938 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -115.68 106.42 13.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.817 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.6 mt -76.76 128.76 37.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.201 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -108.54 122.21 46.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.749 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 p -132.49 145.92 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.228 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.34 -165.33 11.78 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.408 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 55.04 34.62 22.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.76 0.314 . . . . 0.0 111.039 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 28.6 mt -106.68 128.49 54.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.968 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.71 -168.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.797 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.424 ' CE2' ' CD ' ' A' ' 42' ' ' PRO . 0.7 OUTLIER -49.7 -47.47 50.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.788 0.328 . . . . 0.0 111.04 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -145.76 58.79 1.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.706 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.31 -52.87 63.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.266 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 176.03 -32.21 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.102 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.49 -54.15 19.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.323 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -64.83 -15.4 61.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.898 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -90.49 -34.09 15.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.201 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 p -90.12 -21.79 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.858 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.86 -28.43 3.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.748 0.308 . . . . 0.0 111.142 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -71.77 -33.25 68.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.748 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.8 tt -88.9 -32.13 17.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.809 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.35 -23.46 64.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.988 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.6 m -80.91 -23.06 39.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.076 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.06 -37.52 14.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.111 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -101.7 -31.16 10.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.093 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.22 -24.79 9.32 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.655 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.0 tttt 63.88 36.99 9.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 0.0 110.899 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.8 p -61.01 131.98 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.034 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -74.33 -41.92 60.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -150.85 148.32 28.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.0 p -162.95 130.24 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.975 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.99 161.46 4.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.884 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mt -100.83 173.75 6.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.921 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.415 HG12 ' CE2' ' A' ' 45' ' ' PHE . 1.4 pp -112.32 161.26 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.156 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.415 ' CD2' ' HB3' ' A' ' 42' ' ' PRO . 12.4 m-85 -145.34 -174.32 4.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.18 132.0 44.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.97 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -92.14 50.71 1.68 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.791 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -171.65 -42.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.51 -20.52 18.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.08 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.8 mmtp 67.78 44.68 1.56 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.914 0.388 . . . . 0.0 110.934 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -136.56 141.81 36.89 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.924 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.424 ' CD ' ' CE2' ' A' ' 11' ' ' TYR . 66.4 Cg_endo -73.88 134.1 19.36 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.52 2.146 . . . . 0.0 112.268 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.9 mmmt -63.8 -66.83 0.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.847 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.06 44.65 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.64 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.415 ' CE2' HG12 ' A' ' 34' ' ' ILE . 33.2 p90 -177.75 154.47 0.94 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.802 0.334 . . . . 0.0 110.986 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.12 -164.37 9.88 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.451 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -146.15 137.48 24.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.819 0.342 . . . . 0.0 110.908 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.7 t -122.52 111.89 32.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.998 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.37 103.86 10.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.957 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.6 mtm -142.81 152.96 42.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.74 178.86 0.55 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.89 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.72 -159.0 0.08 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.45 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 66.05 -71.58 0.09 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.16 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.3 m -61.29 -30.99 70.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.039 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.4 t -63.73 -44.78 98.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.181 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.14 -25.4 66.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.177 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -90.16 -38.08 13.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.931 0.396 . . . . 0.0 110.727 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -58.41 -64.51 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.895 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.5 mt -58.13 -26.65 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.204 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.78 -53.91 43.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.713 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -90.33 -33.98 15.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.886 0.374 . . . . 0.0 111.428 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 83.6 mt -72.01 -70.79 0.31 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.38 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.414 ' CB ' ' CG1' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -54.91 134.59 48.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.18 -179.583 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -179.98 -67.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.904 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.58 -174.02 2.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -103.86 105.29 15.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.043 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -123.22 -174.75 3.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.813 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 8.5 ptt? -96.02 36.83 1.27 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.991 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.28 36.76 1.17 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.55 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.38 -40.42 2.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.727 0.299 . . . . 0.0 110.976 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.02 -60.99 0.8 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.859 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.9 mt 59.76 159.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.012 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.88 58.69 4.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.926 0.394 . . . . 0.0 110.748 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.414 ' CG1' ' CB ' ' A' ' 63' ' ' ASP . 13.8 p -75.37 158.11 5.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.185 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.9 t -174.15 153.94 2.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.803 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -76.54 124.02 26.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.022 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.86 0.362 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -89.02 175.28 7.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.952 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.409 ' HB3' ' CE2' ' A' ' 47' ' ' PHE . 32.3 m-20 -121.95 129.49 52.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.865 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.6 mt -100.57 146.53 9.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.158 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -125.52 116.36 21.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.899 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 p -120.84 134.18 65.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.084 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.99 -168.64 14.49 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.429 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 59.99 33.23 21.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.844 0.354 . . . . 0.0 110.875 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.401 ' CD1' ' CD2' ' A' ' 33' ' ' LEU . 53.7 mt -87.67 136.39 32.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.4 p -105.89 179.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.778 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -46.43 -53.37 11.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.871 0.367 . . . . 0.0 111.138 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.43 68.11 1.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.569 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.38 -76.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.381 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.49 -23.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.867 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.7 p -47.29 -58.16 4.43 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.728 0.299 . . . . 0.0 111.459 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.24 -12.83 61.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.832 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -90.52 -29.86 17.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.152 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.419 HG23 ' CD1' ' A' ' 22' ' ' PHE . 12.3 p -87.5 -25.48 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.75 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.72 -26.84 6.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.74 0.305 . . . . 0.0 111.22 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -75.0 -34.64 61.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.8 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.5 tp -89.58 -30.18 18.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.995 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.419 ' CD1' HG23 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -58.08 -21.83 47.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.083 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.3 p -82.56 -24.38 34.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.19 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -85.44 -26.48 26.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.222 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.67 -29.27 7.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.256 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.5 -26.78 3.83 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.712 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.0 tttt 64.05 51.1 2.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.369 . . . . 0.0 110.837 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.3 p -54.76 135.76 17.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.235 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -90.96 -42.47 10.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.938 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -138.82 124.92 20.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.9 p -136.15 121.46 28.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -138.4 178.83 6.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.011 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.401 ' CD2' ' CD1' ' A' ' 9' ' ' LEU . 7.4 mt -145.43 173.8 11.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 pp -110.31 179.0 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.144 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -121.61 173.22 7.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.037 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.73 -11.06 60.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.349 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.97 33.2 5.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.948 0.404 . . . . 0.0 110.848 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -165.34 -43.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.856 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.59 -1.51 16.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.346 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.15 33.03 14.78 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.885 0.374 . . . . 0.0 110.856 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.07 148.13 38.78 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.802 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.67 113.19 2.65 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.52 2.147 . . . . 0.0 112.231 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.2 109.19 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.52 -71.58 0.3 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.541 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -165.55 179.07 6.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.351 . . . . 0.0 110.946 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.17 -175.78 16.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.548 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.409 ' CE2' ' HB3' ' A' ' 3' ' ' ASN . 1.2 t80 -140.68 155.09 46.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.801 0.334 . . . . 0.0 110.926 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.1 t -151.36 131.36 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.08 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.88 116.46 31.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.419 ' HE3' ' CD2' ' A' ' 22' ' ' PHE . 4.0 mtt -142.29 168.24 20.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.963 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.0 179.75 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -96.2 35.52 1.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.996 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -123.86 -41.1 2.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.923 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.9 p -87.79 -24.77 23.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.171 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.7 t -65.38 -28.79 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.319 . . . . 0.0 111.319 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.4 m -65.4 -47.33 76.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.111 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -90.24 -25.0 20.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.226 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -50.42 -45.27 55.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.536 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.407 ' O ' HG23 ' A' ' 59' ' ' ILE . 3.9 mp -90.44 -28.31 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.078 0.466 . . . . 0.0 110.929 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.32 -58.84 5.43 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -90.36 -12.46 37.57 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 33.5 mt -90.04 -75.11 0.46 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.888 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.402 ' HB3' ' CG2' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -46.69 132.62 11.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.942 0.401 . . . . 0.0 111.632 -179.185 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 179.96 -67.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.742 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.17 -167.1 1.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.72 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -107.64 111.34 23.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.885 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.05 -167.17 1.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.951 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 3.5 mmt -86.9 56.19 3.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.69 32.67 40.51 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.503 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.7 -29.23 8.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.801 0.334 . . . . 0.0 110.966 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.94 -65.21 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.98 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.2 mt 59.74 159.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.979 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.32 78.58 9.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.698 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.0 p -101.71 153.84 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.206 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.4 t -169.1 161.65 10.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.958 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.45 130.83 47.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.089 179.979 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 120.883 0.373 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.29 169.35 8.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.838 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -104.13 133.55 48.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.6 mt -98.99 111.33 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.099 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -90.54 119.39 30.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.828 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.7 p -131.86 139.05 51.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.044 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.64 -163.6 14.45 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.399 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 55.67 36.26 26.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.788 0.328 . . . . 0.0 110.981 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.1 mt -100.73 109.81 21.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.066 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -78.33 -175.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.653 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -46.79 -48.96 20.57 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.894 0.378 . . . . 0.0 111.098 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -142.3 62.01 1.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.652 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.46 -70.85 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.424 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 175.23 -28.43 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.34 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 26.8 t -48.33 -55.83 9.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.77 0.319 . . . . 0.0 111.345 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.86 -14.7 60.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.912 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -90.48 -41.12 11.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.04 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.7 p -76.57 -14.21 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.759 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -51.77 -40.59 60.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.773 0.32 . . . . 0.0 111.193 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -61.06 -33.25 73.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.818 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.4 tt -88.65 -28.65 20.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.853 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.47 -26.37 61.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.019 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.6 t -73.12 -34.57 66.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.923 0.392 . . . . 0.0 110.867 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -90.15 -4.98 56.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.245 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -114.47 -33.86 5.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.732 0.301 . . . . 0.0 111.238 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.0 -2.46 6.08 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.293 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? 59.63 40.85 19.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.944 0.402 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.6 p -57.52 139.45 17.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.207 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -75.78 -39.09 57.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.933 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -168.83 154.9 6.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.007 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.7 t -138.72 118.79 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.983 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.53 132.27 17.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.108 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.405 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -106.98 174.53 5.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.558 179.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.449 ' CD1' ' CZ ' ' A' ' 45' ' ' PHE . 2.1 pp -105.19 152.12 7.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.263 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 2.7 m-85 -117.73 -173.07 2.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.962 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.1 -168.66 1.9 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.864 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.7 ttt-85 -127.65 36.27 4.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -157.02 -54.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.72 -2.14 26.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.379 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.3 mttm 60.84 36.97 18.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.815 0.341 . . . . 0.0 110.925 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -105.64 141.29 22.34 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.903 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.19 118.28 4.67 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.479 2.119 . . . . 0.0 112.276 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -58.35 -69.11 0.2 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.839 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 173.9 35.11 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.562 -0.828 . . . . 0.0 113.012 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.449 ' CZ ' ' CD1' ' A' ' 34' ' ' ILE . 28.4 p90 -178.5 155.82 0.88 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.077 0.465 . . . . 0.0 111.333 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -141.09 -166.18 10.62 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.388 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -144.08 143.74 31.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.88 0.371 . . . . 0.0 110.967 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.3 t -134.26 138.9 49.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.055 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.33 107.87 19.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.908 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 3.6 mtt -135.78 156.36 48.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.915 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -81.29 154.94 26.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.974 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -51.06 -29.58 13.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.198 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -71.24 -35.09 71.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.95 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.9 p -87.07 -43.65 12.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.938 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.2 t -58.21 -31.11 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.145 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.51 -51.32 70.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.098 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -88.64 -23.51 23.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.157 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -55.04 -41.48 71.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.408 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.434 HG21 ' HB3' ' A' ' 63' ' ' ASP . 4.5 mt -90.25 -24.81 5.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.067 0.46 . . . . 0.0 110.917 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.49 -55.66 30.97 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.29 -19.71 23.78 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 64.9 mt -85.4 -75.15 0.38 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.763 0.316 . . . . 0.0 111.65 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.434 ' HB3' HG21 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -55.97 137.17 51.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.147 -179.522 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 178.78 -61.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.813 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.89 -173.6 3.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -105.78 118.58 36.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.419 ' CD2' ' HD3' ' A' ' 70' ' ' ARG . 0.2 OUTLIER -135.2 -165.52 1.69 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.83 32.27 2.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.026 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.57 33.29 2.11 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.585 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.419 ' HD3' ' CD2' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -113.52 -34.48 5.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 0.0 110.934 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.92 -61.55 0.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.843 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.1 mp 59.94 162.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.908 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.5 mmm-85 -87.75 75.78 8.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.84 156.12 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.9 t -167.23 161.26 14.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.961 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -81.76 107.56 14.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.907 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.167 -0.921 . . . . 0.0 111.089 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.825 0.345 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -135.77 173.32 11.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 -102.61 139.44 38.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.935 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.1 mt -109.8 136.95 44.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.044 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -114.73 122.76 47.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.913 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.3 p -129.06 134.19 64.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.142 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -118.47 -168.3 14.22 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.468 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 59.64 33.9 22.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.858 0.361 . . . . 0.0 110.957 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.4 mt -98.74 -175.03 2.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.909 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.405 ' CG1' ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -167.97 -167.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.733 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.405 ' N ' ' CG1' ' A' ' 10' ' ' VAL . 77.4 m-85 -47.58 -46.76 28.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.798 0.333 . . . . 0.0 111.195 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.44 53.26 0.79 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.824 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.14 -55.32 22.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.184 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 177.07 -33.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.081 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.39 -52.39 53.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.803 0.335 . . . . 0.0 111.103 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -66.62 -15.52 63.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.772 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -90.55 -29.81 17.63 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.308 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.4 p -89.74 -20.94 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.811 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.3 pttp -57.29 -30.47 64.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.693 0.282 . . . . 0.0 111.12 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -72.77 -35.98 67.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.885 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.4 tp -87.56 -27.76 22.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.449 ' CD1' ' CE ' ' A' ' 50' ' ' MET . 0.1 OUTLIER -57.06 -21.96 35.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.211 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 t -83.25 -21.12 33.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.22 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -89.17 -43.65 10.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.125 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -100.05 -29.86 12.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.148 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.34 -21.96 20.82 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.597 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.66 31.69 16.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.911 0.386 . . . . 0.0 110.918 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.0 p -55.2 141.87 10.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.167 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -84.07 -42.63 15.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.62 160.36 40.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 p -149.09 151.15 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.928 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.21 131.92 0.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.088 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.28 -174.31 2.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.603 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.432 HG12 ' CZ ' ' A' ' 45' ' ' PHE . 1.3 pp -107.27 167.71 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.288 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -147.34 157.66 43.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.01 154.25 23.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.872 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -94.71 46.52 1.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -176.52 -40.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.801 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.71 -18.7 16.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.084 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.49 34.84 12.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.871 0.367 . . . . 0.0 110.911 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -113.39 142.13 27.01 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.782 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.24 117.58 4.07 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.443 2.095 . . . . 0.0 112.297 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -60.63 -70.11 0.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.762 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 176.22 35.55 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.737 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.432 ' CZ ' HG12 ' A' ' 34' ' ' ILE . 28.2 p90 -178.66 172.82 1.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.901 0.382 . . . . 0.0 111.082 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -162.58 -164.31 17.27 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.418 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -138.3 164.3 29.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.915 0.388 . . . . 0.0 111.05 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.7 t -149.91 151.55 12.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.926 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.31 110.92 21.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.904 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.449 ' CE ' ' CD1' ' A' ' 22' ' ' PHE . 18.1 mtp -147.3 -176.64 5.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -86.23 148.44 25.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.902 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -57.75 -35.1 70.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.062 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.22 -44.46 92.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.914 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.4 m -77.1 -32.1 56.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.906 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.17 -36.11 71.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.189 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.4 m -60.0 -43.48 95.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.189 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -90.0 -27.82 19.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.283 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -56.88 -41.83 78.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.396 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.421 ' CG2' ' HB3' ' A' ' 63' ' ' ASP . 2.7 mp -90.22 -27.35 5.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.041 0.448 . . . . 0.0 110.966 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.56 -58.35 7.07 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -90.35 -13.0 36.01 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 41.3 mt -89.99 -75.18 0.46 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.775 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.421 ' HB3' ' CG2' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -49.65 129.88 20.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.521 -179.324 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -176.98 -43.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.914 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.39 -175.13 4.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -106.89 99.8 9.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.962 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.69 -168.95 1.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.899 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.38 52.25 2.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.959 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.63 27.93 20.64 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.579 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 ttp180 -107.82 -31.16 8.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.796 0.331 . . . . 0.0 110.868 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.31 -59.2 0.53 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 63' ' ' ASP . 15.5 mt 59.38 161.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.012 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -86.63 56.27 3.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.796 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.0 p -76.81 158.96 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.294 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.2 t -167.76 165.79 13.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -96.76 110.55 22.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.31 -0.852 . . . . 0.0 111.17 179.971 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 ttt . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.788 0.328 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -130.46 161.07 32.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.855 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -103.19 119.24 38.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.891 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.406 ' O ' ' CD1' ' A' ' 47' ' ' PHE . 17.2 mt -92.97 131.83 38.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.18 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -111.17 126.01 54.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.852 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.16 145.0 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.192 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.54 -174.29 14.74 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.474 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 60.48 41.81 15.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 110.875 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.8 mt -103.88 -179.16 3.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 13' ' ' ALA . 5.7 p -173.36 169.76 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.799 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -40.23 -37.73 0.68 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.855 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.0 p -142.61 54.97 1.41 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.842 0.353 . . . . 0.0 111.1 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.483 ' N ' HG12 ' A' ' 10' ' ' VAL . . . -77.11 -69.99 0.49 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.189 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -179.8 -36.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.966 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.8 -51.26 61.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.893 0.378 . . . . 0.0 111.078 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -14.58 62.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -90.33 -31.72 16.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.144 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.8 p -87.76 -24.83 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.593 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -54.02 -28.53 38.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.812 0.339 . . . . 0.0 111.0 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -33.86 69.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.662 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.5 tt -90.13 -28.44 18.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.838 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.19 -26.55 51.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.004 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.1 p -76.23 -33.55 59.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.852 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -90.1 -9.62 47.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.337 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -111.77 -37.18 5.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.715 0.293 . . . . 0.0 111.077 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.03 -8.47 5.57 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.198 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.33 47.35 6.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.882 0.372 . . . . 0.0 110.755 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.7 p -54.28 155.56 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.29 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -93.15 -49.18 6.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.09 143.47 30.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.2 t -150.19 110.74 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.122 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.33 172.94 16.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.5 mt -104.13 156.62 17.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.828 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.439 HG12 ' CE2' ' A' ' 45' ' ' PHE . 2.7 pp -66.04 -35.51 75.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.127 0.489 . . . . 0.0 111.205 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 49.69 -175.97 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.196 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -109.47 141.02 42.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.8 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -90.13 52.43 2.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.942 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -177.49 -40.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.818 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -104.9 -18.35 14.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.167 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.8 mttp 63.32 33.67 13.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.909 0.385 . . . . 0.0 110.883 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -113.89 145.25 33.12 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.883 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.65 120.31 6.11 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.58 2.187 . . . . 0.0 112.352 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -75.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.878 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 175.9 37.11 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.65 -0.785 . . . . 0.0 112.684 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.439 ' CE2' HG12 ' A' ' 34' ' ' ILE . 32.7 p90 -177.14 132.95 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.905 0.383 . . . . 0.0 110.992 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -122.4 -159.3 10.55 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.533 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.406 ' CD1' ' O ' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -145.01 152.59 40.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.841 0.353 . . . . 0.0 111.057 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.7 t -141.75 124.75 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.856 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -95.39 108.4 20.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.2 mtp -136.79 158.96 43.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.54 155.53 25.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -77.75 69.15 3.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.027 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -149.98 -48.27 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.428 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.18 -20.07 23.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.014 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.0 t -59.5 -47.98 88.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.317 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 m -56.01 -56.13 24.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.149 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -69.65 -28.67 66.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.187 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -60.56 -41.72 95.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.281 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.415 HG23 ' HB3' ' A' ' 63' ' ' ASP . 3.3 mt -90.34 -27.28 5.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.045 0.45 . . . . 0.0 111.046 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.53 -57.26 12.09 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -90.45 -14.56 32.58 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 48.8 mt -90.08 -75.08 0.46 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.777 0.322 . . . . 0.0 111.826 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.415 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -48.96 140.58 8.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.979 0.419 . . . . 0.0 111.499 -179.291 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 174.19 -35.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.641 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.72 -170.25 2.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.744 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.2 109.2 17.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.911 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -139.2 -174.22 3.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -74.98 68.2 1.78 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.36 26.55 72.69 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.683 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.3 mtp85 -96.56 -36.36 10.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.898 0.38 . . . . 0.0 110.82 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -138.67 -51.66 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.776 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.0 mt 59.78 159.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.107 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.01 50.54 1.68 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.947 0.403 . . . . 0.0 110.845 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.8 p -72.65 158.81 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.2 t -176.77 157.82 1.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.895 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.18 108.64 14.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.828 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.156 -0.926 . . . . 0.0 111.105 179.976 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 mtt . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.827 0.346 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -109.18 -171.08 1.77 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -121.06 137.92 54.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.948 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.1 mt -109.48 141.05 25.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.103 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -110.23 124.2 51.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.908 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.5 p -129.37 138.16 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.108 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.19 -171.58 17.4 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.45 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.9 t30 58.73 30.22 19.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.831 0.348 . . . . 0.0 110.97 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -86.29 163.38 17.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.455 HG11 ' N ' ' A' ' 13' ' ' ALA . 3.6 p -147.36 172.4 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.853 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -42.58 -41.52 3.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.583 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.3 m -150.25 66.34 0.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.927 0.394 . . . . 0.0 110.953 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.455 ' N ' HG11 ' A' ' 10' ' ' VAL . . . -73.49 -77.38 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.323 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -173.11 -36.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.28 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.3 t -49.79 -52.53 31.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.351 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.81 -14.43 62.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.85 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -90.39 -46.23 8.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.959 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.91 -9.42 12.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.689 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -53.59 -31.03 45.26 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.799 0.333 . . . . 0.0 110.971 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -69.8 -33.15 71.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.828 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.4 tt -90.02 -29.97 18.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.882 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -26.04 61.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.01 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m -76.19 -30.19 57.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.062 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -90.07 -5.17 56.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.348 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -116.18 -36.98 3.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.71 0.29 . . . . 0.0 111.11 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.1 -0.18 3.88 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.32 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 mmtt 56.04 103.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.985 0.393 . . . . 0.0 111.071 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.454 ' CG2' ' CG2' ' A' ' 31' ' ' VAL . 7.1 p -117.17 169.06 7.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.793 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -129.9 -39.51 1.4 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -97.6 -96.3 0.21 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.454 ' CG2' ' CG2' ' A' ' 28' ' ' VAL . 45.4 t 66.58 88.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.734 0.302 . . . . 0.0 110.882 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.67 151.93 22.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.93 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.3 mt -101.47 153.55 19.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.43 HG12 ' CE2' ' A' ' 45' ' ' PHE . 2.7 pp -85.63 -179.36 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -137.9 -172.19 3.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.862 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -91.7 -175.59 4.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.974 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.23 31.71 6.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -160.25 -59.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.881 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 p -92.42 -17.02 25.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.195 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.6 mptt 66.91 30.17 7.85 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.86 0.362 . . . . 0.0 110.882 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.1 pttt -92.15 138.15 24.6 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.789 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.29 115.82 2.54 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.438 2.092 . . . . 0.0 112.302 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -59.64 -74.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.898 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.5 39.36 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.561 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.43 ' CE2' HG12 ' A' ' 34' ' ' ILE . 13.4 p90 -172.1 145.55 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.91 0.386 . . . . 0.0 110.934 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -125.97 -166.05 12.17 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.541 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -145.67 128.94 16.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 111.164 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 52.4 t -114.75 116.0 51.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.863 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -87.26 94.99 9.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.945 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 29.2 mtp -121.18 177.56 5.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.881 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -69.1 158.2 35.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -31.18 69.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.902 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -81.63 -31.17 32.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.012 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.61 -33.0 64.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.051 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.9 t -58.01 -47.6 86.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.395 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.1 m -57.74 -64.77 0.79 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.13 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.15 -26.99 63.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.149 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -68.34 -37.14 80.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.415 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.433 HG21 ' HB3' ' A' ' 63' ' ' ASP . 5.8 mt -90.36 -11.79 9.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.275 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.75 -49.6 12.77 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -90.64 -19.41 23.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.799 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.535 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 78.2 mt -90.07 -75.03 0.47 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.433 ' HB3' HG21 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -59.56 144.95 46.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.023 0.44 . . . . 0.0 111.059 -179.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 179.67 -38.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.803 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.79 -170.39 3.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.824 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -111.15 111.71 22.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.964 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.56 -172.02 2.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.815 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -95.49 39.77 1.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.037 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.17 31.2 3.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.563 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.35 -41.83 4.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.806 0.336 . . . . 0.0 110.881 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.93 -48.9 0.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.5 mt 59.28 165.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.793 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -99.19 48.9 0.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.925 0.393 . . . . 0.0 110.756 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.38 125.19 21.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.064 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.0 t -132.67 162.98 29.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.009 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.86 117.11 21.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.932 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.215 -0.897 . . . . 0.0 111.121 179.969 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.425 ' HG2' ' CZ ' ' A' ' 29' ' ' PHE . 20.9 mtp . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.816 0.341 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -108.22 -169.26 1.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.411 ' HB3' ' CE2' ' A' ' 47' ' ' PHE . 1.6 m120 -121.71 150.5 41.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.89 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.4 mt -116.74 119.15 61.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.126 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -96.16 129.73 43.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.993 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.415 ' CG2' HD21 ' A' ' 9' ' ' LEU . 7.6 p -123.01 136.99 58.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.974 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -124.3 174.92 17.02 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.502 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 62.23 25.6 15.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.613 0.244 . . . . 0.0 110.986 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.415 HD21 ' CG2' ' A' ' 6' ' ' VAL . 1.8 mm? -60.15 138.63 57.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.679 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.7 p -102.49 162.18 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.644 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -43.33 -30.02 0.48 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.162 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -100.57 -71.64 0.7 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.054 0.454 . . . . 0.0 110.057 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 76.39 141.43 0.07 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.411 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 m -106.01 -26.84 11.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.374 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.08 -46.49 80.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.047 0.451 . . . . 0.0 110.09 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -75.75 -12.94 60.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.037 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.46 -41.09 11.64 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.496 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.9 p -78.2 -4.91 7.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.618 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -53.12 -37.16 61.53 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.762 0.315 . . . . 0.0 110.962 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -60.17 -31.53 70.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.707 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.1 tt -89.95 -29.65 18.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.789 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.66 -25.81 60.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.97 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m -67.11 -38.59 85.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.964 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.15 -7.75 52.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.209 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -103.54 -27.51 12.31 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.314 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.85 19.77 0.58 Allowed Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.372 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.4 pttm 42.33 98.99 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.905 0.383 . . . . 0.0 111.925 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.8 p -103.77 133.95 46.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.992 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.425 ' CZ ' ' HG2' ' A' ' 1' ' ' MET . 92.1 m-85 -69.45 -46.13 67.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.012 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -166.95 157.52 11.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.002 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -147.34 129.33 6.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.107 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.67 138.57 13.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.012 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.407 ' HB3' ' CA ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -126.92 148.15 50.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.784 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.425 HG23 ' CZ ' ' A' ' 45' ' ' PHE . 2.9 pp -64.38 177.73 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.043 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -132.89 -177.03 4.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.986 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -60.93 -22.36 64.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.173 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 62.26 33.57 16.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.781 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.06 -46.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.788 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.49 -0.29 32.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.364 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.1 mttt 62.61 35.99 13.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.846 0.355 . . . . 0.0 111.016 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -116.53 128.07 26.28 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.78 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.66 115.71 3.54 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.407 2.071 . . . . 0.0 112.244 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.62 132.04 1.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.943 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 137.7 -72.89 0.44 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.506 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.425 ' CZ ' HG23 ' A' ' 34' ' ' ILE . 20.8 p90 -169.4 168.21 9.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.846 0.355 . . . . 0.0 110.833 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.407 ' CA ' ' HB3' ' A' ' 33' ' ' LEU . . . -137.75 -178.07 15.71 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.601 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.436 ' CZ ' ' CB ' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -150.96 129.61 12.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.82 0.343 . . . . 0.0 111.094 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 51.2 t -126.3 143.51 39.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -111.9 106.09 14.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.978 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 35.5 mtt -137.4 -177.36 4.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.994 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -67.21 168.05 11.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.965 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -66.81 -37.05 83.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.954 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -74.8 -32.5 62.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.963 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.87 -36.31 82.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.6 t -62.32 -44.97 99.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.227 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.4 m -55.94 -63.57 1.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.085 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -62.11 -28.18 69.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.968 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.528 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -61.18 -38.29 85.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.293 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 59' ' ' ILE . 3.5 mt -90.22 -16.9 8.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.23 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.87 -48.34 31.71 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.3 mmmt -90.41 -22.85 21.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.656 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.528 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 78.6 mt -89.96 -69.8 0.7 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.532 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.436 ' CB ' ' CG1' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -63.05 141.42 58.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.087 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -178.63 -38.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.872 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.79 -168.64 2.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.73 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -110.34 104.67 13.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.974 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.9 -167.95 1.83 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.893 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.6 ptm -95.16 43.8 1.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.078 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.54 26.61 8.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.628 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 44.7 mtp85 -103.94 -34.99 8.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.908 0.385 . . . . 0.0 110.74 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.1 t -141.07 -47.06 0.4 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.651 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 63' ' ' ASP . 2.2 mt 57.76 167.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.826 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.4 47.36 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.912 0.387 . . . . 0.0 110.833 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.436 ' CG1' ' CB ' ' A' ' 63' ' ' ASP . 13.2 p -61.93 153.25 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.12 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.0 t -159.97 165.97 30.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -80.25 126.01 30.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.826 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.436 ' CB ' ' CZ ' ' A' ' 47' ' ' PHE . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.173 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 ttm . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.843 0.354 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -123.67 132.54 53.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -76.43 140.43 41.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.881 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.1 mt -106.18 126.02 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.033 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -107.88 104.44 13.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.836 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.0 p -113.32 130.95 66.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.166 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -120.46 -174.01 15.1 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.424 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 59.37 39.19 22.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.901 0.381 . . . . 0.0 110.863 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.6 mt -82.46 178.41 8.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.417 HG13 ' N ' ' A' ' 13' ' ' ALA . 6.3 p -143.69 169.13 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -44.33 -31.49 1.05 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.505 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -170.99 76.3 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.934 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.417 ' N ' HG13 ' A' ' 10' ' ' VAL . . . -81.69 -59.68 2.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.153 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 176.35 -31.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.204 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.9 m -50.51 -53.74 27.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.783 0.325 . . . . 0.0 111.297 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -13.62 62.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.713 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.56 -38.56 13.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.231 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.0 p -84.06 -9.78 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.899 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -56.88 -44.36 82.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.775 0.321 . . . . 0.0 110.932 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -59.74 -33.04 71.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.705 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.7 tt -87.67 -27.46 22.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.836 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.46 ' CD1' ' CE ' ' A' ' 50' ' ' MET . 0.1 OUTLIER -55.76 -23.64 30.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.162 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.8 t -80.26 -26.83 38.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.082 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -90.09 -20.47 23.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.236 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -109.54 -33.59 6.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.208 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.62 -18.25 4.9 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.154 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm 65.64 42.61 3.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.89 0.376 . . . . 0.0 110.741 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.3 p -51.08 151.76 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.33 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -91.79 -43.05 9.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -153.48 157.18 39.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.075 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.9 t -150.83 121.85 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.889 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.58 163.04 33.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.081 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 76.9 mt -129.36 179.67 5.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.791 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.421 HD11 ' CD1' ' A' ' 45' ' ' PHE . 2.5 pp -126.92 171.75 14.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.349 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -115.63 -169.86 1.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.937 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.04 178.33 6.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.81 30.86 7.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.935 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -162.47 -48.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 p -91.92 -20.83 20.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.004 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.43 34.31 8.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.839 0.352 . . . . 0.0 110.96 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -101.69 151.02 37.81 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.851 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.71 97.8 0.92 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.618 2.212 . . . . 0.0 112.628 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.23 135.6 0.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.799 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.42 -59.96 0.44 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.457 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.421 ' CD1' HD11 ' A' ' 34' ' ' ILE . 40.8 p90 -171.52 167.91 6.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.849 0.356 . . . . 0.0 110.962 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.77 174.57 22.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.352 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.86 133.92 38.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.884 0.374 . . . . 0.0 111.017 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.7 t -129.22 151.57 35.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.956 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -125.14 120.31 31.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.914 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.46 ' CE ' ' CD1' ' A' ' 22' ' ' PHE . 32.5 mtp -151.88 166.79 30.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -68.88 159.85 31.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.794 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.51 61.7 3.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.984 0.421 . . . . 0.0 110.903 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.61 -47.79 0.51 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.578 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.8 m -90.18 -25.55 20.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.956 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.6 t -64.4 -35.1 73.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.826 0.346 . . . . 0.0 111.472 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.37 -46.89 88.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.204 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.63 -23.5 21.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.311 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -59.5 -41.54 90.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.458 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.3 mp -90.36 -27.91 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.075 0.464 . . . . 0.0 111.048 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.05 -60.29 3.37 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -90.51 -10.31 44.05 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 26.5 mt -90.06 -75.29 0.46 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.95 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -49.36 149.03 2.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.96 0.409 . . . . 0.0 111.526 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.14 -48.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.762 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -158.96 -173.81 4.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.784 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -95.2 104.48 16.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.888 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.41 ' CZ ' ' NH2' ' A' ' 70' ' ' ARG . 0.3 OUTLIER -126.63 170.04 12.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.953 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 4.9 mtt -83.17 58.81 4.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.07 33.54 11.96 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.511 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.41 ' NH2' ' CZ ' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -111.41 -42.25 3.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.797 0.332 . . . . 0.0 110.835 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.96 -47.96 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.796 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.8 mt 59.74 159.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.033 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.37 69.73 6.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.851 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.7 p -93.09 132.9 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.176 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.4 t -154.02 159.75 41.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -58.38 139.27 55.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.96 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.102 -179.974 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.808 0.337 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -109.36 146.15 34.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.416 ' HB3' ' CE2' ' A' ' 47' ' ' PHE . 4.6 m120 -85.36 129.94 34.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.9 mt -107.69 139.32 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.093 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -113.78 125.57 54.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.844 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.0 p -121.94 124.28 70.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.077 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -112.66 -168.45 17.48 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.531 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.8 32.44 20.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.818 0.342 . . . . 0.0 110.887 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.9 mt -88.35 -178.03 5.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.407 ' CG1' ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -160.68 -168.43 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.819 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.407 ' N ' ' CG1' ' A' ' 10' ' ' VAL . 0.7 OUTLIER -48.56 -45.51 37.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.836 0.351 . . . . 0.0 111.134 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.94 60.64 0.52 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.647 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.44 -77.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.37 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -166.19 -31.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.446 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.3 p -46.85 -55.41 8.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.646 0.26 . . . . 0.0 111.441 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.57 -14.32 62.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.777 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -90.5 -30.97 16.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.09 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.422 HG23 ' CD2' ' A' ' 22' ' ' PHE . 14.8 p -86.54 -29.19 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.495 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.9 pttt -48.93 -28.5 3.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.132 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.8 -34.88 69.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.66 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.4 tt -89.96 -18.89 25.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.037 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.422 ' CD2' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -71.12 -17.09 62.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.236 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.2 p -90.13 -26.23 20.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.438 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -87.4 -47.77 8.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.345 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.57 -11.25 10.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.63 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.9 -22.94 37.05 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.641 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.58 35.17 14.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.81 0.338 . . . . 0.0 110.86 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.9 p -76.81 141.79 15.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.119 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -77.31 -44.79 28.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.96 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -174.7 145.87 0.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.014 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.0 t -127.09 140.95 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.908 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.94 106.59 2.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.071 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.7 mt -85.91 175.16 8.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.634 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.446 HG12 ' CZ ' ' A' ' 45' ' ' PHE . 1.5 pp -107.9 154.53 8.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.22 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.413 ' CE1' ' HG3' ' A' ' 42' ' ' PRO . 83.2 m-85 -140.43 -176.21 4.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.92 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -84.93 -179.6 7.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.934 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -112.09 32.97 5.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -157.79 -54.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.037 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.01 5.65 20.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.415 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 57.85 29.68 17.9 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.839 0.352 . . . . 0.0 110.957 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -76.27 113.96 33.36 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.867 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.413 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 52.8 Cg_exo -52.91 121.73 9.82 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.452 2.101 . . . . 0.0 112.27 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -41.09 69.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.05 37.79 0.11 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.978 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.446 ' CZ ' HG12 ' A' ' 34' ' ' ILE . 31.6 p90 -178.95 165.83 1.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.982 0.42 . . . . 0.0 111.215 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -146.91 -167.69 13.2 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.524 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.416 ' CE2' ' HB3' ' A' ' 3' ' ' ASN . 0.1 OUTLIER -139.56 136.59 34.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.85 0.357 . . . . 0.0 111.021 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.1 t -129.03 136.09 60.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.899 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -105.21 113.13 26.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.885 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -150.38 152.03 33.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.919 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.52 173.06 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.718 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.69 -152.54 0.06 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.376 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 67.49 -68.69 0.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.209 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.2 m -67.63 -28.62 67.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.235 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.2 t -58.16 -25.05 25.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.401 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.2 p -72.22 -50.47 27.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.136 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -83.24 -26.11 31.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.296 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -56.55 -42.65 78.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.494 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.8 mp -90.39 -12.15 9.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.281 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.08 -47.39 13.6 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -90.46 -21.47 21.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.687 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.518 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 80.3 mt -90.03 -69.6 0.71 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.737 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -49.51 124.38 9.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.321 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -177.59 -49.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.857 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.02 -169.5 2.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.82 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -101.71 124.96 48.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.917 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.57 -173.16 4.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 8.5 mtp -72.13 66.09 0.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 59.32 28.94 65.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.509 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.36 -27.76 12.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.728 0.299 . . . . 0.0 110.968 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.57 -71.68 0.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.091 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.6 mt 59.78 159.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.8 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -81.78 74.02 8.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 110.789 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.0 p -90.13 155.23 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.4 t -167.47 152.65 7.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.93 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -68.5 124.78 24.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.911 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.143 179.965 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 tpp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.798 0.333 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -127.75 -177.65 4.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -122.58 153.74 38.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.2 mt -131.56 123.3 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.173 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.499 ' CE2' ' CD2' ' A' ' 45' ' ' PHE . 29.2 t80 -108.84 115.54 30.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 p -124.08 124.17 68.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.156 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.15 -170.17 29.55 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.535 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 59.05 40.89 21.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.917 0.389 . . . . 0.0 110.945 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.1 mt -98.45 -178.14 3.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.908 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -172.85 -168.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.743 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -50.29 -47.95 55.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.827 0.346 . . . . 0.0 111.128 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 p -143.35 55.14 1.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.675 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.91 -72.98 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.196 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -165.44 -41.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.056 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.15 -49.33 66.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.065 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -67.05 -15.59 63.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.718 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -90.41 -36.39 14.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.981 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.407 HG22 ' CD1' ' A' ' 22' ' ' PHE . 12.2 p -90.07 -23.44 6.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.66 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 42.3 pttt -52.58 -34.33 50.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.762 0.315 . . . . 0.0 111.209 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -65.18 -34.45 78.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.723 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 tp -89.86 -26.69 20.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.407 ' CD1' HG22 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -55.74 -23.19 27.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.166 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.6 t -82.91 -29.78 28.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.987 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -90.1 -21.54 22.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -112.82 -30.96 6.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.284 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -117.94 -1.39 16.95 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.113 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.3 pttt 44.92 43.77 7.38 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.85 0.357 . . . . 0.0 111.337 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.9 p -54.67 150.94 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.228 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -91.8 -51.24 5.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.039 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -139.46 158.04 44.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.022 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.0 t -151.48 98.19 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.977 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.84 166.48 11.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.002 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.4 mt -140.68 175.09 9.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.843 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 pp -119.51 -178.79 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.083 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -130.22 -179.13 5.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.054 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -20.29 55.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.17 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.09 36.05 2.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.902 0.382 . . . . 0.0 110.746 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -175.19 -40.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.743 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.3 -10.21 17.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.266 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 mptt 66.66 31.47 7.66 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.86 0.362 . . . . 0.0 110.686 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -111.82 131.04 22.61 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.22 111.17 0.6 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.467 2.112 . . . . 0.0 112.294 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -176.63 127.23 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.918 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.52 -79.09 0.27 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.617 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.499 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 50.3 p90 -168.01 -176.64 3.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.811 0.338 . . . . 0.0 111.032 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.68 169.25 26.09 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.539 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.09 131.35 47.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.802 0.334 . . . . 0.0 111.001 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.8 t -126.26 145.19 34.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.963 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -114.4 114.45 25.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 29.6 mtm -141.83 169.5 17.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -78.48 154.29 30.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -72.01 93.3 1.37 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.904 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -173.43 -49.41 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.466 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.14 -15.34 31.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.994 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.7 t -66.68 -39.51 83.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.825 0.345 . . . . 0.0 111.179 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.12 -24.67 58.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.216 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.26 -42.95 10.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.759 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.86 -67.78 0.33 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.892 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.7 mt -56.53 -29.4 29.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.144 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.75 -57.55 12.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.69 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -90.25 -26.08 20.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.646 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 84.4 mt -75.21 -72.9 0.27 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.81 0.338 . . . . 0.0 111.488 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.9 135.67 23.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.346 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -178.12 -67.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.761 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.76 -172.16 2.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.811 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.51 99.2 8.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.964 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.18 -172.52 2.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.842 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 23.9 mtt -100.22 36.42 1.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.66 32.7 1.4 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.505 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.12 -37.95 3.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.825 0.345 . . . . 0.0 110.953 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.56 -55.69 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.872 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mt 59.79 160.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.991 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.39 59.32 5.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.762 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.3 p -79.72 156.75 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.224 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.0 t -178.46 144.98 0.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.903 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.36 114.61 6.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.069 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.818 0.342 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.21 161.28 13.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -100.96 102.09 13.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.405 ' O ' ' CD1' ' A' ' 47' ' ' PHE . 29.6 mt -72.42 141.08 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.095 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -112.24 138.36 49.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.807 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 p -147.79 129.14 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.285 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.08 -175.79 25.49 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.329 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 58.45 37.83 25.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.816 0.341 . . . . 0.0 110.806 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -87.98 159.63 18.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.033 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -154.03 -167.41 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.78 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.423 ' CD1' ' HG2' ' A' ' 42' ' ' PRO . 80.0 m-85 -49.5 -46.09 47.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.833 0.349 . . . . 0.0 111.088 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -157.18 57.64 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.778 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.04 -52.01 65.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.259 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -177.61 -36.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.099 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.5 m -51.34 -51.88 50.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.223 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.86 -14.87 63.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.787 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -90.54 -36.27 14.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.089 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.424 HG21 ' CD1' ' A' ' 22' ' ' PHE . 10.7 p -86.23 -24.77 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.625 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -53.16 -32.04 45.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.889 0.376 . . . . 0.0 111.072 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.37 -39.28 94.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.632 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.3 tt -83.14 -31.23 27.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.705 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.424 ' CD1' HG21 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -61.2 -28.27 69.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.928 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.27 -26.9 26.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.088 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -85.36 -25.44 27.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.137 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -111.47 -29.57 7.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.195 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -114.15 -24.65 4.42 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.807 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.87 46.53 3.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.861 0.362 . . . . 0.0 110.776 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.1 p -52.02 147.4 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.295 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -73.81 -50.26 21.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.919 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -154.67 157.92 38.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.972 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.4 t -152.76 124.08 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.082 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -160.02 -178.6 7.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.981 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 34.0 mt -122.78 160.01 26.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.851 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.411 HG23 ' CE2' ' A' ' 45' ' ' PHE . 2.5 pp -81.63 -22.11 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.516 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 58.83 171.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.008 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -59.94 160.44 7.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.68 40.53 1.22 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.969 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -170.82 -44.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.763 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.98 -17.97 18.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.186 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp 64.12 33.17 12.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.894 0.378 . . . . 0.0 110.9 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.4 150.42 37.98 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.763 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.423 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 63.5 Cg_exo -51.45 99.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.581 2.188 . . . . 0.0 112.3 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.81 129.4 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 127.9 -76.45 0.4 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.643 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.411 ' CE2' HG23 ' A' ' 34' ' ' ILE . 24.4 p90 -176.09 171.61 2.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.754 0.312 . . . . 0.0 110.913 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.93 171.01 21.9 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.479 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.405 ' CD1' ' O ' ' A' ' 4' ' ' ILE . 2.7 m-85 -134.38 145.52 49.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.836 0.351 . . . . 0.0 110.87 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.8 t -131.59 97.47 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.092 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -68.3 86.91 0.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.973 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.7 mtp -125.42 179.6 5.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.905 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -67.89 173.84 4.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.02 -36.94 48.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.968 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -64.3 -36.04 82.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.02 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.7 t -71.03 -30.27 66.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.033 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.8 t -66.82 -36.37 77.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.267 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.9 t -77.87 -24.99 48.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.214 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.25 -44.9 9.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.753 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -57.48 -68.39 0.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.965 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.3 mt -54.85 -31.1 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.073 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.34 -59.8 4.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.602 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -90.32 -11.48 40.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.106 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 63.6 mt -89.93 -75.08 0.46 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.641 0.258 . . . . 0.0 111.623 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.72 150.33 5.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.035 0.445 . . . . 0.0 111.246 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -178.58 -40.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.847 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -162.85 -169.48 2.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.781 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -107.13 93.55 4.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.818 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.09 -176.28 2.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 15.0 mtm -94.16 46.44 1.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.81 32.99 4.86 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.494 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -113.77 -30.01 6.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.758 0.313 . . . . 0.0 111.152 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 t -152.37 -45.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.013 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 72' ' ' ILE . 20.3 mt 61.6 161.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.796 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.0 mtm180 -94.25 43.38 1.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.984 0.421 . . . . 0.0 111.011 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.2 p -61.81 147.51 11.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.981 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.1 t -158.76 171.83 19.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.918 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -85.03 121.07 27.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.785 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.162 179.916 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttt . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.847 0.356 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.13 -175.33 5.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.886 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -123.12 105.63 10.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.877 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.6 mt -65.16 145.44 13.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.987 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -125.13 115.65 20.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.922 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.6 p -109.66 141.52 24.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.951 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -120.93 62.92 0.5 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.582 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -177.5 62.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.875 0.369 . . . . 0.0 110.636 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.2 mt -109.73 161.61 15.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.061 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.5 p -178.96 161.46 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.723 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -47.23 -27.99 1.73 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.328 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 88.2 p -120.28 30.12 7.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.14 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.51 ' O ' ' CB ' ' A' ' 14' ' ' THR . . . -68.69 -31.42 70.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.235 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.51 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 1.3 m 90.61 5.64 0.1 Allowed 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.721 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.6 m -70.93 -52.74 18.17 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.927 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.78 -18.6 62.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.449 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.43 -39.17 12.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.978 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.9 p -81.87 -24.58 9.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.687 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -51.3 -37.05 45.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.802 0.334 . . . . 0.0 111.031 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.16 -32.59 70.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.007 0.432 . . . . 0.0 110.542 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.3 tt -83.6 -31.01 26.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.563 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -20.79 61.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.935 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.3 t -83.1 -29.24 28.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.954 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -81.64 -22.11 37.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.124 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -112.12 -31.64 6.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.149 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.59 -23.96 4.21 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.926 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? 62.48 50.14 3.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.858 0.361 . . . . 0.0 110.838 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.64 146.68 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.169 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -93.8 -31.05 14.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.968 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -150.71 145.85 26.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.107 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.7 t -147.1 106.43 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.772 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.24 155.7 49.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.186 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.94 155.17 29.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.58 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.455 ' CD1' ' CE1' ' A' ' 45' ' ' PHE . 2.6 pp -82.85 177.29 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.034 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.407 ' CG ' ' O ' ' A' ' 34' ' ' ILE . 70.7 m-85 -157.02 167.55 30.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.33 156.88 22.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.5 38.57 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.941 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -159.97 -45.29 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.927 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p -106.95 -16.27 14.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.206 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.7 mttp 62.39 37.25 13.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.915 0.388 . . . . 0.0 110.965 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -113.32 139.01 22.66 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.809 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.95 118.88 5.64 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.445 2.097 . . . . 0.0 112.402 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -70.2 -64.55 0.87 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.3 50.29 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.413 -0.898 . . . . 0.0 112.987 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.455 ' CE1' ' CD1' ' A' ' 34' ' ' ILE . 27.8 p90 -178.04 153.38 0.8 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.013 0.435 . . . . 0.0 111.081 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.61 -164.73 11.42 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.571 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -140.78 144.96 35.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.85 0.357 . . . . 0.0 111.169 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.9 t -141.97 115.61 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.867 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.65 101.52 13.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.02 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 29.8 mtm -130.58 154.86 47.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.918 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.76 149.45 46.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.892 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.21 -31.72 63.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.088 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -63.25 -34.71 78.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.006 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.5 t -90.0 -39.25 13.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.985 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -54.82 -47.81 74.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.372 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.7 m -52.15 -64.02 0.95 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.19 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -26.83 67.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.004 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -63.94 -39.53 94.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.267 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.445 HG22 ' HB3' ' A' ' 63' ' ' ASP . 5.4 mt -90.12 -7.28 10.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.303 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.7 -44.95 9.67 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.97 -25.0 19.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.451 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.571 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 66.0 mt -90.11 -74.23 0.49 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.901 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.445 ' HB3' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -50.96 142.1 12.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.932 0.396 . . . . 0.0 111.295 -179.395 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -178.83 -38.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.871 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -159.72 -175.05 4.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -104.35 108.66 20.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -124.71 -168.61 1.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.948 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.2 mmt -95.04 44.46 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.82 32.61 6.14 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.499 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.95 -34.62 6.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.83 0.347 . . . . 0.0 110.964 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.62 -53.93 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.992 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.3 mt 59.92 159.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.019 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 61.18 6.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.831 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.4 p -72.82 140.64 17.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.096 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.9 t -164.27 150.91 11.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.868 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -70.33 127.35 32.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.103 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.822 0.344 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -114.4 -178.53 3.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.866 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -110.73 142.5 42.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 mt -118.85 120.08 62.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.463 ' CD2' ' CE1' ' A' ' 47' ' ' PHE . 3.5 t80 -102.17 123.54 46.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.004 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 p -128.47 129.04 68.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.024 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -110.67 -168.84 19.31 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.51 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.38 33.68 23.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.751 0.31 . . . . 0.0 110.9 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.3 mt -85.97 -178.72 6.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.964 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.443 HG11 ' N ' ' A' ' 13' ' ' ALA . 2.5 p -163.98 174.42 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.824 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -43.19 -45.56 5.66 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.75 0.31 . . . . 0.0 111.563 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.9 t -140.78 61.94 1.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.888 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.443 ' N ' HG11 ' A' ' 10' ' ' VAL . . . -68.13 -78.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.327 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -177.43 -32.24 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.312 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.9 t -47.27 -54.95 9.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.76 0.314 . . . . 0.0 111.521 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -14.47 61.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.851 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -90.68 -27.95 18.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.274 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -90.14 -20.69 6.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.842 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.36 -28.01 4.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.778 0.323 . . . . 0.0 111.236 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -72.35 -32.14 66.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.82 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.6 tt -90.01 -30.26 17.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.955 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.85 -22.91 40.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.7 t -76.51 -31.93 57.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.985 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -90.19 -10.67 43.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.42 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.52 -37.77 5.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.645 0.26 . . . . 0.0 111.157 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -127.38 -5.65 5.48 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.516 -0.85 . . . . 0.0 113.265 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp 61.33 47.54 6.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.872 0.367 . . . . 0.0 110.938 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.6 p -53.97 116.05 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.188 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -59.77 -39.9 86.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.887 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -160.08 158.76 30.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 p -155.22 127.88 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.035 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.3 mtpt -160.04 123.23 3.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.973 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.0 mt -84.68 -169.04 2.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.572 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.44 HG12 ' CZ ' ' A' ' 45' ' ' PHE . 1.7 pp -111.93 155.18 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.902 0.382 . . . . 0.0 111.233 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -157.22 169.66 24.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.741 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.61 131.5 34.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -84.1 56.4 3.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.921 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 179.2 -40.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.795 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 p -111.88 -19.82 12.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.203 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.1 tttt 68.92 25.82 5.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.778 0.323 . . . . 0.0 110.904 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -90.73 121.3 68.37 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.831 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.3 125.81 20.27 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.408 2.072 . . . . 0.0 112.337 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.58 -35.47 80.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.745 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 130.11 32.64 0.53 Allowed Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.119 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.44 ' CZ ' HG12 ' A' ' 34' ' ' ILE . 27.8 p90 -178.49 -176.96 0.52 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.992 0.425 . . . . 0.0 111.223 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -161.97 -171.72 28.44 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.453 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.463 ' CE1' ' CD2' ' A' ' 5' ' ' TYR . 1.7 m-85 -144.8 141.17 28.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.938 0.399 . . . . 0.0 111.075 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.6 t -130.24 150.11 34.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.932 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -111.49 109.95 20.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.93 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.4 mtp -143.6 177.68 8.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -71.22 159.27 34.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -67.07 -30.77 70.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.824 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -75.9 -31.81 59.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.908 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.4 m -74.69 -29.46 61.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.063 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.402 ' CG1' ' CD1' ' A' ' 59' ' ' ILE . 21.6 t -65.12 -37.31 79.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.276 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.2 t -74.91 -24.39 58.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.09 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.21 -42.68 10.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.663 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.82 -67.99 0.31 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.818 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.402 ' CD1' ' CG1' ' A' ' 55' ' ' VAL . 3.3 mt -54.88 -30.57 23.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.056 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.04 -59.44 5.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.366 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.15 -9.14 49.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.904 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 71.5 mt -90.09 -74.95 0.47 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.838 0.351 . . . . 0.0 111.336 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.67 152.4 12.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.134 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.57 -40.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.775 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -166.43 -178.28 4.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.873 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.0 p-10 -98.14 102.81 14.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.843 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.22 -168.83 1.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.939 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 1.5 mmt -93.46 46.93 1.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.876 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.37 37.49 6.2 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.546 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.1 tpp85 -116.14 -42.36 3.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.837 0.351 . . . . 0.0 110.92 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.98 -48.77 1.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.914 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.3 mt 59.27 163.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.999 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -94.07 47.64 1.22 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.019 0.437 . . . . 0.0 110.74 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.6 p -62.0 144.29 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.095 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.3 t -149.27 175.88 11.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.986 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.69 133.07 35.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.967 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.131 179.958 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.842 0.353 . . . . 0.0 111.137 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -94.2 -8.57 38.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.503 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.5 m120 54.1 103.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.219 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.3 mt -94.42 158.51 2.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.219 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -139.79 143.47 36.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.682 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.9 p -142.52 146.63 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.268 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -130.29 -174.37 13.67 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.322 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 t30 56.01 33.18 21.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.931 0.396 . . . . 0.0 110.994 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.2 mt -89.43 99.91 12.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.096 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.402 HG13 ' N ' ' A' ' 13' ' ' ALA . 2.7 p -63.33 176.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.642 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -41.54 -35.35 0.7 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.865 0.364 . . . . 0.0 111.419 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 p -157.26 67.47 0.52 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.571 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.402 ' N ' HG13 ' A' ' 10' ' ' VAL . . . -71.62 -65.4 0.76 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.405 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -179.12 -24.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.578 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -46.07 -57.91 4.06 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.747 0.308 . . . . 0.0 111.509 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -66.49 -13.3 60.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.817 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -90.54 -28.3 18.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.291 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.9 p -87.07 -24.49 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.754 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.7 -27.67 12.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.744 0.307 . . . . 0.0 111.171 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -33.1 70.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.764 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.4 tt -88.9 -30.85 18.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.809 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -26.04 62.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.016 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.44 -24.17 24.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.237 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -88.66 -24.38 22.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.265 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -111.47 -30.68 7.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.225 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -117.62 -17.56 5.55 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.575 -0.822 . . . . 0.0 113.067 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm 61.98 43.98 8.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.944 0.402 . . . . 0.0 110.715 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.0 p -46.36 139.54 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.459 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -89.3 -39.1 13.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.835 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -139.29 149.19 43.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.955 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.2 p -172.11 120.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.063 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -157.11 167.3 30.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.949 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.61 160.26 32.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.683 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.435 HG12 ' CE2' ' A' ' 45' ' ' PHE . 1.0 OUTLIER -94.33 170.48 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.054 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -138.77 -174.23 3.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.009 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -101.55 -178.48 3.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -120.28 31.75 6.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.67 -58.25 0.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.876 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.03 -1.08 27.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.403 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt 60.2 36.21 20.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.88 0.371 . . . . 0.0 110.883 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -112.99 152.02 44.59 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.822 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.37 135.25 53.79 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.581 2.187 . . . . 0.0 112.282 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.75 -69.18 0.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.794 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.41 37.59 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.898 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.435 ' CE2' HG12 ' A' ' 34' ' ' ILE . 38.3 p90 -179.9 152.88 0.49 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.987 0.423 . . . . 0.0 111.124 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.28 -169.99 13.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.389 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.445 ' CZ ' ' CB ' ' A' ' 77' ' ' ALA . 1.9 t80 -133.13 156.3 47.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.884 0.373 . . . . 0.0 111.057 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.1 t -149.16 130.45 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.972 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.57 116.17 30.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.02 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.5 mtm -140.63 156.21 46.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.916 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.05 151.73 18.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.971 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -77.24 95.03 4.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.931 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -174.91 -53.44 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.261 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 m -90.02 -16.15 30.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.981 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.0 t -61.09 -43.87 97.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.832 0.348 . . . . 0.0 111.277 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.6 m -56.82 -54.22 48.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.165 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -74.98 -26.47 59.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.106 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -57.61 -39.36 76.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.338 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.2 mt -90.29 -8.94 10.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.181 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.51 -48.75 10.67 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.65 -19.11 24.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.785 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 83.3 mt -89.97 -75.12 0.46 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.93 147.42 15.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.842 0.353 . . . . 0.0 111.041 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -176.6 -41.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.941 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -154.62 -177.66 6.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -103.57 97.45 7.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.16 -169.33 1.46 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 16.9 ptm -98.38 31.57 2.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.92 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.09 33.55 1.49 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.474 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.77 -54.06 2.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.786 0.327 . . . . 0.0 110.883 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 t -119.73 -49.76 2.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.889 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.8 mt 60.15 159.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.212 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.71 51.6 2.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.819 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.0 p -67.18 125.51 24.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.072 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.5 t -141.9 160.22 40.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.02 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -59.82 140.88 56.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.875 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.445 ' CB ' ' CZ ' ' A' ' 47' ' ' PHE . . . . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.095 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mtp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.845 0.355 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -99.16 175.45 5.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.959 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.401 ' HB3' ' CE2' ' A' ' 47' ' ' PHE . 22.0 m-20 -122.07 120.13 33.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.862 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 mp -111.21 132.61 59.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.122 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -107.2 142.85 36.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.904 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.98 121.01 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.99 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.429 ' HA2' ' CD1' ' A' ' 45' ' ' PHE . . . -104.79 -169.53 24.38 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.767 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 63.46 29.66 15.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.715 0.293 . . . . 0.0 110.948 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.0 mt -101.24 159.8 14.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.919 0.39 . . . . 0.0 111.124 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.404 ' CG1' ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -155.07 -166.8 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.666 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.404 ' N ' ' CG1' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -48.77 -44.95 39.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.878 0.371 . . . . 0.0 111.051 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.06 49.04 1.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.593 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.8 -76.1 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.359 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -164.59 -37.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.304 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.94 -52.96 21.81 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.798 0.332 . . . . 0.0 111.36 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -65.43 -15.96 63.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.751 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -90.59 -36.92 14.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.073 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.9 p -90.04 -22.35 6.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.669 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 pttp -50.0 -29.48 8.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.799 0.333 . . . . 0.0 111.101 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -68.22 -35.69 78.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.66 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.3 tp -87.03 -30.36 21.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.899 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.15 -24.48 54.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.116 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.2 m -82.38 -25.9 33.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.158 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -90.02 -24.48 21.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.216 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -110.43 -30.9 7.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.156 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -112.06 -22.24 5.99 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.775 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp 62.98 45.07 5.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.944 0.402 . . . . 0.0 110.901 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.0 p -54.14 153.07 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.107 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -97.26 -36.37 10.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.015 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -166.15 140.87 4.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.124 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t -124.71 119.44 56.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.732 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -123.44 163.14 21.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.024 0.44 . . . . 0.0 111.26 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 mt -141.51 161.29 38.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.397 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.456 ' CD1' ' HA3' ' A' ' 44' ' ' GLY . 2.5 pp -123.62 155.41 30.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.981 0.419 . . . . 0.0 111.29 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -94.36 -165.58 1.34 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.92 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -73.66 -8.53 56.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.332 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 66.42 29.57 9.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.896 0.379 . . . . 0.0 110.743 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -165.61 -44.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.615 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 p -97.48 -13.71 21.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.184 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.29 25.94 2.77 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.803 0.335 . . . . 0.0 110.982 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -102.53 123.62 42.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.7 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.53 107.49 1.63 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.38 2.053 . . . . 0.0 112.101 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.32 42.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.29 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.456 ' HA3' ' CD1' ' A' ' 34' ' ' ILE . . . -132.05 42.02 1.43 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.619 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.429 ' CD1' ' HA2' ' A' ' 7' ' ' GLY . 0.9 OUTLIER 73.94 161.49 0.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.851 0.358 . . . . 0.0 111.033 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.94 -173.84 13.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.582 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 48' ' ' VAL . 46.0 t80 -128.34 159.32 35.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.761 0.315 . . . . 0.0 110.919 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.451 ' N ' ' CD1' ' A' ' 47' ' ' PHE . 31.7 t -144.81 127.7 10.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.06 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -105.3 113.33 26.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.931 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 35.4 mtm -142.26 147.87 37.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.6 155.83 14.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.881 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.07 95.18 4.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.037 0.446 . . . . 0.0 110.906 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -176.36 -49.37 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.263 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.1 m -90.02 -21.73 22.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.916 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.61 -31.62 49.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.379 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.0 m -60.98 -53.93 51.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.243 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.63 -22.93 27.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.292 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -55.47 -41.48 73.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.432 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.412 HG21 ' HB3' ' A' ' 63' ' ' ASP . 3.3 mp -90.32 -21.22 6.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.911 0.386 . . . . 0.0 111.301 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.13 -55.38 25.77 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.44 -14.3 33.13 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 51.0 mt -90.05 -75.27 0.46 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.943 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.412 ' HB3' HG21 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -55.52 150.7 11.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.07 0.462 . . . . 0.0 111.406 -179.114 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 175.1 -36.62 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.715 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.39 -173.89 3.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.81 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.5 96.68 6.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.955 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.407 ' CD2' ' HB2' ' A' ' 70' ' ' ARG . 0.6 OUTLIER -121.71 169.07 11.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 24.2 mmm -80.51 65.05 5.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.953 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.69 31.02 30.92 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.607 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.407 ' HB2' ' CD2' ' A' ' 67' ' ' PHE . 1.5 tmm_? -111.0 -30.1 7.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.793 0.33 . . . . 0.0 111.081 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 t -153.02 -51.09 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.942 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.1 mt 64.65 160.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.033 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.4 48.68 1.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.875 0.369 . . . . 0.0 110.913 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.0 p -72.17 114.58 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.182 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.6 t -135.25 153.85 51.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.042 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -57.13 131.62 50.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.312 -0.851 . . . . 0.0 111.077 179.873 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ptp . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.822 0.344 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.94 -6.11 22.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.496 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.5 t30 59.03 114.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.055 0.455 . . . . 0.0 110.993 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.7 mt -103.31 127.84 56.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.117 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -110.94 126.97 55.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.844 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.1 p -135.03 154.02 35.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.122 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.7 -166.11 12.01 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.394 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 58.98 31.43 21.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.757 0.313 . . . . 0.0 110.787 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.4 mt -93.9 -179.39 4.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.953 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.412 ' CG1' ' N ' ' A' ' 11' ' ' TYR . 0.6 OUTLIER -170.32 -165.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.697 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.412 ' N ' ' CG1' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -46.3 -40.55 11.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.95 0.405 . . . . 0.0 111.269 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -163.72 52.66 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.67 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.24 -46.89 75.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.307 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -177.65 -32.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.416 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.7 p -47.55 -55.09 9.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.779 0.323 . . . . 0.0 111.429 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.01 -12.78 61.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.949 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -90.77 -39.06 12.61 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.204 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.416 HG23 ' CD2' ' A' ' 22' ' ' PHE . 12.3 p -77.2 -27.93 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.865 -179.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.9 ptmm? -53.36 -28.52 29.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.779 0.323 . . . . 0.0 110.992 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -70.94 -35.36 72.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.576 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.7 tp -90.03 -27.27 19.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.721 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.416 ' CD2' HG23 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -54.87 -28.09 47.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.938 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.03 -24.27 47.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.97 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -90.12 -34.27 15.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.773 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -60.82 -41.51 95.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.746 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.07 27.27 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.577 -0.82 . . . . 0.0 113.045 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 57.01 110.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.909 0.385 . . . . 0.0 111.193 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.8 p -96.37 131.33 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -59.18 -43.6 92.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.971 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -171.46 166.48 6.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.953 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.2 p -146.59 123.4 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.03 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -132.53 174.48 10.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.121 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.8 158.98 43.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.757 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.45 ' CD1' ' CE1' ' A' ' 45' ' ' PHE . 2.5 pp -85.18 -178.91 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.14 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -158.17 168.91 25.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -86.71 152.15 22.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.951 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -96.94 41.36 1.11 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.878 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -162.56 -44.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.799 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.22 -11.12 15.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.262 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.71 30.65 16.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.821 0.343 . . . . 0.0 110.85 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.401 ' HG3' ' N ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -107.76 141.76 23.77 Favored Pre-proline 0 N--CA 1.451 -0.395 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.118 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.401 ' N ' ' HG3' ' A' ' 41' ' ' LYS . 37.4 Cg_endo -65.66 115.82 3.6 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.522 2.148 . . . . 0.0 112.332 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -56.69 -67.77 0.28 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.018 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.23 52.61 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.817 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.45 ' CE1' ' CD1' ' A' ' 34' ' ' ILE . 29.4 p90 -177.94 142.5 0.29 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.917 0.389 . . . . 0.0 111.061 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -134.86 -167.07 11.31 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.474 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.99 150.08 40.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.79 0.329 . . . . 0.0 110.934 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.6 t -133.2 152.31 35.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.003 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -117.45 105.14 11.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.929 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -140.72 144.26 35.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.848 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.1 pm0 -55.66 146.53 20.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.089 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -69.32 93.39 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.948 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -172.81 -49.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.431 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.23 -19.91 23.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.952 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.0 t -58.99 -48.24 87.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.845 0.355 . . . . 0.0 111.229 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 t -62.58 -23.73 67.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.035 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -90.2 -35.03 15.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.598 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.78 -65.61 0.66 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.751 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.9 mt -58.22 -29.56 37.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.005 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.32 -56.87 16.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.711 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -90.23 -25.98 20.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.708 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 84.2 mt -76.02 -72.14 0.34 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.763 0.316 . . . . 0.0 111.312 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.42 140.6 27.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.269 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -178.19 -39.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.956 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.57 -169.73 1.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.849 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -106.68 119.92 40.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -147.51 -175.95 5.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.82 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.67 49.41 1.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.017 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.59 35.18 5.26 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.627 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.97 -30.44 7.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.7 0.286 . . . . 0.0 111.001 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.2 t -155.27 -52.03 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.075 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.9 mt 60.76 159.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.031 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.11 53.88 2.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.841 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.3 p -73.92 159.32 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.05 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.1 t -161.15 179.05 8.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.897 0.38 . . . . 0.0 110.957 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.82 108.76 20.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.962 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.184 -0.912 . . . . 0.0 111.049 179.998 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.861 0.362 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.07 171.23 9.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.029 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -113.2 166.32 11.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.0 mp -132.59 125.32 52.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.033 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -99.05 124.05 43.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.012 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.5 p -131.14 142.6 43.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.961 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -136.59 179.81 17.52 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.535 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 62.89 30.6 16.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.785 0.326 . . . . 0.0 110.96 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.428 ' C ' ' CD1' ' A' ' 9' ' ' LEU . 0.8 OUTLIER -123.09 -177.51 3.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.045 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.59 -169.57 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.767 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.42 ' CD1' ' HG2' ' A' ' 42' ' ' PRO . 4.8 t80 -57.05 -52.25 66.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.806 0.336 . . . . 0.0 110.949 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 t -126.45 54.04 1.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.975 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.71 -54.93 3.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.111 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.65 -41.96 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.079 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.3 t -54.46 -48.59 71.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.058 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -69.36 -14.36 62.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.757 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -90.45 -37.52 13.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.084 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 p -83.7 -28.2 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.583 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -53.3 -34.38 57.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.789 0.328 . . . . 0.0 110.983 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.07 -38.36 90.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.752 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.9 tt -86.28 -28.79 23.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.79 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.27 -26.16 62.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.974 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.62 -26.83 55.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.077 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -90.06 -12.8 37.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.489 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -109.04 -36.82 5.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.645 0.26 . . . . 0.0 111.24 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.8 10.27 4.55 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.066 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.6 pttp 43.07 54.78 4.78 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.837 0.351 . . . . 0.0 111.454 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.9 p -47.11 131.56 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.368 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -60.19 -57.43 12.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.894 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -156.65 165.21 36.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.002 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.63 114.49 4.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.005 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -119.02 151.94 37.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.024 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mt -130.76 149.36 52.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.755 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.447 ' CG2' ' CE2' ' A' ' 45' ' ' PHE . 2.7 pp -72.69 -175.14 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.983 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -149.14 -176.2 5.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.999 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -80.83 -168.52 1.81 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.826 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -120.61 35.97 4.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.817 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -163.97 -59.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.964 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.37 -4.94 28.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.387 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.93 35.98 13.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.843 0.354 . . . . 0.0 110.901 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -77.25 116.28 56.27 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.42 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 32.0 Cg_exo -61.27 114.77 2.35 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.54 2.16 . . . . 0.0 112.311 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.411 ' O ' ' CD ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -177.61 137.03 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.976 0.417 . . . . 0.0 110.971 179.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.32 -72.09 0.48 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.633 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.447 ' CE2' ' CG2' ' A' ' 34' ' ' ILE . 1.7 p90 -152.25 -177.8 6.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.764 0.316 . . . . 0.0 110.851 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -154.59 -170.56 20.51 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.587 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.36 135.25 13.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.841 0.353 . . . . 0.0 110.92 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.8 t -123.98 156.7 31.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.015 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -119.74 112.18 18.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.871 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 21.9 mtp -144.96 168.97 18.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.956 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -71.85 160.53 32.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.824 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -82.04 59.38 4.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.76 -46.67 0.45 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.739 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.02 -20.08 23.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.041 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.9 t -64.7 -41.52 92.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.819 0.343 . . . . 0.0 111.166 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.4 m -57.71 -47.69 81.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.162 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -82.8 -28.32 30.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.118 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -58.4 -41.22 84.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.329 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.8 mp -90.32 -24.4 5.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.96 0.41 . . . . 0.0 111.166 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.37 -52.16 62.88 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.45 -19.1 24.27 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 75.8 mt -90.02 -71.21 0.63 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -46.37 136.0 7.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.559 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -177.18 -48.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.784 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -163.94 -175.15 3.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.968 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -91.0 113.62 25.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.941 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -130.25 -171.69 2.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.09 51.53 2.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.88 38.07 10.85 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.465 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.44 -51.53 2.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.348 . . . . 0.0 110.987 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.79 -53.89 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.441 HD11 HG21 ' A' ' 72' ' ' ILE . 5.0 mt 57.73 166.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.913 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.1 48.84 1.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.902 0.382 . . . . 0.0 110.836 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.1 p -66.89 156.03 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.162 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.5 t -166.66 157.94 12.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.65 127.93 34.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.249 -0.882 . . . . 0.0 111.093 179.985 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.885 0.374 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -88.44 175.19 7.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -118.55 129.88 55.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.868 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.6 mt -97.03 152.93 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.164 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -130.18 103.58 6.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.812 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.6 p -113.56 116.97 54.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.164 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.1 -175.11 30.38 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.336 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.3 26.67 10.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.673 0.273 . . . . 0.0 111.323 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.433 ' C ' ' CD1' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -102.76 -171.91 2.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.92 0.39 . . . . 0.0 111.17 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 13' ' ' ALA . 6.7 p -164.49 170.55 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.469 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -40.05 -31.64 0.13 Allowed 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 111.971 0.359 . . . . 0.0 111.971 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.04 50.55 1.33 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.798 0.332 . . . . 0.0 111.197 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.468 ' N ' HG13 ' A' ' 10' ' ' VAL . . . -78.58 -61.16 2.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.123 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 179.47 -36.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.123 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.93 -50.53 68.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.01 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -71.72 -12.66 61.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.669 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -90.71 -28.0 18.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.147 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.435 HG22 ' CD1' ' A' ' 22' ' ' PHE . 14.7 p -90.09 -24.2 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.833 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.3 pttp -48.95 -32.72 9.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.761 0.315 . . . . 0.0 111.207 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -66.1 -33.77 76.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.967 0.413 . . . . 0.0 110.479 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.2 tt -88.87 -27.12 21.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.662 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.435 ' CD1' HG22 ' A' ' 18' ' ' VAL . 2.0 m-30 -53.82 -24.86 16.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.049 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.6 m -61.41 -37.94 85.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.831 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.408 ' HG3' ' N ' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -90.35 -29.1 18.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.941 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.408 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -69.94 -40.4 75.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.936 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.57 21.26 0.16 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.434 -0.888 . . . . 0.0 113.264 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.2 tttm 56.17 111.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.959 0.409 . . . . 0.0 111.316 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.8 p -105.37 121.54 57.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.013 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -67.44 -53.17 31.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.976 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -158.35 159.95 36.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.977 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.3 t -127.93 130.45 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.973 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.65 145.97 51.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.028 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 34.6 mt -141.18 146.55 37.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.728 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.6 pp -82.22 175.65 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.161 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -134.01 175.69 9.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.003 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -75.2 166.39 23.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 mpp_? -105.24 36.61 2.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.911 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -174.18 -41.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.966 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.6 -10.54 19.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.332 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt 61.76 28.97 17.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.782 0.325 . . . . 0.0 110.834 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -105.95 137.05 19.24 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.706 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.25 109.46 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.43 2.087 . . . . 0.0 112.407 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.01 109.68 2.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.993 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 148.54 -63.92 0.41 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.726 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -177.25 170.72 2.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.875 0.369 . . . . 0.0 111.05 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -125.34 179.87 16.01 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.543 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -146.36 129.53 16.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.348 . . . . 0.0 110.917 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.3 t -122.46 148.67 26.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.045 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -117.69 104.76 11.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.927 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 32.0 mtp -138.09 159.73 41.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.7 158.51 34.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.722 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -68.24 93.31 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.096 0.474 . . . . 0.0 110.963 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -169.53 -60.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.999 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 t -90.3 -15.56 30.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.84 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.5 t -68.68 -49.0 68.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.843 0.354 . . . . 0.0 111.173 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.12 -22.36 63.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.157 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -90.28 -37.21 14.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 110.602 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.75 -65.05 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.86 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.6 mp -58.01 -30.63 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.031 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.43 -55.9 28.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.678 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -90.48 -28.07 18.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.684 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.1 mt -74.87 -72.26 0.3 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.782 0.325 . . . . 0.0 111.398 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.25 138.93 30.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.16 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -177.38 -46.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.891 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -158.22 -178.69 7.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.948 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -92.65 106.62 18.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.873 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.67 -164.87 1.0 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.743 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 3.1 mtm -96.86 34.93 1.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.784 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.0 31.03 4.57 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.513 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -112.45 -62.28 1.6 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.862 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.7 -50.14 3.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.843 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.0 mt 56.37 167.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.15 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.4 ttm105 -95.01 45.08 1.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.915 0.388 . . . . 0.0 110.637 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.57 159.29 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.236 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.1 t -157.8 -176.82 6.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.63 44.66 1.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.93 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.141 179.96 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mtm . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.839 0.352 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -107.81 172.52 6.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -111.18 129.68 55.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.2 mt -98.12 143.46 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.093 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.493 ' CE1' ' CD2' ' A' ' 45' ' ' PHE . 41.5 t80 -116.97 123.32 46.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.962 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.0 p -125.92 121.32 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.971 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -107.21 76.8 0.23 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.696 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -178.04 54.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.85 0.357 . . . . 0.0 110.758 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.7 mt -128.73 -168.82 1.97 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.179 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -178.55 -168.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.388 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -47.02 -41.76 17.03 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.859 0.361 . . . . 0.0 111.1 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -167.66 76.43 0.15 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.658 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -97.62 -63.3 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.547 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -163.61 -19.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.989 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.6 t -47.56 -59.16 3.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.821 0.343 . . . . 0.0 111.511 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -67.42 -11.73 58.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.88 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -90.36 -32.61 16.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.062 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.6 p -87.23 -25.96 6.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.748 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -55.62 -29.75 59.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.781 0.324 . . . . 0.0 111.036 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -67.71 -35.96 79.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.757 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.8 tt -85.01 -30.34 24.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.815 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -17.79 65.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.107 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.7 -24.28 41.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.257 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -88.3 -25.97 22.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.225 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -107.24 -32.37 7.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.231 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -114.46 -25.27 4.1 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.806 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.99 53.47 2.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.039 0.447 . . . . 0.0 110.748 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.4 p -57.34 143.63 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.195 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -100.92 -40.12 7.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.875 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -138.59 126.13 21.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.906 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 p -146.47 131.73 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.087 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.4 170.08 7.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 23.2 mt -96.63 154.29 17.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.816 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.429 HG12 ' CE2' ' A' ' 45' ' ' PHE . 2.6 pp -92.82 175.74 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.095 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -144.85 171.89 13.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.44 160.32 24.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.932 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.39 30.82 4.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.963 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -144.46 -57.41 0.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.43 -5.5 25.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.276 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 63.4 34.2 13.14 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.968 0.413 . . . . 0.0 110.934 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -110.72 143.17 27.67 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.831 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.47 133.66 54.3 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.532 2.155 . . . . 0.0 112.257 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 tptp -79.51 -69.02 0.61 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.848 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.99 45.07 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.532 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.493 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 27.0 p90 -177.75 169.31 2.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.904 0.383 . . . . 0.0 110.947 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.89 178.93 19.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.481 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -128.73 136.77 51.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.756 0.312 . . . . 0.0 110.915 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.8 t -127.74 141.62 45.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.093 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.26 113.83 25.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.7 mtp -145.96 -179.78 6.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.823 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -61.15 152.02 29.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.834 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -69.12 -32.6 72.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.016 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -77.13 -29.73 54.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.039 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.6 m -73.86 -32.42 63.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.015 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t -56.74 -49.18 79.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.309 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 m -53.16 -62.49 1.62 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.07 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -63.02 -29.65 70.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.997 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -66.57 -40.09 88.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.413 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.443 HG21 ' HB3' ' A' ' 63' ' ' ASP . 8.0 mt -90.12 -24.08 5.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.978 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.99 -52.8 63.47 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -90.47 -23.48 20.97 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.518 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 78.6 mt -85.39 -75.01 0.38 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.717 0.294 . . . . 0.0 111.702 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.443 ' HB3' HG21 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -52.46 134.04 34.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.875 0.369 . . . . 0.0 111.254 -179.439 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 179.1 -38.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.844 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.61 -165.8 2.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.768 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -119.92 96.95 5.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.921 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.2 -165.54 1.03 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.831 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 4.3 mmt -97.1 36.19 1.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.052 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.37 28.12 3.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.576 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -110.76 -31.15 7.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.815 0.341 . . . . 0.0 110.968 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.82 -56.38 0.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.949 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.0 mt 59.97 159.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.052 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.7 ttt85 -89.29 53.64 2.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.776 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.1 p -74.57 156.81 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.21 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.0 t -178.12 147.89 0.47 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.806 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -61.7 128.72 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.3 -0.857 . . . . 0.0 111.156 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpp? . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.813 0.339 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.4 mmt-85 -118.62 151.99 36.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.854 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.414 ' HB3' ' CE1' ' A' ' 47' ' ' PHE . 26.4 m-20 -89.72 115.74 27.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.5 mt -87.27 127.01 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.134 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -99.62 123.05 43.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.837 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.0 p -121.65 127.21 75.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.096 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.423 ' HA2' ' CD1' ' A' ' 45' ' ' PHE . . . -105.88 -171.98 23.51 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.414 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 59.48 30.49 20.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.809 0.337 . . . . 0.0 110.955 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.7 mt -82.83 166.72 18.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.982 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -162.23 -174.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.796 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.43 ' CZ ' ' HD2' ' A' ' 42' ' ' PRO . 6.9 m-85 -46.73 -52.99 12.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.95 0.405 . . . . 0.0 111.159 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -154.07 75.05 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.61 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.95 -56.72 2.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.429 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.5 m -165.5 -34.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.465 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.27 -54.4 11.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.715 0.293 . . . . 0.0 111.451 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -68.13 -13.08 61.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.96 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -90.62 -43.4 10.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.136 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.416 HG22 ' CD1' ' A' ' 22' ' ' PHE . 12.3 p -79.23 -30.79 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.683 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -52.43 -27.53 16.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.801 0.334 . . . . 0.0 111.15 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -71.95 -37.74 69.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.811 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.1 tp -88.38 -28.44 20.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.416 ' CD1' HG22 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -57.89 -21.67 44.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.163 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 85.8 p -84.57 -27.62 27.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.093 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -89.98 -34.2 16.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.289 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -105.21 -30.23 9.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.271 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.4 -14.95 22.66 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.895 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.75 35.01 24.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.85 0.357 . . . . 0.0 110.86 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.0 p -50.69 143.31 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.336 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -91.26 -34.46 14.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.927 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -167.79 158.18 10.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.918 0.39 . . . . 0.0 111.193 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t -143.48 150.34 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.898 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.0 ttpt -169.64 151.76 4.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.933 0.397 . . . . 0.0 111.288 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.95 -177.27 4.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.329 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.441 ' CD1' ' HA3' ' A' ' 44' ' ' GLY . 1.8 pp -129.57 179.83 3.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.821 0.343 . . . . 0.0 111.189 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.71 -168.59 2.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.952 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.77 -20.67 36.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.513 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.29 26.44 4.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.922 0.392 . . . . 0.0 110.81 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -156.44 -46.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.414 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.07 0.54 25.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.96 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.9 mttm 63.98 38.95 8.34 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.93 0.395 . . . . 0.0 111.044 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.5 mtmm -100.96 100.79 13.76 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.573 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.43 ' HD2' ' CZ ' ' A' ' 11' ' ' TYR . 33.3 Cg_endo -64.8 107.1 0.84 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.354 2.036 . . . . 0.0 112.216 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.5 37.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.195 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.441 ' HA3' ' CD1' ' A' ' 34' ' ' ILE . . . -129.25 32.64 3.2 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.473 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.423 ' CD1' ' HA2' ' A' ' 7' ' ' GLY . 0.5 OUTLIER 72.41 166.05 0.3 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.888 0.375 . . . . 0.0 110.905 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.31 -162.36 9.08 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.482 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.414 ' CE1' ' HB3' ' A' ' 3' ' ' ASN . 0.3 OUTLIER -139.81 160.91 38.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 0.0 111.039 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.7 t -147.91 142.22 19.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.955 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -107.75 114.58 28.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 21.4 mtm -145.54 -178.12 5.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.85 150.65 37.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -61.18 -36.96 81.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -63.47 -31.05 72.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.016 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.41 -35.42 21.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.987 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.7 t -57.69 -30.82 38.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.28 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.39 -23.43 27.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.269 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -90.21 -41.45 11.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.888 0.375 . . . . 0.0 110.84 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -58.34 -66.43 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.949 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.6 mt -58.07 -21.81 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.277 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.66 -54.3 17.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.584 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.19 -29.97 17.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.479 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 92.9 mt -73.2 -74.24 0.18 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.241 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.419 ' CB ' ' CG1' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -57.0 135.86 56.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.055 -179.78 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 t30 179.51 -38.78 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.789 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -159.49 -177.51 6.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.788 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.21 111.4 23.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.988 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -131.71 -171.07 2.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.947 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 21.5 mtp -93.12 45.68 1.18 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.98 39.5 3.8 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.516 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.08 -39.68 2.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.697 0.284 . . . . 0.0 111.075 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.37 -48.86 0.72 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.244 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.9 mt 55.26 174.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.637 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.78 66.16 0.77 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.969 0.414 . . . . 0.0 111.022 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.419 ' CG1' ' CB ' ' A' ' 63' ' ' ASP . 14.7 p -83.25 156.98 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.0 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.4 t -167.31 142.12 3.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.964 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -69.61 134.12 48.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.949 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.044 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mtm . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.783 0.325 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -96.48 167.0 11.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.938 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -115.68 106.42 13.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.817 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.6 mt -76.76 128.76 37.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.201 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -108.54 122.21 46.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.749 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 p -132.49 145.92 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.228 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.34 -165.33 11.78 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.408 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 55.04 34.62 22.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.76 0.314 . . . . 0.0 111.039 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 28.6 mt -106.68 128.49 54.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.968 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.71 -168.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.797 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.424 ' CE2' ' CD ' ' A' ' 42' ' ' PRO . 0.7 OUTLIER -49.7 -47.47 50.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.788 0.328 . . . . 0.0 111.04 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -145.76 58.79 1.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.706 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.31 -52.87 63.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.266 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 176.03 -32.21 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.102 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.49 -54.15 19.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.323 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -64.83 -15.4 61.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.898 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -90.49 -34.09 15.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.201 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 p -90.12 -21.79 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.858 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.86 -28.43 3.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.748 0.308 . . . . 0.0 111.142 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -71.77 -33.25 68.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.748 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.8 tt -88.9 -32.13 17.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.809 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.35 -23.46 64.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.988 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.6 m -80.91 -23.06 39.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.076 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.06 -37.52 14.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.111 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -101.7 -31.16 10.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.093 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.22 -24.79 9.32 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.655 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.0 tttt 63.88 36.99 9.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 0.0 110.899 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.8 p -61.01 131.98 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.034 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -74.33 -41.92 60.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -150.85 148.32 28.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.0 p -162.95 130.24 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.975 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.99 161.46 4.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.884 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mt -100.83 173.75 6.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.921 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.415 HG12 ' CE2' ' A' ' 45' ' ' PHE . 1.4 pp -112.32 161.26 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.156 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.415 ' CD2' ' HB3' ' A' ' 42' ' ' PRO . 12.4 m-85 -145.34 -174.32 4.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.18 132.0 44.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.97 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -92.14 50.71 1.68 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.791 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -171.65 -42.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.51 -20.52 18.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.08 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.8 mmtp 67.78 44.68 1.56 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.914 0.388 . . . . 0.0 110.934 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -136.56 141.81 36.89 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.924 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.424 ' CD ' ' CE2' ' A' ' 11' ' ' TYR . 66.4 Cg_endo -73.88 134.1 19.36 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.52 2.146 . . . . 0.0 112.268 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.9 mmmt -63.8 -66.83 0.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.847 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.06 44.65 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.64 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.415 ' CE2' HG12 ' A' ' 34' ' ' ILE . 33.2 p90 -177.75 154.47 0.94 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.802 0.334 . . . . 0.0 110.986 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.12 -164.37 9.88 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.451 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -146.15 137.48 24.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.819 0.342 . . . . 0.0 110.908 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.7 t -122.52 111.89 32.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.998 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.37 103.86 10.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.957 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.6 mtm -142.81 152.96 42.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.74 178.86 0.55 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.89 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.72 -159.0 0.08 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.45 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 66.05 -71.58 0.09 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.16 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.3 m -61.29 -30.99 70.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.039 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.4 t -63.73 -44.78 98.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.181 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.14 -25.4 66.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.177 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -90.16 -38.08 13.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.931 0.396 . . . . 0.0 110.727 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -58.41 -64.51 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.895 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.5 mt -58.13 -26.65 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.204 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.78 -53.91 43.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.713 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -90.33 -33.98 15.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.886 0.374 . . . . 0.0 111.428 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 83.6 mt -72.01 -70.79 0.31 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.38 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.414 ' CB ' ' CG1' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -54.91 134.59 48.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.18 -179.583 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -179.98 -67.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.904 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.58 -174.02 2.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -103.86 105.29 15.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.043 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -123.22 -174.75 3.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.813 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 8.5 ptt? -96.02 36.83 1.27 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.991 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.28 36.76 1.17 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.55 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.38 -40.42 2.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.727 0.299 . . . . 0.0 110.976 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.02 -60.99 0.8 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.859 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.9 mt 59.76 159.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.012 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.88 58.69 4.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.926 0.394 . . . . 0.0 110.748 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.414 ' CG1' ' CB ' ' A' ' 63' ' ' ASP . 13.8 p -75.37 158.11 5.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.185 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.9 t -174.15 153.94 2.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.803 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -76.54 124.02 26.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.022 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.86 0.362 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.475 ' HB2' HG21 ' A' ' 55' ' ' VAL . 21.9 mmm180 -89.02 175.28 7.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.952 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.406 ' HB3' ' CE2' ' A' ' 47' ' ' PHE . 32.3 m-20 -121.95 129.49 52.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.865 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.524 HG12 HG13 ' A' ' 55' ' ' VAL . 31.6 mt -100.57 146.53 9.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.158 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -125.52 116.36 21.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.899 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 p -120.84 134.18 65.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.084 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.99 -168.64 14.49 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.429 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 59.99 33.23 21.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.844 0.354 . . . . 0.0 110.875 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.676 HD12 ' C ' ' A' ' 45' ' ' PHE . 53.7 mt -87.67 136.39 32.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.946 HG12 ' HB2' ' A' ' 13' ' ' ALA . 1.4 p -105.89 179.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.778 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.643 ' H ' HG22 ' A' ' 10' ' ' VAL . 6.9 m-85 -46.43 -53.37 11.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.871 0.367 . . . . 0.0 111.138 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.432 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -146.43 68.11 1.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.569 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.946 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -77.38 -76.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.381 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.49 -23.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.867 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.405 ' O ' HG12 ' A' ' 18' ' ' VAL . 16.7 p -47.29 -58.16 4.43 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.728 0.299 . . . . 0.0 111.459 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.24 -12.83 61.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.832 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -90.52 -29.86 17.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.152 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 15' ' ' SER . 12.3 p -87.5 -25.48 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.75 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.72 -26.84 6.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.74 0.305 . . . . 0.0 111.22 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -75.0 -34.64 61.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.8 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.5 tp -89.58 -30.18 18.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.995 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.406 ' CD2' ' HE3' ' A' ' 50' ' ' MET . 0.1 OUTLIER -58.08 -21.83 47.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.083 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.3 p -82.56 -24.38 34.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.19 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -85.44 -26.48 26.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.222 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.67 -29.27 7.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.256 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.5 -26.78 3.83 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.712 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.0 tttt 64.05 51.1 2.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.369 . . . . 0.0 110.837 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.3 p -54.76 135.76 17.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.235 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -90.96 -42.47 10.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.938 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -138.82 124.92 20.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 31' ' ' VAL . 10.9 p -136.15 121.46 28.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -138.4 178.83 6.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.011 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.58 ' CD2' HD13 ' A' ' 9' ' ' LEU . 7.4 mt -145.43 173.8 11.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.613 HD11 ' HA3' ' A' ' 44' ' ' GLY . 2.5 pp -110.31 179.0 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.144 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -121.61 173.22 7.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.037 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.73 -11.06 60.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.349 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.97 33.2 5.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.948 0.404 . . . . 0.0 110.848 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -165.34 -43.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.856 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.59 -1.51 16.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.346 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.15 33.03 14.78 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.885 0.374 . . . . 0.0 110.856 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.07 148.13 38.78 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.802 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.67 113.19 2.65 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.52 2.147 . . . . 0.0 112.231 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.2 109.19 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.613 ' HA3' HD11 ' A' ' 34' ' ' ILE . . . 150.52 -71.58 0.3 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.541 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.676 ' C ' HD12 ' A' ' 9' ' ' LEU . 9.9 p90 -165.55 179.07 6.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.351 . . . . 0.0 110.946 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.53 ' N ' HD12 ' A' ' 9' ' ' LEU . . . -143.17 -175.78 16.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.548 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.406 ' CE2' ' HB3' ' A' ' 3' ' ' ASN . 1.2 t80 -140.68 155.09 46.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.801 0.334 . . . . 0.0 110.926 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.1 t -151.36 131.36 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.08 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.88 116.46 31.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.406 ' HE3' ' CD2' ' A' ' 22' ' ' PHE . 4.0 mtt -142.29 168.24 20.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.963 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.654 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -60.0 179.75 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -96.2 35.52 1.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.996 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -123.86 -41.1 2.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.923 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.524 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 24.9 p -87.79 -24.77 23.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.171 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.669 ' O ' HD12 ' A' ' 59' ' ' ILE . 41.7 t -65.38 -28.79 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.319 . . . . 0.0 111.319 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.4 m -65.4 -47.33 76.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.111 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.429 ' HA ' ' HB3' ' A' ' 60' ' ' ALA . 5.4 tt0 -90.24 -25.0 20.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.226 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.524 ' HB2' ' O ' ' A' ' 54' ' ' SER . . . -50.42 -45.27 55.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.536 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.712 HG23 ' HB3' ' A' ' 63' ' ' ASP . 3.9 mp -90.44 -28.31 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.078 0.466 . . . . 0.0 110.929 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.429 ' HB3' ' HA ' ' A' ' 57' ' ' GLU . . . -52.32 -58.84 5.43 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -90.36 -12.46 37.57 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.507 HD12 ' O ' ' A' ' 58' ' ' ALA . 33.5 mt -90.04 -75.11 0.46 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.888 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.712 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -46.69 132.62 11.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.942 0.401 . . . . 0.0 111.632 -179.185 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 179.96 -67.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.742 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.17 -167.1 1.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.72 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -107.64 111.34 23.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.885 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.05 -167.17 1.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.951 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 3.5 mmt -86.9 56.19 3.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.704 ' HA2' HD11 ' A' ' 72' ' ' ILE . . . 78.69 32.67 40.51 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.503 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.7 -29.23 8.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.801 0.334 . . . . 0.0 110.966 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.514 HG23 ' H ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -137.94 -65.21 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.98 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.704 HD11 ' HA2' ' A' ' 69' ' ' GLY . 19.2 mt 59.74 159.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.979 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.49 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -83.32 78.58 9.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.698 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.588 HG13 HG23 ' A' ' 59' ' ' ILE . 14.0 p -101.71 153.84 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.206 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.4 t -169.1 161.65 10.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.958 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.45 130.83 47.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.089 179.979 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 120.883 0.373 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.29 169.35 8.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.838 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -104.13 133.55 48.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.768 HD11 ' HB2' ' A' ' 50' ' ' MET . 25.6 mt -98.99 111.33 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.099 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -90.54 119.39 30.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.828 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.694 HG13 HD11 ' A' ' 9' ' ' LEU . 8.7 p -131.86 139.05 51.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.044 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.553 ' O ' HG21 ' A' ' 72' ' ' ILE . . . -114.64 -163.6 14.45 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.399 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.629 ' HB3' HG23 ' A' ' 72' ' ' ILE . 5.0 t-20 55.67 36.26 26.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.788 0.328 . . . . 0.0 110.981 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.694 HD11 HG13 ' A' ' 6' ' ' VAL . 93.1 mt -100.73 109.81 21.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.066 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.642 HG22 ' H ' ' A' ' 11' ' ' TYR . 1.0 OUTLIER -78.33 -175.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.653 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.642 ' H ' HG22 ' A' ' 10' ' ' VAL . 24.7 m-85 -46.79 -48.96 20.57 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.894 0.378 . . . . 0.0 111.098 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.549 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.1 m -142.3 62.01 1.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.652 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.636 ' O ' HG23 ' A' ' 14' ' ' THR . . . -58.46 -70.85 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.424 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER 175.23 -28.43 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.34 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 26.8 t -48.33 -55.83 9.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.77 0.319 . . . . 0.0 111.345 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.86 -14.7 60.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.912 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -90.48 -41.12 11.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.04 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 18' ' ' VAL . 11.7 p -76.57 -14.21 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.759 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -51.77 -40.59 60.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.773 0.32 . . . . 0.0 111.193 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -61.06 -33.25 73.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.818 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.437 ' O ' HD23 ' A' ' 21' ' ' LEU . 6.4 tt -88.65 -28.65 20.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.853 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.47 -26.37 61.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.019 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.6 t -73.12 -34.57 66.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.923 0.392 . . . . 0.0 110.867 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -90.15 -4.98 56.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.245 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -114.47 -33.86 5.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.732 0.301 . . . . 0.0 111.238 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.0 -2.46 6.08 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.293 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? 59.63 40.85 19.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.944 0.402 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 49' ' ' GLU . 13.6 p -57.52 139.45 17.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.207 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -75.78 -39.09 57.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.933 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -168.83 154.9 6.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.007 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.785 HG22 HG13 ' A' ' 48' ' ' VAL . 21.7 t -138.72 118.79 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.983 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.53 132.27 17.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.108 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.626 ' N ' HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -106.98 174.53 5.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.558 179.692 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.668 HD11 ' CE1' ' A' ' 45' ' ' PHE . 2.1 pp -105.19 152.12 7.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.263 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 2.7 m-85 -117.73 -173.07 2.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.962 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.1 -168.66 1.9 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.864 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.7 ttt-85 -127.65 36.27 4.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -157.02 -54.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.72 -2.14 26.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.379 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.3 mttm 60.84 36.97 18.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.815 0.341 . . . . 0.0 110.925 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -105.64 141.29 22.34 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.903 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 50.3 Cg_exo -53.19 118.28 4.67 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.479 2.119 . . . . 0.0 112.276 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -58.35 -69.11 0.2 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.839 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 173.9 35.11 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.562 -0.828 . . . . 0.0 113.012 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.668 ' CE1' HD11 ' A' ' 34' ' ' ILE . 28.4 p90 -178.5 155.82 0.88 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.077 0.465 . . . . 0.0 111.333 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.475 ' N ' HD12 ' A' ' 9' ' ' LEU . . . -141.09 -166.18 10.62 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.388 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -144.08 143.74 31.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.88 0.371 . . . . 0.0 110.967 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.785 HG13 HG22 ' A' ' 31' ' ' VAL . 35.3 t -134.26 138.9 49.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.055 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -94.33 107.87 19.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.908 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.768 ' HB2' HD11 ' A' ' 4' ' ' ILE . 3.6 mtt -135.78 156.36 48.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.915 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.597 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.7 tt0 -81.29 154.94 26.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.974 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -51.06 -29.58 13.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.198 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -71.24 -35.09 71.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.95 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.9 p -87.07 -43.65 12.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.938 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 51' ' ' GLN . 30.2 t -58.21 -31.11 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.145 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.51 -51.32 70.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.098 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -88.64 -23.51 23.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.157 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.522 ' O ' HD12 ' A' ' 62' ' ' LEU . . . -55.04 -41.48 71.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.408 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.777 HG23 ' HB3' ' A' ' 63' ' ' ASP . 4.5 mt -90.25 -24.81 5.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.067 0.46 . . . . 0.0 110.917 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.49 -55.66 30.97 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.29 -19.71 23.78 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.522 HD12 ' O ' ' A' ' 58' ' ' ALA . 64.9 mt -85.4 -75.15 0.38 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.763 0.316 . . . . 0.0 111.65 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.777 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -55.97 137.17 51.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.147 -179.522 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 178.78 -61.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.813 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.89 -173.6 3.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -105.78 118.58 36.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.435 ' CD2' ' HD3' ' A' ' 70' ' ' ARG . 0.2 OUTLIER -135.2 -165.52 1.69 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.83 32.27 2.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.026 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.428 ' HA2' HD11 ' A' ' 72' ' ' ILE . . . 112.57 33.29 2.11 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.585 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.435 ' HD3' ' CD2' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -113.52 -34.48 5.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 0.0 110.934 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.498 HG23 ' H ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -137.92 -61.55 0.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.843 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.629 HG23 ' HB3' ' A' ' 8' ' ' ASN . 1.1 mp 59.94 162.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.908 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.429 ' N ' HG22 ' A' ' 72' ' ' ILE . 3.5 mmm-85 -87.75 75.78 8.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.859 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.471 HG23 ' HB ' ' A' ' 6' ' ' VAL . 12.5 p -97.84 156.12 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.448 ' N ' HG22 ' A' ' 74' ' ' VAL . 9.9 t -167.23 161.26 14.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.961 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -81.76 107.56 14.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.907 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.167 -0.921 . . . . 0.0 111.089 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.825 0.345 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -135.77 173.32 11.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 -102.61 139.44 38.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.935 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.552 HD11 ' HB2' ' A' ' 50' ' ' MET . 4.1 mt -109.8 136.95 44.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.044 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -114.73 122.76 47.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.913 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.747 HG13 HD11 ' A' ' 9' ' ' LEU . 11.3 p -129.06 134.19 64.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.142 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -118.47 -168.3 14.22 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.468 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 59.64 33.9 22.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.858 0.361 . . . . 0.0 110.957 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.747 HD11 HG13 ' A' ' 6' ' ' VAL . 48.4 mt -98.74 -175.03 2.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.909 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.641 HG13 ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -167.97 -167.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.733 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.641 ' N ' HG13 ' A' ' 10' ' ' VAL . 77.4 m-85 -47.58 -46.76 28.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.798 0.333 . . . . 0.0 111.195 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.484 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -152.44 53.26 0.79 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.824 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.654 ' O ' HG23 ' A' ' 14' ' ' THR . . . -64.14 -55.32 22.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.184 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.7 HG21 ' HA3' ' A' ' 69' ' ' GLY . 0.1 OUTLIER 177.07 -33.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.081 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.565 ' OG ' HD13 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -52.39 -52.39 53.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.803 0.335 . . . . 0.0 111.103 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -66.62 -15.52 63.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.772 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -90.55 -29.81 17.63 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.308 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 15' ' ' SER . 14.4 p -89.74 -20.94 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.811 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.404 ' HB2' HG11 ' A' ' 31' ' ' VAL . 13.3 pttp -57.29 -30.47 64.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.693 0.282 . . . . 0.0 111.12 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -72.77 -35.98 67.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.885 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.4 tp -87.56 -27.76 22.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.493 ' CD1' ' HE3' ' A' ' 50' ' ' MET . 0.1 OUTLIER -57.06 -21.96 35.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.211 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.444 ' HA ' HG12 ' A' ' 28' ' ' VAL . 1.4 t -83.25 -21.12 33.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.22 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -89.17 -43.65 10.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.125 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -100.05 -29.86 12.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.148 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.34 -21.96 20.82 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.597 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.66 31.69 16.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.911 0.386 . . . . 0.0 110.918 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 49' ' ' GLU . 12.0 p -55.2 141.87 10.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.167 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -84.07 -42.63 15.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.62 160.36 40.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.468 HG23 HG22 ' A' ' 48' ' ' VAL . 10.2 p -149.09 151.15 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.928 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.21 131.92 0.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.088 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.725 HD23 ' HA3' ' A' ' 46' ' ' GLY . 1.0 OUTLIER -102.28 -174.31 2.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.603 179.765 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.532 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.3 pp -107.27 167.71 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.288 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -147.34 157.66 43.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.01 154.25 23.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.872 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -94.71 46.52 1.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -176.52 -40.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.801 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.71 -18.7 16.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.084 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.49 34.84 12.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.871 0.367 . . . . 0.0 110.911 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -113.39 142.13 27.01 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.782 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.24 117.58 4.07 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.443 2.095 . . . . 0.0 112.297 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -60.63 -70.11 0.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.762 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 176.22 35.55 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.737 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.444 ' CE2' HG12 ' A' ' 34' ' ' ILE . 28.2 p90 -178.66 172.82 1.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.901 0.382 . . . . 0.0 111.082 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.725 ' HA3' HD23 ' A' ' 33' ' ' LEU . . . -162.58 -164.31 17.27 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.418 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -138.3 164.3 29.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.915 0.388 . . . . 0.0 111.05 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.468 HG22 HG23 ' A' ' 31' ' ' VAL . 32.7 t -149.91 151.55 12.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.926 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.575 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -113.31 110.92 21.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.904 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.552 ' HB2' HD11 ' A' ' 4' ' ' ILE . 18.1 mtp -147.3 -176.64 5.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.891 ' O ' HG23 ' A' ' 55' ' ' VAL . 2.0 tt0 -86.23 148.44 25.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.902 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -57.75 -35.1 70.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.062 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.22 -44.46 92.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.914 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 58.4 m -77.1 -32.1 56.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.906 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.902 ' O ' HD12 ' A' ' 59' ' ' ILE . 39.5 t -69.17 -36.11 71.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.189 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.4 m -60.0 -43.48 95.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.189 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -90.0 -27.82 19.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.283 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.529 ' O ' HD12 ' A' ' 62' ' ' LEU . . . -56.88 -41.83 78.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.396 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.902 HD12 ' O ' ' A' ' 55' ' ' VAL . 2.7 mp -90.22 -27.35 5.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.041 0.448 . . . . 0.0 110.966 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.56 -58.35 7.07 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -90.35 -13.0 36.01 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.529 HD12 ' O ' ' A' ' 58' ' ' ALA . 41.3 mt -89.99 -75.18 0.46 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.775 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.766 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -49.65 129.88 20.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.521 -179.324 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -176.98 -43.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.914 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.39 -175.13 4.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -106.89 99.8 9.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.962 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.69 -168.95 1.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.899 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.38 52.25 2.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.959 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.7 ' HA3' HG21 ' A' ' 14' ' ' THR . . . 89.63 27.93 20.64 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.579 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 ttp180 -107.82 -31.16 8.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.796 0.331 . . . . 0.0 110.868 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.483 HG23 ' H ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -140.31 -59.2 0.53 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.567 HD11 ' HA2' ' A' ' 69' ' ' GLY . 15.5 mt 59.38 161.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.012 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.477 ' N ' HG22 ' A' ' 72' ' ' ILE . 5.5 mtt180 -86.63 56.27 3.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.796 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.556 HG13 HG23 ' A' ' 59' ' ' ILE . 14.0 p -76.81 158.96 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.294 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.565 ' HA ' HG21 ' A' ' 59' ' ' ILE . 10.2 t -167.76 165.79 13.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.886 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -96.76 110.55 22.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.31 -0.852 . . . . 0.0 111.17 179.971 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 ttt . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.788 0.328 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -130.46 161.07 32.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.855 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -103.19 119.24 38.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.891 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.676 HG12 HG13 ' A' ' 55' ' ' VAL . 17.2 mt -92.97 131.83 38.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.18 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.518 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 85.9 t80 -111.17 126.01 54.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.852 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.16 145.0 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.192 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.54 -174.29 14.74 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.474 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 60.48 41.81 15.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 110.875 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.57 HD13 HD21 ' A' ' 33' ' ' LEU . 25.8 mt -103.88 -179.16 3.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.839 HG12 ' HB2' ' A' ' 13' ' ' ALA . 5.7 p -173.36 169.76 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.799 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.564 ' H ' HG22 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -40.23 -37.73 0.68 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.855 -179.593 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.605 ' H ' HG13 ' A' ' 10' ' ' VAL . 21.0 p -142.61 54.97 1.41 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.842 0.353 . . . . 0.0 111.1 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.839 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -77.11 -69.99 0.49 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.189 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -179.8 -36.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.966 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.423 ' HB2' HD22 ' A' ' 9' ' ' LEU . 0.8 OUTLIER -52.8 -51.26 61.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.893 0.378 . . . . 0.0 111.078 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -14.58 62.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -90.33 -31.72 16.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.144 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.8 p -87.76 -24.83 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.593 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.708 ' HB3' HG11 ' A' ' 31' ' ' VAL . 9.8 pttt -54.02 -28.53 38.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.812 0.339 . . . . 0.0 111.0 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -33.86 69.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.662 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.5 tt -90.13 -28.44 18.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.838 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.19 -26.55 51.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.004 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.1 p -76.23 -33.55 59.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.852 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -90.1 -9.62 47.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.337 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -111.77 -37.18 5.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.715 0.293 . . . . 0.0 111.077 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.03 -8.47 5.57 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.198 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.33 47.35 6.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.882 0.372 . . . . 0.0 110.755 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.684 HG21 ' CG2' ' A' ' 31' ' ' VAL . 9.7 p -54.28 155.56 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.29 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.434 ' N ' HG22 ' A' ' 28' ' ' VAL . 14.1 m-85 -93.15 -49.18 6.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.09 143.47 30.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.809 HG22 HG13 ' A' ' 48' ' ' VAL . 21.2 t -150.19 110.74 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.122 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.33 172.94 16.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.57 HD21 HD13 ' A' ' 9' ' ' LEU . 7.5 mt -104.13 156.62 17.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.828 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.839 HD11 ' HB2' ' A' ' 43' ' ' LYS . 2.7 pp -66.04 -35.51 75.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.127 0.489 . . . . 0.0 111.205 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.575 ' N ' HD12 ' A' ' 34' ' ' ILE . 3.1 m-85 49.69 -175.97 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.196 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -109.47 141.02 42.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.8 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -90.13 52.43 2.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.942 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -177.49 -40.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.818 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -104.9 -18.35 14.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.167 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.8 mttp 63.32 33.67 13.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.909 0.385 . . . . 0.0 110.883 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -113.89 145.25 33.12 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.883 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.65 120.31 6.11 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.58 2.187 . . . . 0.0 112.352 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.839 ' HB2' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -68.55 -75.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.878 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 175.9 37.11 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.65 -0.785 . . . . 0.0 112.684 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.435 ' CE2' HG12 ' A' ' 34' ' ' ILE . 32.7 p90 -177.14 132.95 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.905 0.383 . . . . 0.0 110.992 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -122.4 -159.3 10.55 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.533 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.406 ' CD1' ' O ' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -145.01 152.59 40.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.841 0.353 . . . . 0.0 111.057 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.809 HG13 HG22 ' A' ' 31' ' ' VAL . 48.7 t -141.75 124.75 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.856 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -95.39 108.4 20.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.61 ' HG3' HG23 ' A' ' 28' ' ' VAL . 26.2 mtp -136.79 158.96 43.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.421 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -62.54 155.53 25.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -77.75 69.15 3.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.027 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -149.98 -48.27 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.428 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -90.18 -20.07 23.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.014 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.725 ' O ' HD12 ' A' ' 59' ' ' ILE . 30.0 t -59.5 -47.98 88.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.317 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 m -56.01 -56.13 24.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.149 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -69.65 -28.67 66.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.187 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.528 ' O ' HD12 ' A' ' 62' ' ' LEU . . . -60.56 -41.72 95.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.281 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.748 HG23 ' HB3' ' A' ' 63' ' ' ASP . 3.3 mt -90.34 -27.28 5.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.045 0.45 . . . . 0.0 111.046 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.53 -57.26 12.09 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -90.45 -14.56 32.58 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.528 HD12 ' O ' ' A' ' 58' ' ' ALA . 48.8 mt -90.08 -75.08 0.46 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.777 0.322 . . . . 0.0 111.826 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.748 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -48.96 140.58 8.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.979 0.419 . . . . 0.0 111.499 -179.291 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 174.19 -35.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.641 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.72 -170.25 2.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.744 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.2 109.2 17.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.911 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -139.2 -174.22 3.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -74.98 68.2 1.78 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.502 ' HA2' HD11 ' A' ' 72' ' ' ILE . . . 66.36 26.55 72.69 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.683 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.3 mtp85 -96.56 -36.36 10.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.898 0.38 . . . . 0.0 110.82 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -138.67 -51.66 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.776 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.502 HD11 ' HA2' ' A' ' 69' ' ' GLY . 18.0 mt 59.78 159.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.107 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.494 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -92.01 50.54 1.68 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.947 0.403 . . . . 0.0 110.845 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.515 HG13 ' HB3' ' A' ' 63' ' ' ASP . 14.8 p -72.65 158.81 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.536 ' HA ' HG21 ' A' ' 59' ' ' ILE . 3.2 t -176.77 157.82 1.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.895 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.18 108.64 14.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.828 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.518 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.156 -0.926 . . . . 0.0 111.105 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 mtt . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.827 0.346 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -109.18 -171.08 1.77 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -121.06 137.92 54.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.948 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.653 HG12 HG13 ' A' ' 55' ' ' VAL . 21.1 mt -109.48 141.05 25.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.103 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.803 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 7.2 t80 -110.23 124.2 51.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.908 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.5 p -129.37 138.16 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.108 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.19 -171.58 17.4 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.45 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 58.73 30.22 19.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.831 0.348 . . . . 0.0 110.97 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.421 HD12 HD21 ' A' ' 33' ' ' LEU . 3.9 mm? -86.29 163.38 17.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.798 HG12 ' HB2' ' A' ' 13' ' ' ALA . 3.6 p -147.36 172.4 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.853 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.581 ' H ' HG22 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -42.58 -41.52 3.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.583 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.627 ' H ' HG13 ' A' ' 10' ' ' VAL . 18.3 m -150.25 66.34 0.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.927 0.394 . . . . 0.0 110.953 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.798 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -73.49 -77.38 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.323 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 13' ' ' ALA . 0.6 OUTLIER -173.11 -36.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.28 -179.776 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.3 t -49.79 -52.53 31.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.351 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.81 -14.43 62.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.85 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -90.39 -46.23 8.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.959 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.46 ' O ' HG22 ' A' ' 18' ' ' VAL . 12.6 p -71.91 -9.42 12.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.689 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.802 ' CB ' HG11 ' A' ' 31' ' ' VAL . 20.1 pttm -53.59 -31.03 45.26 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.799 0.333 . . . . 0.0 110.971 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -69.8 -33.15 71.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.828 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.4 tt -90.02 -29.97 18.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.882 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.529 ' HZ ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -57.62 -26.04 61.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.01 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m -76.19 -30.19 57.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.062 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -90.07 -5.17 56.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.348 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -116.18 -36.98 3.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.71 0.29 . . . . 0.0 111.11 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.1 -0.18 3.88 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.32 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 mmtt 56.04 103.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.985 0.393 . . . . 0.0 111.071 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.796 HG21 ' CG2' ' A' ' 31' ' ' VAL . 7.1 p -117.17 169.06 7.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.793 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.531 ' H ' HG22 ' A' ' 28' ' ' VAL . 10.4 m-85 -129.9 -39.51 1.4 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -97.6 -96.3 0.21 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.814 HG22 HG13 ' A' ' 48' ' ' VAL . 45.4 t 66.58 88.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.734 0.302 . . . . 0.0 110.882 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.67 151.93 22.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.93 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.755 HD23 ' HA3' ' A' ' 46' ' ' GLY . 10.3 mt -101.47 153.55 19.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.827 HD11 ' HB2' ' A' ' 43' ' ' LYS . 2.7 pp -85.63 -179.36 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -137.9 -172.19 3.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.862 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -91.7 -175.59 4.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.974 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.23 31.71 6.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -160.25 -59.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.881 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 p -92.42 -17.02 25.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.195 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.6 mptt 66.91 30.17 7.85 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.86 0.362 . . . . 0.0 110.882 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.1 pttt -92.15 138.15 24.6 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.789 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.29 115.82 2.54 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.438 2.092 . . . . 0.0 112.302 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.827 ' HB2' HD11 ' A' ' 34' ' ' ILE . 14.6 mmmt -59.64 -74.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.898 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.5 39.36 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.561 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.44 ' CE2' HG12 ' A' ' 34' ' ' ILE . 13.4 p90 -172.1 145.55 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.91 0.386 . . . . 0.0 110.934 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.755 ' HA3' HD23 ' A' ' 33' ' ' LEU . . . -125.97 -166.05 12.17 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.541 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -145.67 128.94 16.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 111.164 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.814 HG13 HG22 ' A' ' 31' ' ' VAL . 52.4 t -114.75 116.0 51.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.863 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -87.26 94.99 9.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.945 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.748 ' HG3' HG12 ' A' ' 48' ' ' VAL . 29.2 mtp -121.18 177.56 5.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.881 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.895 ' O ' HG23 ' A' ' 55' ' ' VAL . 18.8 mt-30 -69.1 158.2 35.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -31.18 69.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.902 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -81.63 -31.17 32.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.012 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 1.0 OUTLIER -73.61 -33.0 64.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.051 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 51' ' ' GLN . 24.9 t -58.01 -47.6 86.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.395 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.1 m -57.74 -64.77 0.79 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.13 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.15 -26.99 63.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.149 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.532 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -68.34 -37.14 80.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.415 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.524 HD12 ' O ' ' A' ' 55' ' ' VAL . 5.8 mt -90.36 -11.79 9.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.275 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.75 -49.6 12.77 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -90.64 -19.41 23.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.799 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 78.2 mt -90.07 -75.03 0.47 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.411 ' HB3' HG13 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -59.56 144.95 46.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.023 0.44 . . . . 0.0 111.059 -179.477 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 179.67 -38.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.803 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.417 ' OG1' HG21 ' A' ' 71' ' ' THR . 0.0 OUTLIER -155.79 -170.39 3.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.824 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -111.15 111.71 22.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.964 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.56 -172.02 2.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.815 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -95.49 39.77 1.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.037 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.17 31.2 3.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.563 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.35 -41.83 4.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.806 0.336 . . . . 0.0 110.881 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.417 HG21 ' OG1' ' A' ' 65' ' ' THR . 0.9 OUTLIER -134.93 -48.9 0.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.47 HG22 ' H ' ' A' ' 73' ' ' ARG . 6.5 mt 59.28 165.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.793 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.47 ' H ' HG22 ' A' ' 72' ' ' ILE . 27.4 mtt180 -99.19 48.9 0.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.925 0.393 . . . . 0.0 110.756 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.411 HG13 ' HB3' ' A' ' 63' ' ' ASP . 7.7 p -65.38 125.19 21.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.064 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.0 t -132.67 162.98 29.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.009 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.86 117.11 21.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.932 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.803 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.215 -0.897 . . . . 0.0 111.121 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.425 ' HG2' ' CZ ' ' A' ' 29' ' ' PHE . 20.9 mtp . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.816 0.341 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -108.22 -169.26 1.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.41 ' HB3' ' CE2' ' A' ' 47' ' ' PHE . 1.6 m120 -121.71 150.5 41.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.89 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.598 HG12 HG13 ' A' ' 55' ' ' VAL . 19.4 mt -116.74 119.15 61.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.126 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.586 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 73.8 t80 -96.16 129.73 43.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.993 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.521 ' CG1' HD21 ' A' ' 9' ' ' LEU . 7.6 p -123.01 136.99 58.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.974 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -124.3 174.92 17.02 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.502 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 62.23 25.6 15.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.613 0.244 . . . . 0.0 110.986 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.521 HD21 ' CG1' ' A' ' 6' ' ' VAL . 1.8 mm? -60.15 138.63 57.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.679 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.524 HG22 ' N ' ' A' ' 11' ' ' TYR . 14.7 p -102.49 162.18 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.644 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.524 ' N ' HG22 ' A' ' 10' ' ' VAL . 42.4 m-85 -43.33 -30.02 0.48 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.162 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.52 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 1.1 m -100.57 -71.64 0.7 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.054 0.454 . . . . 0.0 110.057 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 12' ' ' SER . . . 76.39 141.43 0.07 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.411 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.6 ' O ' HG12 ' A' ' 18' ' ' VAL . 1.7 m -106.01 -26.84 11.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.374 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.08 -46.49 80.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.047 0.451 . . . . 0.0 110.09 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.674 ' HG3' HD21 ' A' ' 33' ' ' LEU . 3.8 tm-20 -75.75 -12.94 60.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.037 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.46 -41.09 11.64 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.496 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.6 HG12 ' O ' ' A' ' 14' ' ' THR . 11.9 p -78.2 -4.91 7.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.618 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 52.5 pttt -53.12 -37.16 61.53 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.762 0.315 . . . . 0.0 110.962 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -60.17 -31.53 70.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.707 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.1 tt -89.95 -29.65 18.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.789 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.412 ' HZ ' HD11 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -57.66 -25.81 60.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.97 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m -67.11 -38.59 85.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.964 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.15 -7.75 52.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.209 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -103.54 -27.51 12.31 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.314 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.85 19.77 0.58 Allowed Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.372 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.4 pttm 42.33 98.99 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.905 0.383 . . . . 0.0 111.925 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.487 HG21 ' CG2' ' A' ' 31' ' ' VAL . 11.8 p -103.77 133.95 46.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.992 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.425 ' CZ ' ' HG2' ' A' ' 1' ' ' MET . 92.1 m-85 -69.45 -46.13 67.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.012 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -166.95 157.52 11.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.002 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.837 HG13 HG22 ' A' ' 48' ' ' VAL . 21.9 t -147.34 129.33 6.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.107 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.505 ' C ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -157.67 138.57 13.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.012 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.674 HD21 ' HG3' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -126.92 148.15 50.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.784 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.583 HD11 ' HA3' ' A' ' 44' ' ' GLY . 2.9 pp -64.38 177.73 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.043 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -132.89 -177.03 4.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.986 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -60.93 -22.36 64.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.173 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 62.26 33.57 16.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.781 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.06 -46.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.788 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.49 -0.29 32.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.364 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.1 mttt 62.61 35.99 13.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.846 0.355 . . . . 0.0 111.016 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -116.53 128.07 26.28 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.78 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.66 115.71 3.54 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.407 2.071 . . . . 0.0 112.244 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.62 132.04 1.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.943 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.583 ' HA3' HD11 ' A' ' 34' ' ' ILE . . . 137.7 -72.89 0.44 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.506 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -169.4 168.21 9.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.846 0.355 . . . . 0.0 110.833 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.415 ' CA ' ' HB3' ' A' ' 33' ' ' LEU . . . -137.75 -178.07 15.71 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.601 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.436 ' CZ ' ' CB ' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -150.96 129.61 12.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.82 0.343 . . . . 0.0 111.094 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.837 HG22 HG13 ' A' ' 31' ' ' VAL . 51.2 t -126.3 143.51 39.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -111.9 106.09 14.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.978 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.486 ' CE ' HG11 ' A' ' 48' ' ' VAL . 35.5 mtt -137.4 -177.36 4.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.994 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.786 ' O ' HG23 ' A' ' 55' ' ' VAL . 3.8 tt0 -67.21 168.05 11.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.965 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -66.81 -37.05 83.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.954 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -74.8 -32.5 62.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.963 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.522 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -66.87 -36.31 82.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 51' ' ' GLN . 31.6 t -62.32 -44.97 99.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.227 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.4 m -55.94 -63.57 1.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.085 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -62.11 -28.18 69.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.968 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.523 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -61.18 -38.29 85.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.293 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.764 HD12 ' O ' ' A' ' 55' ' ' VAL . 3.5 mt -90.22 -16.9 8.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.23 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.87 -48.34 31.71 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.3 mmmt -90.41 -22.85 21.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.656 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.523 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 78.6 mt -89.96 -69.8 0.7 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.532 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.585 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -63.05 141.42 58.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.087 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -178.63 -38.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.872 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.79 -168.64 2.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.73 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -110.34 104.67 13.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.974 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.9 -167.95 1.83 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.893 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.6 ptm -95.16 43.8 1.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.078 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.54 26.61 8.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.628 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 44.7 mtp85 -103.94 -34.99 8.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.908 0.385 . . . . 0.0 110.74 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.1 t -141.07 -47.06 0.4 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.651 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.516 HG22 ' H ' ' A' ' 73' ' ' ARG . 2.2 mt 57.76 167.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.826 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.516 ' H ' HG22 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -99.4 47.36 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.912 0.387 . . . . 0.0 110.833 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.475 HG12 ' CB ' ' A' ' 63' ' ' ASP . 13.2 p -61.93 153.25 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.12 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.0 t -159.97 165.97 30.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -80.25 126.01 30.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.826 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.586 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.173 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 ttm . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.843 0.354 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -123.67 132.54 53.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.47 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 6.9 m-20 -76.43 140.43 41.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.881 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.448 HG12 HG13 ' A' ' 55' ' ' VAL . 14.1 mt -106.18 126.02 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.033 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -107.88 104.44 13.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.836 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.531 ' HB ' HG23 ' A' ' 74' ' ' VAL . 12.0 p -113.32 130.95 66.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.166 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -120.46 -174.01 15.1 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.424 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 59.37 39.19 22.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.901 0.381 . . . . 0.0 110.863 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.547 HD12 ' C ' ' A' ' 45' ' ' PHE . 23.6 mt -82.46 178.41 8.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 1.032 HG12 ' HB2' ' A' ' 13' ' ' ALA . 6.3 p -143.69 169.13 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.545 ' H ' HG22 ' A' ' 10' ' ' VAL . 27.6 m-85 -44.33 -31.49 1.05 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.505 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.725 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.0 OUTLIER -170.99 76.3 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.934 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 1.032 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -81.69 -59.68 2.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.153 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.68 HG23 ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER 176.35 -31.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.204 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.9 m -50.51 -53.74 27.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.783 0.325 . . . . 0.0 111.297 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.618 ' HB3' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -67.95 -13.62 62.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.713 179.597 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.56 -38.56 13.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.231 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.451 ' O ' HG22 ' A' ' 18' ' ' VAL . 14.0 p -84.06 -9.78 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.899 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -56.88 -44.36 82.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.775 0.321 . . . . 0.0 110.932 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -59.74 -33.04 71.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.705 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.511 ' O ' HD23 ' A' ' 21' ' ' LEU . 5.7 tt -87.67 -27.46 22.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.836 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.46 ' CD1' ' CE ' ' A' ' 50' ' ' MET . 0.1 OUTLIER -55.76 -23.64 30.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.162 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.8 t -80.26 -26.83 38.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.082 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -90.09 -20.47 23.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.236 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -109.54 -33.59 6.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.208 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.62 -18.25 4.9 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.154 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm 65.64 42.61 3.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.89 0.376 . . . . 0.0 110.741 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.3 p -51.08 151.76 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.33 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -91.79 -43.05 9.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -153.48 157.18 39.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.075 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.9 t -150.83 121.85 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.889 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.417 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -141.58 163.04 33.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.081 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.618 HD11 ' HB3' ' A' ' 16' ' ' GLU . 76.9 mt -129.36 179.67 5.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.791 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.744 HG21 ' CE2' ' A' ' 45' ' ' PHE . 2.5 pp -126.92 171.75 14.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.349 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -115.63 -169.86 1.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.937 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.04 178.33 6.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.81 30.86 7.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.935 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -162.47 -48.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 p -91.92 -20.83 20.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.004 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.43 34.31 8.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.839 0.352 . . . . 0.0 110.96 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.412 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 1.8 mtpp -101.69 151.02 37.81 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.851 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.71 97.8 0.92 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.618 2.212 . . . . 0.0 112.628 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.412 ' CE ' ' HB2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -178.23 135.6 0.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.799 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.634 ' HA3' HD11 ' A' ' 34' ' ' ILE . . . 149.42 -59.96 0.44 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.457 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.744 ' CE2' HG21 ' A' ' 34' ' ' ILE . 40.8 p90 -171.52 167.91 6.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.849 0.356 . . . . 0.0 110.962 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.77 174.57 22.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.352 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.86 133.92 38.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.884 0.374 . . . . 0.0 111.017 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.435 ' HB ' HD12 ' A' ' 4' ' ' ILE . 41.7 t -129.22 151.57 35.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.956 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -125.14 120.31 31.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.914 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.46 ' CE ' ' CD1' ' A' ' 22' ' ' PHE . 32.5 mtp -151.88 166.79 30.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -68.88 159.85 31.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.794 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.51 61.7 3.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.984 0.421 . . . . 0.0 110.903 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.61 -47.79 0.51 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.578 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 53.8 m -90.18 -25.55 20.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.956 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.512 ' O ' HD12 ' A' ' 59' ' ' ILE . 24.6 t -64.4 -35.1 73.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.826 0.346 . . . . 0.0 111.472 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.37 -46.89 88.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.204 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.63 -23.5 21.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.311 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.53 ' O ' HD12 ' A' ' 62' ' ' LEU . . . -59.5 -41.54 90.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.458 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.533 HG23 ' HB3' ' A' ' 63' ' ' ASP . 2.3 mp -90.36 -27.91 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.075 0.464 . . . . 0.0 111.048 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.05 -60.29 3.37 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -90.51 -10.31 44.05 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.53 HD12 ' O ' ' A' ' 58' ' ' ALA . 26.5 mt -90.06 -75.29 0.46 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.95 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.533 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -49.36 149.03 2.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.96 0.409 . . . . 0.0 111.526 -179.245 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.14 -48.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.762 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -158.96 -173.81 4.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.784 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -95.2 104.48 16.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.888 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.41 ' CZ ' ' NH2' ' A' ' 70' ' ' ARG . 0.3 OUTLIER -126.63 170.04 12.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.953 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 4.9 mtt -83.17 58.81 4.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.07 33.54 11.96 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.511 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.41 ' NH2' ' CZ ' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -111.41 -42.25 3.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.797 0.332 . . . . 0.0 110.835 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.96 -47.96 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.796 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 73' ' ' ARG . 18.8 mt 59.74 159.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.033 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.472 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -90.37 69.73 6.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.851 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.531 HG23 ' HB ' ' A' ' 6' ' ' VAL . 14.7 p -93.09 132.9 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.176 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.4 t -154.02 159.75 41.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -58.38 139.27 55.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.96 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 3' ' ' ASN . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.102 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.808 0.337 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -109.36 146.15 34.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 4.6 m120 -85.36 129.94 34.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.9 mt -107.69 139.32 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.093 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.477 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 25.1 t80 -113.78 125.57 54.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.844 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 6' ' ' VAL . 11.0 p -121.94 124.28 70.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.077 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -112.66 -168.45 17.48 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.531 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.8 32.44 20.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.818 0.342 . . . . 0.0 110.887 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.765 HD12 ' C ' ' A' ' 45' ' ' PHE . 61.9 mt -88.35 -178.03 5.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.928 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.624 HG13 ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -160.68 -168.43 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.819 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.624 ' N ' HG13 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -48.56 -45.51 37.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.836 0.351 . . . . 0.0 111.134 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.533 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -156.94 60.64 0.52 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.647 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.44 -77.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.37 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.567 HG21 ' HA3' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -166.19 -31.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.446 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.3 p -46.85 -55.41 8.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.646 0.26 . . . . 0.0 111.441 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.57 -14.32 62.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.777 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -90.5 -30.97 16.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.09 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.505 HG22 ' CD2' ' A' ' 22' ' ' PHE . 14.8 p -86.54 -29.19 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.495 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.9 pttt -48.93 -28.5 3.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.132 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.8 -34.88 69.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.66 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.4 tt -89.96 -18.89 25.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.037 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.505 ' CD2' HG22 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -71.12 -17.09 62.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.236 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.2 p -90.13 -26.23 20.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.438 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -87.4 -47.77 8.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.345 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.57 -11.25 10.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.63 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.9 -22.94 37.05 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.641 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.58 35.17 14.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.81 0.338 . . . . 0.0 110.86 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.404 ' HA ' ' HG2' ' A' ' 50' ' ' MET . 14.9 p -76.81 141.79 15.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.119 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -77.31 -44.79 28.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.96 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -174.7 145.87 0.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.014 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.457 HG22 HG13 ' A' ' 48' ' ' VAL . 23.0 t -127.09 140.95 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.908 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.94 106.59 2.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.071 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.534 HD22 ' HA3' ' A' ' 46' ' ' GLY . 4.7 mt -85.91 175.16 8.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.634 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.732 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.5 pp -107.9 154.53 8.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.22 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.424 ' CE1' ' HG3' ' A' ' 42' ' ' PRO . 83.2 m-85 -140.43 -176.21 4.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.92 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -84.93 -179.6 7.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.934 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -112.09 32.97 5.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -157.79 -54.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.037 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.01 5.65 20.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.415 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 57.85 29.68 17.9 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.839 0.352 . . . . 0.0 110.957 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -76.27 113.96 33.36 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.867 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.424 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 52.8 Cg_exo -52.91 121.73 9.82 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.452 2.101 . . . . 0.0 112.27 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.557 ' HB2' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -54.65 -41.09 69.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.05 37.79 0.11 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.978 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.765 ' C ' HD12 ' A' ' 9' ' ' LEU . 31.6 p90 -178.95 165.83 1.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.982 0.42 . . . . 0.0 111.215 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.534 ' HA3' HD22 ' A' ' 33' ' ' LEU . . . -146.91 -167.69 13.2 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.524 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 3' ' ' ASN . 0.1 OUTLIER -139.56 136.59 34.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.85 0.357 . . . . 0.0 111.021 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.457 HG13 HG22 ' A' ' 31' ' ' VAL . 45.1 t -129.03 136.09 60.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.899 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -105.21 113.13 26.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.885 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.404 ' HG2' ' HA ' ' A' ' 28' ' ' VAL . 0.5 OUTLIER -150.38 152.03 33.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.919 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.52 173.06 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.718 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.69 -152.54 0.06 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.376 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 67.49 -68.69 0.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.209 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.2 m -67.63 -28.62 67.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.235 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.813 ' O ' HD12 ' A' ' 59' ' ' ILE . 30.2 t -58.16 -25.05 25.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.401 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.2 p -72.22 -50.47 27.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.136 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -83.24 -26.11 31.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.296 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -56.55 -42.65 78.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.494 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.813 HD12 ' O ' ' A' ' 55' ' ' VAL . 2.8 mp -90.39 -12.15 9.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.281 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.08 -47.39 13.6 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -90.46 -21.47 21.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.687 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 80.3 mt -90.03 -69.6 0.71 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.737 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -49.51 124.38 9.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.321 -179.468 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -177.59 -49.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.857 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.02 -169.5 2.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.82 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -101.71 124.96 48.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.917 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.57 -173.16 4.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 8.5 mtp -72.13 66.09 0.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.746 ' HA2' HD11 ' A' ' 72' ' ' ILE . . . 59.32 28.94 65.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.509 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.36 -27.76 12.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.728 0.299 . . . . 0.0 110.968 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.532 HG23 ' H ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -135.57 -71.68 0.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.091 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.746 HD11 ' HA2' ' A' ' 69' ' ' GLY . 25.6 mt 59.78 159.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.8 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.47 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -81.78 74.02 8.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 110.789 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.43 HG22 ' N ' ' A' ' 75' ' ' THR . 11.0 p -90.13 155.23 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.43 ' N ' HG22 ' A' ' 74' ' ' VAL . 5.4 t -167.47 152.65 7.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.93 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -68.5 124.78 24.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.911 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.477 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.143 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 tpp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.798 0.333 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -127.75 -177.65 4.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -122.58 153.74 38.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.2 mt -131.56 123.3 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.173 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.499 ' CE2' ' CD2' ' A' ' 45' ' ' PHE . 29.2 t80 -108.84 115.54 30.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.659 HG13 HD11 ' A' ' 9' ' ' LEU . 11.2 p -124.08 124.17 68.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.156 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.15 -170.17 29.55 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.535 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 59.05 40.89 21.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.917 0.389 . . . . 0.0 110.945 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.659 HD11 HG13 ' A' ' 6' ' ' VAL . 65.1 mt -98.45 -178.14 3.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.623 HG13 ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -172.85 -168.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.743 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.623 ' N ' HG13 ' A' ' 10' ' ' VAL . 29.5 t80 -50.29 -47.95 55.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.827 0.346 . . . . 0.0 111.128 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.518 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.8 p -143.35 55.14 1.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.675 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.91 -72.98 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.196 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -165.44 -41.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.056 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.15 -49.33 66.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.065 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -67.05 -15.59 63.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.718 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -90.41 -36.39 14.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.981 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 p -90.07 -23.44 6.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.66 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 42.3 pttt -52.58 -34.33 50.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.762 0.315 . . . . 0.0 111.209 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -65.18 -34.45 78.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.723 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 tp -89.86 -26.69 20.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.74 -23.19 27.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.166 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.6 t -82.91 -29.78 28.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.987 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -90.1 -21.54 22.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -112.82 -30.96 6.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.284 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -117.94 -1.39 16.95 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.113 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.3 pttt 44.92 43.77 7.38 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.85 0.357 . . . . 0.0 111.337 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.9 p -54.67 150.94 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.228 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -91.8 -51.24 5.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.039 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -139.46 158.04 44.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.022 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.0 t -151.48 98.19 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.977 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.84 166.48 11.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.002 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.528 HD23 ' HA3' ' A' ' 46' ' ' GLY . 19.4 mt -140.68 175.09 9.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.843 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.857 HD11 ' HA3' ' A' ' 44' ' ' GLY . 2.4 pp -119.51 -178.79 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.083 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -130.22 -179.13 5.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.054 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -20.29 55.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.17 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.09 36.05 2.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.902 0.382 . . . . 0.0 110.746 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -175.19 -40.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.743 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.3 -10.21 17.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.266 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 mptt 66.66 31.47 7.66 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.86 0.362 . . . . 0.0 110.686 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -111.82 131.04 22.61 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.22 111.17 0.6 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.467 2.112 . . . . 0.0 112.294 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -176.63 127.23 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.918 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.857 ' HA3' HD11 ' A' ' 34' ' ' ILE . . . 142.52 -79.09 0.27 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.617 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.618 ' C ' HD12 ' A' ' 9' ' ' LEU . 50.3 p90 -168.01 -176.64 3.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.811 0.338 . . . . 0.0 111.032 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.528 ' HA3' HD23 ' A' ' 33' ' ' LEU . . . -143.68 169.25 26.09 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.539 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.09 131.35 47.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.802 0.334 . . . . 0.0 111.001 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.8 t -126.26 145.19 34.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.963 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -114.4 114.45 25.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 29.6 mtm -141.83 169.5 17.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -78.48 154.29 30.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -72.01 93.3 1.37 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.904 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -173.43 -49.41 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.466 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.14 -15.34 31.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.994 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.905 ' O ' HD12 ' A' ' 59' ' ' ILE . 21.7 t -66.68 -39.51 83.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.825 0.345 . . . . 0.0 111.179 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.726 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -75.12 -24.67 58.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.216 -179.832 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.26 -42.95 10.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.759 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.701 ' HB1' HD12 ' A' ' 62' ' ' LEU . . . -58.86 -67.78 0.33 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.905 HD12 ' O ' ' A' ' 55' ' ' VAL . 3.7 mt -56.53 -29.4 29.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.144 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.726 ' HB2' ' O ' ' A' ' 56' ' ' SER . . . -57.75 -57.55 12.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.69 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -90.25 -26.08 20.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.646 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.701 HD12 ' HB1' ' A' ' 58' ' ' ALA . 84.4 mt -75.21 -72.9 0.27 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.81 0.338 . . . . 0.0 111.488 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.623 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -50.9 135.67 23.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.346 -179.398 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -178.12 -67.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.761 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.76 -172.16 2.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.811 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.51 99.2 8.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.964 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.18 -172.52 2.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.842 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 23.9 mtt -100.22 36.42 1.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.66 32.7 1.4 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.505 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.12 -37.95 3.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.825 0.345 . . . . 0.0 110.953 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -140.56 -55.69 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.872 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.485 HG21 ' CG2' ' A' ' 6' ' ' VAL . 1.5 mt 59.79 160.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.991 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.462 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -88.39 59.32 5.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.762 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.446 HG22 ' N ' ' A' ' 75' ' ' THR . 14.3 p -79.72 156.75 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.224 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.446 ' N ' HG22 ' A' ' 74' ' ' VAL . 10.0 t -178.46 144.98 0.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.903 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.36 114.61 6.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.497 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.069 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.818 0.342 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.21 161.28 13.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.718 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 3.6 m-80 -100.96 102.09 13.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.405 ' O ' ' CD1' ' A' ' 47' ' ' PHE . 29.6 mt -72.42 141.08 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.095 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.75 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 76.0 t80 -112.24 138.36 49.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.807 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.497 HG22 HD21 ' A' ' 9' ' ' LEU . 11.2 p -147.79 129.14 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.285 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.08 -175.79 25.49 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.329 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 58.45 37.83 25.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.816 0.341 . . . . 0.0 110.806 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.497 HD21 HG22 ' A' ' 6' ' ' VAL . 3.4 mm? -87.98 159.63 18.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.033 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.646 HG13 ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -154.03 -167.41 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.78 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.646 ' N ' HG13 ' A' ' 10' ' ' VAL . 80.0 m-85 -49.5 -46.09 47.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.833 0.349 . . . . 0.0 111.088 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.514 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.3 m -157.18 57.64 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.778 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.419 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -62.04 -52.01 65.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.259 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.447 ' OG1' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -177.61 -36.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.099 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.5 m -51.34 -51.88 50.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.223 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.86 -14.87 63.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.787 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -90.54 -36.27 14.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.089 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.413 HG22 ' CD1' ' A' ' 22' ' ' PHE . 10.7 p -86.23 -24.77 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.625 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -53.16 -32.04 45.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.889 0.376 . . . . 0.0 111.072 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.37 -39.28 94.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.632 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.3 tt -83.14 -31.23 27.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.705 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.413 ' CD1' HG22 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -61.2 -28.27 69.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.928 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.27 -26.9 26.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.088 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -85.36 -25.44 27.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.137 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -111.47 -29.57 7.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.195 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -114.15 -24.65 4.42 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.807 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.87 46.53 3.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.861 0.362 . . . . 0.0 110.776 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 49' ' ' GLU . 10.1 p -52.02 147.4 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.295 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -73.81 -50.26 21.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.919 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -154.67 157.92 38.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.972 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.406 HG22 HG13 ' A' ' 48' ' ' VAL . 23.4 t -152.76 124.08 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.082 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -160.02 -178.6 7.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.981 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 34.0 mt -122.78 160.01 26.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.851 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.87 HD12 ' O ' ' A' ' 35' ' ' TYR . 2.5 pp -81.63 -22.11 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.516 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.87 ' O ' HD12 ' A' ' 34' ' ' ILE . 21.2 m-85 58.83 171.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.008 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -59.94 160.44 7.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.68 40.53 1.22 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.969 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -170.82 -44.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.763 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.98 -17.97 18.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.186 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp 64.12 33.17 12.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.894 0.378 . . . . 0.0 110.9 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.4 150.42 37.98 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.763 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.42 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 63.5 Cg_exo -51.45 99.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.581 2.188 . . . . 0.0 112.3 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.81 129.4 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 127.9 -76.45 0.4 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.643 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.636 ' CE2' HG21 ' A' ' 34' ' ' ILE . 24.4 p90 -176.09 171.61 2.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.754 0.312 . . . . 0.0 110.913 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.93 171.01 21.9 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.479 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.406 ' CE1' ' HB3' ' A' ' 3' ' ' ASN . 2.7 m-85 -134.38 145.52 49.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.836 0.351 . . . . 0.0 110.87 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.406 HG13 HG22 ' A' ' 31' ' ' VAL . 22.8 t -131.59 97.47 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.092 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.43 ' O ' HG23 ' A' ' 28' ' ' VAL . 68.1 tt0 -68.3 86.91 0.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.973 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.7 mtp -125.42 179.6 5.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.905 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.82 ' O ' HG23 ' A' ' 55' ' ' VAL . 2.4 mt-30 -67.89 173.84 4.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.02 -36.94 48.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.968 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -64.3 -36.04 82.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.02 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.7 t -71.03 -30.27 66.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.033 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.875 ' O ' HD12 ' A' ' 59' ' ' ILE . 25.8 t -66.82 -36.37 77.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.267 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.715 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 42.9 t -77.87 -24.99 48.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.214 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.25 -44.9 9.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.753 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.486 ' HB1' HD12 ' A' ' 62' ' ' LEU . . . -57.48 -68.39 0.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.965 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.875 HD12 ' O ' ' A' ' 55' ' ' VAL . 4.3 mt -54.85 -31.1 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.073 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 56' ' ' SER . . . -56.34 -59.8 4.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.602 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -90.32 -11.48 40.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.106 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.486 HD12 ' HB1' ' A' ' 58' ' ' ALA . 63.6 mt -89.93 -75.08 0.46 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.641 0.258 . . . . 0.0 111.623 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.603 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -52.72 150.33 5.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.035 0.445 . . . . 0.0 111.246 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -178.58 -40.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.847 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -162.85 -169.48 2.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.781 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -107.13 93.55 4.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.818 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.09 -176.28 2.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 15.0 mtm -94.16 46.44 1.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.81 32.99 4.86 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.494 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -113.77 -30.01 6.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.758 0.313 . . . . 0.0 111.152 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 t -152.37 -45.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.013 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 73' ' ' ARG . 20.3 mt 61.6 161.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.796 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.472 ' N ' HG22 ' A' ' 72' ' ' ILE . 4.0 mtm180 -94.25 43.38 1.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.984 0.421 . . . . 0.0 111.011 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.535 HG13 ' HB3' ' A' ' 63' ' ' ASP . 9.2 p -61.81 147.51 11.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.981 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.1 t -158.76 171.83 19.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.918 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -85.03 121.07 27.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.785 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.75 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.162 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttt . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.847 0.356 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.13 -175.33 5.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.886 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -123.12 105.63 10.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.877 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.725 HD11 ' HB2' ' A' ' 50' ' ' MET . 6.6 mt -65.16 145.44 13.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.987 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.731 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 4.7 t80 -125.13 115.65 20.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.922 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.459 ' CG2' HG21 ' A' ' 72' ' ' ILE . 11.6 p -109.66 141.52 24.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.951 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -120.93 62.92 0.5 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.582 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.555 ' HB3' HG23 ' A' ' 72' ' ' ILE . 16.1 t30 -177.5 62.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.875 0.369 . . . . 0.0 110.636 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.586 ' CD1' HD22 ' A' ' 33' ' ' LEU . 8.2 mt -109.73 161.61 15.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.061 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.563 ' N ' ' HB2' ' A' ' 13' ' ' ALA . 14.5 p -178.96 161.46 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.723 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.511 ' N ' HG22 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -47.23 -27.99 1.73 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.328 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 88.2 p -120.28 30.12 7.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.14 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.563 ' HB2' ' N ' ' A' ' 10' ' ' VAL . . . -68.69 -31.42 70.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.235 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.567 ' O ' HG12 ' A' ' 18' ' ' VAL . 1.3 m 90.61 5.64 0.1 Allowed 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.721 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.584 ' HA ' HG12 ' A' ' 18' ' ' VAL . 2.6 m -70.93 -52.74 18.17 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.927 -179.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.78 -18.6 62.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.449 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.43 -39.17 12.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.978 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 15' ' ' SER . 13.9 p -81.87 -24.58 9.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.687 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -51.3 -37.05 45.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.802 0.334 . . . . 0.0 111.031 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.16 -32.59 70.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.007 0.432 . . . . 0.0 110.542 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.3 tt -83.6 -31.01 26.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.563 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -20.79 61.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.935 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.3 t -83.1 -29.24 28.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.954 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -81.64 -22.11 37.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.124 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -112.12 -31.64 6.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.149 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.59 -23.96 4.21 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.926 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? 62.48 50.14 3.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.858 0.361 . . . . 0.0 110.838 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.608 HG21 HG22 ' A' ' 31' ' ' VAL . 9.9 p -55.64 146.68 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.169 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -93.8 -31.05 14.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.968 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -150.71 145.85 26.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.107 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.608 HG22 HG21 ' A' ' 28' ' ' VAL . 24.7 t -147.1 106.43 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.772 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.62 ' C ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -136.24 155.7 49.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.186 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.62 HD23 ' C ' ' A' ' 32' ' ' LYS . 1.0 OUTLIER -116.94 155.17 29.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.58 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.866 HG21 ' CE2' ' A' ' 45' ' ' PHE . 2.6 pp -82.85 177.29 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.034 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.407 ' CG ' ' O ' ' A' ' 34' ' ' ILE . 70.7 m-85 -157.02 167.55 30.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.33 156.88 22.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.5 38.57 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.941 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -159.97 -45.29 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.927 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p -106.95 -16.27 14.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.206 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.7 mttp 62.39 37.25 13.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.915 0.388 . . . . 0.0 110.965 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 32.2 mttp -113.32 139.01 22.66 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.809 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 41' ' ' LYS . 53.0 Cg_exo -54.95 118.88 5.64 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.445 2.097 . . . . 0.0 112.402 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -70.2 -64.55 0.87 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.3 50.29 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.413 -0.898 . . . . 0.0 112.987 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.866 ' CE2' HG21 ' A' ' 34' ' ' ILE . 27.8 p90 -178.04 153.38 0.8 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.013 0.435 . . . . 0.0 111.081 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.61 -164.73 11.42 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.571 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -140.78 144.96 35.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.85 0.357 . . . . 0.0 111.169 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.64 HG12 ' HG3' ' A' ' 50' ' ' MET . 45.9 t -141.97 115.61 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.867 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.65 101.52 13.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.02 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.725 ' HB2' HD11 ' A' ' 4' ' ' ILE . 29.8 mtm -130.58 154.86 47.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.918 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.926 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -63.76 149.45 46.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.892 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.21 -31.72 63.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.088 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -63.25 -34.71 78.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.006 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 9.5 t -90.0 -39.25 13.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.985 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.926 HG23 ' O ' ' A' ' 51' ' ' GLN . 21.4 t -54.82 -47.81 74.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.372 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.7 m -52.15 -64.02 0.95 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.19 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -26.83 67.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.004 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.559 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -63.94 -39.53 94.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.267 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 59' ' ' ILE . 5.4 mt -90.12 -7.28 10.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.303 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.7 -44.95 9.67 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.97 -25.0 19.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.451 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 66.0 mt -90.11 -74.23 0.49 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.901 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.473 ' CB ' HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -50.96 142.1 12.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.932 0.396 . . . . 0.0 111.295 -179.395 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -178.83 -38.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.871 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -159.72 -175.05 4.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -104.35 108.66 20.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -124.71 -168.61 1.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.948 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.2 mmt -95.04 44.46 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.82 32.61 6.14 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.499 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.95 -34.62 6.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.83 0.347 . . . . 0.0 110.964 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.62 -53.93 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.992 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.555 HG23 ' HB3' ' A' ' 8' ' ' ASN . 29.3 mt 59.92 159.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.019 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.479 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -87.41 61.18 6.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.831 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.484 ' O ' HG23 ' A' ' 59' ' ' ILE . 11.4 p -72.82 140.64 17.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.096 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.9 t -164.27 150.91 11.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.868 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -70.33 127.35 32.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.731 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.103 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.822 0.344 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -114.4 -178.53 3.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.866 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.649 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 3.7 m-80 -110.73 142.5 42.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.556 HD11 ' HB2' ' A' ' 50' ' ' MET . 2.2 mt -118.85 120.08 62.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.609 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 3.5 t80 -102.17 123.54 46.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.004 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.562 ' HB ' HG23 ' A' ' 74' ' ' VAL . 11.2 p -128.47 129.04 68.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.024 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -110.67 -168.84 19.31 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.51 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.38 33.68 23.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.751 0.31 . . . . 0.0 110.9 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.74 HD13 HD13 ' A' ' 33' ' ' LEU . 18.3 mt -85.97 -178.72 6.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.964 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.598 HG22 ' H ' ' A' ' 11' ' ' TYR . 2.5 p -163.98 174.42 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.824 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.598 ' H ' HG22 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -43.19 -45.56 5.66 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.75 0.31 . . . . 0.0 111.563 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.576 ' H ' HG13 ' A' ' 10' ' ' VAL . 8.9 t -140.78 61.94 1.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.888 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.7 ' O ' HG23 ' A' ' 14' ' ' THR . . . -68.13 -78.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.327 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 13' ' ' ALA . 0.4 OUTLIER -177.43 -32.24 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.312 -179.746 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.9 t -47.27 -54.95 9.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.76 0.314 . . . . 0.0 111.521 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -14.47 61.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.851 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -90.68 -27.95 18.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.274 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -90.14 -20.69 6.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.842 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.801 ' HB2' HG11 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -49.36 -28.01 4.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.778 0.323 . . . . 0.0 111.236 -179.74 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -72.35 -32.14 66.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.82 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.6 tt -90.01 -30.26 17.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.955 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.85 -22.91 40.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.7 t -76.51 -31.93 57.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.985 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -90.19 -10.67 43.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.42 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.52 -37.77 5.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.645 0.26 . . . . 0.0 111.157 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.529 ' HA3' ' HE1' ' A' ' 50' ' ' MET . . . -127.38 -5.65 5.48 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.516 -0.85 . . . . 0.0 113.265 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp 61.33 47.54 6.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.872 0.367 . . . . 0.0 110.938 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 49' ' ' GLU . 11.6 p -53.97 116.05 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.188 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -59.77 -39.9 86.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.887 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.08 158.76 30.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.819 HG23 HG22 ' A' ' 48' ' ' VAL . 10.2 p -155.22 127.88 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.035 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.3 mtpt -160.04 123.23 3.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.973 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.74 HD13 HD13 ' A' ' 9' ' ' LEU . 9.0 mt -84.68 -169.04 2.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.572 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.762 HD13 ' HB2' ' A' ' 43' ' ' LYS . 1.7 pp -111.93 155.18 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.902 0.382 . . . . 0.0 111.233 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -157.22 169.66 24.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.741 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.61 131.5 34.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -84.1 56.4 3.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.921 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 179.2 -40.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.795 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 p -111.88 -19.82 12.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.203 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.1 tttt 68.92 25.82 5.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.778 0.323 . . . . 0.0 110.904 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -90.73 121.3 68.37 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.831 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.3 125.81 20.27 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.408 2.072 . . . . 0.0 112.337 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.762 ' HB2' HD13 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -63.58 -35.47 80.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.745 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 130.11 32.64 0.53 Allowed Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.119 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.722 ' C ' HD12 ' A' ' 9' ' ' LEU . 27.8 p90 -178.49 -176.96 0.52 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.992 0.425 . . . . 0.0 111.223 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.527 ' HA3' HD22 ' A' ' 33' ' ' LEU . . . -161.97 -171.72 28.44 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.453 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.463 ' CE1' ' CD2' ' A' ' 5' ' ' TYR . 1.7 m-85 -144.8 141.17 28.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.938 0.399 . . . . 0.0 111.075 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.819 HG22 HG23 ' A' ' 31' ' ' VAL . 40.6 t -130.24 150.11 34.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.932 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.581 ' O ' HG23 ' A' ' 28' ' ' VAL . 1.4 tt0 -111.49 109.95 20.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.93 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.556 ' HB2' HD11 ' A' ' 4' ' ' ILE . 40.4 mtp -143.6 177.68 8.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.863 ' O ' HG23 ' A' ' 55' ' ' VAL . 39.7 mt-30 -71.22 159.27 34.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -67.07 -30.77 70.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.824 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -75.9 -31.81 59.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.908 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.4 m -74.69 -29.46 61.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.063 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.863 ' O ' HD12 ' A' ' 59' ' ' ILE . 21.6 t -65.12 -37.31 79.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.276 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.681 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 10.2 t -74.91 -24.39 58.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.09 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.21 -42.68 10.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.663 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.646 ' HB1' HD12 ' A' ' 62' ' ' LEU . . . -58.82 -67.99 0.31 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.818 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.863 HD12 ' O ' ' A' ' 55' ' ' VAL . 3.3 mt -54.88 -30.57 23.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.056 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.681 ' HB2' ' O ' ' A' ' 56' ' ' SER . . . -57.04 -59.44 5.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.366 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.15 -9.14 49.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.904 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.646 HD12 ' HB1' ' A' ' 58' ' ' ALA . 71.5 mt -90.09 -74.95 0.47 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.838 0.351 . . . . 0.0 111.336 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.506 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -56.67 152.4 12.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.134 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.561 ' O ' HG23 ' A' ' 65' ' ' THR . 1.0 OUTLIER -178.57 -40.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.775 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 64' ' ' ASN . 0.6 OUTLIER -166.43 -178.28 4.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.873 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.0 p-10 -98.14 102.81 14.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.843 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.22 -168.83 1.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.939 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 1.5 mmt -93.46 46.93 1.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.876 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.37 37.49 6.2 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.546 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.1 tpp85 -116.14 -42.36 3.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.837 0.351 . . . . 0.0 110.92 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.98 -48.77 1.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.914 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.454 HG22 ' N ' ' A' ' 73' ' ' ARG . 9.3 mt 59.27 163.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.999 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.454 ' N ' HG22 ' A' ' 72' ' ' ILE . 2.2 mtt180 -94.07 47.64 1.22 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.019 0.437 . . . . 0.0 110.74 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.562 HG23 ' HB ' ' A' ' 6' ' ' VAL . 12.6 p -62.0 144.29 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.095 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.3 t -149.27 175.88 11.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.986 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.69 133.07 35.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.967 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.649 ' HB3' ' HB3' ' A' ' 3' ' ' ASN . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.131 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.842 0.353 . . . . 0.0 111.137 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.615 ' HB2' HG21 ' A' ' 55' ' ' VAL . 3.7 mmt180 -94.2 -8.57 38.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.503 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.5 m120 54.1 103.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.219 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.84 HG12 HG13 ' A' ' 55' ' ' VAL . 6.3 mt -94.42 158.51 2.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.219 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.49 ' N ' HG22 ' A' ' 4' ' ' ILE . 37.3 t80 -139.79 143.47 36.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.682 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.71 ' CG1' HD11 ' A' ' 9' ' ' LEU . 9.9 p -142.52 146.63 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.268 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -130.29 -174.37 13.67 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.322 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 t30 56.01 33.18 21.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.931 0.396 . . . . 0.0 110.994 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.71 HD11 ' CG1' ' A' ' 6' ' ' VAL . 64.2 mt -89.43 99.91 12.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.096 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.755 HG13 ' H ' ' A' ' 12' ' ' SER . 2.7 p -63.33 176.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.642 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.637 ' H ' HG22 ' A' ' 10' ' ' VAL . 17.6 m-85 -41.54 -35.35 0.7 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.865 0.364 . . . . 0.0 111.419 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.755 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.2 p -157.26 67.47 0.52 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.571 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 14' ' ' THR . . . -71.62 -65.4 0.76 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.405 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -179.12 -24.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.578 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.612 ' OG ' HD13 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -46.07 -57.91 4.06 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.747 0.308 . . . . 0.0 111.509 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.61 ' HB3' HD11 ' A' ' 33' ' ' LEU . 4.0 pt-20 -66.49 -13.3 60.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.817 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -90.54 -28.3 18.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.291 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 15' ' ' SER . 11.9 p -87.07 -24.49 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.754 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.7 -27.67 12.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.744 0.307 . . . . 0.0 111.171 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -33.1 70.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.764 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.4 tt -88.9 -30.85 18.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.809 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -26.04 62.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.016 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.44 -24.17 24.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.237 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -88.66 -24.38 22.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.265 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -111.47 -30.68 7.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.225 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -117.62 -17.56 5.55 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.575 -0.822 . . . . 0.0 113.067 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm 61.98 43.98 8.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.944 0.402 . . . . 0.0 110.715 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 49' ' ' GLU . 12.0 p -46.36 139.54 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.459 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -89.3 -39.1 13.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.835 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -139.29 149.19 43.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.955 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.729 HG23 HG22 ' A' ' 48' ' ' VAL . 13.2 p -172.11 120.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.063 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -157.11 167.3 30.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.949 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.61 HD11 ' HB3' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -128.61 160.26 32.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.683 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.486 HD13 ' HB3' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -94.33 170.48 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.054 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 42' ' ' PRO . 49.1 m-85 -138.77 -174.23 3.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.009 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -101.55 -178.48 3.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -120.28 31.75 6.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.67 -58.25 0.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.876 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.03 -1.08 27.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.403 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt 60.2 36.21 20.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.88 0.371 . . . . 0.0 110.883 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -112.99 152.02 44.59 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.822 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 53.4 Cg_exo -52.37 135.25 53.79 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.581 2.187 . . . . 0.0 112.282 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.486 ' HB3' HD13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -69.75 -69.18 0.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.794 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.41 37.59 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.898 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.457 ' CE2' HG12 ' A' ' 34' ' ' ILE . 38.3 p90 -179.9 152.88 0.49 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.987 0.423 . . . . 0.0 111.124 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.48 ' HA3' HD23 ' A' ' 33' ' ' LEU . . . -145.28 -169.99 13.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.389 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.445 ' CZ ' ' CB ' ' A' ' 77' ' ' ALA . 1.9 t80 -133.13 156.3 47.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.884 0.373 . . . . 0.0 111.057 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.729 HG22 HG23 ' A' ' 31' ' ' VAL . 24.1 t -149.16 130.45 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.972 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.667 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -110.57 116.17 30.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.02 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.433 ' HG2' HG23 ' A' ' 28' ' ' VAL . 2.5 mtm -140.63 156.21 46.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.916 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.05 151.73 18.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.971 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -77.24 95.03 4.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.931 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -174.91 -53.44 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.261 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 1.8 m -90.02 -16.15 30.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.981 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.84 HG13 HG12 ' A' ' 4' ' ' ILE . 26.0 t -61.09 -43.87 97.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.832 0.348 . . . . 0.0 111.277 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.6 m -56.82 -54.22 48.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.165 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -74.98 -26.47 59.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.106 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -57.61 -39.36 76.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.338 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.694 HD12 ' O ' ' A' ' 55' ' ' VAL . 3.2 mt -90.29 -8.94 10.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.181 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.51 -48.75 10.67 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.65 -19.11 24.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.785 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.525 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 83.3 mt -89.97 -75.12 0.46 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.93 147.42 15.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.842 0.353 . . . . 0.0 111.041 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -176.6 -41.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.941 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.4 ' OG1' HG21 ' A' ' 71' ' ' THR . 0.7 OUTLIER -154.62 -177.66 6.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -103.57 97.45 7.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.16 -169.33 1.46 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 16.9 ptm -98.38 31.57 2.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.92 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.09 33.55 1.49 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.474 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.77 -54.06 2.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.786 0.327 . . . . 0.0 110.883 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.4 HG21 ' OG1' ' A' ' 65' ' ' THR . 1.1 t -119.73 -49.76 2.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.889 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 73' ' ' ARG . 24.8 mt 60.15 159.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.212 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.481 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -90.71 51.6 2.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.819 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.558 ' O ' HG23 ' A' ' 59' ' ' ILE . 11.0 p -67.18 125.51 24.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.072 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.5 t -141.9 160.22 40.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.02 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.418 ' HG3' HD13 ' A' ' 59' ' ' ILE . 52.0 mt-10 -59.82 140.88 56.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.875 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.445 ' CB ' ' CZ ' ' A' ' 47' ' ' PHE . . . . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.095 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mtp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.845 0.355 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -99.16 175.45 5.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.959 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.401 ' HB3' ' CE2' ' A' ' 47' ' ' PHE . 22.0 m-20 -122.07 120.13 33.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.862 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.66 HG12 HG13 ' A' ' 55' ' ' VAL . 1.8 mp -111.21 132.61 59.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.122 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.776 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 6.4 t80 -107.2 142.85 36.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.476 HG13 HD11 ' A' ' 9' ' ' LEU . 7.5 p -143.98 121.01 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.99 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.448 ' HA2' ' CD1' ' A' ' 45' ' ' PHE . . . -104.79 -169.53 24.38 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.767 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 63.46 29.66 15.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.715 0.293 . . . . 0.0 110.948 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.532 HD22 ' HB2' ' A' ' 15' ' ' SER . 32.0 mt -101.24 159.8 14.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.919 0.39 . . . . 0.0 111.124 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.648 HG13 ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -155.07 -166.8 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.666 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.648 ' N ' HG13 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -48.77 -44.95 39.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.878 0.371 . . . . 0.0 111.051 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.509 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -144.06 49.04 1.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.593 179.791 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.8 -76.1 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.359 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.583 HG21 ' CA ' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -164.59 -37.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.304 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.532 ' HB2' HD22 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -48.94 -52.96 21.81 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.798 0.332 . . . . 0.0 111.36 -179.754 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -65.43 -15.96 63.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.751 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -90.59 -36.92 14.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.073 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.9 p -90.04 -22.35 6.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.669 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 pttp -50.0 -29.48 8.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.799 0.333 . . . . 0.0 111.101 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -68.22 -35.69 78.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.66 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.3 tp -87.03 -30.36 21.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.899 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.15 -24.48 54.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.116 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.2 m -82.38 -25.9 33.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.158 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -90.02 -24.48 21.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.216 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -110.43 -30.9 7.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.156 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -112.06 -22.24 5.99 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.775 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp 62.98 45.07 5.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.944 0.402 . . . . 0.0 110.901 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.0 p -54.14 153.07 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.107 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -97.26 -36.37 10.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.015 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -166.15 140.87 4.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.124 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t -124.71 119.44 56.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.732 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -123.44 163.14 21.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.024 0.44 . . . . 0.0 111.26 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 mt -141.51 161.29 38.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.397 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.553 HD11 ' HA3' ' A' ' 44' ' ' GLY . 2.5 pp -123.62 155.41 30.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.981 0.419 . . . . 0.0 111.29 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.478 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.7 m-85 -94.36 -165.58 1.34 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.92 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -73.66 -8.53 56.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.332 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 66.42 29.57 9.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.896 0.379 . . . . 0.0 110.743 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -165.61 -44.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.615 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 p -97.48 -13.71 21.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.184 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.29 25.94 2.77 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.803 0.335 . . . . 0.0 110.982 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -102.53 123.62 42.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.7 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.53 107.49 1.63 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.38 2.053 . . . . 0.0 112.101 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.618 ' HB3' HG23 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -176.32 42.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.29 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.553 ' HA3' HD11 ' A' ' 34' ' ' ILE . . . -132.05 42.02 1.43 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.619 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.448 ' CD1' ' HA2' ' A' ' 7' ' ' GLY . 0.9 OUTLIER 73.94 161.49 0.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.851 0.358 . . . . 0.0 111.033 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.94 -173.84 13.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.582 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 48' ' ' VAL . 46.0 t80 -128.34 159.32 35.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.761 0.315 . . . . 0.0 110.919 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.451 ' N ' ' CD1' ' A' ' 47' ' ' PHE . 31.7 t -144.81 127.7 10.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.06 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -105.3 113.33 26.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.931 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.518 ' HE2' HD13 ' A' ' 4' ' ' ILE . 35.4 mtm -142.26 147.87 37.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.6 155.83 14.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.881 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.07 95.18 4.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.037 0.446 . . . . 0.0 110.906 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -176.36 -49.37 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.263 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 5.1 m -90.02 -21.73 22.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.916 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.717 ' O ' HD12 ' A' ' 59' ' ' ILE . 21.5 t -60.61 -31.62 49.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.379 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.0 m -60.98 -53.93 51.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.243 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.63 -22.93 27.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.292 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -55.47 -41.48 73.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.432 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.717 HD12 ' O ' ' A' ' 55' ' ' VAL . 3.3 mp -90.32 -21.22 6.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.911 0.386 . . . . 0.0 111.301 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.13 -55.38 25.77 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.44 -14.3 33.13 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 51.0 mt -90.05 -75.27 0.46 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.943 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.458 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -55.52 150.7 11.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.07 0.462 . . . . 0.0 111.406 -179.114 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 175.1 -36.62 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.715 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.39 -173.89 3.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.81 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.5 96.68 6.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.955 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.426 ' CD2' ' HB2' ' A' ' 70' ' ' ARG . 0.6 OUTLIER -121.71 169.07 11.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 24.2 mmm -80.51 65.05 5.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.953 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.583 ' CA ' HG21 ' A' ' 14' ' ' THR . . . 82.69 31.02 30.92 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.607 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.426 ' HB2' ' CD2' ' A' ' 67' ' ' PHE . 1.5 tmm_? -111.0 -30.1 7.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.793 0.33 . . . . 0.0 111.081 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 t -153.02 -51.09 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.942 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.498 HG22 ' N ' ' A' ' 73' ' ' ARG . 20.1 mt 64.65 160.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.033 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.498 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -92.4 48.68 1.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.875 0.369 . . . . 0.0 110.913 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.557 ' O ' HG13 ' A' ' 74' ' ' VAL . 12.0 p -72.17 114.58 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.182 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.6 t -135.25 153.85 51.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.042 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -57.13 131.62 50.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.776 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.312 -0.851 . . . . 0.0 111.077 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ptp . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.822 0.344 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.94 -6.11 22.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.496 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.5 t30 59.03 114.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.055 0.455 . . . . 0.0 110.993 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.561 HG12 HG13 ' A' ' 55' ' ' VAL . 23.7 mt -103.31 127.84 56.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.117 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -110.94 126.97 55.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.844 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.48 ' HB ' HG23 ' A' ' 74' ' ' VAL . 11.1 p -135.03 154.02 35.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.122 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.411 ' N ' HG22 ' A' ' 6' ' ' VAL . . . -127.7 -166.11 12.01 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.394 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 58.98 31.43 21.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.757 0.313 . . . . 0.0 110.787 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.65 HD13 HD21 ' A' ' 33' ' ' LEU . 26.4 mt -93.9 -179.39 4.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.953 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.644 HG13 ' N ' ' A' ' 11' ' ' TYR . 0.6 OUTLIER -170.32 -165.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.697 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.644 ' N ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -46.3 -40.55 11.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.95 0.405 . . . . 0.0 111.269 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.485 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.8 m -163.72 52.66 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.67 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.515 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -66.24 -46.89 75.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.307 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.597 HG21 ' HA3' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -177.65 -32.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.416 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.7 p -47.55 -55.09 9.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.779 0.323 . . . . 0.0 111.429 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.01 -12.78 61.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.949 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -90.77 -39.06 12.61 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.204 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -77.2 -27.93 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.865 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.9 ptmm? -53.36 -28.52 29.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.779 0.323 . . . . 0.0 110.992 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -70.94 -35.36 72.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.576 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.7 tp -90.03 -27.27 19.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.721 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.87 -28.09 47.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.938 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.03 -24.27 47.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.97 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -90.12 -34.27 15.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.773 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -60.82 -41.51 95.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.746 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.07 27.27 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.577 -0.82 . . . . 0.0 113.045 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 57.01 110.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.909 0.385 . . . . 0.0 111.193 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.512 HG23 ' HG2' ' A' ' 50' ' ' MET . 10.8 p -96.37 131.33 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -59.18 -43.6 92.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.971 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -171.46 166.48 6.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.953 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 31' ' ' VAL . 11.2 p -146.59 123.4 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.03 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -132.53 174.48 10.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.121 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.65 HD21 HD13 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -143.8 158.98 43.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.757 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.874 HG21 ' CE2' ' A' ' 45' ' ' PHE . 2.5 pp -85.18 -178.91 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.14 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -158.17 168.91 25.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -86.71 152.15 22.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.951 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -96.94 41.36 1.11 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.878 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -162.56 -44.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.799 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.22 -11.12 15.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.262 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.71 30.65 16.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.821 0.343 . . . . 0.0 110.85 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.403 ' HG3' ' N ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -107.76 141.76 23.77 Favored Pre-proline 0 N--CA 1.451 -0.395 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.118 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.403 ' N ' ' HG3' ' A' ' 41' ' ' LYS . 37.4 Cg_endo -65.66 115.82 3.6 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.522 2.148 . . . . 0.0 112.332 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -56.69 -67.77 0.28 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.018 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.23 52.61 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.817 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.874 ' CE2' HG21 ' A' ' 34' ' ' ILE . 29.4 p90 -177.94 142.5 0.29 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.917 0.389 . . . . 0.0 111.061 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -134.86 -167.07 11.31 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.474 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.99 150.08 40.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.79 0.329 . . . . 0.0 110.934 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.6 t -133.2 152.31 35.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.003 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -117.45 105.14 11.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.929 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.512 ' HG2' HG23 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -140.72 144.26 35.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.848 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.1 pm0 -55.66 146.53 20.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.089 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -69.32 93.39 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.948 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -172.81 -49.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.431 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.23 -19.91 23.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.952 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.561 HG13 HG12 ' A' ' 4' ' ' ILE . 20.0 t -58.99 -48.24 87.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.845 0.355 . . . . 0.0 111.229 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.618 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 1.6 t -62.58 -23.73 67.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.035 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -90.2 -35.03 15.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.598 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.625 ' HB1' HD12 ' A' ' 62' ' ' LEU . . . -62.78 -65.61 0.66 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.751 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.664 HG23 ' HB3' ' A' ' 63' ' ' ASP . 3.9 mt -58.22 -29.56 37.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.005 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 56' ' ' SER . . . -57.32 -56.87 16.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.711 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -90.23 -25.98 20.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.708 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.625 HD12 ' HB1' ' A' ' 58' ' ' ALA . 84.2 mt -76.02 -72.14 0.34 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.763 0.316 . . . . 0.0 111.312 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.664 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -53.42 140.6 27.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.269 -179.443 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -178.19 -39.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.956 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.57 -169.73 1.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.849 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -106.68 119.92 40.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -147.51 -175.95 5.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.82 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.67 49.41 1.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.017 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.597 ' HA3' HG21 ' A' ' 14' ' ' THR . . . 97.59 35.18 5.26 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.627 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.97 -30.44 7.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.7 0.286 . . . . 0.0 111.001 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.2 t -155.27 -52.03 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.075 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.476 HG22 ' N ' ' A' ' 73' ' ' ARG . 21.9 mt 60.76 159.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.031 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.476 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -89.11 53.88 2.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.841 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.482 HG22 ' N ' ' A' ' 75' ' ' THR . 12.3 p -73.92 159.32 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.05 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.594 ' HA ' HG21 ' A' ' 59' ' ' ILE . 9.1 t -161.15 179.05 8.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.897 0.38 . . . . 0.0 110.957 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.421 ' OE1' HD13 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -107.82 108.76 20.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.962 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.184 -0.912 . . . . 0.0 111.049 179.998 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.861 0.362 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.07 171.23 9.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.029 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -113.2 166.32 11.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.681 HD11 ' HB2' ' A' ' 50' ' ' MET . 3.0 mp -132.59 125.32 52.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.033 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.664 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 14.7 t80 -99.05 124.05 43.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.012 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.658 HG13 HD21 ' A' ' 9' ' ' LEU . 9.5 p -131.14 142.6 43.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.961 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -136.59 179.81 17.52 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.535 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 62.89 30.6 16.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.785 0.326 . . . . 0.0 110.96 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.658 HD21 HG13 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -123.09 -177.51 3.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.045 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.765 HG12 ' HB2' ' A' ' 13' ' ' ALA . 0.4 OUTLIER -139.59 -169.57 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.767 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.616 ' N ' HG13 ' A' ' 10' ' ' VAL . 4.8 t80 -57.05 -52.25 66.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.806 0.336 . . . . 0.0 110.949 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.463 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.8 t -126.45 54.04 1.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.975 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.765 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -88.71 -54.93 3.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.111 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.537 HG21 ' CA ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -161.65 -41.96 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.079 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.3 t -54.46 -48.59 71.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.058 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -69.36 -14.36 62.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.757 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -90.45 -37.52 13.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.084 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 p -83.7 -28.2 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.583 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.446 ' HB2' HG21 ' A' ' 31' ' ' VAL . 3.7 pttp -53.3 -34.38 57.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.789 0.328 . . . . 0.0 110.983 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.07 -38.36 90.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.752 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.9 tt -86.28 -28.79 23.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.79 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.27 -26.16 62.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.974 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.62 -26.83 55.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.077 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -90.06 -12.8 37.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.489 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -109.04 -36.82 5.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.645 0.26 . . . . 0.0 111.24 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.8 10.27 4.55 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.066 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.6 pttp 43.07 54.78 4.78 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.837 0.351 . . . . 0.0 111.454 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.9 p -47.11 131.56 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.368 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -60.19 -57.43 12.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.894 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -156.65 165.21 36.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.002 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.561 HG13 HG22 ' A' ' 48' ' ' VAL . 21.6 t -141.63 114.49 4.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.005 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -119.02 151.94 37.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.024 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mt -130.76 149.36 52.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.755 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.963 HG21 ' CE2' ' A' ' 45' ' ' PHE . 2.7 pp -72.69 -175.14 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.983 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.434 ' N ' HD12 ' A' ' 34' ' ' ILE . 20.6 m-85 -149.14 -176.2 5.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.999 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.402 ' CB ' ' HE3' ' A' ' 43' ' ' LYS . 4.7 t0 -80.83 -168.52 1.81 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.826 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -120.61 35.97 4.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.817 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -163.97 -59.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.964 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.37 -4.94 28.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.387 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.93 35.98 13.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.843 0.354 . . . . 0.0 110.901 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -77.25 116.28 56.27 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.417 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 32.0 Cg_exo -61.27 114.77 2.35 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.54 2.16 . . . . 0.0 112.311 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.738 ' O ' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -177.61 137.03 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.976 0.417 . . . . 0.0 110.971 179.788 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.32 -72.09 0.48 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.633 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.963 ' CE2' HG21 ' A' ' 34' ' ' ILE . 1.7 p90 -152.25 -177.8 6.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.764 0.316 . . . . 0.0 110.851 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -154.59 -170.56 20.51 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.587 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.36 135.25 13.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.841 0.353 . . . . 0.0 110.92 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.561 HG22 HG13 ' A' ' 31' ' ' VAL . 39.8 t -123.98 156.7 31.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.015 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.464 ' N ' HG12 ' A' ' 48' ' ' VAL . 64.4 tt0 -119.74 112.18 18.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.871 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.681 ' HB2' HD11 ' A' ' 4' ' ' ILE . 21.9 mtp -144.96 168.97 18.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.956 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.405 ' O ' HG23 ' A' ' 55' ' ' VAL . 4.8 mm100 -71.85 160.53 32.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.824 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -82.04 59.38 4.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.76 -46.67 0.45 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.739 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 1.0 OUTLIER -90.02 -20.08 23.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.041 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.915 ' O ' HD12 ' A' ' 59' ' ' ILE . 42.9 t -64.7 -41.52 92.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.819 0.343 . . . . 0.0 111.166 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.4 m -57.71 -47.69 81.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.162 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -82.8 -28.32 30.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.118 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.51 ' O ' HD12 ' A' ' 62' ' ' LEU . . . -58.4 -41.22 84.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.329 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.915 HD12 ' O ' ' A' ' 55' ' ' VAL . 2.8 mp -90.32 -24.4 5.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.96 0.41 . . . . 0.0 111.166 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.37 -52.16 62.88 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.45 -19.1 24.27 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 58' ' ' ALA . 75.8 mt -90.02 -71.21 0.63 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.615 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -46.37 136.0 7.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.559 -179.333 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.467 ' O ' HG23 ' A' ' 65' ' ' THR . 62.1 t30 -177.18 -48.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.784 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 64' ' ' ASN . 0.4 OUTLIER -163.94 -175.15 3.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.968 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -91.0 113.62 25.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.941 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -130.25 -171.69 2.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.09 51.53 2.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.537 ' CA ' HG21 ' A' ' 14' ' ' THR . . . 83.88 38.07 10.85 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.465 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.44 -51.53 2.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.348 . . . . 0.0 110.987 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.79 -53.89 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.48 HG22 ' H ' ' A' ' 73' ' ' ARG . 5.0 mt 57.73 166.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.913 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.48 ' H ' HG22 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -91.1 48.84 1.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.902 0.382 . . . . 0.0 110.836 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.518 HG13 HG23 ' A' ' 59' ' ' ILE . 10.1 p -66.89 156.03 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.162 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.567 ' HA ' HG21 ' A' ' 59' ' ' ILE . 2.5 t -166.66 157.94 12.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.65 127.93 34.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.249 -0.882 . . . . 0.0 111.093 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.885 0.374 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -88.44 175.19 7.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 4.7 m-20 -118.55 129.88 55.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.868 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.806 HD12 ' HB ' ' A' ' 48' ' ' VAL . 30.6 mt -97.03 152.93 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.164 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.401 ' HB3' HG23 ' A' ' 75' ' ' THR . 90.7 t80 -130.18 103.58 6.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.812 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.677 HG13 HD23 ' A' ' 9' ' ' LEU . 10.6 p -113.56 116.97 54.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.164 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.1 -175.11 30.38 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.336 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.3 26.67 10.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.673 0.273 . . . . 0.0 111.323 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.775 HD21 ' N ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -102.76 -171.91 2.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.92 0.39 . . . . 0.0 111.17 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.705 HG13 ' H ' ' A' ' 12' ' ' SER . 6.7 p -164.49 170.55 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.469 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.564 ' H ' HG22 ' A' ' 10' ' ' VAL . 8.7 t80 -40.05 -31.64 0.13 Allowed 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 111.971 0.359 . . . . 0.0 111.971 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.705 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -144.04 50.55 1.33 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.798 0.332 . . . . 0.0 111.197 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.677 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -78.58 -61.16 2.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.123 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.662 HG21 ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER 179.47 -36.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.123 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.93 -50.53 68.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.01 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -71.72 -12.66 61.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.669 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -90.71 -28.0 18.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.147 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.57 HG22 ' CD1' ' A' ' 22' ' ' PHE . 14.7 p -90.09 -24.2 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.833 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.602 ' HB2' HG21 ' A' ' 31' ' ' VAL . 3.3 pttp -48.95 -32.72 9.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.761 0.315 . . . . 0.0 111.207 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -66.1 -33.77 76.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.967 0.413 . . . . 0.0 110.479 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 21' ' ' LEU . 8.2 tt -88.87 -27.12 21.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.662 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.57 ' CD1' HG22 ' A' ' 18' ' ' VAL . 2.0 m-30 -53.82 -24.86 16.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.049 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.6 m -61.41 -37.94 85.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.831 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.408 ' HG3' ' N ' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -90.35 -29.1 18.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.941 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.408 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -69.94 -40.4 75.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.936 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.57 21.26 0.16 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.434 -0.888 . . . . 0.0 113.264 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.2 tttm 56.17 111.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.959 0.409 . . . . 0.0 111.316 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 28' ' ' VAL . 12.8 p -105.37 121.54 57.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.013 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -67.44 -53.17 31.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.976 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -158.35 159.95 36.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.977 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.602 HG21 ' HB2' ' A' ' 19' ' ' LYS . 27.3 t -127.93 130.45 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.973 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.65 145.97 51.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.028 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.471 HD23 ' CA ' ' A' ' 46' ' ' GLY . 34.6 mt -141.18 146.55 37.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.728 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.431 HG21 ' CE1' ' A' ' 45' ' ' PHE . 2.6 pp -82.22 175.65 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.161 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -134.01 175.69 9.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.003 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -75.2 166.39 23.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 mpp_? -105.24 36.61 2.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.911 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -174.18 -41.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.966 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.6 -10.54 19.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.332 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt 61.76 28.97 17.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.782 0.325 . . . . 0.0 110.834 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -105.95 137.05 19.24 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.706 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.25 109.46 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.43 2.087 . . . . 0.0 112.407 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.418 ' C ' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -155.01 109.68 2.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.993 179.932 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 148.54 -63.92 0.41 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.726 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.446 ' CA ' HD11 ' A' ' 9' ' ' LEU . 13.2 p90 -177.25 170.72 2.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.875 0.369 . . . . 0.0 111.05 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.775 ' N ' HD21 ' A' ' 9' ' ' LEU . . . -125.34 179.87 16.01 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.543 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -146.36 129.53 16.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.348 . . . . 0.0 110.917 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.806 ' HB ' HD12 ' A' ' 4' ' ' ILE . 33.3 t -122.46 148.67 26.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.045 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -117.69 104.76 11.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.927 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 32.0 mtp -138.09 159.73 41.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.7 158.51 34.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.722 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -68.24 93.31 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.096 0.474 . . . . 0.0 110.963 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -169.53 -60.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.999 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 t -90.3 -15.56 30.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.84 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.894 ' O ' HD12 ' A' ' 59' ' ' ILE . 25.5 t -68.68 -49.0 68.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.843 0.354 . . . . 0.0 111.173 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 0.6 OUTLIER -70.12 -22.36 63.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.157 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -90.28 -37.21 14.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 110.602 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.64 ' HB1' HD12 ' A' ' 62' ' ' LEU . . . -57.75 -65.05 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.86 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.894 HD12 ' O ' ' A' ' 55' ' ' VAL . 2.6 mp -58.01 -30.63 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.031 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 56' ' ' SER . . . -57.43 -55.9 28.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.678 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -90.48 -28.07 18.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.684 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.64 HD12 ' HB1' ' A' ' 58' ' ' ALA . 94.1 mt -74.87 -72.26 0.3 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.782 0.325 . . . . 0.0 111.398 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.64 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -53.25 138.93 30.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.16 -179.599 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -177.38 -46.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.891 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -158.22 -178.69 7.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.948 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -92.65 106.62 18.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.873 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.67 -164.87 1.0 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.743 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 3.1 mtm -96.86 34.93 1.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.784 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.662 ' O ' HG21 ' A' ' 14' ' ' THR . . . 105.0 31.03 4.57 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.513 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -112.45 -62.28 1.6 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.862 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.7 -50.14 3.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.843 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.496 HG22 ' H ' ' A' ' 73' ' ' ARG . 4.0 mt 56.37 167.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.15 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.496 ' H ' HG22 ' A' ' 72' ' ' ILE . 10.4 ttm105 -95.01 45.08 1.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.915 0.388 . . . . 0.0 110.637 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.487 HG22 ' N ' ' A' ' 75' ' ' THR . 12.4 p -65.57 159.29 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.236 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.626 ' HA ' HG21 ' A' ' 59' ' ' ILE . 9.1 t -157.8 -176.82 6.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.523 ' HG2' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -94.63 44.66 1.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.93 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 3' ' ' ASN . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.141 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mtm . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.839 0.352 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -107.81 172.52 6.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -111.18 129.68 55.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.545 HG12 HG13 ' A' ' 55' ' ' VAL . 21.2 mt -98.12 143.46 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.093 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.493 ' CE1' ' CD2' ' A' ' 45' ' ' PHE . 41.5 t80 -116.97 123.32 46.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.962 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.523 ' CG2' HG21 ' A' ' 72' ' ' ILE . 12.0 p -125.92 121.32 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.971 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -107.21 76.8 0.23 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.696 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.625 ' CB ' HG23 ' A' ' 72' ' ' ILE . 4.5 t30 -178.04 54.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.85 0.357 . . . . 0.0 110.758 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.775 HD22 ' HB2' ' A' ' 15' ' ' SER . 16.7 mt -128.73 -168.82 1.97 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.179 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.607 HG22 ' H ' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -178.55 -168.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.388 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.607 ' H ' HG22 ' A' ' 10' ' ' VAL . 35.5 m-85 -47.02 -41.76 17.03 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.859 0.361 . . . . 0.0 111.1 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.543 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.8 m -167.66 76.43 0.15 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.658 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.56 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -97.62 -63.3 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.547 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -163.61 -19.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.989 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.775 ' HB2' HD22 ' A' ' 9' ' ' LEU . 7.6 t -47.56 -59.16 3.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.821 0.343 . . . . 0.0 111.511 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -67.42 -11.73 58.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.88 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -90.36 -32.61 16.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.062 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.6 p -87.23 -25.96 6.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.748 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.517 ' HB2' HG11 ' A' ' 31' ' ' VAL . 22.2 pttp -55.62 -29.75 59.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.781 0.324 . . . . 0.0 111.036 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -67.71 -35.96 79.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.757 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.8 tt -85.01 -30.34 24.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.815 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -17.79 65.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.107 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.7 -24.28 41.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.257 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -88.3 -25.97 22.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.225 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -107.24 -32.37 7.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.231 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -114.46 -25.27 4.1 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.806 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.99 53.47 2.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.039 0.447 . . . . 0.0 110.748 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.401 HG21 ' HB ' ' A' ' 31' ' ' VAL . 8.4 p -57.34 143.63 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.195 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -100.92 -40.12 7.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.875 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -138.59 126.13 21.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.906 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.517 HG11 ' HB2' ' A' ' 19' ' ' LYS . 11.1 p -146.47 131.73 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.087 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.4 170.08 7.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 10' ' ' VAL . 23.2 mt -96.63 154.29 17.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.816 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.607 HD11 ' HB3' ' A' ' 43' ' ' LYS . 2.6 pp -92.82 175.74 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.095 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -144.85 171.89 13.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.44 160.32 24.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.932 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.39 30.82 4.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.963 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -144.46 -57.41 0.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.43 -5.5 25.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.276 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 63.4 34.2 13.14 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.968 0.413 . . . . 0.0 110.934 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -110.72 143.17 27.67 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.831 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.47 133.66 54.3 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.532 2.155 . . . . 0.0 112.257 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.607 ' HB3' HD11 ' A' ' 34' ' ' ILE . 7.9 tptp -79.51 -69.02 0.61 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.848 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.99 45.07 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.532 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.493 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 27.0 p90 -177.75 169.31 2.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.904 0.383 . . . . 0.0 110.947 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.89 178.93 19.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.481 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -128.73 136.77 51.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.756 0.312 . . . . 0.0 110.915 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.513 HG22 HG23 ' A' ' 31' ' ' VAL . 23.8 t -127.74 141.62 45.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.093 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.26 113.83 25.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.7 mtp -145.96 -179.78 6.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.823 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.833 ' O ' HG23 ' A' ' 55' ' ' VAL . 15.0 tt0 -61.15 152.02 29.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.834 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -69.12 -32.6 72.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.016 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -77.13 -29.73 54.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.039 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.6 m -73.86 -32.42 63.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.015 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 51' ' ' GLN . 21.5 t -56.74 -49.18 79.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.309 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 m -53.16 -62.49 1.62 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.07 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -63.02 -29.65 70.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.997 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -66.57 -40.09 88.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.413 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.718 HG23 ' HB3' ' A' ' 63' ' ' ASP . 8.0 mt -90.12 -24.08 5.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.978 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.99 -52.8 63.47 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -90.47 -23.48 20.97 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 78.6 mt -85.39 -75.01 0.38 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.717 0.294 . . . . 0.0 111.702 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.718 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -52.46 134.04 34.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.875 0.369 . . . . 0.0 111.254 -179.439 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 179.1 -38.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.844 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.61 -165.8 2.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.768 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -119.92 96.95 5.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.921 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.2 -165.54 1.03 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.831 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 4.3 mmt -97.1 36.19 1.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.052 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.37 28.12 3.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.576 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -110.76 -31.15 7.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.815 0.341 . . . . 0.0 110.968 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.469 HG23 ' H ' ' A' ' 72' ' ' ILE . 0.6 OUTLIER -140.82 -56.38 0.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.949 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.625 HG23 ' CB ' ' A' ' 8' ' ' ASN . 18.0 mt 59.97 159.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.052 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.476 ' N ' HG22 ' A' ' 72' ' ' ILE . 5.7 ttt85 -89.29 53.64 2.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.776 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 75' ' ' THR . 12.1 p -74.57 156.81 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.21 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.457 ' N ' HG22 ' A' ' 74' ' ' VAL . 5.0 t -178.12 147.89 0.47 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.806 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -61.7 128.72 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.3 -0.857 . . . . 0.0 111.156 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpp? . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.813 0.339 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.765 ' HB2' HG21 ' A' ' 55' ' ' VAL . 8.4 mmt-85 -118.62 151.99 36.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.854 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.439 ' HB3' ' CE1' ' A' ' 47' ' ' PHE . 26.4 m-20 -89.72 115.74 27.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.694 HG23 HD11 ' A' ' 59' ' ' ILE . 10.5 mt -87.27 127.01 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.134 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -99.62 123.05 43.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.837 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.678 HG13 HD11 ' A' ' 9' ' ' LEU . 12.0 p -121.65 127.21 75.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.096 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.439 ' HA2' ' CD1' ' A' ' 45' ' ' PHE . . . -105.88 -171.98 23.51 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.414 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 m120 59.48 30.49 20.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.809 0.337 . . . . 0.0 110.955 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.742 HD22 ' HB2' ' A' ' 15' ' ' SER . 48.7 mt -82.83 166.72 18.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.982 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.82 HG12 ' HB2' ' A' ' 13' ' ' ALA . 0.8 OUTLIER -162.23 -174.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.796 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.625 ' H ' HG22 ' A' ' 10' ' ' VAL . 6.9 m-85 -46.73 -52.99 12.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.95 0.405 . . . . 0.0 111.159 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.454 ' H ' HG13 ' A' ' 10' ' ' VAL . 2.9 m -154.07 75.05 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.61 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.82 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -94.95 -56.72 2.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.429 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.627 HG21 ' CA ' ' A' ' 69' ' ' GLY . 1.5 m -165.5 -34.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.465 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.742 ' HB2' HD22 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -47.27 -54.4 11.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.715 0.293 . . . . 0.0 111.451 -179.658 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -68.13 -13.08 61.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.96 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -90.62 -43.4 10.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.136 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -79.23 -30.79 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.683 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -52.43 -27.53 16.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.801 0.334 . . . . 0.0 111.15 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -71.95 -37.74 69.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.811 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.1 tp -88.38 -28.44 20.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.89 -21.67 44.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.163 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.459 ' HA ' HG12 ' A' ' 28' ' ' VAL . 85.8 p -84.57 -27.62 27.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.093 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -89.98 -34.2 16.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.289 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -105.21 -30.23 9.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.271 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.4 -14.95 22.66 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.895 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.75 35.01 24.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.85 0.357 . . . . 0.0 110.86 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 23' ' ' SER . 11.0 p -50.69 143.31 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.336 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -91.26 -34.46 14.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.927 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -167.79 158.18 10.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.918 0.39 . . . . 0.0 111.193 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.466 HG13 HG22 ' A' ' 48' ' ' VAL . 21.3 t -143.48 150.34 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.898 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.437 ' C ' HD23 ' A' ' 33' ' ' LEU . 18.0 ttpt -169.64 151.76 4.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.933 0.397 . . . . 0.0 111.288 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.526 HD22 HD13 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -134.95 -177.27 4.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.329 179.762 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.574 HD11 ' HA3' ' A' ' 44' ' ' GLY . 1.8 pp -129.57 179.83 3.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.821 0.343 . . . . 0.0 111.189 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -139.71 -168.59 2.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.952 -179.651 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.77 -20.67 36.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.513 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.29 26.44 4.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.922 0.392 . . . . 0.0 110.81 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -156.44 -46.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.414 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.07 0.54 25.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.96 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.9 mttm 63.98 38.95 8.34 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.93 0.395 . . . . 0.0 111.044 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 42' ' ' PRO . 12.5 mtmm -100.96 100.79 13.76 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.573 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.444 ' HD2' ' CZ ' ' A' ' 11' ' ' TYR . 33.3 Cg_endo -64.8 107.1 0.84 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.354 2.036 . . . . 0.0 112.216 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.5 37.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.195 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.574 ' HA3' HD11 ' A' ' 34' ' ' ILE . . . -129.25 32.64 3.2 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.473 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.477 ' C ' HD12 ' A' ' 9' ' ' LEU . 0.5 OUTLIER 72.41 166.05 0.3 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.888 0.375 . . . . 0.0 110.905 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.651 ' N ' HD12 ' A' ' 9' ' ' LEU . . . -140.31 -162.36 9.08 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.482 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.439 ' CE1' ' HB3' ' A' ' 3' ' ' ASN . 0.3 OUTLIER -139.81 160.91 38.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 0.0 111.039 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.466 HG22 HG13 ' A' ' 31' ' ' VAL . 32.7 t -147.91 142.22 19.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.955 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -107.75 114.58 28.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.584 ' HB2' HD11 ' A' ' 4' ' ' ILE . 21.4 mtm -145.54 -178.12 5.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.887 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -75.85 150.65 37.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 -179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -61.18 -36.96 81.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -63.47 -31.05 72.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.016 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.41 -35.42 21.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.987 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 51' ' ' GLN . 40.7 t -57.69 -30.82 38.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.28 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.563 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -85.39 -23.43 27.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.269 -179.79 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -90.21 -41.45 11.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.888 0.375 . . . . 0.0 110.84 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.555 ' HB1' HD12 ' A' ' 62' ' ' LEU . . . -58.34 -66.43 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.949 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.862 HD12 ' O ' ' A' ' 55' ' ' VAL . 3.6 mt -58.07 -21.81 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.277 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 56' ' ' SER . . . -68.66 -54.3 17.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.584 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.19 -29.97 17.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.479 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.555 HD12 ' HB1' ' A' ' 58' ' ' ALA . 92.9 mt -73.2 -74.24 0.18 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.241 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.524 ' CB ' HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -57.0 135.86 56.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.055 -179.78 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 t30 179.51 -38.78 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.789 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.422 ' OG1' HG21 ' A' ' 71' ' ' THR . 0.5 OUTLIER -159.49 -177.51 6.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.788 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.21 111.4 23.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.988 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -131.71 -171.07 2.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.947 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 21.5 mtp -93.12 45.68 1.18 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.627 ' CA ' HG21 ' A' ' 14' ' ' THR . . . 97.98 39.5 3.8 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.516 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.08 -39.68 2.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.697 0.284 . . . . 0.0 111.075 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.422 HG21 ' OG1' ' A' ' 65' ' ' THR . 0.1 OUTLIER -135.37 -48.86 0.72 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.244 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.623 HG22 ' H ' ' A' ' 73' ' ' ARG . 1.9 mt 55.26 174.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.637 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.623 ' H ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -104.78 66.16 0.77 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.969 0.414 . . . . 0.0 111.022 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.524 HG12 ' CB ' ' A' ' 63' ' ' ASP . 14.7 p -83.25 156.98 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.0 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.453 ' N ' HG22 ' A' ' 74' ' ' VAL . 5.4 t -167.31 142.12 3.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.964 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.484 ' HB3' HG12 ' A' ' 55' ' ' VAL . 18.0 pt-20 -69.61 134.12 48.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.949 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.044 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.413 ' HG2' ' CE1' ' A' ' 29' ' ' PHE . 4.8 mtm . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.783 0.325 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -96.48 167.0 11.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.938 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -115.68 106.42 13.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.817 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.6 mt -76.76 128.76 37.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.201 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.526 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 50.1 t80 -108.54 122.21 46.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.749 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.713 HG13 HD11 ' A' ' 9' ' ' LEU . 10.9 p -132.49 145.92 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.228 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.34 -165.33 11.78 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.408 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 55.04 34.62 22.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.76 0.314 . . . . 0.0 111.039 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.713 HD11 HG13 ' A' ' 6' ' ' VAL . 28.6 mt -106.68 128.49 54.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.968 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.62 HG13 ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -89.71 -168.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.797 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.62 ' N ' HG13 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -49.7 -47.47 50.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.788 0.328 . . . . 0.0 111.04 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.528 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.4 t -145.76 58.79 1.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.706 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.636 ' O ' HG23 ' A' ' 14' ' ' THR . . . -59.31 -52.87 63.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.266 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER 176.03 -32.21 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.102 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.49 -54.15 19.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.323 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -64.83 -15.4 61.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.898 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -90.49 -34.09 15.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.201 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 p -90.12 -21.79 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.858 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.519 ' HB2' HG11 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -48.86 -28.43 3.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.748 0.308 . . . . 0.0 111.142 -179.822 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -71.77 -33.25 68.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.748 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.8 tt -88.9 -32.13 17.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.809 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.35 -23.46 64.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.988 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.6 m -80.91 -23.06 39.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.076 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.06 -37.52 14.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.111 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -101.7 -31.16 10.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.093 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.22 -24.79 9.32 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.655 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.0 tttt 63.88 36.99 9.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 0.0 110.899 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 49' ' ' GLU . 11.8 p -61.01 131.98 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.034 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.413 ' CE1' ' HG2' ' A' ' 1' ' ' MET . 74.8 m-85 -74.33 -41.92 60.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -150.85 148.32 28.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.825 HG23 HG22 ' A' ' 48' ' ' VAL . 11.0 p -162.95 130.24 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.975 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.99 161.46 4.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.884 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mt -100.83 173.75 6.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.921 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.611 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.4 pp -112.32 161.26 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.156 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.401 ' CD2' ' HB3' ' A' ' 42' ' ' PRO . 12.4 m-85 -145.34 -174.32 4.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.18 132.0 44.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.97 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -92.14 50.71 1.68 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.791 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -171.65 -42.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.51 -20.52 18.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.08 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.8 mmtp 67.78 44.68 1.56 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.914 0.388 . . . . 0.0 110.934 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -136.56 141.81 36.89 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.924 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.439 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 66.4 Cg_endo -73.88 134.1 19.36 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.52 2.146 . . . . 0.0 112.268 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.9 mmmt -63.8 -66.83 0.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.847 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.06 44.65 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.64 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.425 ' CE2' HG12 ' A' ' 34' ' ' ILE . 33.2 p90 -177.75 154.47 0.94 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.802 0.334 . . . . 0.0 110.986 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.12 -164.37 9.88 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.451 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -146.15 137.48 24.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.819 0.342 . . . . 0.0 110.908 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.825 HG22 HG23 ' A' ' 31' ' ' VAL . 33.7 t -122.52 111.89 32.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.998 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.604 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.8 OUTLIER -80.37 103.86 10.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.957 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.6 mtm -142.81 152.96 42.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.608 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -63.74 178.86 0.55 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.89 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.72 -159.0 0.08 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.45 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 66.05 -71.58 0.09 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.16 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.3 m -61.29 -30.99 70.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.039 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 51' ' ' GLN . 35.4 t -63.73 -44.78 98.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.181 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -67.14 -25.4 66.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.177 -179.867 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -90.16 -38.08 13.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.931 0.396 . . . . 0.0 110.727 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.712 ' HB1' HD12 ' A' ' 62' ' ' LEU . . . -58.41 -64.51 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.895 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.572 HG23 ' HB3' ' A' ' 63' ' ' ASP . 6.5 mt -58.13 -26.65 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.204 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 56' ' ' SER . . . -63.78 -53.91 43.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.713 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -90.33 -33.98 15.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.886 0.374 . . . . 0.0 111.428 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.712 HD12 ' HB1' ' A' ' 58' ' ' ALA . 83.6 mt -72.01 -70.79 0.31 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.38 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.572 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -54.91 134.59 48.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.18 -179.583 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -179.98 -67.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.904 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.58 -174.02 2.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -103.86 105.29 15.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.043 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -123.22 -174.75 3.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.813 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 8.5 ptt? -96.02 36.83 1.27 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.991 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.28 36.76 1.17 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.55 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.38 -40.42 2.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.727 0.299 . . . . 0.0 110.976 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.445 HG23 ' H ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -134.02 -60.99 0.8 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.859 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.505 HD13 HD21 ' A' ' 9' ' ' LEU . 26.9 mt 59.76 159.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.012 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.491 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -83.88 58.69 4.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.926 0.394 . . . . 0.0 110.748 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.473 HG22 ' N ' ' A' ' 75' ' ' THR . 13.8 p -75.37 158.11 5.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.185 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.473 ' N ' HG22 ' A' ' 74' ' ' VAL . 9.9 t -174.15 153.94 2.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.803 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -76.54 124.02 26.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.526 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.022 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.86 0.362 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.475 ' HB2' HG21 ' A' ' 55' ' ' VAL . 21.9 mmm180 -89.02 175.28 7.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.952 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.406 ' HB3' ' CE2' ' A' ' 47' ' ' PHE . 32.3 m-20 -121.95 129.49 52.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.865 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.524 HG12 HG13 ' A' ' 55' ' ' VAL . 31.6 mt -100.57 146.53 9.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.158 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -125.52 116.36 21.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.899 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 p -120.84 134.18 65.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.084 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.99 -168.64 14.49 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.429 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 59.99 33.23 21.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.844 0.354 . . . . 0.0 110.875 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.676 HD12 ' C ' ' A' ' 45' ' ' PHE . 53.7 mt -87.67 136.39 32.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.946 HG12 ' HB2' ' A' ' 13' ' ' ALA . 1.4 p -105.89 179.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.778 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.643 ' H ' HG22 ' A' ' 10' ' ' VAL . 6.9 m-85 -46.43 -53.37 11.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.871 0.367 . . . . 0.0 111.138 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.432 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -146.43 68.11 1.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.569 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.946 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -77.38 -76.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.381 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.49 -23.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.867 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.405 ' O ' HG12 ' A' ' 18' ' ' VAL . 16.7 p -47.29 -58.16 4.43 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.728 0.299 . . . . 0.0 111.459 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.24 -12.83 61.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.832 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -90.52 -29.86 17.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.152 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 15' ' ' SER . 12.3 p -87.5 -25.48 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.75 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.72 -26.84 6.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.74 0.305 . . . . 0.0 111.22 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -75.0 -34.64 61.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.8 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.5 tp -89.58 -30.18 18.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.995 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.406 ' CD2' ' HE3' ' A' ' 50' ' ' MET . 0.1 OUTLIER -58.08 -21.83 47.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.083 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.3 p -82.56 -24.38 34.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.19 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -85.44 -26.48 26.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.222 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.67 -29.27 7.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.256 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.5 -26.78 3.83 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.712 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.0 tttt 64.05 51.1 2.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.369 . . . . 0.0 110.837 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.3 p -54.76 135.76 17.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.235 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -90.96 -42.47 10.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.938 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -138.82 124.92 20.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 31' ' ' VAL . 10.9 p -136.15 121.46 28.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -138.4 178.83 6.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.011 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.58 ' CD2' HD13 ' A' ' 9' ' ' LEU . 7.4 mt -145.43 173.8 11.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.613 HD11 ' HA3' ' A' ' 44' ' ' GLY . 2.5 pp -110.31 179.0 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.144 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -121.61 173.22 7.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.037 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.73 -11.06 60.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.349 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.97 33.2 5.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.948 0.404 . . . . 0.0 110.848 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -165.34 -43.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.856 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.59 -1.51 16.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.346 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.15 33.03 14.78 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.885 0.374 . . . . 0.0 110.856 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.07 148.13 38.78 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.802 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.67 113.19 2.65 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.52 2.147 . . . . 0.0 112.231 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.2 109.19 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.613 ' HA3' HD11 ' A' ' 34' ' ' ILE . . . 150.52 -71.58 0.3 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.541 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.676 ' C ' HD12 ' A' ' 9' ' ' LEU . 9.9 p90 -165.55 179.07 6.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.351 . . . . 0.0 110.946 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.53 ' N ' HD12 ' A' ' 9' ' ' LEU . . . -143.17 -175.78 16.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.548 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.406 ' CE2' ' HB3' ' A' ' 3' ' ' ASN . 1.2 t80 -140.68 155.09 46.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.801 0.334 . . . . 0.0 110.926 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.1 t -151.36 131.36 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.08 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.88 116.46 31.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.406 ' HE3' ' CD2' ' A' ' 22' ' ' PHE . 4.0 mtt -142.29 168.24 20.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.963 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.654 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -60.0 179.75 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -96.2 35.52 1.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.996 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -123.86 -41.1 2.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.923 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.524 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 24.9 p -87.79 -24.77 23.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.171 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.669 ' O ' HD12 ' A' ' 59' ' ' ILE . 41.7 t -65.38 -28.79 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.319 . . . . 0.0 111.319 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.4 m -65.4 -47.33 76.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.111 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.429 ' HA ' ' HB3' ' A' ' 60' ' ' ALA . 5.4 tt0 -90.24 -25.0 20.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.226 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.524 ' HB2' ' O ' ' A' ' 54' ' ' SER . . . -50.42 -45.27 55.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.536 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.712 HG23 ' HB3' ' A' ' 63' ' ' ASP . 3.9 mp -90.44 -28.31 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.078 0.466 . . . . 0.0 110.929 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.429 ' HB3' ' HA ' ' A' ' 57' ' ' GLU . . . -52.32 -58.84 5.43 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -90.36 -12.46 37.57 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.507 HD12 ' O ' ' A' ' 58' ' ' ALA . 33.5 mt -90.04 -75.11 0.46 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.888 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.712 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -46.69 132.62 11.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.942 0.401 . . . . 0.0 111.632 -179.185 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 179.96 -67.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.742 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.17 -167.1 1.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.72 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -107.64 111.34 23.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.885 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.05 -167.17 1.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.951 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 3.5 mmt -86.9 56.19 3.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.704 ' HA2' HD11 ' A' ' 72' ' ' ILE . . . 78.69 32.67 40.51 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.503 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.7 -29.23 8.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.801 0.334 . . . . 0.0 110.966 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.514 HG23 ' H ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -137.94 -65.21 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.98 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.704 HD11 ' HA2' ' A' ' 69' ' ' GLY . 19.2 mt 59.74 159.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.979 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.49 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -83.32 78.58 9.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.698 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.588 HG13 HG23 ' A' ' 59' ' ' ILE . 14.0 p -101.71 153.84 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.206 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.4 t -169.1 161.65 10.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.958 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.45 130.83 47.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.089 179.979 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 120.883 0.373 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.29 169.35 8.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.838 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -104.13 133.55 48.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.768 HD11 ' HB2' ' A' ' 50' ' ' MET . 25.6 mt -98.99 111.33 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.099 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -90.54 119.39 30.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.828 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.694 HG13 HD11 ' A' ' 9' ' ' LEU . 8.7 p -131.86 139.05 51.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.044 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.553 ' O ' HG21 ' A' ' 72' ' ' ILE . . . -114.64 -163.6 14.45 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.399 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.629 ' HB3' HG23 ' A' ' 72' ' ' ILE . 5.0 t-20 55.67 36.26 26.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.788 0.328 . . . . 0.0 110.981 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.694 HD11 HG13 ' A' ' 6' ' ' VAL . 93.1 mt -100.73 109.81 21.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.066 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.642 HG22 ' H ' ' A' ' 11' ' ' TYR . 1.0 OUTLIER -78.33 -175.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.653 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.642 ' H ' HG22 ' A' ' 10' ' ' VAL . 24.7 m-85 -46.79 -48.96 20.57 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.894 0.378 . . . . 0.0 111.098 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.549 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.1 m -142.3 62.01 1.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.652 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.636 ' O ' HG23 ' A' ' 14' ' ' THR . . . -58.46 -70.85 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.424 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER 175.23 -28.43 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.34 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 26.8 t -48.33 -55.83 9.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.77 0.319 . . . . 0.0 111.345 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.86 -14.7 60.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.912 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -90.48 -41.12 11.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.04 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 18' ' ' VAL . 11.7 p -76.57 -14.21 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.759 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -51.77 -40.59 60.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.773 0.32 . . . . 0.0 111.193 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -61.06 -33.25 73.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.818 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.437 ' O ' HD23 ' A' ' 21' ' ' LEU . 6.4 tt -88.65 -28.65 20.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.853 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.47 -26.37 61.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.019 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.6 t -73.12 -34.57 66.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.923 0.392 . . . . 0.0 110.867 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -90.15 -4.98 56.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.245 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -114.47 -33.86 5.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.732 0.301 . . . . 0.0 111.238 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.0 -2.46 6.08 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.293 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? 59.63 40.85 19.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.944 0.402 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 49' ' ' GLU . 13.6 p -57.52 139.45 17.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.207 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -75.78 -39.09 57.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.933 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -168.83 154.9 6.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.007 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.785 HG22 HG13 ' A' ' 48' ' ' VAL . 21.7 t -138.72 118.79 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.983 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.53 132.27 17.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.108 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.626 ' N ' HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -106.98 174.53 5.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.558 179.692 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.668 HD11 ' CE1' ' A' ' 45' ' ' PHE . 2.1 pp -105.19 152.12 7.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.263 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 2.7 m-85 -117.73 -173.07 2.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.962 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.1 -168.66 1.9 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.864 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.7 ttt-85 -127.65 36.27 4.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -157.02 -54.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.72 -2.14 26.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.379 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.3 mttm 60.84 36.97 18.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.815 0.341 . . . . 0.0 110.925 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -105.64 141.29 22.34 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.903 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 50.3 Cg_exo -53.19 118.28 4.67 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.479 2.119 . . . . 0.0 112.276 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -58.35 -69.11 0.2 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.839 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 173.9 35.11 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.562 -0.828 . . . . 0.0 113.012 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.668 ' CE1' HD11 ' A' ' 34' ' ' ILE . 28.4 p90 -178.5 155.82 0.88 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.077 0.465 . . . . 0.0 111.333 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.475 ' N ' HD12 ' A' ' 9' ' ' LEU . . . -141.09 -166.18 10.62 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.388 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -144.08 143.74 31.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.88 0.371 . . . . 0.0 110.967 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.785 HG13 HG22 ' A' ' 31' ' ' VAL . 35.3 t -134.26 138.9 49.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.055 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -94.33 107.87 19.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.908 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.768 ' HB2' HD11 ' A' ' 4' ' ' ILE . 3.6 mtt -135.78 156.36 48.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.915 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.597 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.7 tt0 -81.29 154.94 26.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.974 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -51.06 -29.58 13.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.198 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -71.24 -35.09 71.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.95 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.9 p -87.07 -43.65 12.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.938 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 51' ' ' GLN . 30.2 t -58.21 -31.11 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.145 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.51 -51.32 70.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.098 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -88.64 -23.51 23.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.157 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.522 ' O ' HD12 ' A' ' 62' ' ' LEU . . . -55.04 -41.48 71.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.408 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.777 HG23 ' HB3' ' A' ' 63' ' ' ASP . 4.5 mt -90.25 -24.81 5.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.067 0.46 . . . . 0.0 110.917 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.49 -55.66 30.97 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.29 -19.71 23.78 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.522 HD12 ' O ' ' A' ' 58' ' ' ALA . 64.9 mt -85.4 -75.15 0.38 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.763 0.316 . . . . 0.0 111.65 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.777 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -55.97 137.17 51.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.147 -179.522 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 178.78 -61.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.813 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.89 -173.6 3.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -105.78 118.58 36.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.435 ' CD2' ' HD3' ' A' ' 70' ' ' ARG . 0.2 OUTLIER -135.2 -165.52 1.69 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.83 32.27 2.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.026 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.428 ' HA2' HD11 ' A' ' 72' ' ' ILE . . . 112.57 33.29 2.11 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.585 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.435 ' HD3' ' CD2' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -113.52 -34.48 5.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 0.0 110.934 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.498 HG23 ' H ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -137.92 -61.55 0.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.843 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.629 HG23 ' HB3' ' A' ' 8' ' ' ASN . 1.1 mp 59.94 162.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.908 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.429 ' N ' HG22 ' A' ' 72' ' ' ILE . 3.5 mmm-85 -87.75 75.78 8.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.859 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.471 HG23 ' HB ' ' A' ' 6' ' ' VAL . 12.5 p -97.84 156.12 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.448 ' N ' HG22 ' A' ' 74' ' ' VAL . 9.9 t -167.23 161.26 14.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.961 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -81.76 107.56 14.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.907 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.167 -0.921 . . . . 0.0 111.089 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.825 0.345 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -135.77 173.32 11.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 -102.61 139.44 38.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.935 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.552 HD11 ' HB2' ' A' ' 50' ' ' MET . 4.1 mt -109.8 136.95 44.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.044 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -114.73 122.76 47.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.913 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.747 HG13 HD11 ' A' ' 9' ' ' LEU . 11.3 p -129.06 134.19 64.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.142 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -118.47 -168.3 14.22 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.468 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 59.64 33.9 22.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.858 0.361 . . . . 0.0 110.957 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.747 HD11 HG13 ' A' ' 6' ' ' VAL . 48.4 mt -98.74 -175.03 2.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.909 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.641 HG13 ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -167.97 -167.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.733 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.641 ' N ' HG13 ' A' ' 10' ' ' VAL . 77.4 m-85 -47.58 -46.76 28.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.798 0.333 . . . . 0.0 111.195 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.484 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -152.44 53.26 0.79 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.824 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.654 ' O ' HG23 ' A' ' 14' ' ' THR . . . -64.14 -55.32 22.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.184 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.7 HG21 ' HA3' ' A' ' 69' ' ' GLY . 0.1 OUTLIER 177.07 -33.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.081 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.565 ' OG ' HD13 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -52.39 -52.39 53.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.803 0.335 . . . . 0.0 111.103 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -66.62 -15.52 63.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.772 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -90.55 -29.81 17.63 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.308 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 15' ' ' SER . 14.4 p -89.74 -20.94 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.811 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.404 ' HB2' HG11 ' A' ' 31' ' ' VAL . 13.3 pttp -57.29 -30.47 64.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.693 0.282 . . . . 0.0 111.12 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -72.77 -35.98 67.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.885 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.4 tp -87.56 -27.76 22.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.493 ' CD1' ' HE3' ' A' ' 50' ' ' MET . 0.1 OUTLIER -57.06 -21.96 35.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.211 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.444 ' HA ' HG12 ' A' ' 28' ' ' VAL . 1.4 t -83.25 -21.12 33.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.22 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -89.17 -43.65 10.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.125 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -100.05 -29.86 12.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.148 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.34 -21.96 20.82 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.597 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.66 31.69 16.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.911 0.386 . . . . 0.0 110.918 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 49' ' ' GLU . 12.0 p -55.2 141.87 10.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.167 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -84.07 -42.63 15.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.62 160.36 40.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.468 HG23 HG22 ' A' ' 48' ' ' VAL . 10.2 p -149.09 151.15 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.928 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.21 131.92 0.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.088 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.725 HD23 ' HA3' ' A' ' 46' ' ' GLY . 1.0 OUTLIER -102.28 -174.31 2.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.603 179.765 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.532 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.3 pp -107.27 167.71 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.288 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -147.34 157.66 43.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.01 154.25 23.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.872 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -94.71 46.52 1.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -176.52 -40.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.801 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.71 -18.7 16.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.084 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.49 34.84 12.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.871 0.367 . . . . 0.0 110.911 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -113.39 142.13 27.01 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.782 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.24 117.58 4.07 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.443 2.095 . . . . 0.0 112.297 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -60.63 -70.11 0.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.762 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 176.22 35.55 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.737 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.444 ' CE2' HG12 ' A' ' 34' ' ' ILE . 28.2 p90 -178.66 172.82 1.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.901 0.382 . . . . 0.0 111.082 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.725 ' HA3' HD23 ' A' ' 33' ' ' LEU . . . -162.58 -164.31 17.27 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.418 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -138.3 164.3 29.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.915 0.388 . . . . 0.0 111.05 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.468 HG22 HG23 ' A' ' 31' ' ' VAL . 32.7 t -149.91 151.55 12.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.926 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.575 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -113.31 110.92 21.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.904 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.552 ' HB2' HD11 ' A' ' 4' ' ' ILE . 18.1 mtp -147.3 -176.64 5.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.891 ' O ' HG23 ' A' ' 55' ' ' VAL . 2.0 tt0 -86.23 148.44 25.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.902 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -57.75 -35.1 70.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.062 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.22 -44.46 92.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.914 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 58.4 m -77.1 -32.1 56.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.906 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.902 ' O ' HD12 ' A' ' 59' ' ' ILE . 39.5 t -69.17 -36.11 71.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.189 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.4 m -60.0 -43.48 95.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.189 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -90.0 -27.82 19.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.283 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.529 ' O ' HD12 ' A' ' 62' ' ' LEU . . . -56.88 -41.83 78.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.396 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.902 HD12 ' O ' ' A' ' 55' ' ' VAL . 2.7 mp -90.22 -27.35 5.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.041 0.448 . . . . 0.0 110.966 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.56 -58.35 7.07 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -90.35 -13.0 36.01 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.529 HD12 ' O ' ' A' ' 58' ' ' ALA . 41.3 mt -89.99 -75.18 0.46 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.775 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.766 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -49.65 129.88 20.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.521 -179.324 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -176.98 -43.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.914 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.39 -175.13 4.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -106.89 99.8 9.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.962 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.69 -168.95 1.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.899 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.38 52.25 2.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.959 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.7 ' HA3' HG21 ' A' ' 14' ' ' THR . . . 89.63 27.93 20.64 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.579 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 ttp180 -107.82 -31.16 8.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.796 0.331 . . . . 0.0 110.868 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.483 HG23 ' H ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -140.31 -59.2 0.53 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.567 HD11 ' HA2' ' A' ' 69' ' ' GLY . 15.5 mt 59.38 161.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.012 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.477 ' N ' HG22 ' A' ' 72' ' ' ILE . 5.5 mtt180 -86.63 56.27 3.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.796 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.556 HG13 HG23 ' A' ' 59' ' ' ILE . 14.0 p -76.81 158.96 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.294 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.565 ' HA ' HG21 ' A' ' 59' ' ' ILE . 10.2 t -167.76 165.79 13.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.886 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -96.76 110.55 22.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.31 -0.852 . . . . 0.0 111.17 179.971 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 ttt . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.788 0.328 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -130.46 161.07 32.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.855 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -103.19 119.24 38.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.891 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.676 HG12 HG13 ' A' ' 55' ' ' VAL . 17.2 mt -92.97 131.83 38.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.18 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.518 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 85.9 t80 -111.17 126.01 54.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.852 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.16 145.0 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.192 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.54 -174.29 14.74 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.474 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 60.48 41.81 15.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 110.875 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.57 HD13 HD21 ' A' ' 33' ' ' LEU . 25.8 mt -103.88 -179.16 3.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.839 HG12 ' HB2' ' A' ' 13' ' ' ALA . 5.7 p -173.36 169.76 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.799 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.564 ' H ' HG22 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -40.23 -37.73 0.68 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.855 -179.593 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.605 ' H ' HG13 ' A' ' 10' ' ' VAL . 21.0 p -142.61 54.97 1.41 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.842 0.353 . . . . 0.0 111.1 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.839 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -77.11 -69.99 0.49 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.189 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -179.8 -36.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.966 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.423 ' HB2' HD22 ' A' ' 9' ' ' LEU . 0.8 OUTLIER -52.8 -51.26 61.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.893 0.378 . . . . 0.0 111.078 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -14.58 62.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -90.33 -31.72 16.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.144 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.8 p -87.76 -24.83 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.593 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.708 ' HB3' HG11 ' A' ' 31' ' ' VAL . 9.8 pttt -54.02 -28.53 38.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.812 0.339 . . . . 0.0 111.0 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -33.86 69.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.662 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.5 tt -90.13 -28.44 18.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.838 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.19 -26.55 51.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.004 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.1 p -76.23 -33.55 59.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.852 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -90.1 -9.62 47.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.337 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -111.77 -37.18 5.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.715 0.293 . . . . 0.0 111.077 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.03 -8.47 5.57 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.198 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.33 47.35 6.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.882 0.372 . . . . 0.0 110.755 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.684 HG21 ' CG2' ' A' ' 31' ' ' VAL . 9.7 p -54.28 155.56 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.29 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.434 ' N ' HG22 ' A' ' 28' ' ' VAL . 14.1 m-85 -93.15 -49.18 6.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.09 143.47 30.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.809 HG22 HG13 ' A' ' 48' ' ' VAL . 21.2 t -150.19 110.74 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.122 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.33 172.94 16.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.57 HD21 HD13 ' A' ' 9' ' ' LEU . 7.5 mt -104.13 156.62 17.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.828 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.839 HD11 ' HB2' ' A' ' 43' ' ' LYS . 2.7 pp -66.04 -35.51 75.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.127 0.489 . . . . 0.0 111.205 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.575 ' N ' HD12 ' A' ' 34' ' ' ILE . 3.1 m-85 49.69 -175.97 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.196 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -109.47 141.02 42.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.8 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -90.13 52.43 2.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.942 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -177.49 -40.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.818 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -104.9 -18.35 14.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.167 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.8 mttp 63.32 33.67 13.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.909 0.385 . . . . 0.0 110.883 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -113.89 145.25 33.12 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.883 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.65 120.31 6.11 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.58 2.187 . . . . 0.0 112.352 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.839 ' HB2' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -68.55 -75.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.878 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 175.9 37.11 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.65 -0.785 . . . . 0.0 112.684 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.435 ' CE2' HG12 ' A' ' 34' ' ' ILE . 32.7 p90 -177.14 132.95 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.905 0.383 . . . . 0.0 110.992 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -122.4 -159.3 10.55 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.533 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.406 ' CD1' ' O ' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -145.01 152.59 40.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.841 0.353 . . . . 0.0 111.057 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.809 HG13 HG22 ' A' ' 31' ' ' VAL . 48.7 t -141.75 124.75 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.856 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -95.39 108.4 20.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.61 ' HG3' HG23 ' A' ' 28' ' ' VAL . 26.2 mtp -136.79 158.96 43.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.421 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -62.54 155.53 25.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -77.75 69.15 3.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.027 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -149.98 -48.27 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.428 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -90.18 -20.07 23.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.014 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.725 ' O ' HD12 ' A' ' 59' ' ' ILE . 30.0 t -59.5 -47.98 88.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.317 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 m -56.01 -56.13 24.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.149 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -69.65 -28.67 66.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.187 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.528 ' O ' HD12 ' A' ' 62' ' ' LEU . . . -60.56 -41.72 95.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.281 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.748 HG23 ' HB3' ' A' ' 63' ' ' ASP . 3.3 mt -90.34 -27.28 5.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.045 0.45 . . . . 0.0 111.046 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.53 -57.26 12.09 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -90.45 -14.56 32.58 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.528 HD12 ' O ' ' A' ' 58' ' ' ALA . 48.8 mt -90.08 -75.08 0.46 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.777 0.322 . . . . 0.0 111.826 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.748 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -48.96 140.58 8.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.979 0.419 . . . . 0.0 111.499 -179.291 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 174.19 -35.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.641 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.72 -170.25 2.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.744 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.2 109.2 17.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.911 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -139.2 -174.22 3.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -74.98 68.2 1.78 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.502 ' HA2' HD11 ' A' ' 72' ' ' ILE . . . 66.36 26.55 72.69 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.683 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.3 mtp85 -96.56 -36.36 10.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.898 0.38 . . . . 0.0 110.82 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -138.67 -51.66 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.776 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.502 HD11 ' HA2' ' A' ' 69' ' ' GLY . 18.0 mt 59.78 159.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.107 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.494 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -92.01 50.54 1.68 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.947 0.403 . . . . 0.0 110.845 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.515 HG13 ' HB3' ' A' ' 63' ' ' ASP . 14.8 p -72.65 158.81 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.536 ' HA ' HG21 ' A' ' 59' ' ' ILE . 3.2 t -176.77 157.82 1.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.895 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.18 108.64 14.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.828 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.518 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.156 -0.926 . . . . 0.0 111.105 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 mtt . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.827 0.346 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -109.18 -171.08 1.77 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -121.06 137.92 54.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.948 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.653 HG12 HG13 ' A' ' 55' ' ' VAL . 21.1 mt -109.48 141.05 25.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.103 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.803 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 7.2 t80 -110.23 124.2 51.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.908 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.5 p -129.37 138.16 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.108 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.19 -171.58 17.4 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.45 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 58.73 30.22 19.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.831 0.348 . . . . 0.0 110.97 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.421 HD12 HD21 ' A' ' 33' ' ' LEU . 3.9 mm? -86.29 163.38 17.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.798 HG12 ' HB2' ' A' ' 13' ' ' ALA . 3.6 p -147.36 172.4 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.853 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.581 ' H ' HG22 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -42.58 -41.52 3.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.583 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.627 ' H ' HG13 ' A' ' 10' ' ' VAL . 18.3 m -150.25 66.34 0.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.927 0.394 . . . . 0.0 110.953 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.798 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -73.49 -77.38 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.323 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 13' ' ' ALA . 0.6 OUTLIER -173.11 -36.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.28 -179.776 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.3 t -49.79 -52.53 31.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.351 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.81 -14.43 62.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.85 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -90.39 -46.23 8.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.959 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.46 ' O ' HG22 ' A' ' 18' ' ' VAL . 12.6 p -71.91 -9.42 12.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.689 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.802 ' CB ' HG11 ' A' ' 31' ' ' VAL . 20.1 pttm -53.59 -31.03 45.26 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.799 0.333 . . . . 0.0 110.971 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -69.8 -33.15 71.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.828 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.4 tt -90.02 -29.97 18.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.882 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.529 ' HZ ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -57.62 -26.04 61.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.01 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m -76.19 -30.19 57.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.062 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -90.07 -5.17 56.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.348 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -116.18 -36.98 3.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.71 0.29 . . . . 0.0 111.11 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.1 -0.18 3.88 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.32 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 mmtt 56.04 103.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.985 0.393 . . . . 0.0 111.071 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.796 HG21 ' CG2' ' A' ' 31' ' ' VAL . 7.1 p -117.17 169.06 7.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.793 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.531 ' H ' HG22 ' A' ' 28' ' ' VAL . 10.4 m-85 -129.9 -39.51 1.4 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -97.6 -96.3 0.21 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.814 HG22 HG13 ' A' ' 48' ' ' VAL . 45.4 t 66.58 88.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.734 0.302 . . . . 0.0 110.882 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.67 151.93 22.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.93 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.755 HD23 ' HA3' ' A' ' 46' ' ' GLY . 10.3 mt -101.47 153.55 19.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.827 HD11 ' HB2' ' A' ' 43' ' ' LYS . 2.7 pp -85.63 -179.36 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -137.9 -172.19 3.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.862 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -91.7 -175.59 4.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.974 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.23 31.71 6.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -160.25 -59.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.881 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 p -92.42 -17.02 25.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.195 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.6 mptt 66.91 30.17 7.85 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.86 0.362 . . . . 0.0 110.882 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.1 pttt -92.15 138.15 24.6 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.789 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.29 115.82 2.54 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.438 2.092 . . . . 0.0 112.302 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.827 ' HB2' HD11 ' A' ' 34' ' ' ILE . 14.6 mmmt -59.64 -74.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.898 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.5 39.36 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.561 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.44 ' CE2' HG12 ' A' ' 34' ' ' ILE . 13.4 p90 -172.1 145.55 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.91 0.386 . . . . 0.0 110.934 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.755 ' HA3' HD23 ' A' ' 33' ' ' LEU . . . -125.97 -166.05 12.17 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.541 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -145.67 128.94 16.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 111.164 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.814 HG13 HG22 ' A' ' 31' ' ' VAL . 52.4 t -114.75 116.0 51.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.863 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -87.26 94.99 9.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.945 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.748 ' HG3' HG12 ' A' ' 48' ' ' VAL . 29.2 mtp -121.18 177.56 5.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.881 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.895 ' O ' HG23 ' A' ' 55' ' ' VAL . 18.8 mt-30 -69.1 158.2 35.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -31.18 69.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.902 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -81.63 -31.17 32.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.012 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 1.0 OUTLIER -73.61 -33.0 64.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.051 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 51' ' ' GLN . 24.9 t -58.01 -47.6 86.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.395 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.1 m -57.74 -64.77 0.79 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.13 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.15 -26.99 63.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.149 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.532 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -68.34 -37.14 80.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.415 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.524 HD12 ' O ' ' A' ' 55' ' ' VAL . 5.8 mt -90.36 -11.79 9.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.275 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.75 -49.6 12.77 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -90.64 -19.41 23.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.799 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 78.2 mt -90.07 -75.03 0.47 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.411 ' HB3' HG13 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -59.56 144.95 46.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.023 0.44 . . . . 0.0 111.059 -179.477 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 179.67 -38.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.803 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.417 ' OG1' HG21 ' A' ' 71' ' ' THR . 0.0 OUTLIER -155.79 -170.39 3.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.824 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -111.15 111.71 22.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.964 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.56 -172.02 2.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.815 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -95.49 39.77 1.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.037 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.17 31.2 3.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.563 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.35 -41.83 4.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.806 0.336 . . . . 0.0 110.881 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.417 HG21 ' OG1' ' A' ' 65' ' ' THR . 0.9 OUTLIER -134.93 -48.9 0.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.47 HG22 ' H ' ' A' ' 73' ' ' ARG . 6.5 mt 59.28 165.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.793 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.47 ' H ' HG22 ' A' ' 72' ' ' ILE . 27.4 mtt180 -99.19 48.9 0.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.925 0.393 . . . . 0.0 110.756 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.411 HG13 ' HB3' ' A' ' 63' ' ' ASP . 7.7 p -65.38 125.19 21.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.064 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.0 t -132.67 162.98 29.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.009 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.86 117.11 21.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.932 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.803 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.215 -0.897 . . . . 0.0 111.121 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.425 ' HG2' ' CZ ' ' A' ' 29' ' ' PHE . 20.9 mtp . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.816 0.341 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -108.22 -169.26 1.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.41 ' HB3' ' CE2' ' A' ' 47' ' ' PHE . 1.6 m120 -121.71 150.5 41.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.89 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.598 HG12 HG13 ' A' ' 55' ' ' VAL . 19.4 mt -116.74 119.15 61.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.126 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.586 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 73.8 t80 -96.16 129.73 43.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.993 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.521 ' CG1' HD21 ' A' ' 9' ' ' LEU . 7.6 p -123.01 136.99 58.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.974 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -124.3 174.92 17.02 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.502 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 62.23 25.6 15.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.613 0.244 . . . . 0.0 110.986 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.521 HD21 ' CG1' ' A' ' 6' ' ' VAL . 1.8 mm? -60.15 138.63 57.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.679 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.524 HG22 ' N ' ' A' ' 11' ' ' TYR . 14.7 p -102.49 162.18 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.644 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.524 ' N ' HG22 ' A' ' 10' ' ' VAL . 42.4 m-85 -43.33 -30.02 0.48 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.162 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.52 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 1.1 m -100.57 -71.64 0.7 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.054 0.454 . . . . 0.0 110.057 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 12' ' ' SER . . . 76.39 141.43 0.07 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.411 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.6 ' O ' HG12 ' A' ' 18' ' ' VAL . 1.7 m -106.01 -26.84 11.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.374 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.08 -46.49 80.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.047 0.451 . . . . 0.0 110.09 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.674 ' HG3' HD21 ' A' ' 33' ' ' LEU . 3.8 tm-20 -75.75 -12.94 60.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.037 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.46 -41.09 11.64 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.496 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.6 HG12 ' O ' ' A' ' 14' ' ' THR . 11.9 p -78.2 -4.91 7.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.618 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 52.5 pttt -53.12 -37.16 61.53 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.762 0.315 . . . . 0.0 110.962 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -60.17 -31.53 70.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.707 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.1 tt -89.95 -29.65 18.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.789 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.412 ' HZ ' HD11 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -57.66 -25.81 60.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.97 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m -67.11 -38.59 85.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.964 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.15 -7.75 52.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.209 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -103.54 -27.51 12.31 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.314 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.85 19.77 0.58 Allowed Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.372 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.4 pttm 42.33 98.99 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.905 0.383 . . . . 0.0 111.925 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.487 HG21 ' CG2' ' A' ' 31' ' ' VAL . 11.8 p -103.77 133.95 46.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.992 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.425 ' CZ ' ' HG2' ' A' ' 1' ' ' MET . 92.1 m-85 -69.45 -46.13 67.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.012 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -166.95 157.52 11.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.002 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.837 HG13 HG22 ' A' ' 48' ' ' VAL . 21.9 t -147.34 129.33 6.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.107 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.505 ' C ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -157.67 138.57 13.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.012 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.674 HD21 ' HG3' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -126.92 148.15 50.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.784 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.583 HD11 ' HA3' ' A' ' 44' ' ' GLY . 2.9 pp -64.38 177.73 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.043 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -132.89 -177.03 4.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.986 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -60.93 -22.36 64.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.173 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 62.26 33.57 16.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.781 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.06 -46.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.788 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.49 -0.29 32.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.364 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.1 mttt 62.61 35.99 13.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.846 0.355 . . . . 0.0 111.016 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -116.53 128.07 26.28 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.78 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.66 115.71 3.54 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.407 2.071 . . . . 0.0 112.244 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.62 132.04 1.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.943 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.583 ' HA3' HD11 ' A' ' 34' ' ' ILE . . . 137.7 -72.89 0.44 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.506 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -169.4 168.21 9.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.846 0.355 . . . . 0.0 110.833 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.415 ' CA ' ' HB3' ' A' ' 33' ' ' LEU . . . -137.75 -178.07 15.71 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.601 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.436 ' CZ ' ' CB ' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -150.96 129.61 12.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.82 0.343 . . . . 0.0 111.094 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.837 HG22 HG13 ' A' ' 31' ' ' VAL . 51.2 t -126.3 143.51 39.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -111.9 106.09 14.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.978 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.486 ' CE ' HG11 ' A' ' 48' ' ' VAL . 35.5 mtt -137.4 -177.36 4.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.994 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.786 ' O ' HG23 ' A' ' 55' ' ' VAL . 3.8 tt0 -67.21 168.05 11.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.965 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -66.81 -37.05 83.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.954 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -74.8 -32.5 62.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.963 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.522 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -66.87 -36.31 82.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 51' ' ' GLN . 31.6 t -62.32 -44.97 99.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.227 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.4 m -55.94 -63.57 1.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.085 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -62.11 -28.18 69.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.968 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.523 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -61.18 -38.29 85.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.293 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.764 HD12 ' O ' ' A' ' 55' ' ' VAL . 3.5 mt -90.22 -16.9 8.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.23 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.87 -48.34 31.71 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.3 mmmt -90.41 -22.85 21.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.656 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.523 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 78.6 mt -89.96 -69.8 0.7 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.532 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.585 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -63.05 141.42 58.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.087 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -178.63 -38.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.872 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.79 -168.64 2.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.73 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -110.34 104.67 13.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.974 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.9 -167.95 1.83 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.893 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.6 ptm -95.16 43.8 1.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.078 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.54 26.61 8.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.628 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 44.7 mtp85 -103.94 -34.99 8.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.908 0.385 . . . . 0.0 110.74 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.1 t -141.07 -47.06 0.4 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.651 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.516 HG22 ' H ' ' A' ' 73' ' ' ARG . 2.2 mt 57.76 167.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.826 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.516 ' H ' HG22 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -99.4 47.36 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.912 0.387 . . . . 0.0 110.833 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.475 HG12 ' CB ' ' A' ' 63' ' ' ASP . 13.2 p -61.93 153.25 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.12 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.0 t -159.97 165.97 30.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -80.25 126.01 30.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.826 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.586 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.173 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 ttm . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.843 0.354 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -123.67 132.54 53.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.47 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 6.9 m-20 -76.43 140.43 41.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.881 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.448 HG12 HG13 ' A' ' 55' ' ' VAL . 14.1 mt -106.18 126.02 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.033 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -107.88 104.44 13.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.836 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.531 ' HB ' HG23 ' A' ' 74' ' ' VAL . 12.0 p -113.32 130.95 66.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.166 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -120.46 -174.01 15.1 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.424 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 59.37 39.19 22.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.901 0.381 . . . . 0.0 110.863 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.547 HD12 ' C ' ' A' ' 45' ' ' PHE . 23.6 mt -82.46 178.41 8.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 1.032 HG12 ' HB2' ' A' ' 13' ' ' ALA . 6.3 p -143.69 169.13 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.545 ' H ' HG22 ' A' ' 10' ' ' VAL . 27.6 m-85 -44.33 -31.49 1.05 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.505 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.725 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.0 OUTLIER -170.99 76.3 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.934 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 1.032 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -81.69 -59.68 2.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.153 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.68 HG23 ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER 176.35 -31.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.204 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.9 m -50.51 -53.74 27.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.783 0.325 . . . . 0.0 111.297 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.618 ' HB3' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -67.95 -13.62 62.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.713 179.597 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.56 -38.56 13.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.231 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.451 ' O ' HG22 ' A' ' 18' ' ' VAL . 14.0 p -84.06 -9.78 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.899 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -56.88 -44.36 82.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.775 0.321 . . . . 0.0 110.932 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -59.74 -33.04 71.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.705 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.511 ' O ' HD23 ' A' ' 21' ' ' LEU . 5.7 tt -87.67 -27.46 22.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.836 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.46 ' CD1' ' CE ' ' A' ' 50' ' ' MET . 0.1 OUTLIER -55.76 -23.64 30.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.162 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.8 t -80.26 -26.83 38.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.082 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -90.09 -20.47 23.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.236 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -109.54 -33.59 6.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.208 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.62 -18.25 4.9 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.154 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm 65.64 42.61 3.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.89 0.376 . . . . 0.0 110.741 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.3 p -51.08 151.76 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.33 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -91.79 -43.05 9.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -153.48 157.18 39.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.075 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.9 t -150.83 121.85 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.889 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.417 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -141.58 163.04 33.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.081 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.618 HD11 ' HB3' ' A' ' 16' ' ' GLU . 76.9 mt -129.36 179.67 5.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.791 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.744 HG21 ' CE2' ' A' ' 45' ' ' PHE . 2.5 pp -126.92 171.75 14.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.349 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -115.63 -169.86 1.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.937 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.04 178.33 6.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.81 30.86 7.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.935 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -162.47 -48.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 p -91.92 -20.83 20.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.004 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.43 34.31 8.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.839 0.352 . . . . 0.0 110.96 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.412 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 1.8 mtpp -101.69 151.02 37.81 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.851 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.71 97.8 0.92 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.618 2.212 . . . . 0.0 112.628 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.412 ' CE ' ' HB2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -178.23 135.6 0.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.799 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.634 ' HA3' HD11 ' A' ' 34' ' ' ILE . . . 149.42 -59.96 0.44 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.457 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.744 ' CE2' HG21 ' A' ' 34' ' ' ILE . 40.8 p90 -171.52 167.91 6.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.849 0.356 . . . . 0.0 110.962 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.77 174.57 22.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.352 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.86 133.92 38.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.884 0.374 . . . . 0.0 111.017 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.435 ' HB ' HD12 ' A' ' 4' ' ' ILE . 41.7 t -129.22 151.57 35.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.956 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -125.14 120.31 31.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.914 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.46 ' CE ' ' CD1' ' A' ' 22' ' ' PHE . 32.5 mtp -151.88 166.79 30.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -68.88 159.85 31.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.794 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.51 61.7 3.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.984 0.421 . . . . 0.0 110.903 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.61 -47.79 0.51 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.578 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 53.8 m -90.18 -25.55 20.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.956 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.512 ' O ' HD12 ' A' ' 59' ' ' ILE . 24.6 t -64.4 -35.1 73.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.826 0.346 . . . . 0.0 111.472 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.37 -46.89 88.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.204 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.63 -23.5 21.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.311 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.53 ' O ' HD12 ' A' ' 62' ' ' LEU . . . -59.5 -41.54 90.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.458 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.533 HG23 ' HB3' ' A' ' 63' ' ' ASP . 2.3 mp -90.36 -27.91 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.075 0.464 . . . . 0.0 111.048 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.05 -60.29 3.37 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -90.51 -10.31 44.05 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.53 HD12 ' O ' ' A' ' 58' ' ' ALA . 26.5 mt -90.06 -75.29 0.46 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.95 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.533 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -49.36 149.03 2.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.96 0.409 . . . . 0.0 111.526 -179.245 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.14 -48.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.762 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -158.96 -173.81 4.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.784 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -95.2 104.48 16.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.888 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.41 ' CZ ' ' NH2' ' A' ' 70' ' ' ARG . 0.3 OUTLIER -126.63 170.04 12.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.953 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 4.9 mtt -83.17 58.81 4.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.07 33.54 11.96 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.511 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.41 ' NH2' ' CZ ' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -111.41 -42.25 3.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.797 0.332 . . . . 0.0 110.835 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.96 -47.96 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.796 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 73' ' ' ARG . 18.8 mt 59.74 159.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.033 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.472 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -90.37 69.73 6.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.851 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.531 HG23 ' HB ' ' A' ' 6' ' ' VAL . 14.7 p -93.09 132.9 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.176 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.4 t -154.02 159.75 41.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -58.38 139.27 55.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.96 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 3' ' ' ASN . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.102 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.808 0.337 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -109.36 146.15 34.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 4.6 m120 -85.36 129.94 34.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.9 mt -107.69 139.32 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.093 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.477 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 25.1 t80 -113.78 125.57 54.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.844 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 6' ' ' VAL . 11.0 p -121.94 124.28 70.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.077 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -112.66 -168.45 17.48 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.531 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.8 32.44 20.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.818 0.342 . . . . 0.0 110.887 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.765 HD12 ' C ' ' A' ' 45' ' ' PHE . 61.9 mt -88.35 -178.03 5.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.928 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.624 HG13 ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -160.68 -168.43 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.819 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.624 ' N ' HG13 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -48.56 -45.51 37.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.836 0.351 . . . . 0.0 111.134 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.533 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -156.94 60.64 0.52 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.647 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.44 -77.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.37 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.567 HG21 ' HA3' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -166.19 -31.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.446 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.3 p -46.85 -55.41 8.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.646 0.26 . . . . 0.0 111.441 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.57 -14.32 62.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.777 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -90.5 -30.97 16.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.09 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.505 HG22 ' CD2' ' A' ' 22' ' ' PHE . 14.8 p -86.54 -29.19 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.495 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.9 pttt -48.93 -28.5 3.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.132 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.8 -34.88 69.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.66 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.4 tt -89.96 -18.89 25.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.037 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.505 ' CD2' HG22 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -71.12 -17.09 62.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.236 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.2 p -90.13 -26.23 20.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.438 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -87.4 -47.77 8.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.345 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.57 -11.25 10.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.63 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.9 -22.94 37.05 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.641 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.58 35.17 14.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.81 0.338 . . . . 0.0 110.86 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.404 ' HA ' ' HG2' ' A' ' 50' ' ' MET . 14.9 p -76.81 141.79 15.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.119 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -77.31 -44.79 28.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.96 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -174.7 145.87 0.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.014 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.457 HG22 HG13 ' A' ' 48' ' ' VAL . 23.0 t -127.09 140.95 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.908 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.94 106.59 2.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.071 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.534 HD22 ' HA3' ' A' ' 46' ' ' GLY . 4.7 mt -85.91 175.16 8.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.634 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.732 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.5 pp -107.9 154.53 8.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.22 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.424 ' CE1' ' HG3' ' A' ' 42' ' ' PRO . 83.2 m-85 -140.43 -176.21 4.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.92 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -84.93 -179.6 7.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.934 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -112.09 32.97 5.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -157.79 -54.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.037 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.01 5.65 20.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.415 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 57.85 29.68 17.9 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.839 0.352 . . . . 0.0 110.957 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -76.27 113.96 33.36 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.867 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.424 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 52.8 Cg_exo -52.91 121.73 9.82 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.452 2.101 . . . . 0.0 112.27 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.557 ' HB2' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -54.65 -41.09 69.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.05 37.79 0.11 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.978 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.765 ' C ' HD12 ' A' ' 9' ' ' LEU . 31.6 p90 -178.95 165.83 1.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.982 0.42 . . . . 0.0 111.215 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.534 ' HA3' HD22 ' A' ' 33' ' ' LEU . . . -146.91 -167.69 13.2 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.524 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 3' ' ' ASN . 0.1 OUTLIER -139.56 136.59 34.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.85 0.357 . . . . 0.0 111.021 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.457 HG13 HG22 ' A' ' 31' ' ' VAL . 45.1 t -129.03 136.09 60.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.899 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -105.21 113.13 26.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.885 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.404 ' HG2' ' HA ' ' A' ' 28' ' ' VAL . 0.5 OUTLIER -150.38 152.03 33.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.919 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.52 173.06 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.718 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.69 -152.54 0.06 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.376 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 67.49 -68.69 0.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.209 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.2 m -67.63 -28.62 67.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.235 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.813 ' O ' HD12 ' A' ' 59' ' ' ILE . 30.2 t -58.16 -25.05 25.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.401 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.2 p -72.22 -50.47 27.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.136 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -83.24 -26.11 31.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.296 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -56.55 -42.65 78.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.494 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.813 HD12 ' O ' ' A' ' 55' ' ' VAL . 2.8 mp -90.39 -12.15 9.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.281 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.08 -47.39 13.6 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -90.46 -21.47 21.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.687 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 80.3 mt -90.03 -69.6 0.71 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.737 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -49.51 124.38 9.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.321 -179.468 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -177.59 -49.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.857 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.02 -169.5 2.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.82 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -101.71 124.96 48.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.917 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.57 -173.16 4.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 8.5 mtp -72.13 66.09 0.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.746 ' HA2' HD11 ' A' ' 72' ' ' ILE . . . 59.32 28.94 65.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.509 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.36 -27.76 12.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.728 0.299 . . . . 0.0 110.968 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.532 HG23 ' H ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -135.57 -71.68 0.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.091 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.746 HD11 ' HA2' ' A' ' 69' ' ' GLY . 25.6 mt 59.78 159.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.8 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.47 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -81.78 74.02 8.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 110.789 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.43 HG22 ' N ' ' A' ' 75' ' ' THR . 11.0 p -90.13 155.23 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.43 ' N ' HG22 ' A' ' 74' ' ' VAL . 5.4 t -167.47 152.65 7.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.93 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -68.5 124.78 24.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.911 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.477 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.143 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 tpp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.798 0.333 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -127.75 -177.65 4.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -122.58 153.74 38.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.2 mt -131.56 123.3 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.173 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.499 ' CE2' ' CD2' ' A' ' 45' ' ' PHE . 29.2 t80 -108.84 115.54 30.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.659 HG13 HD11 ' A' ' 9' ' ' LEU . 11.2 p -124.08 124.17 68.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.156 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.15 -170.17 29.55 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.535 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 59.05 40.89 21.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.917 0.389 . . . . 0.0 110.945 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.659 HD11 HG13 ' A' ' 6' ' ' VAL . 65.1 mt -98.45 -178.14 3.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.623 HG13 ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -172.85 -168.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.743 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.623 ' N ' HG13 ' A' ' 10' ' ' VAL . 29.5 t80 -50.29 -47.95 55.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.827 0.346 . . . . 0.0 111.128 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.518 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.8 p -143.35 55.14 1.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.675 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.91 -72.98 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.196 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -165.44 -41.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.056 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.15 -49.33 66.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.065 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -67.05 -15.59 63.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.718 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -90.41 -36.39 14.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.981 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 p -90.07 -23.44 6.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.66 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 42.3 pttt -52.58 -34.33 50.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.762 0.315 . . . . 0.0 111.209 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -65.18 -34.45 78.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.723 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 tp -89.86 -26.69 20.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.74 -23.19 27.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.166 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.6 t -82.91 -29.78 28.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.987 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -90.1 -21.54 22.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -112.82 -30.96 6.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.284 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -117.94 -1.39 16.95 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.113 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.3 pttt 44.92 43.77 7.38 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.85 0.357 . . . . 0.0 111.337 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.9 p -54.67 150.94 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.228 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -91.8 -51.24 5.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.039 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -139.46 158.04 44.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.022 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.0 t -151.48 98.19 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.977 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.84 166.48 11.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.002 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.528 HD23 ' HA3' ' A' ' 46' ' ' GLY . 19.4 mt -140.68 175.09 9.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.843 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.857 HD11 ' HA3' ' A' ' 44' ' ' GLY . 2.4 pp -119.51 -178.79 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.083 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -130.22 -179.13 5.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.054 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -20.29 55.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.17 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.09 36.05 2.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.902 0.382 . . . . 0.0 110.746 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -175.19 -40.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.743 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.3 -10.21 17.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.266 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 mptt 66.66 31.47 7.66 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.86 0.362 . . . . 0.0 110.686 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -111.82 131.04 22.61 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.22 111.17 0.6 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.467 2.112 . . . . 0.0 112.294 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -176.63 127.23 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.918 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.857 ' HA3' HD11 ' A' ' 34' ' ' ILE . . . 142.52 -79.09 0.27 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.617 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.618 ' C ' HD12 ' A' ' 9' ' ' LEU . 50.3 p90 -168.01 -176.64 3.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.811 0.338 . . . . 0.0 111.032 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.528 ' HA3' HD23 ' A' ' 33' ' ' LEU . . . -143.68 169.25 26.09 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.539 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.09 131.35 47.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.802 0.334 . . . . 0.0 111.001 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.8 t -126.26 145.19 34.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.963 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -114.4 114.45 25.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 29.6 mtm -141.83 169.5 17.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -78.48 154.29 30.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -72.01 93.3 1.37 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.904 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -173.43 -49.41 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.466 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.14 -15.34 31.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.994 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.905 ' O ' HD12 ' A' ' 59' ' ' ILE . 21.7 t -66.68 -39.51 83.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.825 0.345 . . . . 0.0 111.179 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.726 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -75.12 -24.67 58.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.216 -179.832 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.26 -42.95 10.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.759 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.701 ' HB1' HD12 ' A' ' 62' ' ' LEU . . . -58.86 -67.78 0.33 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.905 HD12 ' O ' ' A' ' 55' ' ' VAL . 3.7 mt -56.53 -29.4 29.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.144 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.726 ' HB2' ' O ' ' A' ' 56' ' ' SER . . . -57.75 -57.55 12.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.69 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -90.25 -26.08 20.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.646 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.701 HD12 ' HB1' ' A' ' 58' ' ' ALA . 84.4 mt -75.21 -72.9 0.27 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.81 0.338 . . . . 0.0 111.488 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.623 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -50.9 135.67 23.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.346 -179.398 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -178.12 -67.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.761 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.76 -172.16 2.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.811 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.51 99.2 8.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.964 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.18 -172.52 2.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.842 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 23.9 mtt -100.22 36.42 1.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.66 32.7 1.4 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.505 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.12 -37.95 3.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.825 0.345 . . . . 0.0 110.953 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -140.56 -55.69 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.872 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.485 HG21 ' CG2' ' A' ' 6' ' ' VAL . 1.5 mt 59.79 160.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.991 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.462 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -88.39 59.32 5.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.762 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.446 HG22 ' N ' ' A' ' 75' ' ' THR . 14.3 p -79.72 156.75 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.224 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.446 ' N ' HG22 ' A' ' 74' ' ' VAL . 10.0 t -178.46 144.98 0.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.903 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.36 114.61 6.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.497 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.069 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.818 0.342 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.21 161.28 13.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.718 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 3.6 m-80 -100.96 102.09 13.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.405 ' O ' ' CD1' ' A' ' 47' ' ' PHE . 29.6 mt -72.42 141.08 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.095 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.75 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 76.0 t80 -112.24 138.36 49.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.807 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.497 HG22 HD21 ' A' ' 9' ' ' LEU . 11.2 p -147.79 129.14 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.285 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.08 -175.79 25.49 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.329 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 58.45 37.83 25.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.816 0.341 . . . . 0.0 110.806 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.497 HD21 HG22 ' A' ' 6' ' ' VAL . 3.4 mm? -87.98 159.63 18.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.033 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.646 HG13 ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -154.03 -167.41 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.78 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.646 ' N ' HG13 ' A' ' 10' ' ' VAL . 80.0 m-85 -49.5 -46.09 47.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.833 0.349 . . . . 0.0 111.088 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.514 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.3 m -157.18 57.64 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.778 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.419 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -62.04 -52.01 65.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.259 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.447 ' OG1' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -177.61 -36.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.099 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.5 m -51.34 -51.88 50.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.223 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.86 -14.87 63.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.787 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -90.54 -36.27 14.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.089 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.413 HG22 ' CD1' ' A' ' 22' ' ' PHE . 10.7 p -86.23 -24.77 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.625 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -53.16 -32.04 45.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.889 0.376 . . . . 0.0 111.072 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.37 -39.28 94.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.632 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.3 tt -83.14 -31.23 27.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.705 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.413 ' CD1' HG22 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -61.2 -28.27 69.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.928 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.27 -26.9 26.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.088 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -85.36 -25.44 27.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.137 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -111.47 -29.57 7.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.195 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -114.15 -24.65 4.42 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.807 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.87 46.53 3.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.861 0.362 . . . . 0.0 110.776 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 49' ' ' GLU . 10.1 p -52.02 147.4 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.295 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -73.81 -50.26 21.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.919 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -154.67 157.92 38.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.972 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.406 HG22 HG13 ' A' ' 48' ' ' VAL . 23.4 t -152.76 124.08 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.082 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -160.02 -178.6 7.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.981 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 34.0 mt -122.78 160.01 26.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.851 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.87 HD12 ' O ' ' A' ' 35' ' ' TYR . 2.5 pp -81.63 -22.11 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.516 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.87 ' O ' HD12 ' A' ' 34' ' ' ILE . 21.2 m-85 58.83 171.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.008 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -59.94 160.44 7.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.68 40.53 1.22 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.969 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -170.82 -44.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.763 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.98 -17.97 18.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.186 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp 64.12 33.17 12.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.894 0.378 . . . . 0.0 110.9 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.4 150.42 37.98 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.763 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.42 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 63.5 Cg_exo -51.45 99.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.581 2.188 . . . . 0.0 112.3 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.81 129.4 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 127.9 -76.45 0.4 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.643 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.636 ' CE2' HG21 ' A' ' 34' ' ' ILE . 24.4 p90 -176.09 171.61 2.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.754 0.312 . . . . 0.0 110.913 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.93 171.01 21.9 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.479 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.406 ' CE1' ' HB3' ' A' ' 3' ' ' ASN . 2.7 m-85 -134.38 145.52 49.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.836 0.351 . . . . 0.0 110.87 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.406 HG13 HG22 ' A' ' 31' ' ' VAL . 22.8 t -131.59 97.47 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.092 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.43 ' O ' HG23 ' A' ' 28' ' ' VAL . 68.1 tt0 -68.3 86.91 0.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.973 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.7 mtp -125.42 179.6 5.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.905 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.82 ' O ' HG23 ' A' ' 55' ' ' VAL . 2.4 mt-30 -67.89 173.84 4.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.02 -36.94 48.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.968 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -64.3 -36.04 82.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.02 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.7 t -71.03 -30.27 66.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.033 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.875 ' O ' HD12 ' A' ' 59' ' ' ILE . 25.8 t -66.82 -36.37 77.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.267 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.715 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 42.9 t -77.87 -24.99 48.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.214 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.25 -44.9 9.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.753 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.486 ' HB1' HD12 ' A' ' 62' ' ' LEU . . . -57.48 -68.39 0.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.965 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.875 HD12 ' O ' ' A' ' 55' ' ' VAL . 4.3 mt -54.85 -31.1 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.073 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 56' ' ' SER . . . -56.34 -59.8 4.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.602 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -90.32 -11.48 40.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.106 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.486 HD12 ' HB1' ' A' ' 58' ' ' ALA . 63.6 mt -89.93 -75.08 0.46 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.641 0.258 . . . . 0.0 111.623 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.603 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -52.72 150.33 5.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.035 0.445 . . . . 0.0 111.246 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -178.58 -40.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.847 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -162.85 -169.48 2.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.781 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -107.13 93.55 4.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.818 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.09 -176.28 2.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 15.0 mtm -94.16 46.44 1.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.81 32.99 4.86 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.494 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -113.77 -30.01 6.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.758 0.313 . . . . 0.0 111.152 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 t -152.37 -45.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.013 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 73' ' ' ARG . 20.3 mt 61.6 161.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.796 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.472 ' N ' HG22 ' A' ' 72' ' ' ILE . 4.0 mtm180 -94.25 43.38 1.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.984 0.421 . . . . 0.0 111.011 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.535 HG13 ' HB3' ' A' ' 63' ' ' ASP . 9.2 p -61.81 147.51 11.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.981 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.1 t -158.76 171.83 19.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.918 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -85.03 121.07 27.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.785 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.75 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.162 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttt . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.847 0.356 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.13 -175.33 5.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.886 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -123.12 105.63 10.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.877 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.725 HD11 ' HB2' ' A' ' 50' ' ' MET . 6.6 mt -65.16 145.44 13.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.987 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.731 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 4.7 t80 -125.13 115.65 20.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.922 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.459 ' CG2' HG21 ' A' ' 72' ' ' ILE . 11.6 p -109.66 141.52 24.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.951 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -120.93 62.92 0.5 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.582 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.555 ' HB3' HG23 ' A' ' 72' ' ' ILE . 16.1 t30 -177.5 62.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.875 0.369 . . . . 0.0 110.636 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.586 ' CD1' HD22 ' A' ' 33' ' ' LEU . 8.2 mt -109.73 161.61 15.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.061 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.563 ' N ' ' HB2' ' A' ' 13' ' ' ALA . 14.5 p -178.96 161.46 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.723 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.511 ' N ' HG22 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -47.23 -27.99 1.73 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.328 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 88.2 p -120.28 30.12 7.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.14 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.563 ' HB2' ' N ' ' A' ' 10' ' ' VAL . . . -68.69 -31.42 70.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.235 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.567 ' O ' HG12 ' A' ' 18' ' ' VAL . 1.3 m 90.61 5.64 0.1 Allowed 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.721 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.584 ' HA ' HG12 ' A' ' 18' ' ' VAL . 2.6 m -70.93 -52.74 18.17 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.927 -179.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.78 -18.6 62.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.449 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.43 -39.17 12.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.978 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 15' ' ' SER . 13.9 p -81.87 -24.58 9.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.687 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -51.3 -37.05 45.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.802 0.334 . . . . 0.0 111.031 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.16 -32.59 70.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.007 0.432 . . . . 0.0 110.542 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.3 tt -83.6 -31.01 26.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.563 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -20.79 61.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.935 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.3 t -83.1 -29.24 28.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.954 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -81.64 -22.11 37.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.124 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -112.12 -31.64 6.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.149 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.59 -23.96 4.21 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.926 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? 62.48 50.14 3.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.858 0.361 . . . . 0.0 110.838 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.608 HG21 HG22 ' A' ' 31' ' ' VAL . 9.9 p -55.64 146.68 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.169 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -93.8 -31.05 14.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.968 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -150.71 145.85 26.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.107 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.608 HG22 HG21 ' A' ' 28' ' ' VAL . 24.7 t -147.1 106.43 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.772 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.62 ' C ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -136.24 155.7 49.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.186 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.62 HD23 ' C ' ' A' ' 32' ' ' LYS . 1.0 OUTLIER -116.94 155.17 29.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.58 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.866 HG21 ' CE2' ' A' ' 45' ' ' PHE . 2.6 pp -82.85 177.29 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.034 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.407 ' CG ' ' O ' ' A' ' 34' ' ' ILE . 70.7 m-85 -157.02 167.55 30.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.33 156.88 22.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.5 38.57 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.941 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -159.97 -45.29 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.927 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p -106.95 -16.27 14.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.206 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.7 mttp 62.39 37.25 13.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.915 0.388 . . . . 0.0 110.965 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 32.2 mttp -113.32 139.01 22.66 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.809 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 41' ' ' LYS . 53.0 Cg_exo -54.95 118.88 5.64 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.445 2.097 . . . . 0.0 112.402 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -70.2 -64.55 0.87 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.3 50.29 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.413 -0.898 . . . . 0.0 112.987 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.866 ' CE2' HG21 ' A' ' 34' ' ' ILE . 27.8 p90 -178.04 153.38 0.8 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.013 0.435 . . . . 0.0 111.081 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.61 -164.73 11.42 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.571 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -140.78 144.96 35.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.85 0.357 . . . . 0.0 111.169 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.64 HG12 ' HG3' ' A' ' 50' ' ' MET . 45.9 t -141.97 115.61 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.867 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.65 101.52 13.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.02 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.725 ' HB2' HD11 ' A' ' 4' ' ' ILE . 29.8 mtm -130.58 154.86 47.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.918 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.926 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -63.76 149.45 46.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.892 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.21 -31.72 63.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.088 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -63.25 -34.71 78.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.006 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 9.5 t -90.0 -39.25 13.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.985 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.926 HG23 ' O ' ' A' ' 51' ' ' GLN . 21.4 t -54.82 -47.81 74.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.372 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.7 m -52.15 -64.02 0.95 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.19 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -26.83 67.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.004 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.559 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -63.94 -39.53 94.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.267 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 59' ' ' ILE . 5.4 mt -90.12 -7.28 10.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.303 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.7 -44.95 9.67 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.97 -25.0 19.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.451 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 66.0 mt -90.11 -74.23 0.49 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.901 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.473 ' CB ' HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -50.96 142.1 12.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.932 0.396 . . . . 0.0 111.295 -179.395 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -178.83 -38.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.871 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -159.72 -175.05 4.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -104.35 108.66 20.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -124.71 -168.61 1.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.948 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.2 mmt -95.04 44.46 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.82 32.61 6.14 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.499 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.95 -34.62 6.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.83 0.347 . . . . 0.0 110.964 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.62 -53.93 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.992 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.555 HG23 ' HB3' ' A' ' 8' ' ' ASN . 29.3 mt 59.92 159.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.019 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.479 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -87.41 61.18 6.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.831 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.484 ' O ' HG23 ' A' ' 59' ' ' ILE . 11.4 p -72.82 140.64 17.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.096 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.9 t -164.27 150.91 11.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.868 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -70.33 127.35 32.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.731 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.103 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.822 0.344 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -114.4 -178.53 3.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.866 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.649 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 3.7 m-80 -110.73 142.5 42.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.556 HD11 ' HB2' ' A' ' 50' ' ' MET . 2.2 mt -118.85 120.08 62.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.609 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 3.5 t80 -102.17 123.54 46.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.004 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.562 ' HB ' HG23 ' A' ' 74' ' ' VAL . 11.2 p -128.47 129.04 68.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.024 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -110.67 -168.84 19.31 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.51 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.38 33.68 23.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.751 0.31 . . . . 0.0 110.9 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.74 HD13 HD13 ' A' ' 33' ' ' LEU . 18.3 mt -85.97 -178.72 6.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.964 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.598 HG22 ' H ' ' A' ' 11' ' ' TYR . 2.5 p -163.98 174.42 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.824 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.598 ' H ' HG22 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -43.19 -45.56 5.66 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.75 0.31 . . . . 0.0 111.563 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.576 ' H ' HG13 ' A' ' 10' ' ' VAL . 8.9 t -140.78 61.94 1.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.888 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.7 ' O ' HG23 ' A' ' 14' ' ' THR . . . -68.13 -78.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.327 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 13' ' ' ALA . 0.4 OUTLIER -177.43 -32.24 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.312 -179.746 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.9 t -47.27 -54.95 9.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.76 0.314 . . . . 0.0 111.521 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -14.47 61.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.851 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -90.68 -27.95 18.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.274 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -90.14 -20.69 6.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.842 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.801 ' HB2' HG11 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -49.36 -28.01 4.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.778 0.323 . . . . 0.0 111.236 -179.74 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -72.35 -32.14 66.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.82 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.6 tt -90.01 -30.26 17.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.955 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.85 -22.91 40.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.7 t -76.51 -31.93 57.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.985 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -90.19 -10.67 43.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.42 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.52 -37.77 5.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.645 0.26 . . . . 0.0 111.157 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.529 ' HA3' ' HE1' ' A' ' 50' ' ' MET . . . -127.38 -5.65 5.48 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.516 -0.85 . . . . 0.0 113.265 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp 61.33 47.54 6.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.872 0.367 . . . . 0.0 110.938 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 49' ' ' GLU . 11.6 p -53.97 116.05 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.188 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -59.77 -39.9 86.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.887 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.08 158.76 30.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.819 HG23 HG22 ' A' ' 48' ' ' VAL . 10.2 p -155.22 127.88 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.035 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.3 mtpt -160.04 123.23 3.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.973 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.74 HD13 HD13 ' A' ' 9' ' ' LEU . 9.0 mt -84.68 -169.04 2.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.572 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.762 HD13 ' HB2' ' A' ' 43' ' ' LYS . 1.7 pp -111.93 155.18 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.902 0.382 . . . . 0.0 111.233 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -157.22 169.66 24.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.741 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.61 131.5 34.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -84.1 56.4 3.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.921 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 179.2 -40.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.795 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 p -111.88 -19.82 12.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.203 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.1 tttt 68.92 25.82 5.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.778 0.323 . . . . 0.0 110.904 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -90.73 121.3 68.37 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.831 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.3 125.81 20.27 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.408 2.072 . . . . 0.0 112.337 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.762 ' HB2' HD13 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -63.58 -35.47 80.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.745 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 130.11 32.64 0.53 Allowed Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.119 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.722 ' C ' HD12 ' A' ' 9' ' ' LEU . 27.8 p90 -178.49 -176.96 0.52 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.992 0.425 . . . . 0.0 111.223 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.527 ' HA3' HD22 ' A' ' 33' ' ' LEU . . . -161.97 -171.72 28.44 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.453 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.463 ' CE1' ' CD2' ' A' ' 5' ' ' TYR . 1.7 m-85 -144.8 141.17 28.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.938 0.399 . . . . 0.0 111.075 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.819 HG22 HG23 ' A' ' 31' ' ' VAL . 40.6 t -130.24 150.11 34.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.932 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.581 ' O ' HG23 ' A' ' 28' ' ' VAL . 1.4 tt0 -111.49 109.95 20.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.93 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.556 ' HB2' HD11 ' A' ' 4' ' ' ILE . 40.4 mtp -143.6 177.68 8.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.863 ' O ' HG23 ' A' ' 55' ' ' VAL . 39.7 mt-30 -71.22 159.27 34.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -67.07 -30.77 70.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.824 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -75.9 -31.81 59.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.908 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.4 m -74.69 -29.46 61.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.063 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.863 ' O ' HD12 ' A' ' 59' ' ' ILE . 21.6 t -65.12 -37.31 79.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.276 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.681 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 10.2 t -74.91 -24.39 58.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.09 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.21 -42.68 10.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.663 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.646 ' HB1' HD12 ' A' ' 62' ' ' LEU . . . -58.82 -67.99 0.31 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.818 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.863 HD12 ' O ' ' A' ' 55' ' ' VAL . 3.3 mt -54.88 -30.57 23.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.056 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.681 ' HB2' ' O ' ' A' ' 56' ' ' SER . . . -57.04 -59.44 5.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.366 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.15 -9.14 49.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.904 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.646 HD12 ' HB1' ' A' ' 58' ' ' ALA . 71.5 mt -90.09 -74.95 0.47 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.838 0.351 . . . . 0.0 111.336 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.506 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -56.67 152.4 12.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.134 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.561 ' O ' HG23 ' A' ' 65' ' ' THR . 1.0 OUTLIER -178.57 -40.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.775 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 64' ' ' ASN . 0.6 OUTLIER -166.43 -178.28 4.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.873 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.0 p-10 -98.14 102.81 14.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.843 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.22 -168.83 1.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.939 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 1.5 mmt -93.46 46.93 1.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.876 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.37 37.49 6.2 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.546 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.1 tpp85 -116.14 -42.36 3.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.837 0.351 . . . . 0.0 110.92 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.98 -48.77 1.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.914 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.454 HG22 ' N ' ' A' ' 73' ' ' ARG . 9.3 mt 59.27 163.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.999 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.454 ' N ' HG22 ' A' ' 72' ' ' ILE . 2.2 mtt180 -94.07 47.64 1.22 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.019 0.437 . . . . 0.0 110.74 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.562 HG23 ' HB ' ' A' ' 6' ' ' VAL . 12.6 p -62.0 144.29 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.095 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.3 t -149.27 175.88 11.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.986 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.69 133.07 35.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.967 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.649 ' HB3' ' HB3' ' A' ' 3' ' ' ASN . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.131 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.842 0.353 . . . . 0.0 111.137 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.615 ' HB2' HG21 ' A' ' 55' ' ' VAL . 3.7 mmt180 -94.2 -8.57 38.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.503 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.5 m120 54.1 103.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.219 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.84 HG12 HG13 ' A' ' 55' ' ' VAL . 6.3 mt -94.42 158.51 2.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.219 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.49 ' N ' HG22 ' A' ' 4' ' ' ILE . 37.3 t80 -139.79 143.47 36.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.682 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.71 ' CG1' HD11 ' A' ' 9' ' ' LEU . 9.9 p -142.52 146.63 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.268 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -130.29 -174.37 13.67 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.322 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 t30 56.01 33.18 21.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.931 0.396 . . . . 0.0 110.994 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.71 HD11 ' CG1' ' A' ' 6' ' ' VAL . 64.2 mt -89.43 99.91 12.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.096 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.755 HG13 ' H ' ' A' ' 12' ' ' SER . 2.7 p -63.33 176.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.642 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.637 ' H ' HG22 ' A' ' 10' ' ' VAL . 17.6 m-85 -41.54 -35.35 0.7 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.865 0.364 . . . . 0.0 111.419 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.755 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.2 p -157.26 67.47 0.52 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.571 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 14' ' ' THR . . . -71.62 -65.4 0.76 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.405 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -179.12 -24.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.578 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.612 ' OG ' HD13 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -46.07 -57.91 4.06 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.747 0.308 . . . . 0.0 111.509 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.61 ' HB3' HD11 ' A' ' 33' ' ' LEU . 4.0 pt-20 -66.49 -13.3 60.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.817 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -90.54 -28.3 18.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.291 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 15' ' ' SER . 11.9 p -87.07 -24.49 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.754 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.7 -27.67 12.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.744 0.307 . . . . 0.0 111.171 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -33.1 70.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.764 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.4 tt -88.9 -30.85 18.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.809 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -26.04 62.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.016 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.44 -24.17 24.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.237 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -88.66 -24.38 22.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.265 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -111.47 -30.68 7.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.225 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -117.62 -17.56 5.55 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.575 -0.822 . . . . 0.0 113.067 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm 61.98 43.98 8.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.944 0.402 . . . . 0.0 110.715 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 49' ' ' GLU . 12.0 p -46.36 139.54 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.459 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -89.3 -39.1 13.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.835 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -139.29 149.19 43.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.955 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.729 HG23 HG22 ' A' ' 48' ' ' VAL . 13.2 p -172.11 120.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.063 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -157.11 167.3 30.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.949 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.61 HD11 ' HB3' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -128.61 160.26 32.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.683 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.486 HD13 ' HB3' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -94.33 170.48 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.054 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 42' ' ' PRO . 49.1 m-85 -138.77 -174.23 3.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.009 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -101.55 -178.48 3.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -120.28 31.75 6.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.67 -58.25 0.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.876 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.03 -1.08 27.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.403 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt 60.2 36.21 20.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.88 0.371 . . . . 0.0 110.883 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -112.99 152.02 44.59 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.822 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 53.4 Cg_exo -52.37 135.25 53.79 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.581 2.187 . . . . 0.0 112.282 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.486 ' HB3' HD13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -69.75 -69.18 0.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.794 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.41 37.59 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.898 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.457 ' CE2' HG12 ' A' ' 34' ' ' ILE . 38.3 p90 -179.9 152.88 0.49 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.987 0.423 . . . . 0.0 111.124 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.48 ' HA3' HD23 ' A' ' 33' ' ' LEU . . . -145.28 -169.99 13.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.389 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.445 ' CZ ' ' CB ' ' A' ' 77' ' ' ALA . 1.9 t80 -133.13 156.3 47.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.884 0.373 . . . . 0.0 111.057 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.729 HG22 HG23 ' A' ' 31' ' ' VAL . 24.1 t -149.16 130.45 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.972 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.667 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -110.57 116.17 30.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.02 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.433 ' HG2' HG23 ' A' ' 28' ' ' VAL . 2.5 mtm -140.63 156.21 46.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.916 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.05 151.73 18.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.971 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -77.24 95.03 4.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.931 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -174.91 -53.44 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.261 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 1.8 m -90.02 -16.15 30.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.981 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.84 HG13 HG12 ' A' ' 4' ' ' ILE . 26.0 t -61.09 -43.87 97.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.832 0.348 . . . . 0.0 111.277 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.6 m -56.82 -54.22 48.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.165 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -74.98 -26.47 59.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.106 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -57.61 -39.36 76.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.338 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.694 HD12 ' O ' ' A' ' 55' ' ' VAL . 3.2 mt -90.29 -8.94 10.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.181 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.51 -48.75 10.67 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.65 -19.11 24.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.785 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.525 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 83.3 mt -89.97 -75.12 0.46 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.93 147.42 15.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.842 0.353 . . . . 0.0 111.041 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -176.6 -41.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.941 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.4 ' OG1' HG21 ' A' ' 71' ' ' THR . 0.7 OUTLIER -154.62 -177.66 6.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -103.57 97.45 7.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.16 -169.33 1.46 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 16.9 ptm -98.38 31.57 2.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.92 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.09 33.55 1.49 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.474 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.77 -54.06 2.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.786 0.327 . . . . 0.0 110.883 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.4 HG21 ' OG1' ' A' ' 65' ' ' THR . 1.1 t -119.73 -49.76 2.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.889 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 73' ' ' ARG . 24.8 mt 60.15 159.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.212 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.481 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -90.71 51.6 2.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.819 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.558 ' O ' HG23 ' A' ' 59' ' ' ILE . 11.0 p -67.18 125.51 24.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.072 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.5 t -141.9 160.22 40.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.02 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.418 ' HG3' HD13 ' A' ' 59' ' ' ILE . 52.0 mt-10 -59.82 140.88 56.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.875 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.445 ' CB ' ' CZ ' ' A' ' 47' ' ' PHE . . . . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.095 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mtp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.845 0.355 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -99.16 175.45 5.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.959 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.401 ' HB3' ' CE2' ' A' ' 47' ' ' PHE . 22.0 m-20 -122.07 120.13 33.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.862 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.66 HG12 HG13 ' A' ' 55' ' ' VAL . 1.8 mp -111.21 132.61 59.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.122 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.776 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 6.4 t80 -107.2 142.85 36.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.476 HG13 HD11 ' A' ' 9' ' ' LEU . 7.5 p -143.98 121.01 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.99 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.448 ' HA2' ' CD1' ' A' ' 45' ' ' PHE . . . -104.79 -169.53 24.38 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.767 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 63.46 29.66 15.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.715 0.293 . . . . 0.0 110.948 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.532 HD22 ' HB2' ' A' ' 15' ' ' SER . 32.0 mt -101.24 159.8 14.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.919 0.39 . . . . 0.0 111.124 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.648 HG13 ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -155.07 -166.8 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.666 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.648 ' N ' HG13 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -48.77 -44.95 39.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.878 0.371 . . . . 0.0 111.051 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.509 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -144.06 49.04 1.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.593 179.791 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.8 -76.1 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.359 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.583 HG21 ' CA ' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -164.59 -37.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.304 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.532 ' HB2' HD22 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -48.94 -52.96 21.81 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.798 0.332 . . . . 0.0 111.36 -179.754 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -65.43 -15.96 63.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.751 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -90.59 -36.92 14.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.073 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.9 p -90.04 -22.35 6.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.669 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 pttp -50.0 -29.48 8.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.799 0.333 . . . . 0.0 111.101 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -68.22 -35.69 78.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.66 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.3 tp -87.03 -30.36 21.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.899 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.15 -24.48 54.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.116 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.2 m -82.38 -25.9 33.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.158 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -90.02 -24.48 21.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.216 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -110.43 -30.9 7.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.156 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -112.06 -22.24 5.99 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.775 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp 62.98 45.07 5.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.944 0.402 . . . . 0.0 110.901 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.0 p -54.14 153.07 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.107 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -97.26 -36.37 10.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.015 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -166.15 140.87 4.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.124 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t -124.71 119.44 56.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.732 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -123.44 163.14 21.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.024 0.44 . . . . 0.0 111.26 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 mt -141.51 161.29 38.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.397 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.553 HD11 ' HA3' ' A' ' 44' ' ' GLY . 2.5 pp -123.62 155.41 30.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.981 0.419 . . . . 0.0 111.29 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.478 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.7 m-85 -94.36 -165.58 1.34 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.92 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -73.66 -8.53 56.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.332 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 66.42 29.57 9.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.896 0.379 . . . . 0.0 110.743 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -165.61 -44.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.615 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 p -97.48 -13.71 21.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.184 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.29 25.94 2.77 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.803 0.335 . . . . 0.0 110.982 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -102.53 123.62 42.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.7 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.53 107.49 1.63 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.38 2.053 . . . . 0.0 112.101 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.618 ' HB3' HG23 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -176.32 42.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.29 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.553 ' HA3' HD11 ' A' ' 34' ' ' ILE . . . -132.05 42.02 1.43 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.619 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.448 ' CD1' ' HA2' ' A' ' 7' ' ' GLY . 0.9 OUTLIER 73.94 161.49 0.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.851 0.358 . . . . 0.0 111.033 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.94 -173.84 13.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.582 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 48' ' ' VAL . 46.0 t80 -128.34 159.32 35.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.761 0.315 . . . . 0.0 110.919 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.451 ' N ' ' CD1' ' A' ' 47' ' ' PHE . 31.7 t -144.81 127.7 10.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.06 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -105.3 113.33 26.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.931 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.518 ' HE2' HD13 ' A' ' 4' ' ' ILE . 35.4 mtm -142.26 147.87 37.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.6 155.83 14.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.881 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.07 95.18 4.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.037 0.446 . . . . 0.0 110.906 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -176.36 -49.37 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.263 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 5.1 m -90.02 -21.73 22.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.916 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.717 ' O ' HD12 ' A' ' 59' ' ' ILE . 21.5 t -60.61 -31.62 49.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.379 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.0 m -60.98 -53.93 51.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.243 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.63 -22.93 27.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.292 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -55.47 -41.48 73.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.432 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.717 HD12 ' O ' ' A' ' 55' ' ' VAL . 3.3 mp -90.32 -21.22 6.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.911 0.386 . . . . 0.0 111.301 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.13 -55.38 25.77 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.44 -14.3 33.13 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 51.0 mt -90.05 -75.27 0.46 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.943 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.458 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -55.52 150.7 11.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.07 0.462 . . . . 0.0 111.406 -179.114 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 175.1 -36.62 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.715 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.39 -173.89 3.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.81 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.5 96.68 6.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.955 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.426 ' CD2' ' HB2' ' A' ' 70' ' ' ARG . 0.6 OUTLIER -121.71 169.07 11.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 24.2 mmm -80.51 65.05 5.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.953 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.583 ' CA ' HG21 ' A' ' 14' ' ' THR . . . 82.69 31.02 30.92 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.607 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.426 ' HB2' ' CD2' ' A' ' 67' ' ' PHE . 1.5 tmm_? -111.0 -30.1 7.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.793 0.33 . . . . 0.0 111.081 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 t -153.02 -51.09 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.942 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.498 HG22 ' N ' ' A' ' 73' ' ' ARG . 20.1 mt 64.65 160.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.033 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.498 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -92.4 48.68 1.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.875 0.369 . . . . 0.0 110.913 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.557 ' O ' HG13 ' A' ' 74' ' ' VAL . 12.0 p -72.17 114.58 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.182 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.6 t -135.25 153.85 51.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.042 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -57.13 131.62 50.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.776 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.312 -0.851 . . . . 0.0 111.077 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ptp . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.822 0.344 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.94 -6.11 22.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.496 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.5 t30 59.03 114.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.055 0.455 . . . . 0.0 110.993 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.561 HG12 HG13 ' A' ' 55' ' ' VAL . 23.7 mt -103.31 127.84 56.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.117 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -110.94 126.97 55.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.844 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.48 ' HB ' HG23 ' A' ' 74' ' ' VAL . 11.1 p -135.03 154.02 35.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.122 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.411 ' N ' HG22 ' A' ' 6' ' ' VAL . . . -127.7 -166.11 12.01 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.394 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 58.98 31.43 21.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.757 0.313 . . . . 0.0 110.787 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.65 HD13 HD21 ' A' ' 33' ' ' LEU . 26.4 mt -93.9 -179.39 4.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.953 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.644 HG13 ' N ' ' A' ' 11' ' ' TYR . 0.6 OUTLIER -170.32 -165.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.697 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.644 ' N ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -46.3 -40.55 11.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.95 0.405 . . . . 0.0 111.269 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.485 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.8 m -163.72 52.66 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.67 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.515 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -66.24 -46.89 75.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.307 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.597 HG21 ' HA3' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -177.65 -32.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.416 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.7 p -47.55 -55.09 9.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.779 0.323 . . . . 0.0 111.429 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.01 -12.78 61.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.949 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -90.77 -39.06 12.61 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.204 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -77.2 -27.93 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.865 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.9 ptmm? -53.36 -28.52 29.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.779 0.323 . . . . 0.0 110.992 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -70.94 -35.36 72.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.576 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.7 tp -90.03 -27.27 19.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.721 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.87 -28.09 47.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.938 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.03 -24.27 47.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.97 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -90.12 -34.27 15.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.773 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -60.82 -41.51 95.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.746 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.07 27.27 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.577 -0.82 . . . . 0.0 113.045 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 57.01 110.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.909 0.385 . . . . 0.0 111.193 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.512 HG23 ' HG2' ' A' ' 50' ' ' MET . 10.8 p -96.37 131.33 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -59.18 -43.6 92.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.971 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -171.46 166.48 6.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.953 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 31' ' ' VAL . 11.2 p -146.59 123.4 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.03 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -132.53 174.48 10.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.121 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.65 HD21 HD13 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -143.8 158.98 43.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.757 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.874 HG21 ' CE2' ' A' ' 45' ' ' PHE . 2.5 pp -85.18 -178.91 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.14 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -158.17 168.91 25.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -86.71 152.15 22.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.951 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -96.94 41.36 1.11 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.878 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -162.56 -44.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.799 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.22 -11.12 15.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.262 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.71 30.65 16.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.821 0.343 . . . . 0.0 110.85 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.403 ' HG3' ' N ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -107.76 141.76 23.77 Favored Pre-proline 0 N--CA 1.451 -0.395 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.118 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.403 ' N ' ' HG3' ' A' ' 41' ' ' LYS . 37.4 Cg_endo -65.66 115.82 3.6 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.522 2.148 . . . . 0.0 112.332 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -56.69 -67.77 0.28 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.018 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.23 52.61 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.817 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.874 ' CE2' HG21 ' A' ' 34' ' ' ILE . 29.4 p90 -177.94 142.5 0.29 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.917 0.389 . . . . 0.0 111.061 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -134.86 -167.07 11.31 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.474 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.99 150.08 40.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.79 0.329 . . . . 0.0 110.934 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.6 t -133.2 152.31 35.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.003 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -117.45 105.14 11.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.929 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.512 ' HG2' HG23 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -140.72 144.26 35.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.848 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.1 pm0 -55.66 146.53 20.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.089 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -69.32 93.39 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.948 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -172.81 -49.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.431 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.23 -19.91 23.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.952 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.561 HG13 HG12 ' A' ' 4' ' ' ILE . 20.0 t -58.99 -48.24 87.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.845 0.355 . . . . 0.0 111.229 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.618 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 1.6 t -62.58 -23.73 67.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.035 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -90.2 -35.03 15.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.598 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.625 ' HB1' HD12 ' A' ' 62' ' ' LEU . . . -62.78 -65.61 0.66 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.751 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.664 HG23 ' HB3' ' A' ' 63' ' ' ASP . 3.9 mt -58.22 -29.56 37.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.005 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 56' ' ' SER . . . -57.32 -56.87 16.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.711 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -90.23 -25.98 20.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.708 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.625 HD12 ' HB1' ' A' ' 58' ' ' ALA . 84.2 mt -76.02 -72.14 0.34 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.763 0.316 . . . . 0.0 111.312 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.664 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -53.42 140.6 27.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.269 -179.443 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -178.19 -39.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.956 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.57 -169.73 1.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.849 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -106.68 119.92 40.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -147.51 -175.95 5.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.82 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.67 49.41 1.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.017 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.597 ' HA3' HG21 ' A' ' 14' ' ' THR . . . 97.59 35.18 5.26 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.627 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.97 -30.44 7.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.7 0.286 . . . . 0.0 111.001 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.2 t -155.27 -52.03 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.075 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.476 HG22 ' N ' ' A' ' 73' ' ' ARG . 21.9 mt 60.76 159.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.031 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.476 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -89.11 53.88 2.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.841 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.482 HG22 ' N ' ' A' ' 75' ' ' THR . 12.3 p -73.92 159.32 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.05 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.594 ' HA ' HG21 ' A' ' 59' ' ' ILE . 9.1 t -161.15 179.05 8.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.897 0.38 . . . . 0.0 110.957 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.421 ' OE1' HD13 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -107.82 108.76 20.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.962 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.184 -0.912 . . . . 0.0 111.049 179.998 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.861 0.362 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.07 171.23 9.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.029 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -113.2 166.32 11.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.681 HD11 ' HB2' ' A' ' 50' ' ' MET . 3.0 mp -132.59 125.32 52.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.033 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.664 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 14.7 t80 -99.05 124.05 43.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.012 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.658 HG13 HD21 ' A' ' 9' ' ' LEU . 9.5 p -131.14 142.6 43.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.961 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -136.59 179.81 17.52 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.535 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 62.89 30.6 16.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.785 0.326 . . . . 0.0 110.96 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.658 HD21 HG13 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -123.09 -177.51 3.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.045 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.765 HG12 ' HB2' ' A' ' 13' ' ' ALA . 0.4 OUTLIER -139.59 -169.57 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.767 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.616 ' N ' HG13 ' A' ' 10' ' ' VAL . 4.8 t80 -57.05 -52.25 66.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.806 0.336 . . . . 0.0 110.949 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.463 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.8 t -126.45 54.04 1.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.975 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.765 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -88.71 -54.93 3.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.111 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.537 HG21 ' CA ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -161.65 -41.96 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.079 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.3 t -54.46 -48.59 71.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.058 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -69.36 -14.36 62.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.757 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -90.45 -37.52 13.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.084 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 p -83.7 -28.2 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.583 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.446 ' HB2' HG21 ' A' ' 31' ' ' VAL . 3.7 pttp -53.3 -34.38 57.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.789 0.328 . . . . 0.0 110.983 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.07 -38.36 90.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.752 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.9 tt -86.28 -28.79 23.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.79 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.27 -26.16 62.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.974 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.62 -26.83 55.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.077 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -90.06 -12.8 37.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.489 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -109.04 -36.82 5.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.645 0.26 . . . . 0.0 111.24 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.8 10.27 4.55 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.066 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.6 pttp 43.07 54.78 4.78 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.837 0.351 . . . . 0.0 111.454 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.9 p -47.11 131.56 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.368 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -60.19 -57.43 12.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.894 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -156.65 165.21 36.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.002 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.561 HG13 HG22 ' A' ' 48' ' ' VAL . 21.6 t -141.63 114.49 4.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.005 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -119.02 151.94 37.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.024 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mt -130.76 149.36 52.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.755 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.963 HG21 ' CE2' ' A' ' 45' ' ' PHE . 2.7 pp -72.69 -175.14 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.983 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.434 ' N ' HD12 ' A' ' 34' ' ' ILE . 20.6 m-85 -149.14 -176.2 5.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.999 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.402 ' CB ' ' HE3' ' A' ' 43' ' ' LYS . 4.7 t0 -80.83 -168.52 1.81 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.826 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -120.61 35.97 4.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.817 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -163.97 -59.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.964 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.37 -4.94 28.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.387 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.93 35.98 13.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.843 0.354 . . . . 0.0 110.901 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -77.25 116.28 56.27 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.417 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 32.0 Cg_exo -61.27 114.77 2.35 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.54 2.16 . . . . 0.0 112.311 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.738 ' O ' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -177.61 137.03 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.976 0.417 . . . . 0.0 110.971 179.788 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.32 -72.09 0.48 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.633 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.963 ' CE2' HG21 ' A' ' 34' ' ' ILE . 1.7 p90 -152.25 -177.8 6.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.764 0.316 . . . . 0.0 110.851 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -154.59 -170.56 20.51 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.587 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.36 135.25 13.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.841 0.353 . . . . 0.0 110.92 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.561 HG22 HG13 ' A' ' 31' ' ' VAL . 39.8 t -123.98 156.7 31.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.015 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.464 ' N ' HG12 ' A' ' 48' ' ' VAL . 64.4 tt0 -119.74 112.18 18.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.871 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.681 ' HB2' HD11 ' A' ' 4' ' ' ILE . 21.9 mtp -144.96 168.97 18.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.956 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.405 ' O ' HG23 ' A' ' 55' ' ' VAL . 4.8 mm100 -71.85 160.53 32.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.824 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -82.04 59.38 4.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.76 -46.67 0.45 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.739 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 1.0 OUTLIER -90.02 -20.08 23.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.041 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.915 ' O ' HD12 ' A' ' 59' ' ' ILE . 42.9 t -64.7 -41.52 92.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.819 0.343 . . . . 0.0 111.166 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.4 m -57.71 -47.69 81.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.162 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -82.8 -28.32 30.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.118 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.51 ' O ' HD12 ' A' ' 62' ' ' LEU . . . -58.4 -41.22 84.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.329 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.915 HD12 ' O ' ' A' ' 55' ' ' VAL . 2.8 mp -90.32 -24.4 5.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.96 0.41 . . . . 0.0 111.166 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.37 -52.16 62.88 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.45 -19.1 24.27 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 58' ' ' ALA . 75.8 mt -90.02 -71.21 0.63 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.615 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -46.37 136.0 7.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.559 -179.333 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.467 ' O ' HG23 ' A' ' 65' ' ' THR . 62.1 t30 -177.18 -48.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.784 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 64' ' ' ASN . 0.4 OUTLIER -163.94 -175.15 3.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.968 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -91.0 113.62 25.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.941 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -130.25 -171.69 2.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.09 51.53 2.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.537 ' CA ' HG21 ' A' ' 14' ' ' THR . . . 83.88 38.07 10.85 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.465 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.44 -51.53 2.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.348 . . . . 0.0 110.987 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.79 -53.89 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.48 HG22 ' H ' ' A' ' 73' ' ' ARG . 5.0 mt 57.73 166.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.913 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.48 ' H ' HG22 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -91.1 48.84 1.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.902 0.382 . . . . 0.0 110.836 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.518 HG13 HG23 ' A' ' 59' ' ' ILE . 10.1 p -66.89 156.03 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.162 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.567 ' HA ' HG21 ' A' ' 59' ' ' ILE . 2.5 t -166.66 157.94 12.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.65 127.93 34.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.249 -0.882 . . . . 0.0 111.093 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.885 0.374 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -88.44 175.19 7.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 4.7 m-20 -118.55 129.88 55.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.868 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.806 HD12 ' HB ' ' A' ' 48' ' ' VAL . 30.6 mt -97.03 152.93 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.164 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.401 ' HB3' HG23 ' A' ' 75' ' ' THR . 90.7 t80 -130.18 103.58 6.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.812 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.677 HG13 HD23 ' A' ' 9' ' ' LEU . 10.6 p -113.56 116.97 54.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.164 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.1 -175.11 30.38 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.336 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.3 26.67 10.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.673 0.273 . . . . 0.0 111.323 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.775 HD21 ' N ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -102.76 -171.91 2.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.92 0.39 . . . . 0.0 111.17 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.705 HG13 ' H ' ' A' ' 12' ' ' SER . 6.7 p -164.49 170.55 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.469 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.564 ' H ' HG22 ' A' ' 10' ' ' VAL . 8.7 t80 -40.05 -31.64 0.13 Allowed 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 111.971 0.359 . . . . 0.0 111.971 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.705 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -144.04 50.55 1.33 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.798 0.332 . . . . 0.0 111.197 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.677 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -78.58 -61.16 2.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.123 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.662 HG21 ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER 179.47 -36.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.123 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.93 -50.53 68.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.01 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -71.72 -12.66 61.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.669 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -90.71 -28.0 18.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.147 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.57 HG22 ' CD1' ' A' ' 22' ' ' PHE . 14.7 p -90.09 -24.2 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.833 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.602 ' HB2' HG21 ' A' ' 31' ' ' VAL . 3.3 pttp -48.95 -32.72 9.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.761 0.315 . . . . 0.0 111.207 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -66.1 -33.77 76.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.967 0.413 . . . . 0.0 110.479 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 21' ' ' LEU . 8.2 tt -88.87 -27.12 21.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.662 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.57 ' CD1' HG22 ' A' ' 18' ' ' VAL . 2.0 m-30 -53.82 -24.86 16.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.049 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.6 m -61.41 -37.94 85.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.831 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.408 ' HG3' ' N ' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -90.35 -29.1 18.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.941 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.408 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -69.94 -40.4 75.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.936 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.57 21.26 0.16 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.434 -0.888 . . . . 0.0 113.264 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.2 tttm 56.17 111.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.959 0.409 . . . . 0.0 111.316 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 28' ' ' VAL . 12.8 p -105.37 121.54 57.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.013 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -67.44 -53.17 31.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.976 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -158.35 159.95 36.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.977 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.602 HG21 ' HB2' ' A' ' 19' ' ' LYS . 27.3 t -127.93 130.45 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.973 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.65 145.97 51.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.028 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.471 HD23 ' CA ' ' A' ' 46' ' ' GLY . 34.6 mt -141.18 146.55 37.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.728 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.431 HG21 ' CE1' ' A' ' 45' ' ' PHE . 2.6 pp -82.22 175.65 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.161 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -134.01 175.69 9.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.003 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -75.2 166.39 23.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 mpp_? -105.24 36.61 2.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.911 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -174.18 -41.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.966 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.6 -10.54 19.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.332 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt 61.76 28.97 17.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.782 0.325 . . . . 0.0 110.834 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -105.95 137.05 19.24 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.706 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.25 109.46 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.43 2.087 . . . . 0.0 112.407 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.418 ' C ' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -155.01 109.68 2.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.993 179.932 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 148.54 -63.92 0.41 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.726 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.446 ' CA ' HD11 ' A' ' 9' ' ' LEU . 13.2 p90 -177.25 170.72 2.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.875 0.369 . . . . 0.0 111.05 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.775 ' N ' HD21 ' A' ' 9' ' ' LEU . . . -125.34 179.87 16.01 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.543 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -146.36 129.53 16.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.348 . . . . 0.0 110.917 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.806 ' HB ' HD12 ' A' ' 4' ' ' ILE . 33.3 t -122.46 148.67 26.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.045 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -117.69 104.76 11.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.927 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 32.0 mtp -138.09 159.73 41.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.7 158.51 34.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.722 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -68.24 93.31 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.096 0.474 . . . . 0.0 110.963 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -169.53 -60.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.999 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 t -90.3 -15.56 30.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.84 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.894 ' O ' HD12 ' A' ' 59' ' ' ILE . 25.5 t -68.68 -49.0 68.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.843 0.354 . . . . 0.0 111.173 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 0.6 OUTLIER -70.12 -22.36 63.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.157 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -90.28 -37.21 14.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 110.602 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.64 ' HB1' HD12 ' A' ' 62' ' ' LEU . . . -57.75 -65.05 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.86 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.894 HD12 ' O ' ' A' ' 55' ' ' VAL . 2.6 mp -58.01 -30.63 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.031 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 56' ' ' SER . . . -57.43 -55.9 28.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.678 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -90.48 -28.07 18.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.684 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.64 HD12 ' HB1' ' A' ' 58' ' ' ALA . 94.1 mt -74.87 -72.26 0.3 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.782 0.325 . . . . 0.0 111.398 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.64 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -53.25 138.93 30.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.16 -179.599 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -177.38 -46.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.891 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -158.22 -178.69 7.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.948 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -92.65 106.62 18.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.873 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.67 -164.87 1.0 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.743 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 3.1 mtm -96.86 34.93 1.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.784 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.662 ' O ' HG21 ' A' ' 14' ' ' THR . . . 105.0 31.03 4.57 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.513 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -112.45 -62.28 1.6 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.862 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.7 -50.14 3.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.843 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.496 HG22 ' H ' ' A' ' 73' ' ' ARG . 4.0 mt 56.37 167.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.15 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.496 ' H ' HG22 ' A' ' 72' ' ' ILE . 10.4 ttm105 -95.01 45.08 1.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.915 0.388 . . . . 0.0 110.637 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.487 HG22 ' N ' ' A' ' 75' ' ' THR . 12.4 p -65.57 159.29 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.236 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.626 ' HA ' HG21 ' A' ' 59' ' ' ILE . 9.1 t -157.8 -176.82 6.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.523 ' HG2' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -94.63 44.66 1.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.93 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 3' ' ' ASN . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.141 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mtm . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.839 0.352 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -107.81 172.52 6.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -111.18 129.68 55.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.545 HG12 HG13 ' A' ' 55' ' ' VAL . 21.2 mt -98.12 143.46 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.093 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.493 ' CE1' ' CD2' ' A' ' 45' ' ' PHE . 41.5 t80 -116.97 123.32 46.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.962 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.523 ' CG2' HG21 ' A' ' 72' ' ' ILE . 12.0 p -125.92 121.32 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.971 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -107.21 76.8 0.23 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.696 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.625 ' CB ' HG23 ' A' ' 72' ' ' ILE . 4.5 t30 -178.04 54.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.85 0.357 . . . . 0.0 110.758 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.775 HD22 ' HB2' ' A' ' 15' ' ' SER . 16.7 mt -128.73 -168.82 1.97 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.179 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.607 HG22 ' H ' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -178.55 -168.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.388 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.607 ' H ' HG22 ' A' ' 10' ' ' VAL . 35.5 m-85 -47.02 -41.76 17.03 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.859 0.361 . . . . 0.0 111.1 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.543 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.8 m -167.66 76.43 0.15 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.658 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.56 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -97.62 -63.3 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.547 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -163.61 -19.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.989 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.775 ' HB2' HD22 ' A' ' 9' ' ' LEU . 7.6 t -47.56 -59.16 3.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.821 0.343 . . . . 0.0 111.511 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -67.42 -11.73 58.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.88 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -90.36 -32.61 16.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.062 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.6 p -87.23 -25.96 6.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.748 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.517 ' HB2' HG11 ' A' ' 31' ' ' VAL . 22.2 pttp -55.62 -29.75 59.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.781 0.324 . . . . 0.0 111.036 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -67.71 -35.96 79.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.757 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.8 tt -85.01 -30.34 24.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.815 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -17.79 65.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.107 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.7 -24.28 41.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.257 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -88.3 -25.97 22.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.225 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -107.24 -32.37 7.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.231 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -114.46 -25.27 4.1 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.806 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.99 53.47 2.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.039 0.447 . . . . 0.0 110.748 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.401 HG21 ' HB ' ' A' ' 31' ' ' VAL . 8.4 p -57.34 143.63 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.195 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -100.92 -40.12 7.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.875 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -138.59 126.13 21.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.906 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.517 HG11 ' HB2' ' A' ' 19' ' ' LYS . 11.1 p -146.47 131.73 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.087 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.4 170.08 7.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 10' ' ' VAL . 23.2 mt -96.63 154.29 17.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.816 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.607 HD11 ' HB3' ' A' ' 43' ' ' LYS . 2.6 pp -92.82 175.74 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.095 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -144.85 171.89 13.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.44 160.32 24.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.932 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.39 30.82 4.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.963 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -144.46 -57.41 0.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.43 -5.5 25.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.276 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 63.4 34.2 13.14 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.968 0.413 . . . . 0.0 110.934 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -110.72 143.17 27.67 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.831 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.47 133.66 54.3 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.532 2.155 . . . . 0.0 112.257 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.607 ' HB3' HD11 ' A' ' 34' ' ' ILE . 7.9 tptp -79.51 -69.02 0.61 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.848 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.99 45.07 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.532 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.493 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 27.0 p90 -177.75 169.31 2.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.904 0.383 . . . . 0.0 110.947 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.89 178.93 19.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.481 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -128.73 136.77 51.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.756 0.312 . . . . 0.0 110.915 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.513 HG22 HG23 ' A' ' 31' ' ' VAL . 23.8 t -127.74 141.62 45.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.093 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.26 113.83 25.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.7 mtp -145.96 -179.78 6.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.823 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.833 ' O ' HG23 ' A' ' 55' ' ' VAL . 15.0 tt0 -61.15 152.02 29.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.834 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -69.12 -32.6 72.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.016 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -77.13 -29.73 54.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.039 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.6 m -73.86 -32.42 63.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.015 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 51' ' ' GLN . 21.5 t -56.74 -49.18 79.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.309 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 m -53.16 -62.49 1.62 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.07 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -63.02 -29.65 70.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.997 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -66.57 -40.09 88.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.413 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.718 HG23 ' HB3' ' A' ' 63' ' ' ASP . 8.0 mt -90.12 -24.08 5.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.978 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.99 -52.8 63.47 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -90.47 -23.48 20.97 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 78.6 mt -85.39 -75.01 0.38 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.717 0.294 . . . . 0.0 111.702 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.718 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -52.46 134.04 34.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.875 0.369 . . . . 0.0 111.254 -179.439 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 179.1 -38.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.844 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.61 -165.8 2.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.768 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -119.92 96.95 5.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.921 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.2 -165.54 1.03 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.831 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 4.3 mmt -97.1 36.19 1.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.052 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.37 28.12 3.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.576 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -110.76 -31.15 7.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.815 0.341 . . . . 0.0 110.968 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.469 HG23 ' H ' ' A' ' 72' ' ' ILE . 0.6 OUTLIER -140.82 -56.38 0.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.949 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.625 HG23 ' CB ' ' A' ' 8' ' ' ASN . 18.0 mt 59.97 159.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.052 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.476 ' N ' HG22 ' A' ' 72' ' ' ILE . 5.7 ttt85 -89.29 53.64 2.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.776 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 75' ' ' THR . 12.1 p -74.57 156.81 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.21 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.457 ' N ' HG22 ' A' ' 74' ' ' VAL . 5.0 t -178.12 147.89 0.47 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.806 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -61.7 128.72 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.3 -0.857 . . . . 0.0 111.156 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpp? . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.813 0.339 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.765 ' HB2' HG21 ' A' ' 55' ' ' VAL . 8.4 mmt-85 -118.62 151.99 36.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.854 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.439 ' HB3' ' CE1' ' A' ' 47' ' ' PHE . 26.4 m-20 -89.72 115.74 27.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.694 HG23 HD11 ' A' ' 59' ' ' ILE . 10.5 mt -87.27 127.01 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.134 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -99.62 123.05 43.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.837 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.678 HG13 HD11 ' A' ' 9' ' ' LEU . 12.0 p -121.65 127.21 75.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.096 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.439 ' HA2' ' CD1' ' A' ' 45' ' ' PHE . . . -105.88 -171.98 23.51 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.414 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 m120 59.48 30.49 20.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.809 0.337 . . . . 0.0 110.955 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.742 HD22 ' HB2' ' A' ' 15' ' ' SER . 48.7 mt -82.83 166.72 18.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.982 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.82 HG12 ' HB2' ' A' ' 13' ' ' ALA . 0.8 OUTLIER -162.23 -174.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.796 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.625 ' H ' HG22 ' A' ' 10' ' ' VAL . 6.9 m-85 -46.73 -52.99 12.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.95 0.405 . . . . 0.0 111.159 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.454 ' H ' HG13 ' A' ' 10' ' ' VAL . 2.9 m -154.07 75.05 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.61 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.82 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -94.95 -56.72 2.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.429 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.627 HG21 ' CA ' ' A' ' 69' ' ' GLY . 1.5 m -165.5 -34.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.465 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.742 ' HB2' HD22 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -47.27 -54.4 11.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.715 0.293 . . . . 0.0 111.451 -179.658 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -68.13 -13.08 61.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.96 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -90.62 -43.4 10.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.136 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -79.23 -30.79 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.683 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -52.43 -27.53 16.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.801 0.334 . . . . 0.0 111.15 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -71.95 -37.74 69.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.811 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.1 tp -88.38 -28.44 20.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.89 -21.67 44.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.163 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.459 ' HA ' HG12 ' A' ' 28' ' ' VAL . 85.8 p -84.57 -27.62 27.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.093 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -89.98 -34.2 16.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.289 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -105.21 -30.23 9.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.271 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.4 -14.95 22.66 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.895 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.75 35.01 24.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.85 0.357 . . . . 0.0 110.86 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 23' ' ' SER . 11.0 p -50.69 143.31 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.336 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -91.26 -34.46 14.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.927 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -167.79 158.18 10.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.918 0.39 . . . . 0.0 111.193 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.466 HG13 HG22 ' A' ' 48' ' ' VAL . 21.3 t -143.48 150.34 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.898 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.437 ' C ' HD23 ' A' ' 33' ' ' LEU . 18.0 ttpt -169.64 151.76 4.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.933 0.397 . . . . 0.0 111.288 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.526 HD22 HD13 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -134.95 -177.27 4.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.329 179.762 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.574 HD11 ' HA3' ' A' ' 44' ' ' GLY . 1.8 pp -129.57 179.83 3.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.821 0.343 . . . . 0.0 111.189 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -139.71 -168.59 2.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.952 -179.651 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.77 -20.67 36.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.513 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.29 26.44 4.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.922 0.392 . . . . 0.0 110.81 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -156.44 -46.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.414 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.07 0.54 25.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.96 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.9 mttm 63.98 38.95 8.34 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.93 0.395 . . . . 0.0 111.044 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 42' ' ' PRO . 12.5 mtmm -100.96 100.79 13.76 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.573 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.444 ' HD2' ' CZ ' ' A' ' 11' ' ' TYR . 33.3 Cg_endo -64.8 107.1 0.84 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.354 2.036 . . . . 0.0 112.216 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.5 37.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.195 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.574 ' HA3' HD11 ' A' ' 34' ' ' ILE . . . -129.25 32.64 3.2 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.473 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.477 ' C ' HD12 ' A' ' 9' ' ' LEU . 0.5 OUTLIER 72.41 166.05 0.3 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.888 0.375 . . . . 0.0 110.905 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.651 ' N ' HD12 ' A' ' 9' ' ' LEU . . . -140.31 -162.36 9.08 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.482 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.439 ' CE1' ' HB3' ' A' ' 3' ' ' ASN . 0.3 OUTLIER -139.81 160.91 38.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 0.0 111.039 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.466 HG22 HG13 ' A' ' 31' ' ' VAL . 32.7 t -147.91 142.22 19.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.955 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -107.75 114.58 28.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.584 ' HB2' HD11 ' A' ' 4' ' ' ILE . 21.4 mtm -145.54 -178.12 5.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.887 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -75.85 150.65 37.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 -179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -61.18 -36.96 81.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -63.47 -31.05 72.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.016 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.41 -35.42 21.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.987 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 51' ' ' GLN . 40.7 t -57.69 -30.82 38.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.28 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.563 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -85.39 -23.43 27.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.269 -179.79 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -90.21 -41.45 11.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.888 0.375 . . . . 0.0 110.84 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.555 ' HB1' HD12 ' A' ' 62' ' ' LEU . . . -58.34 -66.43 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.949 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.862 HD12 ' O ' ' A' ' 55' ' ' VAL . 3.6 mt -58.07 -21.81 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.277 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 56' ' ' SER . . . -68.66 -54.3 17.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.584 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.19 -29.97 17.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.479 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.555 HD12 ' HB1' ' A' ' 58' ' ' ALA . 92.9 mt -73.2 -74.24 0.18 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.241 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.524 ' CB ' HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -57.0 135.86 56.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.055 -179.78 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 t30 179.51 -38.78 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.789 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.422 ' OG1' HG21 ' A' ' 71' ' ' THR . 0.5 OUTLIER -159.49 -177.51 6.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.788 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.21 111.4 23.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.988 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -131.71 -171.07 2.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.947 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 21.5 mtp -93.12 45.68 1.18 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.627 ' CA ' HG21 ' A' ' 14' ' ' THR . . . 97.98 39.5 3.8 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.516 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.08 -39.68 2.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.697 0.284 . . . . 0.0 111.075 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.422 HG21 ' OG1' ' A' ' 65' ' ' THR . 0.1 OUTLIER -135.37 -48.86 0.72 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.244 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.623 HG22 ' H ' ' A' ' 73' ' ' ARG . 1.9 mt 55.26 174.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.637 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.623 ' H ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -104.78 66.16 0.77 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.969 0.414 . . . . 0.0 111.022 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.524 HG12 ' CB ' ' A' ' 63' ' ' ASP . 14.7 p -83.25 156.98 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.0 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.453 ' N ' HG22 ' A' ' 74' ' ' VAL . 5.4 t -167.31 142.12 3.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.964 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.484 ' HB3' HG12 ' A' ' 55' ' ' VAL . 18.0 pt-20 -69.61 134.12 48.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.949 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.044 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.413 ' HG2' ' CE1' ' A' ' 29' ' ' PHE . 4.8 mtm . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.783 0.325 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -96.48 167.0 11.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.938 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -115.68 106.42 13.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.817 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.6 mt -76.76 128.76 37.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.201 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.526 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 50.1 t80 -108.54 122.21 46.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.749 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.713 HG13 HD11 ' A' ' 9' ' ' LEU . 10.9 p -132.49 145.92 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.228 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.34 -165.33 11.78 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.408 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 55.04 34.62 22.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.76 0.314 . . . . 0.0 111.039 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.713 HD11 HG13 ' A' ' 6' ' ' VAL . 28.6 mt -106.68 128.49 54.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.968 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.62 HG13 ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -89.71 -168.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.797 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.62 ' N ' HG13 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -49.7 -47.47 50.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.788 0.328 . . . . 0.0 111.04 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.528 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.4 t -145.76 58.79 1.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.706 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.636 ' O ' HG23 ' A' ' 14' ' ' THR . . . -59.31 -52.87 63.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.266 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER 176.03 -32.21 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.102 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.49 -54.15 19.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.323 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -64.83 -15.4 61.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.898 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -90.49 -34.09 15.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.201 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 p -90.12 -21.79 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.858 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.519 ' HB2' HG11 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -48.86 -28.43 3.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.748 0.308 . . . . 0.0 111.142 -179.822 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -71.77 -33.25 68.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.748 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.8 tt -88.9 -32.13 17.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.809 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.35 -23.46 64.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.988 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.6 m -80.91 -23.06 39.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.076 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.06 -37.52 14.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.111 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -101.7 -31.16 10.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.093 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.22 -24.79 9.32 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.655 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.0 tttt 63.88 36.99 9.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 0.0 110.899 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 49' ' ' GLU . 11.8 p -61.01 131.98 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.034 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.413 ' CE1' ' HG2' ' A' ' 1' ' ' MET . 74.8 m-85 -74.33 -41.92 60.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -150.85 148.32 28.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.825 HG23 HG22 ' A' ' 48' ' ' VAL . 11.0 p -162.95 130.24 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.975 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.99 161.46 4.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.884 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mt -100.83 173.75 6.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.921 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.611 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.4 pp -112.32 161.26 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.156 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.401 ' CD2' ' HB3' ' A' ' 42' ' ' PRO . 12.4 m-85 -145.34 -174.32 4.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.18 132.0 44.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.97 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -92.14 50.71 1.68 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.791 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -171.65 -42.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.51 -20.52 18.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.08 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.8 mmtp 67.78 44.68 1.56 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.914 0.388 . . . . 0.0 110.934 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -136.56 141.81 36.89 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.924 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.439 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 66.4 Cg_endo -73.88 134.1 19.36 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.52 2.146 . . . . 0.0 112.268 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.9 mmmt -63.8 -66.83 0.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.847 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.06 44.65 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.64 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.425 ' CE2' HG12 ' A' ' 34' ' ' ILE . 33.2 p90 -177.75 154.47 0.94 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.802 0.334 . . . . 0.0 110.986 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.12 -164.37 9.88 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.451 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -146.15 137.48 24.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.819 0.342 . . . . 0.0 110.908 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.825 HG22 HG23 ' A' ' 31' ' ' VAL . 33.7 t -122.52 111.89 32.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.998 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.604 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.8 OUTLIER -80.37 103.86 10.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.957 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.6 mtm -142.81 152.96 42.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.608 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -63.74 178.86 0.55 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.89 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.72 -159.0 0.08 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.45 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 66.05 -71.58 0.09 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.16 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.3 m -61.29 -30.99 70.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.039 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 51' ' ' GLN . 35.4 t -63.73 -44.78 98.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.181 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -67.14 -25.4 66.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.177 -179.867 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -90.16 -38.08 13.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.931 0.396 . . . . 0.0 110.727 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.712 ' HB1' HD12 ' A' ' 62' ' ' LEU . . . -58.41 -64.51 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.895 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.572 HG23 ' HB3' ' A' ' 63' ' ' ASP . 6.5 mt -58.13 -26.65 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.204 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 56' ' ' SER . . . -63.78 -53.91 43.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.713 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -90.33 -33.98 15.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.886 0.374 . . . . 0.0 111.428 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.712 HD12 ' HB1' ' A' ' 58' ' ' ALA . 83.6 mt -72.01 -70.79 0.31 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.38 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.572 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -54.91 134.59 48.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.18 -179.583 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -179.98 -67.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.904 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.58 -174.02 2.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -103.86 105.29 15.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.043 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -123.22 -174.75 3.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.813 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 8.5 ptt? -96.02 36.83 1.27 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.991 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.28 36.76 1.17 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.55 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.38 -40.42 2.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.727 0.299 . . . . 0.0 110.976 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.445 HG23 ' H ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -134.02 -60.99 0.8 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.859 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.505 HD13 HD21 ' A' ' 9' ' ' LEU . 26.9 mt 59.76 159.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.012 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.491 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -83.88 58.69 4.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.926 0.394 . . . . 0.0 110.748 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.473 HG22 ' N ' ' A' ' 75' ' ' THR . 13.8 p -75.37 158.11 5.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.185 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.473 ' N ' HG22 ' A' ' 74' ' ' VAL . 9.9 t -174.15 153.94 2.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.803 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -76.54 124.02 26.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.526 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.022 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.86 0.362 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.475 ' HB2' HG21 ' A' ' 55' ' ' VAL . 21.9 mmm180 -89.02 175.28 7.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.952 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.406 ' HB3' ' CE2' ' A' ' 47' ' ' PHE . 32.3 m-20 -121.95 129.49 52.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.865 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.524 HG12 HG13 ' A' ' 55' ' ' VAL . 31.6 mt -100.57 146.53 9.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.158 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -125.52 116.36 21.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.899 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 p -120.84 134.18 65.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.084 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.99 -168.64 14.49 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.429 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 59.99 33.23 21.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.844 0.354 . . . . 0.0 110.875 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.676 HD12 ' C ' ' A' ' 45' ' ' PHE . 53.7 mt -87.67 136.39 32.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.946 HG12 ' HB2' ' A' ' 13' ' ' ALA . 1.4 p -105.89 179.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.778 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.643 ' H ' HG22 ' A' ' 10' ' ' VAL . 6.9 m-85 -46.43 -53.37 11.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.871 0.367 . . . . 0.0 111.138 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.432 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -146.43 68.11 1.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.569 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.946 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -77.38 -76.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.381 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.49 -23.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.867 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.405 ' O ' HG12 ' A' ' 18' ' ' VAL . 16.7 p -47.29 -58.16 4.43 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.728 0.299 . . . . 0.0 111.459 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.24 -12.83 61.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.832 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -90.52 -29.86 17.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.152 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 15' ' ' SER . 12.3 p -87.5 -25.48 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.75 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.72 -26.84 6.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.74 0.305 . . . . 0.0 111.22 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -75.0 -34.64 61.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.8 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.5 tp -89.58 -30.18 18.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.995 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.406 ' CD2' ' HE3' ' A' ' 50' ' ' MET . 0.1 OUTLIER -58.08 -21.83 47.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.083 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.3 p -82.56 -24.38 34.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.19 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -85.44 -26.48 26.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.222 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.67 -29.27 7.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.256 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.5 -26.78 3.83 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.712 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.0 tttt 64.05 51.1 2.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.369 . . . . 0.0 110.837 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.3 p -54.76 135.76 17.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.235 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -90.96 -42.47 10.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.938 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -138.82 124.92 20.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 31' ' ' VAL . 10.9 p -136.15 121.46 28.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -138.4 178.83 6.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.011 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.58 ' CD2' HD13 ' A' ' 9' ' ' LEU . 7.4 mt -145.43 173.8 11.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.613 HD11 ' HA3' ' A' ' 44' ' ' GLY . 2.5 pp -110.31 179.0 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.144 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -121.61 173.22 7.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.037 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.73 -11.06 60.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.349 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.97 33.2 5.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.948 0.404 . . . . 0.0 110.848 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -165.34 -43.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.856 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.59 -1.51 16.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.346 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.15 33.03 14.78 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.885 0.374 . . . . 0.0 110.856 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.07 148.13 38.78 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.802 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.67 113.19 2.65 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.52 2.147 . . . . 0.0 112.231 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.2 109.19 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.613 ' HA3' HD11 ' A' ' 34' ' ' ILE . . . 150.52 -71.58 0.3 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.541 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.676 ' C ' HD12 ' A' ' 9' ' ' LEU . 9.9 p90 -165.55 179.07 6.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.351 . . . . 0.0 110.946 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.53 ' N ' HD12 ' A' ' 9' ' ' LEU . . . -143.17 -175.78 16.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.548 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.406 ' CE2' ' HB3' ' A' ' 3' ' ' ASN . 1.2 t80 -140.68 155.09 46.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.801 0.334 . . . . 0.0 110.926 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.1 t -151.36 131.36 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.08 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.88 116.46 31.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.406 ' HE3' ' CD2' ' A' ' 22' ' ' PHE . 4.0 mtt -142.29 168.24 20.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.963 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.654 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -60.0 179.75 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -96.2 35.52 1.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.996 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -123.86 -41.1 2.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.923 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.524 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 24.9 p -87.79 -24.77 23.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.171 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.669 ' O ' HD12 ' A' ' 59' ' ' ILE . 41.7 t -65.38 -28.79 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.319 . . . . 0.0 111.319 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.4 m -65.4 -47.33 76.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.111 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.429 ' HA ' ' HB3' ' A' ' 60' ' ' ALA . 5.4 tt0 -90.24 -25.0 20.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.226 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.524 ' HB2' ' O ' ' A' ' 54' ' ' SER . . . -50.42 -45.27 55.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.536 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.712 HG23 ' HB3' ' A' ' 63' ' ' ASP . 3.9 mp -90.44 -28.31 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.078 0.466 . . . . 0.0 110.929 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.429 ' HB3' ' HA ' ' A' ' 57' ' ' GLU . . . -52.32 -58.84 5.43 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -90.36 -12.46 37.57 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.507 HD12 ' O ' ' A' ' 58' ' ' ALA . 33.5 mt -90.04 -75.11 0.46 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.888 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.712 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -46.69 132.62 11.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.942 0.401 . . . . 0.0 111.632 -179.185 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 179.96 -67.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.742 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.17 -167.1 1.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.72 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -107.64 111.34 23.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.885 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.05 -167.17 1.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.951 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 3.5 mmt -86.9 56.19 3.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.704 ' HA2' HD11 ' A' ' 72' ' ' ILE . . . 78.69 32.67 40.51 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.503 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.7 -29.23 8.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.801 0.334 . . . . 0.0 110.966 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.514 HG23 ' H ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -137.94 -65.21 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.98 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.704 HD11 ' HA2' ' A' ' 69' ' ' GLY . 19.2 mt 59.74 159.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.979 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.49 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -83.32 78.58 9.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.698 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.588 HG13 HG23 ' A' ' 59' ' ' ILE . 14.0 p -101.71 153.84 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.206 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.4 t -169.1 161.65 10.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.958 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.45 130.83 47.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.089 179.979 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 120.883 0.373 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.29 169.35 8.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.838 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -104.13 133.55 48.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.768 HD11 ' HB2' ' A' ' 50' ' ' MET . 25.6 mt -98.99 111.33 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.099 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -90.54 119.39 30.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.828 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.694 HG13 HD11 ' A' ' 9' ' ' LEU . 8.7 p -131.86 139.05 51.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.044 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.553 ' O ' HG21 ' A' ' 72' ' ' ILE . . . -114.64 -163.6 14.45 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.399 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.629 ' HB3' HG23 ' A' ' 72' ' ' ILE . 5.0 t-20 55.67 36.26 26.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.788 0.328 . . . . 0.0 110.981 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.694 HD11 HG13 ' A' ' 6' ' ' VAL . 93.1 mt -100.73 109.81 21.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.066 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.642 HG22 ' H ' ' A' ' 11' ' ' TYR . 1.0 OUTLIER -78.33 -175.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.653 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.642 ' H ' HG22 ' A' ' 10' ' ' VAL . 24.7 m-85 -46.79 -48.96 20.57 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.894 0.378 . . . . 0.0 111.098 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.549 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.1 m -142.3 62.01 1.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.652 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.636 ' O ' HG23 ' A' ' 14' ' ' THR . . . -58.46 -70.85 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.424 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER 175.23 -28.43 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.34 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 26.8 t -48.33 -55.83 9.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.77 0.319 . . . . 0.0 111.345 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.86 -14.7 60.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.912 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -90.48 -41.12 11.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.04 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 18' ' ' VAL . 11.7 p -76.57 -14.21 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.759 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -51.77 -40.59 60.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.773 0.32 . . . . 0.0 111.193 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -61.06 -33.25 73.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.818 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.437 ' O ' HD23 ' A' ' 21' ' ' LEU . 6.4 tt -88.65 -28.65 20.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.853 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.47 -26.37 61.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.019 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.6 t -73.12 -34.57 66.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.923 0.392 . . . . 0.0 110.867 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -90.15 -4.98 56.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.245 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -114.47 -33.86 5.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.732 0.301 . . . . 0.0 111.238 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.0 -2.46 6.08 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.293 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? 59.63 40.85 19.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.944 0.402 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 49' ' ' GLU . 13.6 p -57.52 139.45 17.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.207 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -75.78 -39.09 57.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.933 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -168.83 154.9 6.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.007 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.785 HG22 HG13 ' A' ' 48' ' ' VAL . 21.7 t -138.72 118.79 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.983 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.53 132.27 17.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.108 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.626 HD23 ' N ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -106.98 174.53 5.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.558 179.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.668 HD11 ' CE1' ' A' ' 45' ' ' PHE . 2.1 pp -105.19 152.12 7.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.263 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 2.7 m-85 -117.73 -173.07 2.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.962 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.1 -168.66 1.9 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.864 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.7 ttt-85 -127.65 36.27 4.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -157.02 -54.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.72 -2.14 26.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.379 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.3 mttm 60.84 36.97 18.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.815 0.341 . . . . 0.0 110.925 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -105.64 141.29 22.34 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.903 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 50.3 Cg_exo -53.19 118.28 4.67 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.479 2.119 . . . . 0.0 112.276 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -58.35 -69.11 0.2 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.839 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 173.9 35.11 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.562 -0.828 . . . . 0.0 113.012 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.668 ' CE1' HD11 ' A' ' 34' ' ' ILE . 28.4 p90 -178.5 155.82 0.88 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.077 0.465 . . . . 0.0 111.333 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.475 ' N ' HD12 ' A' ' 9' ' ' LEU . . . -141.09 -166.18 10.62 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.388 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -144.08 143.74 31.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.88 0.371 . . . . 0.0 110.967 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.785 HG13 HG22 ' A' ' 31' ' ' VAL . 35.3 t -134.26 138.9 49.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.055 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -94.33 107.87 19.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.908 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.768 ' HB2' HD11 ' A' ' 4' ' ' ILE . 3.6 mtt -135.78 156.36 48.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.915 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.597 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.7 tt0 -81.29 154.94 26.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.974 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -51.06 -29.58 13.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.198 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -71.24 -35.09 71.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.95 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.9 p -87.07 -43.65 12.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.938 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 51' ' ' GLN . 30.2 t -58.21 -31.11 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.145 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.51 -51.32 70.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.098 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -88.64 -23.51 23.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.157 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.522 ' O ' HD12 ' A' ' 62' ' ' LEU . . . -55.04 -41.48 71.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.408 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.777 HG23 ' HB3' ' A' ' 63' ' ' ASP . 4.5 mt -90.25 -24.81 5.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.067 0.46 . . . . 0.0 110.917 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.49 -55.66 30.97 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.29 -19.71 23.78 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.522 HD12 ' O ' ' A' ' 58' ' ' ALA . 64.9 mt -85.4 -75.15 0.38 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.763 0.316 . . . . 0.0 111.65 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.777 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -55.97 137.17 51.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.147 -179.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 178.78 -61.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.813 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.89 -173.6 3.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -105.78 118.58 36.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.435 ' CD2' ' HD3' ' A' ' 70' ' ' ARG . 0.2 OUTLIER -135.2 -165.52 1.69 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.83 32.27 2.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.026 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.428 ' HA2' HD11 ' A' ' 72' ' ' ILE . . . 112.57 33.29 2.11 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.585 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.435 ' HD3' ' CD2' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -113.52 -34.48 5.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 0.0 110.934 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.498 HG23 ' H ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -137.92 -61.55 0.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.843 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.629 HG23 ' HB3' ' A' ' 8' ' ' ASN . 1.1 mp 59.94 162.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.908 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.429 ' N ' HG22 ' A' ' 72' ' ' ILE . 3.5 mmm-85 -87.75 75.78 8.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.859 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.471 HG23 ' HB ' ' A' ' 6' ' ' VAL . 12.5 p -97.84 156.12 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.448 ' N ' HG22 ' A' ' 74' ' ' VAL . 9.9 t -167.23 161.26 14.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.961 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -81.76 107.56 14.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.907 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.167 -0.921 . . . . 0.0 111.089 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.825 0.345 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -135.77 173.32 11.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 -102.61 139.44 38.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.935 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.552 HD11 ' HB2' ' A' ' 50' ' ' MET . 4.1 mt -109.8 136.95 44.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.044 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -114.73 122.76 47.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.913 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.747 HG13 HD11 ' A' ' 9' ' ' LEU . 11.3 p -129.06 134.19 64.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.142 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -118.47 -168.3 14.22 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.468 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 59.64 33.9 22.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.858 0.361 . . . . 0.0 110.957 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.747 HD11 HG13 ' A' ' 6' ' ' VAL . 48.4 mt -98.74 -175.03 2.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.909 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.641 HG13 ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -167.97 -167.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.733 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.641 ' N ' HG13 ' A' ' 10' ' ' VAL . 77.4 m-85 -47.58 -46.76 28.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.798 0.333 . . . . 0.0 111.195 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.484 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -152.44 53.26 0.79 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.824 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.654 ' O ' HG23 ' A' ' 14' ' ' THR . . . -64.14 -55.32 22.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.184 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.7 HG21 ' HA3' ' A' ' 69' ' ' GLY . 0.1 OUTLIER 177.07 -33.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.081 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.565 ' OG ' HD13 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -52.39 -52.39 53.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.803 0.335 . . . . 0.0 111.103 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -66.62 -15.52 63.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.772 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -90.55 -29.81 17.63 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.308 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 15' ' ' SER . 14.4 p -89.74 -20.94 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.811 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.404 ' HB2' HG11 ' A' ' 31' ' ' VAL . 13.3 pttp -57.29 -30.47 64.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.693 0.282 . . . . 0.0 111.12 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -72.77 -35.98 67.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.885 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.4 tp -87.56 -27.76 22.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.493 ' CD1' ' HE3' ' A' ' 50' ' ' MET . 0.1 OUTLIER -57.06 -21.96 35.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.211 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.444 ' HA ' HG12 ' A' ' 28' ' ' VAL . 1.4 t -83.25 -21.12 33.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.22 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -89.17 -43.65 10.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.125 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -100.05 -29.86 12.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.148 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.34 -21.96 20.82 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.597 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.66 31.69 16.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.911 0.386 . . . . 0.0 110.918 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 49' ' ' GLU . 12.0 p -55.2 141.87 10.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.167 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -84.07 -42.63 15.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.62 160.36 40.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.468 HG23 HG22 ' A' ' 48' ' ' VAL . 10.2 p -149.09 151.15 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.928 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.21 131.92 0.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.088 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.725 HD23 ' HA3' ' A' ' 46' ' ' GLY . 1.0 OUTLIER -102.28 -174.31 2.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.603 179.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.532 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.3 pp -107.27 167.71 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.288 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -147.34 157.66 43.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.01 154.25 23.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.872 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -94.71 46.52 1.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -176.52 -40.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.801 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.71 -18.7 16.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.084 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.49 34.84 12.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.871 0.367 . . . . 0.0 110.911 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -113.39 142.13 27.01 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.782 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.24 117.58 4.07 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.443 2.095 . . . . 0.0 112.297 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -60.63 -70.11 0.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.762 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 176.22 35.55 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.737 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.444 ' CE2' HG12 ' A' ' 34' ' ' ILE . 28.2 p90 -178.66 172.82 1.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.901 0.382 . . . . 0.0 111.082 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.725 ' HA3' HD23 ' A' ' 33' ' ' LEU . . . -162.58 -164.31 17.27 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.418 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -138.3 164.3 29.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.915 0.388 . . . . 0.0 111.05 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.468 HG22 HG23 ' A' ' 31' ' ' VAL . 32.7 t -149.91 151.55 12.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.926 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.575 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -113.31 110.92 21.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.904 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.552 ' HB2' HD11 ' A' ' 4' ' ' ILE . 18.1 mtp -147.3 -176.64 5.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.891 ' O ' HG23 ' A' ' 55' ' ' VAL . 2.0 tt0 -86.23 148.44 25.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.902 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -57.75 -35.1 70.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.062 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.22 -44.46 92.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.914 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 58.4 m -77.1 -32.1 56.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.906 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.902 ' O ' HD12 ' A' ' 59' ' ' ILE . 39.5 t -69.17 -36.11 71.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.189 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.4 m -60.0 -43.48 95.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.189 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -90.0 -27.82 19.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.283 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.529 ' O ' HD12 ' A' ' 62' ' ' LEU . . . -56.88 -41.83 78.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.396 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.902 HD12 ' O ' ' A' ' 55' ' ' VAL . 2.7 mp -90.22 -27.35 5.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.041 0.448 . . . . 0.0 110.966 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.56 -58.35 7.07 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -90.35 -13.0 36.01 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.529 HD12 ' O ' ' A' ' 58' ' ' ALA . 41.3 mt -89.99 -75.18 0.46 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.775 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.766 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -49.65 129.88 20.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.521 -179.324 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -176.98 -43.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.914 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.39 -175.13 4.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -106.89 99.8 9.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.962 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.69 -168.95 1.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.899 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.38 52.25 2.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.959 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.7 ' HA3' HG21 ' A' ' 14' ' ' THR . . . 89.63 27.93 20.64 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.579 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 ttp180 -107.82 -31.16 8.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.796 0.331 . . . . 0.0 110.868 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.483 HG23 ' H ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -140.31 -59.2 0.53 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.567 HD11 ' HA2' ' A' ' 69' ' ' GLY . 15.5 mt 59.38 161.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.012 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.477 ' N ' HG22 ' A' ' 72' ' ' ILE . 5.5 mtt180 -86.63 56.27 3.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.796 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.556 HG13 HG23 ' A' ' 59' ' ' ILE . 14.0 p -76.81 158.96 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.294 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.565 ' HA ' HG21 ' A' ' 59' ' ' ILE . 10.2 t -167.76 165.79 13.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.886 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -96.76 110.55 22.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.31 -0.852 . . . . 0.0 111.17 179.971 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 ttt . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.788 0.328 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -130.46 161.07 32.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.855 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -103.19 119.24 38.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.891 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.676 HG12 HG13 ' A' ' 55' ' ' VAL . 17.2 mt -92.97 131.83 38.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.18 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.518 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 85.9 t80 -111.17 126.01 54.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.852 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.16 145.0 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.192 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.54 -174.29 14.74 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.474 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 60.48 41.81 15.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 110.875 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.57 HD13 HD21 ' A' ' 33' ' ' LEU . 25.8 mt -103.88 -179.16 3.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.839 HG12 ' HB2' ' A' ' 13' ' ' ALA . 5.7 p -173.36 169.76 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.799 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.564 ' H ' HG22 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -40.23 -37.73 0.68 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.855 -179.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.605 ' H ' HG13 ' A' ' 10' ' ' VAL . 21.0 p -142.61 54.97 1.41 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.842 0.353 . . . . 0.0 111.1 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.839 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -77.11 -69.99 0.49 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.189 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -179.8 -36.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.966 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.423 ' HB2' HD22 ' A' ' 9' ' ' LEU . 0.8 OUTLIER -52.8 -51.26 61.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.893 0.378 . . . . 0.0 111.078 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -14.58 62.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -90.33 -31.72 16.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.144 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.8 p -87.76 -24.83 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.593 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.708 ' HB3' HG11 ' A' ' 31' ' ' VAL . 9.8 pttt -54.02 -28.53 38.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.812 0.339 . . . . 0.0 111.0 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -33.86 69.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.662 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.5 tt -90.13 -28.44 18.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.838 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.19 -26.55 51.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.004 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.1 p -76.23 -33.55 59.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.852 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -90.1 -9.62 47.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.337 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -111.77 -37.18 5.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.715 0.293 . . . . 0.0 111.077 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.03 -8.47 5.57 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.198 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.33 47.35 6.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.882 0.372 . . . . 0.0 110.755 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.684 HG21 ' CG2' ' A' ' 31' ' ' VAL . 9.7 p -54.28 155.56 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.29 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.434 ' N ' HG22 ' A' ' 28' ' ' VAL . 14.1 m-85 -93.15 -49.18 6.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.09 143.47 30.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.809 HG22 HG13 ' A' ' 48' ' ' VAL . 21.2 t -150.19 110.74 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.122 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.33 172.94 16.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.57 HD21 HD13 ' A' ' 9' ' ' LEU . 7.5 mt -104.13 156.62 17.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.828 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.839 HD11 ' HB2' ' A' ' 43' ' ' LYS . 2.7 pp -66.04 -35.51 75.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.127 0.489 . . . . 0.0 111.205 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.575 ' N ' HD12 ' A' ' 34' ' ' ILE . 3.1 m-85 49.69 -175.97 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.196 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -109.47 141.02 42.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.8 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -90.13 52.43 2.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.942 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -177.49 -40.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.818 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -104.9 -18.35 14.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.167 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.8 mttp 63.32 33.67 13.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.909 0.385 . . . . 0.0 110.883 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -113.89 145.25 33.12 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.883 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.65 120.31 6.11 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.58 2.187 . . . . 0.0 112.352 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.839 ' HB2' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -68.55 -75.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.878 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 175.9 37.11 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.65 -0.785 . . . . 0.0 112.684 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.435 ' CE2' HG12 ' A' ' 34' ' ' ILE . 32.7 p90 -177.14 132.95 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.905 0.383 . . . . 0.0 110.992 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -122.4 -159.3 10.55 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.533 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.406 ' CD1' ' O ' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -145.01 152.59 40.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.841 0.353 . . . . 0.0 111.057 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.809 HG13 HG22 ' A' ' 31' ' ' VAL . 48.7 t -141.75 124.75 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.856 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -95.39 108.4 20.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.61 ' HG3' HG23 ' A' ' 28' ' ' VAL . 26.2 mtp -136.79 158.96 43.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.421 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -62.54 155.53 25.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -77.75 69.15 3.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.027 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -149.98 -48.27 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.428 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -90.18 -20.07 23.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.014 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.725 ' O ' HD12 ' A' ' 59' ' ' ILE . 30.0 t -59.5 -47.98 88.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.317 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 m -56.01 -56.13 24.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.149 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -69.65 -28.67 66.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.187 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.528 ' O ' HD12 ' A' ' 62' ' ' LEU . . . -60.56 -41.72 95.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.281 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.748 HG23 ' HB3' ' A' ' 63' ' ' ASP . 3.3 mt -90.34 -27.28 5.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.045 0.45 . . . . 0.0 111.046 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.53 -57.26 12.09 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -90.45 -14.56 32.58 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.528 HD12 ' O ' ' A' ' 58' ' ' ALA . 48.8 mt -90.08 -75.08 0.46 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.777 0.322 . . . . 0.0 111.826 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.748 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -48.96 140.58 8.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.979 0.419 . . . . 0.0 111.499 -179.291 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 174.19 -35.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.641 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.72 -170.25 2.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.744 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.2 109.2 17.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.911 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -139.2 -174.22 3.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -74.98 68.2 1.78 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.502 ' HA2' HD11 ' A' ' 72' ' ' ILE . . . 66.36 26.55 72.69 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.683 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.3 mtp85 -96.56 -36.36 10.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.898 0.38 . . . . 0.0 110.82 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -138.67 -51.66 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.776 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.502 HD11 ' HA2' ' A' ' 69' ' ' GLY . 18.0 mt 59.78 159.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.107 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.494 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -92.01 50.54 1.68 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.947 0.403 . . . . 0.0 110.845 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.515 HG13 ' HB3' ' A' ' 63' ' ' ASP . 14.8 p -72.65 158.81 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.536 ' HA ' HG21 ' A' ' 59' ' ' ILE . 3.2 t -176.77 157.82 1.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.895 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.18 108.64 14.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.828 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.518 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.156 -0.926 . . . . 0.0 111.105 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 mtt . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.827 0.346 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -109.18 -171.08 1.77 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -121.06 137.92 54.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.948 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.653 HG12 HG13 ' A' ' 55' ' ' VAL . 21.1 mt -109.48 141.05 25.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.103 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.803 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 7.2 t80 -110.23 124.2 51.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.908 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.5 p -129.37 138.16 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.108 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.19 -171.58 17.4 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.45 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.9 t30 58.73 30.22 19.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.831 0.348 . . . . 0.0 110.97 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.421 HD12 HD21 ' A' ' 33' ' ' LEU . 3.9 mm? -86.29 163.38 17.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.798 HG12 ' HB2' ' A' ' 13' ' ' ALA . 3.6 p -147.36 172.4 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.853 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.581 ' H ' HG22 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -42.58 -41.52 3.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.583 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.627 ' H ' HG13 ' A' ' 10' ' ' VAL . 18.3 m -150.25 66.34 0.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.927 0.394 . . . . 0.0 110.953 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.798 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -73.49 -77.38 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.323 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 13' ' ' ALA . 0.6 OUTLIER -173.11 -36.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.28 -179.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.3 t -49.79 -52.53 31.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.351 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.81 -14.43 62.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.85 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -90.39 -46.23 8.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.959 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.46 ' O ' HG22 ' A' ' 18' ' ' VAL . 12.6 p -71.91 -9.42 12.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.689 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.802 ' CB ' HG11 ' A' ' 31' ' ' VAL . 20.1 pttm -53.59 -31.03 45.26 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.799 0.333 . . . . 0.0 110.971 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -69.8 -33.15 71.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.828 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.4 tt -90.02 -29.97 18.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.882 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.529 ' HZ ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -57.62 -26.04 61.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.01 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m -76.19 -30.19 57.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.062 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -90.07 -5.17 56.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.348 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -116.18 -36.98 3.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.71 0.29 . . . . 0.0 111.11 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.1 -0.18 3.88 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.32 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 mmtt 56.04 103.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.985 0.393 . . . . 0.0 111.071 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.796 HG21 ' CG2' ' A' ' 31' ' ' VAL . 7.1 p -117.17 169.06 7.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.793 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.531 ' H ' HG22 ' A' ' 28' ' ' VAL . 10.4 m-85 -129.9 -39.51 1.4 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -97.6 -96.3 0.21 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.814 HG22 HG13 ' A' ' 48' ' ' VAL . 45.4 t 66.58 88.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.734 0.302 . . . . 0.0 110.882 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.67 151.93 22.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.93 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.755 HD23 ' HA3' ' A' ' 46' ' ' GLY . 10.3 mt -101.47 153.55 19.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.827 HD11 ' HB2' ' A' ' 43' ' ' LYS . 2.7 pp -85.63 -179.36 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -137.9 -172.19 3.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.862 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -91.7 -175.59 4.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.974 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.23 31.71 6.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -160.25 -59.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.881 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 p -92.42 -17.02 25.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.195 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.6 mptt 66.91 30.17 7.85 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.86 0.362 . . . . 0.0 110.882 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.1 pttt -92.15 138.15 24.6 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.789 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.29 115.82 2.54 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.438 2.092 . . . . 0.0 112.302 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.827 ' HB2' HD11 ' A' ' 34' ' ' ILE . 14.6 mmmt -59.64 -74.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.898 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.5 39.36 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.561 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.44 ' CE2' HG12 ' A' ' 34' ' ' ILE . 13.4 p90 -172.1 145.55 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.91 0.386 . . . . 0.0 110.934 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.755 ' HA3' HD23 ' A' ' 33' ' ' LEU . . . -125.97 -166.05 12.17 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.541 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -145.67 128.94 16.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 111.164 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.814 HG13 HG22 ' A' ' 31' ' ' VAL . 52.4 t -114.75 116.0 51.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.863 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -87.26 94.99 9.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.945 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.748 ' HG3' HG12 ' A' ' 48' ' ' VAL . 29.2 mtp -121.18 177.56 5.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.881 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.895 ' O ' HG23 ' A' ' 55' ' ' VAL . 18.8 mt-30 -69.1 158.2 35.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -31.18 69.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.902 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -81.63 -31.17 32.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.012 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 1.0 OUTLIER -73.61 -33.0 64.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.051 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 51' ' ' GLN . 24.9 t -58.01 -47.6 86.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.395 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.1 m -57.74 -64.77 0.79 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.13 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.15 -26.99 63.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.149 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.532 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -68.34 -37.14 80.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.415 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.524 HD12 ' O ' ' A' ' 55' ' ' VAL . 5.8 mt -90.36 -11.79 9.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.275 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.75 -49.6 12.77 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -90.64 -19.41 23.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.799 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 78.2 mt -90.07 -75.03 0.47 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.411 ' HB3' HG13 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -59.56 144.95 46.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.023 0.44 . . . . 0.0 111.059 -179.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 179.67 -38.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.803 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.417 ' OG1' HG21 ' A' ' 71' ' ' THR . 0.0 OUTLIER -155.79 -170.39 3.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.824 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -111.15 111.71 22.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.964 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.56 -172.02 2.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.815 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -95.49 39.77 1.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.037 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.17 31.2 3.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.563 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.35 -41.83 4.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.806 0.336 . . . . 0.0 110.881 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.417 HG21 ' OG1' ' A' ' 65' ' ' THR . 0.9 OUTLIER -134.93 -48.9 0.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.47 HG22 ' H ' ' A' ' 73' ' ' ARG . 6.5 mt 59.28 165.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.793 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.47 ' H ' HG22 ' A' ' 72' ' ' ILE . 27.4 mtt180 -99.19 48.9 0.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.925 0.393 . . . . 0.0 110.756 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.411 HG13 ' HB3' ' A' ' 63' ' ' ASP . 7.7 p -65.38 125.19 21.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.064 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.0 t -132.67 162.98 29.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.009 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.86 117.11 21.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.932 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.803 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.215 -0.897 . . . . 0.0 111.121 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.425 ' HG2' ' CZ ' ' A' ' 29' ' ' PHE . 20.9 mtp . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.816 0.341 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -108.22 -169.26 1.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.41 ' HB3' ' CE2' ' A' ' 47' ' ' PHE . 1.6 m120 -121.71 150.5 41.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.89 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.598 HG12 HG13 ' A' ' 55' ' ' VAL . 19.4 mt -116.74 119.15 61.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.126 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.586 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 73.8 t80 -96.16 129.73 43.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.993 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.521 ' CG1' HD21 ' A' ' 9' ' ' LEU . 7.6 p -123.01 136.99 58.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.974 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -124.3 174.92 17.02 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.502 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 62.23 25.6 15.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.613 0.244 . . . . 0.0 110.986 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.521 HD21 ' CG1' ' A' ' 6' ' ' VAL . 1.8 mm? -60.15 138.63 57.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.679 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.524 HG22 ' N ' ' A' ' 11' ' ' TYR . 14.7 p -102.49 162.18 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.644 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.524 ' N ' HG22 ' A' ' 10' ' ' VAL . 42.4 m-85 -43.33 -30.02 0.48 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.162 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.52 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 1.1 m -100.57 -71.64 0.7 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.054 0.454 . . . . 0.0 110.057 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 12' ' ' SER . . . 76.39 141.43 0.07 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.411 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.6 ' O ' HG12 ' A' ' 18' ' ' VAL . 1.7 m -106.01 -26.84 11.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.374 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.08 -46.49 80.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.047 0.451 . . . . 0.0 110.09 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.674 ' HG3' HD21 ' A' ' 33' ' ' LEU . 3.8 tm-20 -75.75 -12.94 60.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.037 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.46 -41.09 11.64 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.496 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.6 HG12 ' O ' ' A' ' 14' ' ' THR . 11.9 p -78.2 -4.91 7.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.618 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 52.5 pttt -53.12 -37.16 61.53 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.762 0.315 . . . . 0.0 110.962 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -60.17 -31.53 70.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.707 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.1 tt -89.95 -29.65 18.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.789 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.412 ' HZ ' HD11 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -57.66 -25.81 60.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.97 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m -67.11 -38.59 85.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.964 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.15 -7.75 52.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.209 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -103.54 -27.51 12.31 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.314 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.85 19.77 0.58 Allowed Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.372 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.4 pttm 42.33 98.99 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.905 0.383 . . . . 0.0 111.925 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.487 HG21 ' CG2' ' A' ' 31' ' ' VAL . 11.8 p -103.77 133.95 46.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.992 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.425 ' CZ ' ' HG2' ' A' ' 1' ' ' MET . 92.1 m-85 -69.45 -46.13 67.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.012 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -166.95 157.52 11.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.002 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.837 HG13 HG22 ' A' ' 48' ' ' VAL . 21.9 t -147.34 129.33 6.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.107 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.505 ' C ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -157.67 138.57 13.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.012 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.674 HD21 ' HG3' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -126.92 148.15 50.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.784 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.583 HD11 ' HA3' ' A' ' 44' ' ' GLY . 2.9 pp -64.38 177.73 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.043 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -132.89 -177.03 4.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.986 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -60.93 -22.36 64.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.173 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 62.26 33.57 16.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.781 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.06 -46.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.788 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.49 -0.29 32.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.364 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.1 mttt 62.61 35.99 13.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.846 0.355 . . . . 0.0 111.016 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -116.53 128.07 26.28 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.78 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.66 115.71 3.54 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.407 2.071 . . . . 0.0 112.244 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.62 132.04 1.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.943 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.583 ' HA3' HD11 ' A' ' 34' ' ' ILE . . . 137.7 -72.89 0.44 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.506 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -169.4 168.21 9.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.846 0.355 . . . . 0.0 110.833 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.415 ' CA ' ' HB3' ' A' ' 33' ' ' LEU . . . -137.75 -178.07 15.71 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.601 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.436 ' CZ ' ' CB ' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -150.96 129.61 12.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.82 0.343 . . . . 0.0 111.094 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.837 HG22 HG13 ' A' ' 31' ' ' VAL . 51.2 t -126.3 143.51 39.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -111.9 106.09 14.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.978 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.486 ' CE ' HG11 ' A' ' 48' ' ' VAL . 35.5 mtt -137.4 -177.36 4.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.994 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.786 ' O ' HG23 ' A' ' 55' ' ' VAL . 3.8 tt0 -67.21 168.05 11.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.965 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -66.81 -37.05 83.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.954 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -74.8 -32.5 62.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.963 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.522 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -66.87 -36.31 82.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 51' ' ' GLN . 31.6 t -62.32 -44.97 99.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.227 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.4 m -55.94 -63.57 1.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.085 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -62.11 -28.18 69.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.968 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.523 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -61.18 -38.29 85.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.293 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.764 HD12 ' O ' ' A' ' 55' ' ' VAL . 3.5 mt -90.22 -16.9 8.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.23 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.87 -48.34 31.71 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.3 mmmt -90.41 -22.85 21.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.656 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.523 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 78.6 mt -89.96 -69.8 0.7 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.532 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.585 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -63.05 141.42 58.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.087 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -178.63 -38.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.872 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.79 -168.64 2.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.73 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -110.34 104.67 13.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.974 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.9 -167.95 1.83 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.893 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.6 ptm -95.16 43.8 1.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.078 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.54 26.61 8.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.628 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 44.7 mtp85 -103.94 -34.99 8.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.908 0.385 . . . . 0.0 110.74 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.1 t -141.07 -47.06 0.4 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.651 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.516 HG22 ' H ' ' A' ' 73' ' ' ARG . 2.2 mt 57.76 167.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.826 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.516 ' H ' HG22 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -99.4 47.36 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.912 0.387 . . . . 0.0 110.833 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.475 HG12 ' CB ' ' A' ' 63' ' ' ASP . 13.2 p -61.93 153.25 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.12 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.0 t -159.97 165.97 30.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -80.25 126.01 30.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.826 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.586 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.173 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 ttm . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.843 0.354 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -123.67 132.54 53.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.47 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 6.9 m-20 -76.43 140.43 41.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.881 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.448 HG12 HG13 ' A' ' 55' ' ' VAL . 14.1 mt -106.18 126.02 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.033 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -107.88 104.44 13.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.836 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.531 ' HB ' HG23 ' A' ' 74' ' ' VAL . 12.0 p -113.32 130.95 66.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.166 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -120.46 -174.01 15.1 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.424 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 59.37 39.19 22.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.901 0.381 . . . . 0.0 110.863 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.547 HD12 ' C ' ' A' ' 45' ' ' PHE . 23.6 mt -82.46 178.41 8.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 1.032 HG12 ' HB2' ' A' ' 13' ' ' ALA . 6.3 p -143.69 169.13 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.545 ' H ' HG22 ' A' ' 10' ' ' VAL . 27.6 m-85 -44.33 -31.49 1.05 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.505 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.725 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.0 OUTLIER -170.99 76.3 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.934 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 1.032 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -81.69 -59.68 2.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.153 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.68 HG23 ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER 176.35 -31.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.204 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.9 m -50.51 -53.74 27.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.783 0.325 . . . . 0.0 111.297 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.618 ' HB3' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -67.95 -13.62 62.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.713 179.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.56 -38.56 13.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.231 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.451 ' O ' HG22 ' A' ' 18' ' ' VAL . 14.0 p -84.06 -9.78 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.899 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -56.88 -44.36 82.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.775 0.321 . . . . 0.0 110.932 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -59.74 -33.04 71.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.705 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.511 ' O ' HD23 ' A' ' 21' ' ' LEU . 5.7 tt -87.67 -27.46 22.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.836 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.46 ' CD1' ' CE ' ' A' ' 50' ' ' MET . 0.1 OUTLIER -55.76 -23.64 30.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.162 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.8 t -80.26 -26.83 38.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.082 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -90.09 -20.47 23.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.236 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -109.54 -33.59 6.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.208 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.62 -18.25 4.9 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.154 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm 65.64 42.61 3.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.89 0.376 . . . . 0.0 110.741 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.3 p -51.08 151.76 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.33 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -91.79 -43.05 9.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -153.48 157.18 39.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.075 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.9 t -150.83 121.85 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.889 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.417 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -141.58 163.04 33.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.081 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.618 HD11 ' HB3' ' A' ' 16' ' ' GLU . 76.9 mt -129.36 179.67 5.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.791 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.744 HG21 ' CE2' ' A' ' 45' ' ' PHE . 2.5 pp -126.92 171.75 14.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.349 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -115.63 -169.86 1.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.937 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.04 178.33 6.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.81 30.86 7.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.935 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -162.47 -48.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 p -91.92 -20.83 20.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.004 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.43 34.31 8.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.839 0.352 . . . . 0.0 110.96 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.412 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 1.8 mtpp -101.69 151.02 37.81 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.851 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.71 97.8 0.92 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.618 2.212 . . . . 0.0 112.628 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.412 ' CE ' ' HB2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -178.23 135.6 0.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.799 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.634 ' HA3' HD11 ' A' ' 34' ' ' ILE . . . 149.42 -59.96 0.44 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.457 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.744 ' CE2' HG21 ' A' ' 34' ' ' ILE . 40.8 p90 -171.52 167.91 6.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.849 0.356 . . . . 0.0 110.962 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.77 174.57 22.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.352 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.86 133.92 38.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.884 0.374 . . . . 0.0 111.017 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.435 ' HB ' HD12 ' A' ' 4' ' ' ILE . 41.7 t -129.22 151.57 35.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.956 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -125.14 120.31 31.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.914 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.46 ' CE ' ' CD1' ' A' ' 22' ' ' PHE . 32.5 mtp -151.88 166.79 30.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -68.88 159.85 31.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.794 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.51 61.7 3.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.984 0.421 . . . . 0.0 110.903 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.61 -47.79 0.51 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.578 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 53.8 m -90.18 -25.55 20.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.956 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.512 ' O ' HD12 ' A' ' 59' ' ' ILE . 24.6 t -64.4 -35.1 73.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.826 0.346 . . . . 0.0 111.472 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.37 -46.89 88.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.204 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.63 -23.5 21.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.311 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.53 ' O ' HD12 ' A' ' 62' ' ' LEU . . . -59.5 -41.54 90.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.458 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.533 HG23 ' HB3' ' A' ' 63' ' ' ASP . 2.3 mp -90.36 -27.91 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.075 0.464 . . . . 0.0 111.048 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.05 -60.29 3.37 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -90.51 -10.31 44.05 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.53 HD12 ' O ' ' A' ' 58' ' ' ALA . 26.5 mt -90.06 -75.29 0.46 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.95 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.533 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -49.36 149.03 2.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.96 0.409 . . . . 0.0 111.526 -179.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.14 -48.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.762 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -158.96 -173.81 4.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.784 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -95.2 104.48 16.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.888 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.41 ' CZ ' ' NH2' ' A' ' 70' ' ' ARG . 0.3 OUTLIER -126.63 170.04 12.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.953 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 4.9 mtt -83.17 58.81 4.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.07 33.54 11.96 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.511 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.41 ' NH2' ' CZ ' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -111.41 -42.25 3.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.797 0.332 . . . . 0.0 110.835 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.96 -47.96 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.796 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 73' ' ' ARG . 18.8 mt 59.74 159.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.033 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.472 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -90.37 69.73 6.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.851 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.531 HG23 ' HB ' ' A' ' 6' ' ' VAL . 14.7 p -93.09 132.9 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.176 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.4 t -154.02 159.75 41.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -58.38 139.27 55.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.96 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 3' ' ' ASN . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.102 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.808 0.337 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -109.36 146.15 34.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 4.6 m120 -85.36 129.94 34.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.9 mt -107.69 139.32 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.093 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.477 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 25.1 t80 -113.78 125.57 54.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.844 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 6' ' ' VAL . 11.0 p -121.94 124.28 70.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.077 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -112.66 -168.45 17.48 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.531 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.8 32.44 20.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.818 0.342 . . . . 0.0 110.887 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.765 HD12 ' C ' ' A' ' 45' ' ' PHE . 61.9 mt -88.35 -178.03 5.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.928 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.624 HG13 ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -160.68 -168.43 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.819 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.624 ' N ' HG13 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -48.56 -45.51 37.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.836 0.351 . . . . 0.0 111.134 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.533 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -156.94 60.64 0.52 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.647 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.44 -77.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.37 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.567 HG21 ' HA3' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -166.19 -31.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.446 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.3 p -46.85 -55.41 8.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.646 0.26 . . . . 0.0 111.441 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.57 -14.32 62.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.777 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -90.5 -30.97 16.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.09 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.505 HG22 ' CD2' ' A' ' 22' ' ' PHE . 14.8 p -86.54 -29.19 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.495 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.9 pttt -48.93 -28.5 3.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.132 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.8 -34.88 69.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.66 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.4 tt -89.96 -18.89 25.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.037 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.505 ' CD2' HG22 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -71.12 -17.09 62.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.236 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.2 p -90.13 -26.23 20.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.438 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -87.4 -47.77 8.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.345 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.57 -11.25 10.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.63 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.9 -22.94 37.05 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.641 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.58 35.17 14.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.81 0.338 . . . . 0.0 110.86 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.404 ' HA ' ' HG2' ' A' ' 50' ' ' MET . 14.9 p -76.81 141.79 15.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.119 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -77.31 -44.79 28.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.96 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -174.7 145.87 0.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.014 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.457 HG22 HG13 ' A' ' 48' ' ' VAL . 23.0 t -127.09 140.95 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.908 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.94 106.59 2.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.071 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.534 HD22 ' HA3' ' A' ' 46' ' ' GLY . 4.7 mt -85.91 175.16 8.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.634 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.732 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.5 pp -107.9 154.53 8.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.22 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.424 ' CE1' ' HG3' ' A' ' 42' ' ' PRO . 83.2 m-85 -140.43 -176.21 4.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.92 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -84.93 -179.6 7.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.934 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -112.09 32.97 5.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -157.79 -54.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.037 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.01 5.65 20.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.415 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 57.85 29.68 17.9 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.839 0.352 . . . . 0.0 110.957 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -76.27 113.96 33.36 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.867 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.424 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 52.8 Cg_exo -52.91 121.73 9.82 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.452 2.101 . . . . 0.0 112.27 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.557 ' HB2' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -54.65 -41.09 69.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.05 37.79 0.11 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.978 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.765 ' C ' HD12 ' A' ' 9' ' ' LEU . 31.6 p90 -178.95 165.83 1.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.982 0.42 . . . . 0.0 111.215 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.534 ' HA3' HD22 ' A' ' 33' ' ' LEU . . . -146.91 -167.69 13.2 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.524 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 3' ' ' ASN . 0.1 OUTLIER -139.56 136.59 34.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.85 0.357 . . . . 0.0 111.021 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.457 HG13 HG22 ' A' ' 31' ' ' VAL . 45.1 t -129.03 136.09 60.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.899 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -105.21 113.13 26.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.885 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.404 ' HG2' ' HA ' ' A' ' 28' ' ' VAL . 0.5 OUTLIER -150.38 152.03 33.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.919 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.52 173.06 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.718 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.69 -152.54 0.06 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.376 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 67.49 -68.69 0.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.209 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.2 m -67.63 -28.62 67.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.235 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.813 ' O ' HD12 ' A' ' 59' ' ' ILE . 30.2 t -58.16 -25.05 25.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.401 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.2 p -72.22 -50.47 27.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.136 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -83.24 -26.11 31.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.296 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -56.55 -42.65 78.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.494 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.813 HD12 ' O ' ' A' ' 55' ' ' VAL . 2.8 mp -90.39 -12.15 9.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.281 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.08 -47.39 13.6 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -90.46 -21.47 21.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.687 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 80.3 mt -90.03 -69.6 0.71 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.737 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -49.51 124.38 9.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.321 -179.468 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -177.59 -49.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.857 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.02 -169.5 2.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.82 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -101.71 124.96 48.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.917 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.57 -173.16 4.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 8.5 mtp -72.13 66.09 0.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.746 ' HA2' HD11 ' A' ' 72' ' ' ILE . . . 59.32 28.94 65.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.509 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.36 -27.76 12.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.728 0.299 . . . . 0.0 110.968 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.532 HG23 ' H ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -135.57 -71.68 0.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.091 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.746 HD11 ' HA2' ' A' ' 69' ' ' GLY . 25.6 mt 59.78 159.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.8 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.47 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -81.78 74.02 8.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 110.789 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.43 HG22 ' N ' ' A' ' 75' ' ' THR . 11.0 p -90.13 155.23 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.43 ' N ' HG22 ' A' ' 74' ' ' VAL . 5.4 t -167.47 152.65 7.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.93 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -68.5 124.78 24.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.911 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.477 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.143 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 tpp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.798 0.333 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -127.75 -177.65 4.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -122.58 153.74 38.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.2 mt -131.56 123.3 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.173 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.499 ' CE2' ' CD2' ' A' ' 45' ' ' PHE . 29.2 t80 -108.84 115.54 30.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.659 HG13 HD11 ' A' ' 9' ' ' LEU . 11.2 p -124.08 124.17 68.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.156 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.15 -170.17 29.55 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.535 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 59.05 40.89 21.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.917 0.389 . . . . 0.0 110.945 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.659 HD11 HG13 ' A' ' 6' ' ' VAL . 65.1 mt -98.45 -178.14 3.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.623 HG13 ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -172.85 -168.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.743 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.623 ' N ' HG13 ' A' ' 10' ' ' VAL . 29.5 t80 -50.29 -47.95 55.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.827 0.346 . . . . 0.0 111.128 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.518 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.8 p -143.35 55.14 1.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.675 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.91 -72.98 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.196 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -165.44 -41.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.056 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.15 -49.33 66.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.065 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -67.05 -15.59 63.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.718 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -90.41 -36.39 14.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.981 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 p -90.07 -23.44 6.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.66 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 42.3 pttt -52.58 -34.33 50.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.762 0.315 . . . . 0.0 111.209 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -65.18 -34.45 78.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.723 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 tp -89.86 -26.69 20.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.74 -23.19 27.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.166 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.6 t -82.91 -29.78 28.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.987 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -90.1 -21.54 22.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -112.82 -30.96 6.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.284 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -117.94 -1.39 16.95 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.113 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.3 pttt 44.92 43.77 7.38 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.85 0.357 . . . . 0.0 111.337 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.9 p -54.67 150.94 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.228 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -91.8 -51.24 5.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.039 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -139.46 158.04 44.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.022 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.0 t -151.48 98.19 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.977 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.84 166.48 11.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.002 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.528 HD23 ' HA3' ' A' ' 46' ' ' GLY . 19.4 mt -140.68 175.09 9.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.843 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.857 HD11 ' HA3' ' A' ' 44' ' ' GLY . 2.4 pp -119.51 -178.79 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.083 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -130.22 -179.13 5.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.054 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -20.29 55.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.17 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.09 36.05 2.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.902 0.382 . . . . 0.0 110.746 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -175.19 -40.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.743 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.3 -10.21 17.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.266 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 mptt 66.66 31.47 7.66 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.86 0.362 . . . . 0.0 110.686 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -111.82 131.04 22.61 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.22 111.17 0.6 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.467 2.112 . . . . 0.0 112.294 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -176.63 127.23 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.918 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.857 ' HA3' HD11 ' A' ' 34' ' ' ILE . . . 142.52 -79.09 0.27 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.617 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.618 ' C ' HD12 ' A' ' 9' ' ' LEU . 50.3 p90 -168.01 -176.64 3.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.811 0.338 . . . . 0.0 111.032 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.528 ' HA3' HD23 ' A' ' 33' ' ' LEU . . . -143.68 169.25 26.09 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.539 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.09 131.35 47.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.802 0.334 . . . . 0.0 111.001 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.8 t -126.26 145.19 34.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.963 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -114.4 114.45 25.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 29.6 mtm -141.83 169.5 17.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -78.48 154.29 30.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -72.01 93.3 1.37 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.904 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -173.43 -49.41 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.466 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.14 -15.34 31.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.994 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.905 ' O ' HD12 ' A' ' 59' ' ' ILE . 21.7 t -66.68 -39.51 83.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.825 0.345 . . . . 0.0 111.179 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.726 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -75.12 -24.67 58.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.216 -179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.26 -42.95 10.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.759 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.701 ' HB1' HD12 ' A' ' 62' ' ' LEU . . . -58.86 -67.78 0.33 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.905 HD12 ' O ' ' A' ' 55' ' ' VAL . 3.7 mt -56.53 -29.4 29.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.144 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.726 ' HB2' ' O ' ' A' ' 56' ' ' SER . . . -57.75 -57.55 12.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.69 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -90.25 -26.08 20.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.646 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.701 HD12 ' HB1' ' A' ' 58' ' ' ALA . 84.4 mt -75.21 -72.9 0.27 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.81 0.338 . . . . 0.0 111.488 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.623 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -50.9 135.67 23.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.346 -179.398 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -178.12 -67.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.761 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.76 -172.16 2.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.811 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.51 99.2 8.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.964 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.18 -172.52 2.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.842 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 23.9 mtt -100.22 36.42 1.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.66 32.7 1.4 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.505 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.12 -37.95 3.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.825 0.345 . . . . 0.0 110.953 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -140.56 -55.69 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.872 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.485 HG21 ' CG2' ' A' ' 6' ' ' VAL . 1.5 mt 59.79 160.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.991 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.462 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -88.39 59.32 5.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.762 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.446 HG22 ' N ' ' A' ' 75' ' ' THR . 14.3 p -79.72 156.75 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.224 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.446 ' N ' HG22 ' A' ' 74' ' ' VAL . 10.0 t -178.46 144.98 0.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.903 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.36 114.61 6.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.497 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.069 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.818 0.342 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.21 161.28 13.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.718 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 3.6 m-80 -100.96 102.09 13.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.405 ' O ' ' CD1' ' A' ' 47' ' ' PHE . 29.6 mt -72.42 141.08 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.095 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.75 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 76.0 t80 -112.24 138.36 49.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.807 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.497 HG22 HD21 ' A' ' 9' ' ' LEU . 11.2 p -147.79 129.14 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.285 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.08 -175.79 25.49 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.329 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 58.45 37.83 25.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.816 0.341 . . . . 0.0 110.806 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.497 HD21 HG22 ' A' ' 6' ' ' VAL . 3.4 mm? -87.98 159.63 18.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.033 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.646 HG13 ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -154.03 -167.41 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.78 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.646 ' N ' HG13 ' A' ' 10' ' ' VAL . 80.0 m-85 -49.5 -46.09 47.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.833 0.349 . . . . 0.0 111.088 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.514 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.3 m -157.18 57.64 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.778 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.419 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -62.04 -52.01 65.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.259 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.447 ' OG1' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -177.61 -36.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.099 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.5 m -51.34 -51.88 50.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.223 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.86 -14.87 63.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.787 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -90.54 -36.27 14.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.089 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.413 HG22 ' CD1' ' A' ' 22' ' ' PHE . 10.7 p -86.23 -24.77 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.625 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -53.16 -32.04 45.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.889 0.376 . . . . 0.0 111.072 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.37 -39.28 94.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.632 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.3 tt -83.14 -31.23 27.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.705 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.413 ' CD1' HG22 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -61.2 -28.27 69.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.928 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.27 -26.9 26.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.088 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -85.36 -25.44 27.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.137 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -111.47 -29.57 7.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.195 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -114.15 -24.65 4.42 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.807 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.87 46.53 3.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.861 0.362 . . . . 0.0 110.776 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 49' ' ' GLU . 10.1 p -52.02 147.4 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.295 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -73.81 -50.26 21.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.919 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -154.67 157.92 38.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.972 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.406 HG22 HG13 ' A' ' 48' ' ' VAL . 23.4 t -152.76 124.08 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.082 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -160.02 -178.6 7.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.981 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 34.0 mt -122.78 160.01 26.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.851 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.87 HD12 ' O ' ' A' ' 35' ' ' TYR . 2.5 pp -81.63 -22.11 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.516 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.87 ' O ' HD12 ' A' ' 34' ' ' ILE . 21.2 m-85 58.83 171.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.008 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -59.94 160.44 7.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.68 40.53 1.22 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.969 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -170.82 -44.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.763 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.98 -17.97 18.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.186 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp 64.12 33.17 12.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.894 0.378 . . . . 0.0 110.9 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.4 150.42 37.98 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.763 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.42 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 63.5 Cg_exo -51.45 99.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.581 2.188 . . . . 0.0 112.3 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.81 129.4 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 127.9 -76.45 0.4 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.643 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.636 ' CE2' HG21 ' A' ' 34' ' ' ILE . 24.4 p90 -176.09 171.61 2.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.754 0.312 . . . . 0.0 110.913 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.93 171.01 21.9 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.479 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.406 ' CE1' ' HB3' ' A' ' 3' ' ' ASN . 2.7 m-85 -134.38 145.52 49.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.836 0.351 . . . . 0.0 110.87 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.406 HG13 HG22 ' A' ' 31' ' ' VAL . 22.8 t -131.59 97.47 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.092 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.43 ' O ' HG23 ' A' ' 28' ' ' VAL . 68.1 tt0 -68.3 86.91 0.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.973 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.7 mtp -125.42 179.6 5.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.905 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.82 ' O ' HG23 ' A' ' 55' ' ' VAL . 2.4 mt-30 -67.89 173.84 4.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.02 -36.94 48.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.968 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -64.3 -36.04 82.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.02 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.7 t -71.03 -30.27 66.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.033 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.875 ' O ' HD12 ' A' ' 59' ' ' ILE . 25.8 t -66.82 -36.37 77.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.267 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.715 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 42.9 t -77.87 -24.99 48.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.214 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.25 -44.9 9.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.753 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.486 ' HB1' HD12 ' A' ' 62' ' ' LEU . . . -57.48 -68.39 0.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.965 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.875 HD12 ' O ' ' A' ' 55' ' ' VAL . 4.3 mt -54.85 -31.1 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.073 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 56' ' ' SER . . . -56.34 -59.8 4.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.602 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -90.32 -11.48 40.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.106 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.486 HD12 ' HB1' ' A' ' 58' ' ' ALA . 63.6 mt -89.93 -75.08 0.46 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.641 0.258 . . . . 0.0 111.623 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.603 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -52.72 150.33 5.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.035 0.445 . . . . 0.0 111.246 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -178.58 -40.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.847 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -162.85 -169.48 2.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.781 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -107.13 93.55 4.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.818 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.09 -176.28 2.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 15.0 mtm -94.16 46.44 1.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.81 32.99 4.86 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.494 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -113.77 -30.01 6.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.758 0.313 . . . . 0.0 111.152 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 t -152.37 -45.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.013 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 73' ' ' ARG . 20.3 mt 61.6 161.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.796 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.472 ' N ' HG22 ' A' ' 72' ' ' ILE . 4.0 mtm180 -94.25 43.38 1.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.984 0.421 . . . . 0.0 111.011 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.535 HG13 ' HB3' ' A' ' 63' ' ' ASP . 9.2 p -61.81 147.51 11.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.981 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.1 t -158.76 171.83 19.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.918 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -85.03 121.07 27.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.785 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.75 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.162 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttt . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.847 0.356 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.13 -175.33 5.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.886 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -123.12 105.63 10.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.877 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.725 HD11 ' HB2' ' A' ' 50' ' ' MET . 6.6 mt -65.16 145.44 13.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.987 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.731 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 4.7 t80 -125.13 115.65 20.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.922 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.459 ' CG2' HG21 ' A' ' 72' ' ' ILE . 11.6 p -109.66 141.52 24.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.951 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -120.93 62.92 0.5 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.582 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.555 ' HB3' HG23 ' A' ' 72' ' ' ILE . 16.1 t30 -177.5 62.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.875 0.369 . . . . 0.0 110.636 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.586 ' CD1' HD22 ' A' ' 33' ' ' LEU . 8.2 mt -109.73 161.61 15.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.061 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.563 ' N ' ' HB2' ' A' ' 13' ' ' ALA . 14.5 p -178.96 161.46 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.723 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.511 ' N ' HG22 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -47.23 -27.99 1.73 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.328 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 88.2 p -120.28 30.12 7.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.14 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.563 ' HB2' ' N ' ' A' ' 10' ' ' VAL . . . -68.69 -31.42 70.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.235 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.567 ' O ' HG12 ' A' ' 18' ' ' VAL . 1.3 m 90.61 5.64 0.1 Allowed 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.721 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.584 ' HA ' HG12 ' A' ' 18' ' ' VAL . 2.6 m -70.93 -52.74 18.17 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.927 -179.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.78 -18.6 62.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.449 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.43 -39.17 12.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.978 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 15' ' ' SER . 13.9 p -81.87 -24.58 9.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.687 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -51.3 -37.05 45.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.802 0.334 . . . . 0.0 111.031 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.16 -32.59 70.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.007 0.432 . . . . 0.0 110.542 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.3 tt -83.6 -31.01 26.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.563 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -20.79 61.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.935 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.3 t -83.1 -29.24 28.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.954 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -81.64 -22.11 37.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.124 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -112.12 -31.64 6.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.149 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.59 -23.96 4.21 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.926 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? 62.48 50.14 3.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.858 0.361 . . . . 0.0 110.838 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.608 HG21 HG22 ' A' ' 31' ' ' VAL . 9.9 p -55.64 146.68 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.169 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -93.8 -31.05 14.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.968 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -150.71 145.85 26.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.107 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.608 HG22 HG21 ' A' ' 28' ' ' VAL . 24.7 t -147.1 106.43 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.772 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.62 ' C ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -136.24 155.7 49.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.186 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.62 HD23 ' C ' ' A' ' 32' ' ' LYS . 1.0 OUTLIER -116.94 155.17 29.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.58 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.866 HG21 ' CE2' ' A' ' 45' ' ' PHE . 2.6 pp -82.85 177.29 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.034 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.407 ' CG ' ' O ' ' A' ' 34' ' ' ILE . 70.7 m-85 -157.02 167.55 30.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.33 156.88 22.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.5 38.57 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.941 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -159.97 -45.29 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.927 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p -106.95 -16.27 14.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.206 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.7 mttp 62.39 37.25 13.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.915 0.388 . . . . 0.0 110.965 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 32.2 mttp -113.32 139.01 22.66 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.809 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 41' ' ' LYS . 53.0 Cg_exo -54.95 118.88 5.64 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.445 2.097 . . . . 0.0 112.402 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -70.2 -64.55 0.87 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.3 50.29 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.413 -0.898 . . . . 0.0 112.987 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.866 ' CE2' HG21 ' A' ' 34' ' ' ILE . 27.8 p90 -178.04 153.38 0.8 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.013 0.435 . . . . 0.0 111.081 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.61 -164.73 11.42 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.571 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -140.78 144.96 35.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.85 0.357 . . . . 0.0 111.169 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.64 HG12 ' HG3' ' A' ' 50' ' ' MET . 45.9 t -141.97 115.61 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.867 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.65 101.52 13.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.02 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.725 ' HB2' HD11 ' A' ' 4' ' ' ILE . 29.8 mtm -130.58 154.86 47.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.918 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.926 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -63.76 149.45 46.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.892 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.21 -31.72 63.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.088 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -63.25 -34.71 78.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.006 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 9.5 t -90.0 -39.25 13.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.985 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.926 HG23 ' O ' ' A' ' 51' ' ' GLN . 21.4 t -54.82 -47.81 74.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.372 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.7 m -52.15 -64.02 0.95 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.19 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -26.83 67.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.004 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.559 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -63.94 -39.53 94.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.267 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.526 ' O ' HG22 ' A' ' 59' ' ' ILE . 5.4 mt -90.12 -7.28 10.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.303 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.7 -44.95 9.67 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.97 -25.0 19.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.451 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 66.0 mt -90.11 -74.23 0.49 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.901 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.473 ' CB ' HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -50.96 142.1 12.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.932 0.396 . . . . 0.0 111.295 -179.395 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -178.83 -38.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.871 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -159.72 -175.05 4.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -104.35 108.66 20.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -124.71 -168.61 1.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.948 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.2 mmt -95.04 44.46 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.82 32.61 6.14 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.499 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.95 -34.62 6.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.83 0.347 . . . . 0.0 110.964 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.62 -53.93 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.992 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.555 HG23 ' HB3' ' A' ' 8' ' ' ASN . 29.3 mt 59.92 159.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.019 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.479 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -87.41 61.18 6.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.831 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.484 ' O ' HG23 ' A' ' 59' ' ' ILE . 11.4 p -72.82 140.64 17.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.096 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.9 t -164.27 150.91 11.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.868 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -70.33 127.35 32.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.731 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.103 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.822 0.344 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -114.4 -178.53 3.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.866 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.649 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 3.7 m-80 -110.73 142.5 42.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.556 HD11 ' HB2' ' A' ' 50' ' ' MET . 2.2 mt -118.85 120.08 62.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.609 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 3.5 t80 -102.17 123.54 46.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.004 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.562 ' HB ' HG23 ' A' ' 74' ' ' VAL . 11.2 p -128.47 129.04 68.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.024 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -110.67 -168.84 19.31 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.51 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.38 33.68 23.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.751 0.31 . . . . 0.0 110.9 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.74 HD13 HD13 ' A' ' 33' ' ' LEU . 18.3 mt -85.97 -178.72 6.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.964 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.598 HG22 ' H ' ' A' ' 11' ' ' TYR . 2.5 p -163.98 174.42 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.824 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.598 ' H ' HG22 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -43.19 -45.56 5.66 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.75 0.31 . . . . 0.0 111.563 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.576 ' H ' HG13 ' A' ' 10' ' ' VAL . 8.9 t -140.78 61.94 1.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.888 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.7 ' O ' HG23 ' A' ' 14' ' ' THR . . . -68.13 -78.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.327 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 13' ' ' ALA . 0.4 OUTLIER -177.43 -32.24 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.312 -179.746 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.9 t -47.27 -54.95 9.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.76 0.314 . . . . 0.0 111.521 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -14.47 61.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.851 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -90.68 -27.95 18.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.274 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -90.14 -20.69 6.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.842 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.801 ' HB2' HG11 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -49.36 -28.01 4.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.778 0.323 . . . . 0.0 111.236 -179.74 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -72.35 -32.14 66.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.82 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.6 tt -90.01 -30.26 17.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.955 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.85 -22.91 40.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.7 t -76.51 -31.93 57.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.985 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -90.19 -10.67 43.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.42 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.52 -37.77 5.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.645 0.26 . . . . 0.0 111.157 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.529 ' HA3' ' HE1' ' A' ' 50' ' ' MET . . . -127.38 -5.65 5.48 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.516 -0.85 . . . . 0.0 113.265 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp 61.33 47.54 6.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.872 0.367 . . . . 0.0 110.938 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 49' ' ' GLU . 11.6 p -53.97 116.05 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.188 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -59.77 -39.9 86.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.887 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -160.08 158.76 30.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.819 HG23 HG22 ' A' ' 48' ' ' VAL . 10.2 p -155.22 127.88 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.035 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.3 mtpt -160.04 123.23 3.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.973 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.74 HD13 HD13 ' A' ' 9' ' ' LEU . 9.0 mt -84.68 -169.04 2.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.572 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.762 HD13 ' HB2' ' A' ' 43' ' ' LYS . 1.7 pp -111.93 155.18 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.902 0.382 . . . . 0.0 111.233 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -157.22 169.66 24.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.741 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.61 131.5 34.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -84.1 56.4 3.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.921 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 179.2 -40.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.795 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 p -111.88 -19.82 12.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.203 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.1 tttt 68.92 25.82 5.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.778 0.323 . . . . 0.0 110.904 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -90.73 121.3 68.37 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.831 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.3 125.81 20.27 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.408 2.072 . . . . 0.0 112.337 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.762 ' HB2' HD13 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -63.58 -35.47 80.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.745 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 130.11 32.64 0.53 Allowed Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.119 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.722 ' C ' HD12 ' A' ' 9' ' ' LEU . 27.8 p90 -178.49 -176.96 0.52 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.992 0.425 . . . . 0.0 111.223 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.527 ' HA3' HD22 ' A' ' 33' ' ' LEU . . . -161.97 -171.72 28.44 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.453 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.463 ' CE1' ' CD2' ' A' ' 5' ' ' TYR . 1.7 m-85 -144.8 141.17 28.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.938 0.399 . . . . 0.0 111.075 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.819 HG22 HG23 ' A' ' 31' ' ' VAL . 40.6 t -130.24 150.11 34.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.932 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.581 ' O ' HG23 ' A' ' 28' ' ' VAL . 1.4 tt0 -111.49 109.95 20.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.93 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.556 ' HB2' HD11 ' A' ' 4' ' ' ILE . 40.4 mtp -143.6 177.68 8.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.863 ' O ' HG23 ' A' ' 55' ' ' VAL . 39.7 mt-30 -71.22 159.27 34.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -67.07 -30.77 70.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.824 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -75.9 -31.81 59.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.908 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.4 m -74.69 -29.46 61.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.063 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.863 HG23 ' O ' ' A' ' 51' ' ' GLN . 21.6 t -65.12 -37.31 79.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.276 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.681 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 10.2 t -74.91 -24.39 58.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.09 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.21 -42.68 10.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.663 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.646 ' HB1' HD12 ' A' ' 62' ' ' LEU . . . -58.82 -67.99 0.31 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.818 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.863 HD12 ' O ' ' A' ' 55' ' ' VAL . 3.3 mt -54.88 -30.57 23.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.056 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.681 ' HB2' ' O ' ' A' ' 56' ' ' SER . . . -57.04 -59.44 5.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.366 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.15 -9.14 49.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.904 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.646 HD12 ' HB1' ' A' ' 58' ' ' ALA . 71.5 mt -90.09 -74.95 0.47 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.838 0.351 . . . . 0.0 111.336 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.506 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -56.67 152.4 12.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.134 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.561 ' O ' HG23 ' A' ' 65' ' ' THR . 1.0 OUTLIER -178.57 -40.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.775 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 64' ' ' ASN . 0.6 OUTLIER -166.43 -178.28 4.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.873 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.0 p-10 -98.14 102.81 14.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.843 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.22 -168.83 1.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.939 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 1.5 mmt -93.46 46.93 1.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.876 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.37 37.49 6.2 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.546 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.1 tpp85 -116.14 -42.36 3.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.837 0.351 . . . . 0.0 110.92 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.98 -48.77 1.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.914 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.454 HG22 ' N ' ' A' ' 73' ' ' ARG . 9.3 mt 59.27 163.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.999 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.454 ' N ' HG22 ' A' ' 72' ' ' ILE . 2.2 mtt180 -94.07 47.64 1.22 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.019 0.437 . . . . 0.0 110.74 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.562 HG23 ' HB ' ' A' ' 6' ' ' VAL . 12.6 p -62.0 144.29 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.095 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.3 t -149.27 175.88 11.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.986 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.69 133.07 35.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.967 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.649 ' HB3' ' HB3' ' A' ' 3' ' ' ASN . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.131 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.842 0.353 . . . . 0.0 111.137 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.615 ' HB2' HG21 ' A' ' 55' ' ' VAL . 3.7 mmt180 -94.2 -8.57 38.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.503 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.5 m120 54.1 103.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.219 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.84 HG12 HG13 ' A' ' 55' ' ' VAL . 6.3 mt -94.42 158.51 2.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.219 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.49 ' N ' HG22 ' A' ' 4' ' ' ILE . 37.3 t80 -139.79 143.47 36.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.682 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.71 ' CG1' HD11 ' A' ' 9' ' ' LEU . 9.9 p -142.52 146.63 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.268 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -130.29 -174.37 13.67 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.322 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 t30 56.01 33.18 21.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.931 0.396 . . . . 0.0 110.994 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.71 HD11 ' CG1' ' A' ' 6' ' ' VAL . 64.2 mt -89.43 99.91 12.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.096 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.755 HG13 ' H ' ' A' ' 12' ' ' SER . 2.7 p -63.33 176.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.642 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.637 ' H ' HG22 ' A' ' 10' ' ' VAL . 17.6 m-85 -41.54 -35.35 0.7 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.865 0.364 . . . . 0.0 111.419 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.755 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.2 p -157.26 67.47 0.52 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.571 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 14' ' ' THR . . . -71.62 -65.4 0.76 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.405 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -179.12 -24.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.578 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.612 ' OG ' HD13 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -46.07 -57.91 4.06 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.747 0.308 . . . . 0.0 111.509 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.61 ' HB3' HD11 ' A' ' 33' ' ' LEU . 4.0 pt-20 -66.49 -13.3 60.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.817 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -90.54 -28.3 18.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.291 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 15' ' ' SER . 11.9 p -87.07 -24.49 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.754 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.7 -27.67 12.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.744 0.307 . . . . 0.0 111.171 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -33.1 70.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.764 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.4 tt -88.9 -30.85 18.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.809 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -26.04 62.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.016 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.44 -24.17 24.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.237 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -88.66 -24.38 22.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.265 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -111.47 -30.68 7.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.225 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -117.62 -17.56 5.55 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.575 -0.822 . . . . 0.0 113.067 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm 61.98 43.98 8.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.944 0.402 . . . . 0.0 110.715 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 49' ' ' GLU . 12.0 p -46.36 139.54 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.459 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -89.3 -39.1 13.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.835 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -139.29 149.19 43.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.955 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.729 HG23 HG22 ' A' ' 48' ' ' VAL . 13.2 p -172.11 120.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.063 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -157.11 167.3 30.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.949 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.61 HD11 ' HB3' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -128.61 160.26 32.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.683 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.486 HD13 ' HB3' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -94.33 170.48 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.054 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 42' ' ' PRO . 49.1 m-85 -138.77 -174.23 3.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.009 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -101.55 -178.48 3.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -120.28 31.75 6.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.67 -58.25 0.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.876 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.03 -1.08 27.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.403 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt 60.2 36.21 20.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.88 0.371 . . . . 0.0 110.883 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -112.99 152.02 44.59 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.822 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 53.4 Cg_exo -52.37 135.25 53.79 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.581 2.187 . . . . 0.0 112.282 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.486 ' HB3' HD13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -69.75 -69.18 0.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.794 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.41 37.59 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.898 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.457 ' CE2' HG12 ' A' ' 34' ' ' ILE . 38.3 p90 -179.9 152.88 0.49 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.987 0.423 . . . . 0.0 111.124 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.48 ' HA3' HD23 ' A' ' 33' ' ' LEU . . . -145.28 -169.99 13.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.389 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.445 ' CZ ' ' CB ' ' A' ' 77' ' ' ALA . 1.9 t80 -133.13 156.3 47.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.884 0.373 . . . . 0.0 111.057 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.729 HG22 HG23 ' A' ' 31' ' ' VAL . 24.1 t -149.16 130.45 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.972 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.667 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -110.57 116.17 30.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.02 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.433 ' HG2' HG23 ' A' ' 28' ' ' VAL . 2.5 mtm -140.63 156.21 46.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.916 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.05 151.73 18.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.971 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -77.24 95.03 4.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.931 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -174.91 -53.44 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.261 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 1.8 m -90.02 -16.15 30.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.981 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.84 HG13 HG12 ' A' ' 4' ' ' ILE . 26.0 t -61.09 -43.87 97.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.832 0.348 . . . . 0.0 111.277 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.6 m -56.82 -54.22 48.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.165 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -74.98 -26.47 59.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.106 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -57.61 -39.36 76.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.338 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.694 HD12 ' O ' ' A' ' 55' ' ' VAL . 3.2 mt -90.29 -8.94 10.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.181 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.51 -48.75 10.67 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.65 -19.11 24.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.785 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.525 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 83.3 mt -89.97 -75.12 0.46 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.93 147.42 15.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.842 0.353 . . . . 0.0 111.041 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -176.6 -41.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.941 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.4 ' OG1' HG21 ' A' ' 71' ' ' THR . 0.7 OUTLIER -154.62 -177.66 6.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -103.57 97.45 7.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.16 -169.33 1.46 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 16.9 ptm -98.38 31.57 2.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.92 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.09 33.55 1.49 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.474 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.77 -54.06 2.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.786 0.327 . . . . 0.0 110.883 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.4 HG21 ' OG1' ' A' ' 65' ' ' THR . 1.1 t -119.73 -49.76 2.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.889 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 73' ' ' ARG . 24.8 mt 60.15 159.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.212 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.481 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -90.71 51.6 2.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.819 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.558 ' O ' HG23 ' A' ' 59' ' ' ILE . 11.0 p -67.18 125.51 24.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.072 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.5 t -141.9 160.22 40.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.02 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.418 ' HG3' HD13 ' A' ' 59' ' ' ILE . 52.0 mt-10 -59.82 140.88 56.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.875 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.445 ' CB ' ' CZ ' ' A' ' 47' ' ' PHE . . . . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.095 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mtp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.845 0.355 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -99.16 175.45 5.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.959 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.401 ' HB3' ' CE2' ' A' ' 47' ' ' PHE . 22.0 m-20 -122.07 120.13 33.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.862 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.66 HG12 HG13 ' A' ' 55' ' ' VAL . 1.8 mp -111.21 132.61 59.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.122 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.776 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 6.4 t80 -107.2 142.85 36.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.476 HG13 HD11 ' A' ' 9' ' ' LEU . 7.5 p -143.98 121.01 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.99 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.448 ' HA2' ' CD1' ' A' ' 45' ' ' PHE . . . -104.79 -169.53 24.38 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.767 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 63.46 29.66 15.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.715 0.293 . . . . 0.0 110.948 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.532 HD22 ' HB2' ' A' ' 15' ' ' SER . 32.0 mt -101.24 159.8 14.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.919 0.39 . . . . 0.0 111.124 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.648 HG13 ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -155.07 -166.8 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.666 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.648 ' N ' HG13 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -48.77 -44.95 39.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.878 0.371 . . . . 0.0 111.051 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.509 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -144.06 49.04 1.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.593 179.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.8 -76.1 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.359 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.583 HG21 ' CA ' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -164.59 -37.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.304 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.532 ' HB2' HD22 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -48.94 -52.96 21.81 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.798 0.332 . . . . 0.0 111.36 -179.754 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -65.43 -15.96 63.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.751 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -90.59 -36.92 14.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.073 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.9 p -90.04 -22.35 6.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.669 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 pttp -50.0 -29.48 8.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.799 0.333 . . . . 0.0 111.101 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -68.22 -35.69 78.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.66 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.3 tp -87.03 -30.36 21.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.899 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.15 -24.48 54.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.116 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.2 m -82.38 -25.9 33.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.158 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -90.02 -24.48 21.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.216 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -110.43 -30.9 7.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.156 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -112.06 -22.24 5.99 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.775 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp 62.98 45.07 5.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.944 0.402 . . . . 0.0 110.901 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.0 p -54.14 153.07 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.107 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -97.26 -36.37 10.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.015 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -166.15 140.87 4.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.124 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t -124.71 119.44 56.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.732 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -123.44 163.14 21.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.024 0.44 . . . . 0.0 111.26 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 mt -141.51 161.29 38.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.397 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.553 HD11 ' HA3' ' A' ' 44' ' ' GLY . 2.5 pp -123.62 155.41 30.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.981 0.419 . . . . 0.0 111.29 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.478 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.7 m-85 -94.36 -165.58 1.34 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.92 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -73.66 -8.53 56.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.332 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 66.42 29.57 9.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.896 0.379 . . . . 0.0 110.743 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -165.61 -44.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.615 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 p -97.48 -13.71 21.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.184 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.29 25.94 2.77 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.803 0.335 . . . . 0.0 110.982 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -102.53 123.62 42.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.7 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.53 107.49 1.63 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.38 2.053 . . . . 0.0 112.101 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.618 ' HB3' HG23 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -176.32 42.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.29 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.553 ' HA3' HD11 ' A' ' 34' ' ' ILE . . . -132.05 42.02 1.43 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.619 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.448 ' CD1' ' HA2' ' A' ' 7' ' ' GLY . 0.9 OUTLIER 73.94 161.49 0.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.851 0.358 . . . . 0.0 111.033 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.94 -173.84 13.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.582 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 48' ' ' VAL . 46.0 t80 -128.34 159.32 35.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.761 0.315 . . . . 0.0 110.919 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.451 ' N ' ' CD1' ' A' ' 47' ' ' PHE . 31.7 t -144.81 127.7 10.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.06 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -105.3 113.33 26.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.931 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.518 ' HE2' HD13 ' A' ' 4' ' ' ILE . 35.4 mtm -142.26 147.87 37.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.6 155.83 14.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.881 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.07 95.18 4.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.037 0.446 . . . . 0.0 110.906 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -176.36 -49.37 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.263 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 5.1 m -90.02 -21.73 22.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.916 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.717 ' O ' HD12 ' A' ' 59' ' ' ILE . 21.5 t -60.61 -31.62 49.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.379 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.0 m -60.98 -53.93 51.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.243 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.63 -22.93 27.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.292 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -55.47 -41.48 73.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.432 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.717 HD12 ' O ' ' A' ' 55' ' ' VAL . 3.3 mp -90.32 -21.22 6.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.911 0.386 . . . . 0.0 111.301 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.13 -55.38 25.77 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.44 -14.3 33.13 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 51.0 mt -90.05 -75.27 0.46 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.943 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.458 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -55.52 150.7 11.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.07 0.462 . . . . 0.0 111.406 -179.114 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 175.1 -36.62 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.715 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.39 -173.89 3.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.81 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.5 96.68 6.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.955 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.426 ' CD2' ' HB2' ' A' ' 70' ' ' ARG . 0.6 OUTLIER -121.71 169.07 11.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 24.2 mmm -80.51 65.05 5.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.953 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.583 ' CA ' HG21 ' A' ' 14' ' ' THR . . . 82.69 31.02 30.92 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.607 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.426 ' HB2' ' CD2' ' A' ' 67' ' ' PHE . 1.5 tmm_? -111.0 -30.1 7.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.793 0.33 . . . . 0.0 111.081 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 t -153.02 -51.09 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.942 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.498 HG22 ' N ' ' A' ' 73' ' ' ARG . 20.1 mt 64.65 160.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.033 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.498 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -92.4 48.68 1.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.875 0.369 . . . . 0.0 110.913 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 74' ' ' VAL . 12.0 p -72.17 114.58 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.182 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.6 t -135.25 153.85 51.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.042 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -57.13 131.62 50.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.776 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.312 -0.851 . . . . 0.0 111.077 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ptp . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.822 0.344 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.94 -6.11 22.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.496 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.5 t30 59.03 114.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.055 0.455 . . . . 0.0 110.993 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.561 HG12 HG13 ' A' ' 55' ' ' VAL . 23.7 mt -103.31 127.84 56.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.117 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -110.94 126.97 55.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.844 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.48 ' HB ' HG23 ' A' ' 74' ' ' VAL . 11.1 p -135.03 154.02 35.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.122 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.411 ' N ' HG22 ' A' ' 6' ' ' VAL . . . -127.7 -166.11 12.01 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.394 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 58.98 31.43 21.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.757 0.313 . . . . 0.0 110.787 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.65 HD13 HD21 ' A' ' 33' ' ' LEU . 26.4 mt -93.9 -179.39 4.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.953 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.644 HG13 ' N ' ' A' ' 11' ' ' TYR . 0.6 OUTLIER -170.32 -165.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.697 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.644 ' N ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -46.3 -40.55 11.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.95 0.405 . . . . 0.0 111.269 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.485 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.8 m -163.72 52.66 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.67 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.515 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -66.24 -46.89 75.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.307 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.597 HG21 ' HA3' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -177.65 -32.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.416 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.7 p -47.55 -55.09 9.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.779 0.323 . . . . 0.0 111.429 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.01 -12.78 61.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.949 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -90.77 -39.06 12.61 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.204 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -77.2 -27.93 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.865 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.9 ptmm? -53.36 -28.52 29.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.779 0.323 . . . . 0.0 110.992 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -70.94 -35.36 72.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.576 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.7 tp -90.03 -27.27 19.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.721 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.87 -28.09 47.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.938 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.03 -24.27 47.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.97 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -90.12 -34.27 15.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.773 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -60.82 -41.51 95.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.746 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.07 27.27 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.577 -0.82 . . . . 0.0 113.045 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 57.01 110.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.909 0.385 . . . . 0.0 111.193 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.512 HG23 ' HG2' ' A' ' 50' ' ' MET . 10.8 p -96.37 131.33 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -59.18 -43.6 92.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.971 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -171.46 166.48 6.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.953 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 31' ' ' VAL . 11.2 p -146.59 123.4 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.03 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -132.53 174.48 10.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.121 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.65 HD21 HD13 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -143.8 158.98 43.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.757 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.874 HG21 ' CE2' ' A' ' 45' ' ' PHE . 2.5 pp -85.18 -178.91 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.14 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -158.17 168.91 25.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -86.71 152.15 22.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.951 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -96.94 41.36 1.11 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.878 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -162.56 -44.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.799 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.22 -11.12 15.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.262 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.71 30.65 16.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.821 0.343 . . . . 0.0 110.85 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.403 ' HG3' ' N ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -107.76 141.76 23.77 Favored Pre-proline 0 N--CA 1.451 -0.395 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.118 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.403 ' N ' ' HG3' ' A' ' 41' ' ' LYS . 37.4 Cg_endo -65.66 115.82 3.6 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.522 2.148 . . . . 0.0 112.332 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -56.69 -67.77 0.28 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.018 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.23 52.61 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.817 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.874 ' CE2' HG21 ' A' ' 34' ' ' ILE . 29.4 p90 -177.94 142.5 0.29 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.917 0.389 . . . . 0.0 111.061 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -134.86 -167.07 11.31 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.474 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.99 150.08 40.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.79 0.329 . . . . 0.0 110.934 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.6 t -133.2 152.31 35.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.003 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -117.45 105.14 11.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.929 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.512 ' HG2' HG23 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -140.72 144.26 35.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.848 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.1 pm0 -55.66 146.53 20.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.089 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -69.32 93.39 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.948 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -172.81 -49.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.431 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.23 -19.91 23.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.952 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.561 HG13 HG12 ' A' ' 4' ' ' ILE . 20.0 t -58.99 -48.24 87.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.845 0.355 . . . . 0.0 111.229 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.618 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 1.6 t -62.58 -23.73 67.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.035 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -90.2 -35.03 15.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.598 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.625 ' HB1' HD12 ' A' ' 62' ' ' LEU . . . -62.78 -65.61 0.66 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.751 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.664 HG23 ' HB3' ' A' ' 63' ' ' ASP . 3.9 mt -58.22 -29.56 37.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.005 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 56' ' ' SER . . . -57.32 -56.87 16.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.711 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -90.23 -25.98 20.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.708 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.625 HD12 ' HB1' ' A' ' 58' ' ' ALA . 84.2 mt -76.02 -72.14 0.34 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.763 0.316 . . . . 0.0 111.312 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.664 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -53.42 140.6 27.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.269 -179.443 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -178.19 -39.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.956 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.57 -169.73 1.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.849 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -106.68 119.92 40.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -147.51 -175.95 5.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.82 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.67 49.41 1.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.017 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.597 ' HA3' HG21 ' A' ' 14' ' ' THR . . . 97.59 35.18 5.26 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.627 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.97 -30.44 7.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.7 0.286 . . . . 0.0 111.001 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.2 t -155.27 -52.03 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.075 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.476 HG22 ' N ' ' A' ' 73' ' ' ARG . 21.9 mt 60.76 159.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.031 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.476 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -89.11 53.88 2.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.841 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.482 HG22 ' N ' ' A' ' 75' ' ' THR . 12.3 p -73.92 159.32 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.05 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.594 ' HA ' HG21 ' A' ' 59' ' ' ILE . 9.1 t -161.15 179.05 8.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.897 0.38 . . . . 0.0 110.957 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.421 ' OE1' HD13 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -107.82 108.76 20.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.962 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.184 -0.912 . . . . 0.0 111.049 179.998 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.861 0.362 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.07 171.23 9.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.029 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -113.2 166.32 11.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.681 HD11 ' HB2' ' A' ' 50' ' ' MET . 3.0 mp -132.59 125.32 52.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.033 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.664 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 14.7 t80 -99.05 124.05 43.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.012 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.658 HG13 HD21 ' A' ' 9' ' ' LEU . 9.5 p -131.14 142.6 43.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.961 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -136.59 179.81 17.52 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.535 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 62.89 30.6 16.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.785 0.326 . . . . 0.0 110.96 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.658 HD21 HG13 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -123.09 -177.51 3.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.045 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.765 HG12 ' HB2' ' A' ' 13' ' ' ALA . 0.4 OUTLIER -139.59 -169.57 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.767 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.616 ' N ' HG13 ' A' ' 10' ' ' VAL . 4.8 t80 -57.05 -52.25 66.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.806 0.336 . . . . 0.0 110.949 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.463 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.8 t -126.45 54.04 1.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.975 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.765 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -88.71 -54.93 3.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.111 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.537 HG21 ' CA ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -161.65 -41.96 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.079 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.3 t -54.46 -48.59 71.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.058 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -69.36 -14.36 62.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.757 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -90.45 -37.52 13.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.084 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 p -83.7 -28.2 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.583 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.446 ' HB2' HG21 ' A' ' 31' ' ' VAL . 3.7 pttp -53.3 -34.38 57.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.789 0.328 . . . . 0.0 110.983 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.07 -38.36 90.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.752 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.9 tt -86.28 -28.79 23.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.79 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.27 -26.16 62.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.974 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.62 -26.83 55.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.077 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -90.06 -12.8 37.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.489 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -109.04 -36.82 5.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.645 0.26 . . . . 0.0 111.24 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.8 10.27 4.55 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.066 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.6 pttp 43.07 54.78 4.78 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.837 0.351 . . . . 0.0 111.454 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.9 p -47.11 131.56 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.368 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -60.19 -57.43 12.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.894 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -156.65 165.21 36.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.002 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.561 HG13 HG22 ' A' ' 48' ' ' VAL . 21.6 t -141.63 114.49 4.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.005 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -119.02 151.94 37.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.024 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mt -130.76 149.36 52.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.755 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.963 HG21 ' CE2' ' A' ' 45' ' ' PHE . 2.7 pp -72.69 -175.14 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.983 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.434 ' N ' HD12 ' A' ' 34' ' ' ILE . 20.6 m-85 -149.14 -176.2 5.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.999 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.402 ' CB ' ' HE3' ' A' ' 43' ' ' LYS . 4.7 t0 -80.83 -168.52 1.81 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.826 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -120.61 35.97 4.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.817 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -163.97 -59.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.964 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.37 -4.94 28.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.387 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.93 35.98 13.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.843 0.354 . . . . 0.0 110.901 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -77.25 116.28 56.27 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.417 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 32.0 Cg_exo -61.27 114.77 2.35 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.54 2.16 . . . . 0.0 112.311 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.738 ' O ' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -177.61 137.03 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.976 0.417 . . . . 0.0 110.971 179.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.32 -72.09 0.48 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.633 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.963 ' CE2' HG21 ' A' ' 34' ' ' ILE . 1.7 p90 -152.25 -177.8 6.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.764 0.316 . . . . 0.0 110.851 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -154.59 -170.56 20.51 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.587 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.36 135.25 13.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.841 0.353 . . . . 0.0 110.92 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.561 HG22 HG13 ' A' ' 31' ' ' VAL . 39.8 t -123.98 156.7 31.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.015 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.464 ' N ' HG12 ' A' ' 48' ' ' VAL . 64.4 tt0 -119.74 112.18 18.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.871 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.681 ' HB2' HD11 ' A' ' 4' ' ' ILE . 21.9 mtp -144.96 168.97 18.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.956 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.405 ' O ' HG23 ' A' ' 55' ' ' VAL . 4.8 mm100 -71.85 160.53 32.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.824 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -82.04 59.38 4.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.76 -46.67 0.45 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.739 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 1.0 OUTLIER -90.02 -20.08 23.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.041 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.915 ' O ' HD12 ' A' ' 59' ' ' ILE . 42.9 t -64.7 -41.52 92.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.819 0.343 . . . . 0.0 111.166 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.4 m -57.71 -47.69 81.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.162 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -82.8 -28.32 30.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.118 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.51 ' O ' HD12 ' A' ' 62' ' ' LEU . . . -58.4 -41.22 84.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.329 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.915 HD12 ' O ' ' A' ' 55' ' ' VAL . 2.8 mp -90.32 -24.4 5.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.96 0.41 . . . . 0.0 111.166 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.37 -52.16 62.88 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.45 -19.1 24.27 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 58' ' ' ALA . 75.8 mt -90.02 -71.21 0.63 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.615 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -46.37 136.0 7.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.559 -179.333 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.467 ' O ' HG23 ' A' ' 65' ' ' THR . 62.1 t30 -177.18 -48.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.784 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 64' ' ' ASN . 0.4 OUTLIER -163.94 -175.15 3.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.968 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -91.0 113.62 25.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.941 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -130.25 -171.69 2.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.09 51.53 2.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.537 ' CA ' HG21 ' A' ' 14' ' ' THR . . . 83.88 38.07 10.85 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.465 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.44 -51.53 2.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.348 . . . . 0.0 110.987 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.79 -53.89 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.48 HG22 ' H ' ' A' ' 73' ' ' ARG . 5.0 mt 57.73 166.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.913 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.48 ' H ' HG22 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -91.1 48.84 1.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.902 0.382 . . . . 0.0 110.836 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.518 HG13 HG23 ' A' ' 59' ' ' ILE . 10.1 p -66.89 156.03 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.162 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.567 ' HA ' HG21 ' A' ' 59' ' ' ILE . 2.5 t -166.66 157.94 12.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.65 127.93 34.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.249 -0.882 . . . . 0.0 111.093 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.885 0.374 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -88.44 175.19 7.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 4.7 m-20 -118.55 129.88 55.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.868 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.806 HD12 ' HB ' ' A' ' 48' ' ' VAL . 30.6 mt -97.03 152.93 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.164 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.401 ' HB3' HG23 ' A' ' 75' ' ' THR . 90.7 t80 -130.18 103.58 6.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.812 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.677 HG13 HD23 ' A' ' 9' ' ' LEU . 10.6 p -113.56 116.97 54.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.164 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.1 -175.11 30.38 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.336 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.3 26.67 10.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.673 0.273 . . . . 0.0 111.323 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.775 HD21 ' N ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -102.76 -171.91 2.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.92 0.39 . . . . 0.0 111.17 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.705 HG13 ' H ' ' A' ' 12' ' ' SER . 6.7 p -164.49 170.55 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.469 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.564 ' H ' HG22 ' A' ' 10' ' ' VAL . 8.7 t80 -40.05 -31.64 0.13 Allowed 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 111.971 0.359 . . . . 0.0 111.971 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.705 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -144.04 50.55 1.33 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.798 0.332 . . . . 0.0 111.197 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.677 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -78.58 -61.16 2.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.123 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.662 HG21 ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER 179.47 -36.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.123 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.93 -50.53 68.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.01 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -71.72 -12.66 61.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.669 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -90.71 -28.0 18.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.147 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.57 HG22 ' CD1' ' A' ' 22' ' ' PHE . 14.7 p -90.09 -24.2 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.833 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.602 ' HB2' HG21 ' A' ' 31' ' ' VAL . 3.3 pttp -48.95 -32.72 9.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.761 0.315 . . . . 0.0 111.207 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -66.1 -33.77 76.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.967 0.413 . . . . 0.0 110.479 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 21' ' ' LEU . 8.2 tt -88.87 -27.12 21.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.662 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.57 ' CD1' HG22 ' A' ' 18' ' ' VAL . 2.0 m-30 -53.82 -24.86 16.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.049 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.6 m -61.41 -37.94 85.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.831 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.408 ' HG3' ' N ' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -90.35 -29.1 18.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.941 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.408 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -69.94 -40.4 75.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.936 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.57 21.26 0.16 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.434 -0.888 . . . . 0.0 113.264 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.2 tttm 56.17 111.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.959 0.409 . . . . 0.0 111.316 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 28' ' ' VAL . 12.8 p -105.37 121.54 57.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.013 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -67.44 -53.17 31.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.976 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -158.35 159.95 36.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.977 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.602 HG21 ' HB2' ' A' ' 19' ' ' LYS . 27.3 t -127.93 130.45 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.973 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.65 145.97 51.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.028 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.471 HD23 ' CA ' ' A' ' 46' ' ' GLY . 34.6 mt -141.18 146.55 37.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.728 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.431 HG21 ' CE1' ' A' ' 45' ' ' PHE . 2.6 pp -82.22 175.65 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.161 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -134.01 175.69 9.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.003 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -75.2 166.39 23.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 mpp_? -105.24 36.61 2.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.911 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -174.18 -41.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.966 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.6 -10.54 19.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.332 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt 61.76 28.97 17.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.782 0.325 . . . . 0.0 110.834 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -105.95 137.05 19.24 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.706 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.25 109.46 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.43 2.087 . . . . 0.0 112.407 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.418 ' C ' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -155.01 109.68 2.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.993 179.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 148.54 -63.92 0.41 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.726 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.446 ' CA ' HD11 ' A' ' 9' ' ' LEU . 13.2 p90 -177.25 170.72 2.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.875 0.369 . . . . 0.0 111.05 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.775 ' N ' HD21 ' A' ' 9' ' ' LEU . . . -125.34 179.87 16.01 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.543 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -146.36 129.53 16.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.348 . . . . 0.0 110.917 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.806 ' HB ' HD12 ' A' ' 4' ' ' ILE . 33.3 t -122.46 148.67 26.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.045 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -117.69 104.76 11.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.927 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 32.0 mtp -138.09 159.73 41.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.7 158.51 34.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.722 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -68.24 93.31 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.096 0.474 . . . . 0.0 110.963 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -169.53 -60.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.999 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 t -90.3 -15.56 30.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.84 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.894 ' O ' HD12 ' A' ' 59' ' ' ILE . 25.5 t -68.68 -49.0 68.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.843 0.354 . . . . 0.0 111.173 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 0.6 OUTLIER -70.12 -22.36 63.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.157 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -90.28 -37.21 14.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 110.602 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.64 ' HB1' HD12 ' A' ' 62' ' ' LEU . . . -57.75 -65.05 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.86 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.894 HD12 ' O ' ' A' ' 55' ' ' VAL . 2.6 mp -58.01 -30.63 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.031 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 56' ' ' SER . . . -57.43 -55.9 28.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.678 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -90.48 -28.07 18.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.684 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.64 HD12 ' HB1' ' A' ' 58' ' ' ALA . 94.1 mt -74.87 -72.26 0.3 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.782 0.325 . . . . 0.0 111.398 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.64 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -53.25 138.93 30.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.16 -179.599 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -177.38 -46.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.891 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -158.22 -178.69 7.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.948 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -92.65 106.62 18.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.873 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.67 -164.87 1.0 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.743 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 3.1 mtm -96.86 34.93 1.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.784 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.662 ' O ' HG21 ' A' ' 14' ' ' THR . . . 105.0 31.03 4.57 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.513 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -112.45 -62.28 1.6 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.862 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.7 -50.14 3.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.843 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.496 HG22 ' H ' ' A' ' 73' ' ' ARG . 4.0 mt 56.37 167.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.15 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.496 ' H ' HG22 ' A' ' 72' ' ' ILE . 10.4 ttm105 -95.01 45.08 1.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.915 0.388 . . . . 0.0 110.637 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.487 HG22 ' N ' ' A' ' 75' ' ' THR . 12.4 p -65.57 159.29 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.236 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.626 ' HA ' HG21 ' A' ' 59' ' ' ILE . 9.1 t -157.8 -176.82 6.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.523 ' HG2' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -94.63 44.66 1.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.93 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 3' ' ' ASN . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.141 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mtm . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.839 0.352 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -107.81 172.52 6.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -111.18 129.68 55.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.545 HG12 HG13 ' A' ' 55' ' ' VAL . 21.2 mt -98.12 143.46 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.093 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.493 ' CE1' ' CD2' ' A' ' 45' ' ' PHE . 41.5 t80 -116.97 123.32 46.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.962 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.523 ' CG2' HG21 ' A' ' 72' ' ' ILE . 12.0 p -125.92 121.32 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.971 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -107.21 76.8 0.23 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.696 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.625 ' CB ' HG23 ' A' ' 72' ' ' ILE . 4.5 t30 -178.04 54.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.85 0.357 . . . . 0.0 110.758 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.775 HD22 ' HB2' ' A' ' 15' ' ' SER . 16.7 mt -128.73 -168.82 1.97 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.179 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.607 HG22 ' H ' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -178.55 -168.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.388 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.607 ' H ' HG22 ' A' ' 10' ' ' VAL . 35.5 m-85 -47.02 -41.76 17.03 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.859 0.361 . . . . 0.0 111.1 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.543 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.8 m -167.66 76.43 0.15 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.658 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.56 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -97.62 -63.3 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.547 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -163.61 -19.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.989 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.775 ' HB2' HD22 ' A' ' 9' ' ' LEU . 7.6 t -47.56 -59.16 3.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.821 0.343 . . . . 0.0 111.511 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -67.42 -11.73 58.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.88 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -90.36 -32.61 16.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.062 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.6 p -87.23 -25.96 6.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.748 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.517 ' HB2' HG11 ' A' ' 31' ' ' VAL . 22.2 pttp -55.62 -29.75 59.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.781 0.324 . . . . 0.0 111.036 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -67.71 -35.96 79.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.757 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.8 tt -85.01 -30.34 24.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.815 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -17.79 65.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.107 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.7 -24.28 41.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.257 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -88.3 -25.97 22.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.225 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -107.24 -32.37 7.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.231 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -114.46 -25.27 4.1 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.806 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.99 53.47 2.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.039 0.447 . . . . 0.0 110.748 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.401 HG21 ' HB ' ' A' ' 31' ' ' VAL . 8.4 p -57.34 143.63 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.195 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -100.92 -40.12 7.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.875 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -138.59 126.13 21.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.906 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.517 HG11 ' HB2' ' A' ' 19' ' ' LYS . 11.1 p -146.47 131.73 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.087 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.4 170.08 7.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 10' ' ' VAL . 23.2 mt -96.63 154.29 17.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.816 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.607 HD11 ' HB3' ' A' ' 43' ' ' LYS . 2.6 pp -92.82 175.74 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.095 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -144.85 171.89 13.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.44 160.32 24.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.932 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.39 30.82 4.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.963 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -144.46 -57.41 0.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.43 -5.5 25.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.276 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 63.4 34.2 13.14 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.968 0.413 . . . . 0.0 110.934 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -110.72 143.17 27.67 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.831 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.47 133.66 54.3 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.532 2.155 . . . . 0.0 112.257 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.607 ' HB3' HD11 ' A' ' 34' ' ' ILE . 7.9 tptp -79.51 -69.02 0.61 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.848 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.99 45.07 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.532 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.493 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 27.0 p90 -177.75 169.31 2.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.904 0.383 . . . . 0.0 110.947 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.89 178.93 19.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.481 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -128.73 136.77 51.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.756 0.312 . . . . 0.0 110.915 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.513 HG22 HG23 ' A' ' 31' ' ' VAL . 23.8 t -127.74 141.62 45.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.093 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.26 113.83 25.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.7 mtp -145.96 -179.78 6.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.823 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.833 ' O ' HG23 ' A' ' 55' ' ' VAL . 15.0 tt0 -61.15 152.02 29.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.834 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -69.12 -32.6 72.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.016 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -77.13 -29.73 54.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.039 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.6 m -73.86 -32.42 63.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.015 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 51' ' ' GLN . 21.5 t -56.74 -49.18 79.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.309 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 m -53.16 -62.49 1.62 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.07 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -63.02 -29.65 70.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.997 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -66.57 -40.09 88.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.413 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.718 HG23 ' HB3' ' A' ' 63' ' ' ASP . 8.0 mt -90.12 -24.08 5.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.978 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.99 -52.8 63.47 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -90.47 -23.48 20.97 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 78.6 mt -85.39 -75.01 0.38 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.717 0.294 . . . . 0.0 111.702 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.718 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -52.46 134.04 34.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.875 0.369 . . . . 0.0 111.254 -179.439 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 179.1 -38.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.844 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.61 -165.8 2.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.768 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -119.92 96.95 5.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.921 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.2 -165.54 1.03 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.831 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 4.3 mmt -97.1 36.19 1.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.052 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.37 28.12 3.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.576 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -110.76 -31.15 7.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.815 0.341 . . . . 0.0 110.968 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.469 HG23 ' H ' ' A' ' 72' ' ' ILE . 0.6 OUTLIER -140.82 -56.38 0.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.949 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.625 HG23 ' CB ' ' A' ' 8' ' ' ASN . 18.0 mt 59.97 159.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.052 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.476 ' N ' HG22 ' A' ' 72' ' ' ILE . 5.7 ttt85 -89.29 53.64 2.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.776 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 75' ' ' THR . 12.1 p -74.57 156.81 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.21 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.457 ' N ' HG22 ' A' ' 74' ' ' VAL . 5.0 t -178.12 147.89 0.47 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.806 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -61.7 128.72 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.3 -0.857 . . . . 0.0 111.156 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpp? . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.813 0.339 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.765 ' HB2' HG21 ' A' ' 55' ' ' VAL . 8.4 mmt-85 -118.62 151.99 36.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.854 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.439 ' HB3' ' CE1' ' A' ' 47' ' ' PHE . 26.4 m-20 -89.72 115.74 27.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.694 HG23 HD11 ' A' ' 59' ' ' ILE . 10.5 mt -87.27 127.01 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.134 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -99.62 123.05 43.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.837 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.678 HG13 HD11 ' A' ' 9' ' ' LEU . 12.0 p -121.65 127.21 75.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.096 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.439 ' HA2' ' CD1' ' A' ' 45' ' ' PHE . . . -105.88 -171.98 23.51 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.414 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 59.48 30.49 20.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.809 0.337 . . . . 0.0 110.955 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.742 HD22 ' HB2' ' A' ' 15' ' ' SER . 48.7 mt -82.83 166.72 18.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.982 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.82 HG12 ' HB2' ' A' ' 13' ' ' ALA . 0.8 OUTLIER -162.23 -174.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.796 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.625 ' H ' HG22 ' A' ' 10' ' ' VAL . 6.9 m-85 -46.73 -52.99 12.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.95 0.405 . . . . 0.0 111.159 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.454 ' H ' HG13 ' A' ' 10' ' ' VAL . 2.9 m -154.07 75.05 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.61 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.82 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -94.95 -56.72 2.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.429 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.627 HG21 ' CA ' ' A' ' 69' ' ' GLY . 1.5 m -165.5 -34.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.465 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.742 ' HB2' HD22 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -47.27 -54.4 11.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.715 0.293 . . . . 0.0 111.451 -179.658 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -68.13 -13.08 61.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.96 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -90.62 -43.4 10.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.136 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -79.23 -30.79 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.683 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -52.43 -27.53 16.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.801 0.334 . . . . 0.0 111.15 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -71.95 -37.74 69.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.811 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.1 tp -88.38 -28.44 20.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.89 -21.67 44.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.163 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.459 ' HA ' HG12 ' A' ' 28' ' ' VAL . 85.8 p -84.57 -27.62 27.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.093 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -89.98 -34.2 16.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.289 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -105.21 -30.23 9.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.271 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.4 -14.95 22.66 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.895 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.75 35.01 24.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.85 0.357 . . . . 0.0 110.86 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 23' ' ' SER . 11.0 p -50.69 143.31 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.336 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -91.26 -34.46 14.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.927 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -167.79 158.18 10.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.918 0.39 . . . . 0.0 111.193 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.466 HG13 HG22 ' A' ' 48' ' ' VAL . 21.3 t -143.48 150.34 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.898 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.437 ' C ' HD23 ' A' ' 33' ' ' LEU . 18.0 ttpt -169.64 151.76 4.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.933 0.397 . . . . 0.0 111.288 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.526 HD22 HD13 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -134.95 -177.27 4.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.329 179.762 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.574 HD11 ' HA3' ' A' ' 44' ' ' GLY . 1.8 pp -129.57 179.83 3.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.821 0.343 . . . . 0.0 111.189 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -139.71 -168.59 2.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.952 -179.651 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.77 -20.67 36.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.513 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.29 26.44 4.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.922 0.392 . . . . 0.0 110.81 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -156.44 -46.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.414 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.07 0.54 25.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.96 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.9 mttm 63.98 38.95 8.34 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.93 0.395 . . . . 0.0 111.044 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 42' ' ' PRO . 12.5 mtmm -100.96 100.79 13.76 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.573 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.444 ' HD2' ' CZ ' ' A' ' 11' ' ' TYR . 33.3 Cg_endo -64.8 107.1 0.84 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.354 2.036 . . . . 0.0 112.216 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.5 37.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.195 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.574 ' HA3' HD11 ' A' ' 34' ' ' ILE . . . -129.25 32.64 3.2 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.473 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.477 ' C ' HD12 ' A' ' 9' ' ' LEU . 0.5 OUTLIER 72.41 166.05 0.3 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.888 0.375 . . . . 0.0 110.905 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.651 ' N ' HD12 ' A' ' 9' ' ' LEU . . . -140.31 -162.36 9.08 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.482 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.439 ' CE1' ' HB3' ' A' ' 3' ' ' ASN . 0.3 OUTLIER -139.81 160.91 38.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 0.0 111.039 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.466 HG22 HG13 ' A' ' 31' ' ' VAL . 32.7 t -147.91 142.22 19.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.955 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -107.75 114.58 28.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.584 ' HB2' HD11 ' A' ' 4' ' ' ILE . 21.4 mtm -145.54 -178.12 5.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.887 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -75.85 150.65 37.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 -179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -61.18 -36.96 81.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -63.47 -31.05 72.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.016 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.41 -35.42 21.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.987 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 51' ' ' GLN . 40.7 t -57.69 -30.82 38.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.28 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.563 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -85.39 -23.43 27.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.269 -179.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -90.21 -41.45 11.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.888 0.375 . . . . 0.0 110.84 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.555 ' HB1' HD12 ' A' ' 62' ' ' LEU . . . -58.34 -66.43 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.949 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.862 HD12 ' O ' ' A' ' 55' ' ' VAL . 3.6 mt -58.07 -21.81 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.277 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 56' ' ' SER . . . -68.66 -54.3 17.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.584 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.19 -29.97 17.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.479 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.555 HD12 ' HB1' ' A' ' 58' ' ' ALA . 92.9 mt -73.2 -74.24 0.18 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.241 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.524 ' CB ' HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -57.0 135.86 56.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.055 -179.78 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 t30 179.51 -38.78 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.789 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.422 ' OG1' HG21 ' A' ' 71' ' ' THR . 0.5 OUTLIER -159.49 -177.51 6.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.788 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.21 111.4 23.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.988 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -131.71 -171.07 2.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.947 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 21.5 mtp -93.12 45.68 1.18 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.627 ' CA ' HG21 ' A' ' 14' ' ' THR . . . 97.98 39.5 3.8 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.516 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.08 -39.68 2.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.697 0.284 . . . . 0.0 111.075 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.422 HG21 ' OG1' ' A' ' 65' ' ' THR . 0.1 OUTLIER -135.37 -48.86 0.72 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.244 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.623 HG22 ' H ' ' A' ' 73' ' ' ARG . 1.9 mt 55.26 174.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.637 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.623 ' H ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -104.78 66.16 0.77 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.969 0.414 . . . . 0.0 111.022 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.524 HG12 ' CB ' ' A' ' 63' ' ' ASP . 14.7 p -83.25 156.98 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.0 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.453 ' N ' HG22 ' A' ' 74' ' ' VAL . 5.4 t -167.31 142.12 3.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.964 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.484 ' HB3' HG12 ' A' ' 55' ' ' VAL . 18.0 pt-20 -69.61 134.12 48.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.949 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.044 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.413 ' HG2' ' CE1' ' A' ' 29' ' ' PHE . 4.8 mtm . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.783 0.325 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -96.48 167.0 11.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.938 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -115.68 106.42 13.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.817 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.6 mt -76.76 128.76 37.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.201 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.526 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 50.1 t80 -108.54 122.21 46.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.749 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.713 HG13 HD11 ' A' ' 9' ' ' LEU . 10.9 p -132.49 145.92 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.228 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.34 -165.33 11.78 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.408 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 55.04 34.62 22.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.76 0.314 . . . . 0.0 111.039 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.713 HD11 HG13 ' A' ' 6' ' ' VAL . 28.6 mt -106.68 128.49 54.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.968 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.62 HG13 ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -89.71 -168.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.797 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.62 ' N ' HG13 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -49.7 -47.47 50.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.788 0.328 . . . . 0.0 111.04 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.528 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.4 t -145.76 58.79 1.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.706 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.636 ' O ' HG23 ' A' ' 14' ' ' THR . . . -59.31 -52.87 63.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.266 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER 176.03 -32.21 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.102 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.49 -54.15 19.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.323 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -64.83 -15.4 61.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.898 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -90.49 -34.09 15.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.201 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 p -90.12 -21.79 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.858 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.519 ' HB2' HG11 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -48.86 -28.43 3.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.748 0.308 . . . . 0.0 111.142 -179.822 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -71.77 -33.25 68.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.748 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.8 tt -88.9 -32.13 17.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.809 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.35 -23.46 64.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.988 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.6 m -80.91 -23.06 39.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.076 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.06 -37.52 14.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.111 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -101.7 -31.16 10.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.093 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.22 -24.79 9.32 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.655 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.0 tttt 63.88 36.99 9.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 0.0 110.899 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 49' ' ' GLU . 11.8 p -61.01 131.98 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.034 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.413 ' CE1' ' HG2' ' A' ' 1' ' ' MET . 74.8 m-85 -74.33 -41.92 60.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -150.85 148.32 28.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.825 HG23 HG22 ' A' ' 48' ' ' VAL . 11.0 p -162.95 130.24 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.975 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.99 161.46 4.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.884 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mt -100.83 173.75 6.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.921 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.611 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.4 pp -112.32 161.26 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.156 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.401 ' CD2' ' HB3' ' A' ' 42' ' ' PRO . 12.4 m-85 -145.34 -174.32 4.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.18 132.0 44.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.97 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -92.14 50.71 1.68 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.791 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -171.65 -42.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.51 -20.52 18.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.08 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.8 mmtp 67.78 44.68 1.56 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.914 0.388 . . . . 0.0 110.934 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -136.56 141.81 36.89 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.924 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.439 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 66.4 Cg_endo -73.88 134.1 19.36 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.52 2.146 . . . . 0.0 112.268 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.9 mmmt -63.8 -66.83 0.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.847 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.06 44.65 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.64 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.425 ' CE2' HG12 ' A' ' 34' ' ' ILE . 33.2 p90 -177.75 154.47 0.94 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.802 0.334 . . . . 0.0 110.986 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.12 -164.37 9.88 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.451 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -146.15 137.48 24.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.819 0.342 . . . . 0.0 110.908 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.825 HG22 HG23 ' A' ' 31' ' ' VAL . 33.7 t -122.52 111.89 32.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.998 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.604 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.8 OUTLIER -80.37 103.86 10.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.957 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.6 mtm -142.81 152.96 42.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.608 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -63.74 178.86 0.55 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.89 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.72 -159.0 0.08 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.45 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 66.05 -71.58 0.09 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.16 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.3 m -61.29 -30.99 70.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.039 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 51' ' ' GLN . 35.4 t -63.73 -44.78 98.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.181 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -67.14 -25.4 66.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.177 -179.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -90.16 -38.08 13.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.931 0.396 . . . . 0.0 110.727 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.712 ' HB1' HD12 ' A' ' 62' ' ' LEU . . . -58.41 -64.51 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.895 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.572 HG23 ' HB3' ' A' ' 63' ' ' ASP . 6.5 mt -58.13 -26.65 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.204 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 56' ' ' SER . . . -63.78 -53.91 43.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.713 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -90.33 -33.98 15.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.886 0.374 . . . . 0.0 111.428 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.712 HD12 ' HB1' ' A' ' 58' ' ' ALA . 83.6 mt -72.01 -70.79 0.31 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.38 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.572 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -54.91 134.59 48.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.18 -179.583 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -179.98 -67.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.904 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.58 -174.02 2.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -103.86 105.29 15.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.043 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -123.22 -174.75 3.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.813 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 8.5 ptt? -96.02 36.83 1.27 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.991 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.28 36.76 1.17 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.55 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.38 -40.42 2.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.727 0.299 . . . . 0.0 110.976 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.445 HG23 ' H ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -134.02 -60.99 0.8 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.859 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.505 HD13 HD21 ' A' ' 9' ' ' LEU . 26.9 mt 59.76 159.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.012 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.491 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -83.88 58.69 4.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.926 0.394 . . . . 0.0 110.748 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.473 HG22 ' N ' ' A' ' 75' ' ' THR . 13.8 p -75.37 158.11 5.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.185 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.473 ' N ' HG22 ' A' ' 74' ' ' VAL . 9.9 t -174.15 153.94 2.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.803 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -76.54 124.02 26.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.526 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.022 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.86 0.362 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.475 ' HB2' HG21 ' A' ' 55' ' ' VAL . 21.9 mmm180 -89.02 175.28 7.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.952 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.406 ' HB3' ' CE2' ' A' ' 47' ' ' PHE . 32.3 m-20 -121.95 129.49 52.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.865 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.524 HG12 HG13 ' A' ' 55' ' ' VAL . 31.6 mt -100.57 146.53 9.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.158 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -125.52 116.36 21.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.899 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 p -120.84 134.18 65.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.084 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.99 -168.64 14.49 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.429 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 59.99 33.23 21.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.844 0.354 . . . . 0.0 110.875 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.676 HD12 ' C ' ' A' ' 45' ' ' PHE . 53.7 mt -87.67 136.39 32.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.946 HG12 ' HB2' ' A' ' 13' ' ' ALA . 1.4 p -105.89 179.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.778 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.643 ' H ' HG22 ' A' ' 10' ' ' VAL . 6.9 m-85 -46.43 -53.37 11.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.871 0.367 . . . . 0.0 111.138 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.432 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -146.43 68.11 1.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.569 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.946 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -77.38 -76.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.381 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.49 -23.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.867 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.405 ' O ' HG12 ' A' ' 18' ' ' VAL . 16.7 p -47.29 -58.16 4.43 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.728 0.299 . . . . 0.0 111.459 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.24 -12.83 61.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.832 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -90.52 -29.86 17.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.152 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 15' ' ' SER . 12.3 p -87.5 -25.48 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.75 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.72 -26.84 6.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.74 0.305 . . . . 0.0 111.22 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -75.0 -34.64 61.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.8 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.5 tp -89.58 -30.18 18.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.995 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.406 ' CD2' ' HE3' ' A' ' 50' ' ' MET . 0.1 OUTLIER -58.08 -21.83 47.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.083 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.3 p -82.56 -24.38 34.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.19 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -85.44 -26.48 26.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.222 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.67 -29.27 7.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.256 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.5 -26.78 3.83 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.712 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.0 tttt 64.05 51.1 2.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.369 . . . . 0.0 110.837 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.3 p -54.76 135.76 17.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.235 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -90.96 -42.47 10.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.938 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -138.82 124.92 20.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 31' ' ' VAL . 10.9 p -136.15 121.46 28.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -138.4 178.83 6.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.011 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.58 ' CD2' HD13 ' A' ' 9' ' ' LEU . 7.4 mt -145.43 173.8 11.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.613 HD11 ' HA3' ' A' ' 44' ' ' GLY . 2.5 pp -110.31 179.0 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.144 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -121.61 173.22 7.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.037 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.73 -11.06 60.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.349 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.97 33.2 5.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.948 0.404 . . . . 0.0 110.848 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -165.34 -43.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.856 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.59 -1.51 16.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.346 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.15 33.03 14.78 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.885 0.374 . . . . 0.0 110.856 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.07 148.13 38.78 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.802 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.67 113.19 2.65 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.52 2.147 . . . . 0.0 112.231 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.2 109.19 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.613 ' HA3' HD11 ' A' ' 34' ' ' ILE . . . 150.52 -71.58 0.3 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.541 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.676 ' C ' HD12 ' A' ' 9' ' ' LEU . 9.9 p90 -165.55 179.07 6.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.351 . . . . 0.0 110.946 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.53 ' N ' HD12 ' A' ' 9' ' ' LEU . . . -143.17 -175.78 16.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.548 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.406 ' CE2' ' HB3' ' A' ' 3' ' ' ASN . 1.2 t80 -140.68 155.09 46.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.801 0.334 . . . . 0.0 110.926 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.1 t -151.36 131.36 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.08 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.88 116.46 31.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.406 ' HE3' ' CD2' ' A' ' 22' ' ' PHE . 4.0 mtt -142.29 168.24 20.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.963 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.654 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -60.0 179.75 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -96.2 35.52 1.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.996 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -123.86 -41.1 2.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.923 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.524 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 24.9 p -87.79 -24.77 23.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.171 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.669 ' O ' HD12 ' A' ' 59' ' ' ILE . 41.7 t -65.38 -28.79 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.319 . . . . 0.0 111.319 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.4 m -65.4 -47.33 76.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.111 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.429 ' HA ' ' HB3' ' A' ' 60' ' ' ALA . 5.4 tt0 -90.24 -25.0 20.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.226 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.524 ' HB2' ' O ' ' A' ' 54' ' ' SER . . . -50.42 -45.27 55.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.536 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.712 HG23 ' HB3' ' A' ' 63' ' ' ASP . 3.9 mp -90.44 -28.31 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.078 0.466 . . . . 0.0 110.929 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.429 ' HB3' ' HA ' ' A' ' 57' ' ' GLU . . . -52.32 -58.84 5.43 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -90.36 -12.46 37.57 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.507 HD12 ' O ' ' A' ' 58' ' ' ALA . 33.5 mt -90.04 -75.11 0.46 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.888 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.712 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -46.69 132.62 11.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.942 0.401 . . . . 0.0 111.632 -179.185 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 179.96 -67.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.742 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.17 -167.1 1.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.72 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -107.64 111.34 23.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.885 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.05 -167.17 1.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.951 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 3.5 mmt -86.9 56.19 3.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.704 ' HA2' HD11 ' A' ' 72' ' ' ILE . . . 78.69 32.67 40.51 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.503 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.7 -29.23 8.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.801 0.334 . . . . 0.0 110.966 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.514 HG23 ' H ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -137.94 -65.21 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.98 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.704 HD11 ' HA2' ' A' ' 69' ' ' GLY . 19.2 mt 59.74 159.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.979 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.49 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -83.32 78.58 9.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.698 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.588 HG13 HG23 ' A' ' 59' ' ' ILE . 14.0 p -101.71 153.84 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.206 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.4 t -169.1 161.65 10.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.958 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.45 130.83 47.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.089 179.979 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 120.883 0.373 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.29 169.35 8.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.838 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -104.13 133.55 48.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.768 HD11 ' HB2' ' A' ' 50' ' ' MET . 25.6 mt -98.99 111.33 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.099 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -90.54 119.39 30.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.828 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.694 HG13 HD11 ' A' ' 9' ' ' LEU . 8.7 p -131.86 139.05 51.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.044 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.553 ' O ' HG21 ' A' ' 72' ' ' ILE . . . -114.64 -163.6 14.45 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.399 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.629 ' HB3' HG23 ' A' ' 72' ' ' ILE . 5.0 t-20 55.67 36.26 26.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.788 0.328 . . . . 0.0 110.981 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.694 HD11 HG13 ' A' ' 6' ' ' VAL . 93.1 mt -100.73 109.81 21.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.066 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.642 HG22 ' H ' ' A' ' 11' ' ' TYR . 1.0 OUTLIER -78.33 -175.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.653 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.642 ' H ' HG22 ' A' ' 10' ' ' VAL . 24.7 m-85 -46.79 -48.96 20.57 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.894 0.378 . . . . 0.0 111.098 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.549 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.1 m -142.3 62.01 1.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.652 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.636 ' O ' HG23 ' A' ' 14' ' ' THR . . . -58.46 -70.85 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.424 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER 175.23 -28.43 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.34 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 26.8 t -48.33 -55.83 9.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.77 0.319 . . . . 0.0 111.345 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.86 -14.7 60.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.912 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -90.48 -41.12 11.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.04 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 18' ' ' VAL . 11.7 p -76.57 -14.21 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.759 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -51.77 -40.59 60.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.773 0.32 . . . . 0.0 111.193 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -61.06 -33.25 73.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.818 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.437 ' O ' HD23 ' A' ' 21' ' ' LEU . 6.4 tt -88.65 -28.65 20.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.853 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.47 -26.37 61.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.019 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.6 t -73.12 -34.57 66.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.923 0.392 . . . . 0.0 110.867 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -90.15 -4.98 56.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.245 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -114.47 -33.86 5.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.732 0.301 . . . . 0.0 111.238 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.0 -2.46 6.08 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.293 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? 59.63 40.85 19.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.944 0.402 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 49' ' ' GLU . 13.6 p -57.52 139.45 17.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.207 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -75.78 -39.09 57.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.933 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -168.83 154.9 6.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.007 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.785 HG22 HG13 ' A' ' 48' ' ' VAL . 21.7 t -138.72 118.79 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.983 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.53 132.27 17.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.108 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.626 HD23 ' N ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -106.98 174.53 5.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.558 179.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.668 HD11 ' CE1' ' A' ' 45' ' ' PHE . 2.1 pp -105.19 152.12 7.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.263 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 2.7 m-85 -117.73 -173.07 2.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.962 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.1 -168.66 1.9 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.864 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.7 ttt-85 -127.65 36.27 4.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -157.02 -54.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.72 -2.14 26.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.379 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.3 mttm 60.84 36.97 18.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.815 0.341 . . . . 0.0 110.925 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -105.64 141.29 22.34 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.903 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 50.3 Cg_exo -53.19 118.28 4.67 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.479 2.119 . . . . 0.0 112.276 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -58.35 -69.11 0.2 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.839 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 173.9 35.11 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.562 -0.828 . . . . 0.0 113.012 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.668 ' CE1' HD11 ' A' ' 34' ' ' ILE . 28.4 p90 -178.5 155.82 0.88 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.077 0.465 . . . . 0.0 111.333 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.475 ' N ' HD12 ' A' ' 9' ' ' LEU . . . -141.09 -166.18 10.62 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.388 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -144.08 143.74 31.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.88 0.371 . . . . 0.0 110.967 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.785 HG13 HG22 ' A' ' 31' ' ' VAL . 35.3 t -134.26 138.9 49.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.055 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -94.33 107.87 19.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.908 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.768 ' HB2' HD11 ' A' ' 4' ' ' ILE . 3.6 mtt -135.78 156.36 48.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.915 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.597 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.7 tt0 -81.29 154.94 26.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.974 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -51.06 -29.58 13.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.198 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -71.24 -35.09 71.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.95 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.9 p -87.07 -43.65 12.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.938 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 51' ' ' GLN . 30.2 t -58.21 -31.11 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.145 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.51 -51.32 70.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.098 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -88.64 -23.51 23.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.157 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.522 ' O ' HD12 ' A' ' 62' ' ' LEU . . . -55.04 -41.48 71.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.408 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.777 HG23 ' HB3' ' A' ' 63' ' ' ASP . 4.5 mt -90.25 -24.81 5.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.067 0.46 . . . . 0.0 110.917 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.49 -55.66 30.97 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.29 -19.71 23.78 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.522 HD12 ' O ' ' A' ' 58' ' ' ALA . 64.9 mt -85.4 -75.15 0.38 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.763 0.316 . . . . 0.0 111.65 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.777 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -55.97 137.17 51.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.147 -179.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 178.78 -61.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.813 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.89 -173.6 3.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -105.78 118.58 36.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.435 ' CD2' ' HD3' ' A' ' 70' ' ' ARG . 0.2 OUTLIER -135.2 -165.52 1.69 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.83 32.27 2.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.026 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.428 ' HA2' HD11 ' A' ' 72' ' ' ILE . . . 112.57 33.29 2.11 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.585 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.435 ' HD3' ' CD2' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -113.52 -34.48 5.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 0.0 110.934 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.498 HG23 ' H ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -137.92 -61.55 0.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.843 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.629 HG23 ' HB3' ' A' ' 8' ' ' ASN . 1.1 mp 59.94 162.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.908 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.429 ' N ' HG22 ' A' ' 72' ' ' ILE . 3.5 mmm-85 -87.75 75.78 8.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.859 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.471 HG23 ' HB ' ' A' ' 6' ' ' VAL . 12.5 p -97.84 156.12 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.448 ' N ' HG22 ' A' ' 74' ' ' VAL . 9.9 t -167.23 161.26 14.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.961 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -81.76 107.56 14.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.907 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.167 -0.921 . . . . 0.0 111.089 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.825 0.345 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -135.77 173.32 11.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 -102.61 139.44 38.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.935 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.552 HD11 ' HB2' ' A' ' 50' ' ' MET . 4.1 mt -109.8 136.95 44.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.044 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -114.73 122.76 47.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.913 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.747 HG13 HD11 ' A' ' 9' ' ' LEU . 11.3 p -129.06 134.19 64.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.142 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -118.47 -168.3 14.22 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.468 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 59.64 33.9 22.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.858 0.361 . . . . 0.0 110.957 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.747 HD11 HG13 ' A' ' 6' ' ' VAL . 48.4 mt -98.74 -175.03 2.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.909 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.641 HG13 ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -167.97 -167.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.733 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.641 ' N ' HG13 ' A' ' 10' ' ' VAL . 77.4 m-85 -47.58 -46.76 28.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.798 0.333 . . . . 0.0 111.195 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.484 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -152.44 53.26 0.79 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.824 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.654 ' O ' HG23 ' A' ' 14' ' ' THR . . . -64.14 -55.32 22.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.184 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.7 HG21 ' HA3' ' A' ' 69' ' ' GLY . 0.1 OUTLIER 177.07 -33.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.081 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.565 ' OG ' HD13 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -52.39 -52.39 53.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.803 0.335 . . . . 0.0 111.103 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -66.62 -15.52 63.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.772 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -90.55 -29.81 17.63 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.308 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 15' ' ' SER . 14.4 p -89.74 -20.94 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.811 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.404 ' HB2' HG11 ' A' ' 31' ' ' VAL . 13.3 pttp -57.29 -30.47 64.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.693 0.282 . . . . 0.0 111.12 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -72.77 -35.98 67.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.885 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.4 tp -87.56 -27.76 22.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.493 ' CD1' ' HE3' ' A' ' 50' ' ' MET . 0.1 OUTLIER -57.06 -21.96 35.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.211 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.444 ' HA ' HG12 ' A' ' 28' ' ' VAL . 1.4 t -83.25 -21.12 33.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.22 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -89.17 -43.65 10.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.125 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -100.05 -29.86 12.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.148 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.34 -21.96 20.82 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.597 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.66 31.69 16.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.911 0.386 . . . . 0.0 110.918 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 49' ' ' GLU . 12.0 p -55.2 141.87 10.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.167 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -84.07 -42.63 15.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.62 160.36 40.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.468 HG23 HG22 ' A' ' 48' ' ' VAL . 10.2 p -149.09 151.15 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.928 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.21 131.92 0.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.088 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.725 HD23 ' HA3' ' A' ' 46' ' ' GLY . 1.0 OUTLIER -102.28 -174.31 2.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.603 179.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.532 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.3 pp -107.27 167.71 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.288 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -147.34 157.66 43.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.01 154.25 23.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.872 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -94.71 46.52 1.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -176.52 -40.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.801 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.71 -18.7 16.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.084 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.49 34.84 12.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.871 0.367 . . . . 0.0 110.911 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -113.39 142.13 27.01 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.782 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.24 117.58 4.07 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.443 2.095 . . . . 0.0 112.297 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -60.63 -70.11 0.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.762 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 176.22 35.55 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.737 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.444 ' CE2' HG12 ' A' ' 34' ' ' ILE . 28.2 p90 -178.66 172.82 1.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.901 0.382 . . . . 0.0 111.082 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.725 ' HA3' HD23 ' A' ' 33' ' ' LEU . . . -162.58 -164.31 17.27 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.418 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -138.3 164.3 29.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.915 0.388 . . . . 0.0 111.05 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.468 HG22 HG23 ' A' ' 31' ' ' VAL . 32.7 t -149.91 151.55 12.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.926 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.575 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -113.31 110.92 21.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.904 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.552 ' HB2' HD11 ' A' ' 4' ' ' ILE . 18.1 mtp -147.3 -176.64 5.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.891 ' O ' HG23 ' A' ' 55' ' ' VAL . 2.0 tt0 -86.23 148.44 25.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.902 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -57.75 -35.1 70.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.062 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.22 -44.46 92.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.914 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 58.4 m -77.1 -32.1 56.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.906 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.902 ' O ' HD12 ' A' ' 59' ' ' ILE . 39.5 t -69.17 -36.11 71.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.189 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.4 m -60.0 -43.48 95.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.189 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -90.0 -27.82 19.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.283 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.529 ' O ' HD12 ' A' ' 62' ' ' LEU . . . -56.88 -41.83 78.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.396 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.902 HD12 ' O ' ' A' ' 55' ' ' VAL . 2.7 mp -90.22 -27.35 5.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.041 0.448 . . . . 0.0 110.966 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.56 -58.35 7.07 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -90.35 -13.0 36.01 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.529 HD12 ' O ' ' A' ' 58' ' ' ALA . 41.3 mt -89.99 -75.18 0.46 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.775 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.766 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -49.65 129.88 20.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.521 -179.324 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -176.98 -43.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.914 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.39 -175.13 4.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -106.89 99.8 9.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.962 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.69 -168.95 1.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.899 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.38 52.25 2.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.959 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.7 ' HA3' HG21 ' A' ' 14' ' ' THR . . . 89.63 27.93 20.64 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.579 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 ttp180 -107.82 -31.16 8.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.796 0.331 . . . . 0.0 110.868 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.483 HG23 ' H ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -140.31 -59.2 0.53 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.567 HD11 ' HA2' ' A' ' 69' ' ' GLY . 15.5 mt 59.38 161.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.012 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.477 ' N ' HG22 ' A' ' 72' ' ' ILE . 5.5 mtt180 -86.63 56.27 3.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.796 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.556 HG13 HG23 ' A' ' 59' ' ' ILE . 14.0 p -76.81 158.96 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.294 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.565 ' HA ' HG21 ' A' ' 59' ' ' ILE . 10.2 t -167.76 165.79 13.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.886 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -96.76 110.55 22.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.31 -0.852 . . . . 0.0 111.17 179.971 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 ttt . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.788 0.328 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -130.46 161.07 32.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.855 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -103.19 119.24 38.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.891 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.676 HG12 HG13 ' A' ' 55' ' ' VAL . 17.2 mt -92.97 131.83 38.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.18 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.518 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 85.9 t80 -111.17 126.01 54.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.852 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.16 145.0 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.192 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.54 -174.29 14.74 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.474 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 60.48 41.81 15.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 110.875 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.57 HD13 HD21 ' A' ' 33' ' ' LEU . 25.8 mt -103.88 -179.16 3.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.839 HG12 ' HB2' ' A' ' 13' ' ' ALA . 5.7 p -173.36 169.76 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.799 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.564 ' H ' HG22 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -40.23 -37.73 0.68 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.855 -179.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.605 ' H ' HG13 ' A' ' 10' ' ' VAL . 21.0 p -142.61 54.97 1.41 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.842 0.353 . . . . 0.0 111.1 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.839 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -77.11 -69.99 0.49 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.189 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -179.8 -36.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.966 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.423 ' HB2' HD22 ' A' ' 9' ' ' LEU . 0.8 OUTLIER -52.8 -51.26 61.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.893 0.378 . . . . 0.0 111.078 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -14.58 62.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -90.33 -31.72 16.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.144 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.8 p -87.76 -24.83 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.593 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.708 ' HB3' HG11 ' A' ' 31' ' ' VAL . 9.8 pttt -54.02 -28.53 38.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.812 0.339 . . . . 0.0 111.0 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -33.86 69.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.662 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.5 tt -90.13 -28.44 18.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.838 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.19 -26.55 51.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.004 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.1 p -76.23 -33.55 59.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.852 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -90.1 -9.62 47.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.337 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -111.77 -37.18 5.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.715 0.293 . . . . 0.0 111.077 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.03 -8.47 5.57 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.198 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.33 47.35 6.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.882 0.372 . . . . 0.0 110.755 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.684 HG21 ' CG2' ' A' ' 31' ' ' VAL . 9.7 p -54.28 155.56 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.29 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.434 ' N ' HG22 ' A' ' 28' ' ' VAL . 14.1 m-85 -93.15 -49.18 6.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.09 143.47 30.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.809 HG22 HG13 ' A' ' 48' ' ' VAL . 21.2 t -150.19 110.74 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.122 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.33 172.94 16.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.57 HD21 HD13 ' A' ' 9' ' ' LEU . 7.5 mt -104.13 156.62 17.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.828 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.839 HD11 ' HB2' ' A' ' 43' ' ' LYS . 2.7 pp -66.04 -35.51 75.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.127 0.489 . . . . 0.0 111.205 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.575 ' N ' HD12 ' A' ' 34' ' ' ILE . 3.1 m-85 49.69 -175.97 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.196 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -109.47 141.02 42.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.8 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -90.13 52.43 2.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.942 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -177.49 -40.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.818 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -104.9 -18.35 14.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.167 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.8 mttp 63.32 33.67 13.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.909 0.385 . . . . 0.0 110.883 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -113.89 145.25 33.12 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.883 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.65 120.31 6.11 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.58 2.187 . . . . 0.0 112.352 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.839 ' HB2' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -68.55 -75.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.878 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 175.9 37.11 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.65 -0.785 . . . . 0.0 112.684 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.435 ' CE2' HG12 ' A' ' 34' ' ' ILE . 32.7 p90 -177.14 132.95 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.905 0.383 . . . . 0.0 110.992 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -122.4 -159.3 10.55 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.533 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.406 ' CD1' ' O ' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -145.01 152.59 40.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.841 0.353 . . . . 0.0 111.057 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.809 HG13 HG22 ' A' ' 31' ' ' VAL . 48.7 t -141.75 124.75 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.856 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -95.39 108.4 20.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.61 ' HG3' HG23 ' A' ' 28' ' ' VAL . 26.2 mtp -136.79 158.96 43.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.421 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -62.54 155.53 25.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -77.75 69.15 3.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.027 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -149.98 -48.27 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.428 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -90.18 -20.07 23.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.014 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.725 ' O ' HD12 ' A' ' 59' ' ' ILE . 30.0 t -59.5 -47.98 88.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.317 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 m -56.01 -56.13 24.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.149 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -69.65 -28.67 66.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.187 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.528 ' O ' HD12 ' A' ' 62' ' ' LEU . . . -60.56 -41.72 95.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.281 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.748 HG23 ' HB3' ' A' ' 63' ' ' ASP . 3.3 mt -90.34 -27.28 5.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.045 0.45 . . . . 0.0 111.046 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.53 -57.26 12.09 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -90.45 -14.56 32.58 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.528 HD12 ' O ' ' A' ' 58' ' ' ALA . 48.8 mt -90.08 -75.08 0.46 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.777 0.322 . . . . 0.0 111.826 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.748 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -48.96 140.58 8.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.979 0.419 . . . . 0.0 111.499 -179.291 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 174.19 -35.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.641 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.72 -170.25 2.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.744 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.2 109.2 17.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.911 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -139.2 -174.22 3.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -74.98 68.2 1.78 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.502 ' HA2' HD11 ' A' ' 72' ' ' ILE . . . 66.36 26.55 72.69 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.683 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.3 mtp85 -96.56 -36.36 10.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.898 0.38 . . . . 0.0 110.82 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -138.67 -51.66 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.776 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.502 HD11 ' HA2' ' A' ' 69' ' ' GLY . 18.0 mt 59.78 159.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.107 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.494 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -92.01 50.54 1.68 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.947 0.403 . . . . 0.0 110.845 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.515 HG13 ' HB3' ' A' ' 63' ' ' ASP . 14.8 p -72.65 158.81 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.536 ' HA ' HG21 ' A' ' 59' ' ' ILE . 3.2 t -176.77 157.82 1.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.895 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.18 108.64 14.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.828 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.518 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.156 -0.926 . . . . 0.0 111.105 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 mtt . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.827 0.346 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -109.18 -171.08 1.77 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -121.06 137.92 54.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.948 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.653 HG12 HG13 ' A' ' 55' ' ' VAL . 21.1 mt -109.48 141.05 25.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.103 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.803 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 7.2 t80 -110.23 124.2 51.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.908 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.5 p -129.37 138.16 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.108 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.19 -171.58 17.4 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.45 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.9 t30 58.73 30.22 19.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.831 0.348 . . . . 0.0 110.97 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.421 HD12 HD21 ' A' ' 33' ' ' LEU . 3.9 mm? -86.29 163.38 17.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.798 HG12 ' HB2' ' A' ' 13' ' ' ALA . 3.6 p -147.36 172.4 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.853 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.581 ' H ' HG22 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -42.58 -41.52 3.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.583 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.627 ' H ' HG13 ' A' ' 10' ' ' VAL . 18.3 m -150.25 66.34 0.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.927 0.394 . . . . 0.0 110.953 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.798 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -73.49 -77.38 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.323 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 13' ' ' ALA . 0.6 OUTLIER -173.11 -36.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.28 -179.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.3 t -49.79 -52.53 31.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.351 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.81 -14.43 62.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.85 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -90.39 -46.23 8.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.959 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.46 ' O ' HG22 ' A' ' 18' ' ' VAL . 12.6 p -71.91 -9.42 12.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.689 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.802 ' CB ' HG11 ' A' ' 31' ' ' VAL . 20.1 pttm -53.59 -31.03 45.26 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.799 0.333 . . . . 0.0 110.971 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -69.8 -33.15 71.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.828 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.4 tt -90.02 -29.97 18.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.882 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.529 ' HZ ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -57.62 -26.04 61.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.01 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m -76.19 -30.19 57.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.062 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -90.07 -5.17 56.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.348 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -116.18 -36.98 3.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.71 0.29 . . . . 0.0 111.11 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.1 -0.18 3.88 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.32 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 mmtt 56.04 103.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.985 0.393 . . . . 0.0 111.071 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.796 HG21 ' CG2' ' A' ' 31' ' ' VAL . 7.1 p -117.17 169.06 7.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.793 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.531 ' H ' HG22 ' A' ' 28' ' ' VAL . 10.4 m-85 -129.9 -39.51 1.4 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -97.6 -96.3 0.21 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.814 HG22 HG13 ' A' ' 48' ' ' VAL . 45.4 t 66.58 88.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.734 0.302 . . . . 0.0 110.882 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.67 151.93 22.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.93 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.755 HD23 ' HA3' ' A' ' 46' ' ' GLY . 10.3 mt -101.47 153.55 19.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.827 HD11 ' HB2' ' A' ' 43' ' ' LYS . 2.7 pp -85.63 -179.36 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -137.9 -172.19 3.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.862 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -91.7 -175.59 4.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.974 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.23 31.71 6.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -160.25 -59.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.881 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 p -92.42 -17.02 25.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.195 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.6 mptt 66.91 30.17 7.85 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.86 0.362 . . . . 0.0 110.882 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.1 pttt -92.15 138.15 24.6 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.789 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.29 115.82 2.54 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.438 2.092 . . . . 0.0 112.302 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.827 ' HB2' HD11 ' A' ' 34' ' ' ILE . 14.6 mmmt -59.64 -74.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.898 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.5 39.36 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.561 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.44 ' CE2' HG12 ' A' ' 34' ' ' ILE . 13.4 p90 -172.1 145.55 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.91 0.386 . . . . 0.0 110.934 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.755 ' HA3' HD23 ' A' ' 33' ' ' LEU . . . -125.97 -166.05 12.17 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.541 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -145.67 128.94 16.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 111.164 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.814 HG13 HG22 ' A' ' 31' ' ' VAL . 52.4 t -114.75 116.0 51.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.863 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -87.26 94.99 9.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.945 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.748 ' HG3' HG12 ' A' ' 48' ' ' VAL . 29.2 mtp -121.18 177.56 5.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.881 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.895 ' O ' HG23 ' A' ' 55' ' ' VAL . 18.8 mt-30 -69.1 158.2 35.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -31.18 69.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.902 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -81.63 -31.17 32.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.012 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 1.0 OUTLIER -73.61 -33.0 64.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.051 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 51' ' ' GLN . 24.9 t -58.01 -47.6 86.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.395 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.1 m -57.74 -64.77 0.79 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.13 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.15 -26.99 63.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.149 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.532 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -68.34 -37.14 80.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.415 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.524 HD12 ' O ' ' A' ' 55' ' ' VAL . 5.8 mt -90.36 -11.79 9.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.275 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.75 -49.6 12.77 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -90.64 -19.41 23.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.799 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 78.2 mt -90.07 -75.03 0.47 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.411 ' HB3' HG13 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -59.56 144.95 46.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.023 0.44 . . . . 0.0 111.059 -179.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 179.67 -38.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.803 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.417 ' OG1' HG21 ' A' ' 71' ' ' THR . 0.0 OUTLIER -155.79 -170.39 3.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.824 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -111.15 111.71 22.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.964 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.56 -172.02 2.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.815 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -95.49 39.77 1.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.037 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.17 31.2 3.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.563 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.35 -41.83 4.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.806 0.336 . . . . 0.0 110.881 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.417 HG21 ' OG1' ' A' ' 65' ' ' THR . 0.9 OUTLIER -134.93 -48.9 0.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.47 HG22 ' H ' ' A' ' 73' ' ' ARG . 6.5 mt 59.28 165.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.793 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.47 ' H ' HG22 ' A' ' 72' ' ' ILE . 27.4 mtt180 -99.19 48.9 0.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.925 0.393 . . . . 0.0 110.756 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.411 HG13 ' HB3' ' A' ' 63' ' ' ASP . 7.7 p -65.38 125.19 21.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.064 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.0 t -132.67 162.98 29.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.009 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.86 117.11 21.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.932 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.803 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.215 -0.897 . . . . 0.0 111.121 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.425 ' HG2' ' CZ ' ' A' ' 29' ' ' PHE . 20.9 mtp . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.816 0.341 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -108.22 -169.26 1.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.41 ' HB3' ' CE2' ' A' ' 47' ' ' PHE . 1.6 m120 -121.71 150.5 41.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.89 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.598 HG12 HG13 ' A' ' 55' ' ' VAL . 19.4 mt -116.74 119.15 61.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.126 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.586 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 73.8 t80 -96.16 129.73 43.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.993 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.521 ' CG1' HD21 ' A' ' 9' ' ' LEU . 7.6 p -123.01 136.99 58.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.974 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -124.3 174.92 17.02 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.502 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 62.23 25.6 15.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.613 0.244 . . . . 0.0 110.986 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.521 HD21 ' CG1' ' A' ' 6' ' ' VAL . 1.8 mm? -60.15 138.63 57.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.679 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.524 HG22 ' N ' ' A' ' 11' ' ' TYR . 14.7 p -102.49 162.18 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.644 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.524 ' N ' HG22 ' A' ' 10' ' ' VAL . 42.4 m-85 -43.33 -30.02 0.48 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.162 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.52 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 1.1 m -100.57 -71.64 0.7 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.054 0.454 . . . . 0.0 110.057 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 12' ' ' SER . . . 76.39 141.43 0.07 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.411 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.6 ' O ' HG12 ' A' ' 18' ' ' VAL . 1.7 m -106.01 -26.84 11.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.374 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.08 -46.49 80.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.047 0.451 . . . . 0.0 110.09 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.674 ' HG3' HD21 ' A' ' 33' ' ' LEU . 3.8 tm-20 -75.75 -12.94 60.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.037 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.46 -41.09 11.64 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.496 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.6 HG12 ' O ' ' A' ' 14' ' ' THR . 11.9 p -78.2 -4.91 7.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.618 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 52.5 pttt -53.12 -37.16 61.53 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.762 0.315 . . . . 0.0 110.962 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -60.17 -31.53 70.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.707 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.1 tt -89.95 -29.65 18.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.789 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.412 ' HZ ' HD11 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -57.66 -25.81 60.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.97 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m -67.11 -38.59 85.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.964 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.15 -7.75 52.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.209 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -103.54 -27.51 12.31 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.314 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.85 19.77 0.58 Allowed Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.372 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.4 pttm 42.33 98.99 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.905 0.383 . . . . 0.0 111.925 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.487 HG21 ' CG2' ' A' ' 31' ' ' VAL . 11.8 p -103.77 133.95 46.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.992 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.425 ' CZ ' ' HG2' ' A' ' 1' ' ' MET . 92.1 m-85 -69.45 -46.13 67.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.012 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -166.95 157.52 11.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.002 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.837 HG13 HG22 ' A' ' 48' ' ' VAL . 21.9 t -147.34 129.33 6.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.107 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.505 ' C ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -157.67 138.57 13.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.012 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.674 HD21 ' HG3' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -126.92 148.15 50.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.784 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.583 HD11 ' HA3' ' A' ' 44' ' ' GLY . 2.9 pp -64.38 177.73 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.043 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -132.89 -177.03 4.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.986 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -60.93 -22.36 64.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.173 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 62.26 33.57 16.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.781 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.06 -46.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.788 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.49 -0.29 32.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.364 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.1 mttt 62.61 35.99 13.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.846 0.355 . . . . 0.0 111.016 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -116.53 128.07 26.28 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.78 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.66 115.71 3.54 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.407 2.071 . . . . 0.0 112.244 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.62 132.04 1.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.943 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.583 ' HA3' HD11 ' A' ' 34' ' ' ILE . . . 137.7 -72.89 0.44 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.506 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -169.4 168.21 9.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.846 0.355 . . . . 0.0 110.833 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.415 ' CA ' ' HB3' ' A' ' 33' ' ' LEU . . . -137.75 -178.07 15.71 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.601 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.436 ' CZ ' ' CB ' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -150.96 129.61 12.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.82 0.343 . . . . 0.0 111.094 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.837 HG22 HG13 ' A' ' 31' ' ' VAL . 51.2 t -126.3 143.51 39.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -111.9 106.09 14.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.978 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.486 ' CE ' HG11 ' A' ' 48' ' ' VAL . 35.5 mtt -137.4 -177.36 4.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.994 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.786 ' O ' HG23 ' A' ' 55' ' ' VAL . 3.8 tt0 -67.21 168.05 11.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.965 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -66.81 -37.05 83.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.954 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -74.8 -32.5 62.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.963 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.522 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -66.87 -36.31 82.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 51' ' ' GLN . 31.6 t -62.32 -44.97 99.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.227 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.4 m -55.94 -63.57 1.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.085 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -62.11 -28.18 69.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.968 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.523 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -61.18 -38.29 85.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.293 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.764 HD12 ' O ' ' A' ' 55' ' ' VAL . 3.5 mt -90.22 -16.9 8.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.23 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.87 -48.34 31.71 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.3 mmmt -90.41 -22.85 21.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.656 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.523 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 78.6 mt -89.96 -69.8 0.7 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.532 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.585 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -63.05 141.42 58.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.087 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -178.63 -38.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.872 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.79 -168.64 2.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.73 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -110.34 104.67 13.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.974 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.9 -167.95 1.83 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.893 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.6 ptm -95.16 43.8 1.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.078 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.54 26.61 8.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.628 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 44.7 mtp85 -103.94 -34.99 8.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.908 0.385 . . . . 0.0 110.74 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.1 t -141.07 -47.06 0.4 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.651 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.516 HG22 ' H ' ' A' ' 73' ' ' ARG . 2.2 mt 57.76 167.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.826 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.516 ' H ' HG22 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -99.4 47.36 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.912 0.387 . . . . 0.0 110.833 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.475 HG12 ' CB ' ' A' ' 63' ' ' ASP . 13.2 p -61.93 153.25 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.12 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.0 t -159.97 165.97 30.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -80.25 126.01 30.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.826 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.586 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.173 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 ttm . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.843 0.354 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -123.67 132.54 53.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.47 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 6.9 m-20 -76.43 140.43 41.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.881 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.448 HG12 HG13 ' A' ' 55' ' ' VAL . 14.1 mt -106.18 126.02 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.033 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -107.88 104.44 13.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.836 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.531 ' HB ' HG23 ' A' ' 74' ' ' VAL . 12.0 p -113.32 130.95 66.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.166 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -120.46 -174.01 15.1 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.424 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 59.37 39.19 22.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.901 0.381 . . . . 0.0 110.863 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.547 HD12 ' C ' ' A' ' 45' ' ' PHE . 23.6 mt -82.46 178.41 8.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 1.032 HG12 ' HB2' ' A' ' 13' ' ' ALA . 6.3 p -143.69 169.13 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.545 ' H ' HG22 ' A' ' 10' ' ' VAL . 27.6 m-85 -44.33 -31.49 1.05 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.505 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.725 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.0 OUTLIER -170.99 76.3 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.934 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 1.032 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -81.69 -59.68 2.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.153 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.68 HG23 ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER 176.35 -31.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.204 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.9 m -50.51 -53.74 27.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.783 0.325 . . . . 0.0 111.297 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.618 ' HB3' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -67.95 -13.62 62.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.713 179.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.56 -38.56 13.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.231 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.451 ' O ' HG22 ' A' ' 18' ' ' VAL . 14.0 p -84.06 -9.78 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.899 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -56.88 -44.36 82.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.775 0.321 . . . . 0.0 110.932 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -59.74 -33.04 71.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.705 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.511 ' O ' HD23 ' A' ' 21' ' ' LEU . 5.7 tt -87.67 -27.46 22.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.836 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.46 ' CD1' ' CE ' ' A' ' 50' ' ' MET . 0.1 OUTLIER -55.76 -23.64 30.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.162 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.8 t -80.26 -26.83 38.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.082 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -90.09 -20.47 23.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.236 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -109.54 -33.59 6.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.208 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.62 -18.25 4.9 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.154 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm 65.64 42.61 3.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.89 0.376 . . . . 0.0 110.741 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.3 p -51.08 151.76 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.33 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -91.79 -43.05 9.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -153.48 157.18 39.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.075 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.9 t -150.83 121.85 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.889 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.417 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -141.58 163.04 33.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.081 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.618 HD11 ' HB3' ' A' ' 16' ' ' GLU . 76.9 mt -129.36 179.67 5.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.791 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.744 HG21 ' CE2' ' A' ' 45' ' ' PHE . 2.5 pp -126.92 171.75 14.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.349 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -115.63 -169.86 1.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.937 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.04 178.33 6.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.81 30.86 7.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.935 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -162.47 -48.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 p -91.92 -20.83 20.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.004 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.43 34.31 8.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.839 0.352 . . . . 0.0 110.96 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.412 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 1.8 mtpp -101.69 151.02 37.81 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.851 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.71 97.8 0.92 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.618 2.212 . . . . 0.0 112.628 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.412 ' CE ' ' HB2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -178.23 135.6 0.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.799 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.634 ' HA3' HD11 ' A' ' 34' ' ' ILE . . . 149.42 -59.96 0.44 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.457 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.744 ' CE2' HG21 ' A' ' 34' ' ' ILE . 40.8 p90 -171.52 167.91 6.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.849 0.356 . . . . 0.0 110.962 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.77 174.57 22.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.352 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.86 133.92 38.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.884 0.374 . . . . 0.0 111.017 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.435 ' HB ' HD12 ' A' ' 4' ' ' ILE . 41.7 t -129.22 151.57 35.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.956 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -125.14 120.31 31.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.914 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.46 ' CE ' ' CD1' ' A' ' 22' ' ' PHE . 32.5 mtp -151.88 166.79 30.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -68.88 159.85 31.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.794 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.51 61.7 3.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.984 0.421 . . . . 0.0 110.903 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.61 -47.79 0.51 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.578 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 53.8 m -90.18 -25.55 20.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.956 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.512 ' O ' HD12 ' A' ' 59' ' ' ILE . 24.6 t -64.4 -35.1 73.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.826 0.346 . . . . 0.0 111.472 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.37 -46.89 88.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.204 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.63 -23.5 21.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.311 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.53 ' O ' HD12 ' A' ' 62' ' ' LEU . . . -59.5 -41.54 90.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.458 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.533 HG23 ' HB3' ' A' ' 63' ' ' ASP . 2.3 mp -90.36 -27.91 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.075 0.464 . . . . 0.0 111.048 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.05 -60.29 3.37 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -90.51 -10.31 44.05 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.53 HD12 ' O ' ' A' ' 58' ' ' ALA . 26.5 mt -90.06 -75.29 0.46 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.95 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.533 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -49.36 149.03 2.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.96 0.409 . . . . 0.0 111.526 -179.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.14 -48.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.762 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -158.96 -173.81 4.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.784 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -95.2 104.48 16.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.888 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.41 ' CZ ' ' NH2' ' A' ' 70' ' ' ARG . 0.3 OUTLIER -126.63 170.04 12.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.953 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 4.9 mtt -83.17 58.81 4.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.07 33.54 11.96 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.511 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.41 ' NH2' ' CZ ' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -111.41 -42.25 3.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.797 0.332 . . . . 0.0 110.835 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.96 -47.96 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.796 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 73' ' ' ARG . 18.8 mt 59.74 159.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.033 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.472 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -90.37 69.73 6.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.851 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.531 HG23 ' HB ' ' A' ' 6' ' ' VAL . 14.7 p -93.09 132.9 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.176 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.4 t -154.02 159.75 41.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -58.38 139.27 55.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.96 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 3' ' ' ASN . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.102 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.808 0.337 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -109.36 146.15 34.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 4.6 m120 -85.36 129.94 34.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.9 mt -107.69 139.32 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.093 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.477 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 25.1 t80 -113.78 125.57 54.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.844 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 6' ' ' VAL . 11.0 p -121.94 124.28 70.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.077 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -112.66 -168.45 17.48 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.531 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.8 32.44 20.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.818 0.342 . . . . 0.0 110.887 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.765 HD12 ' C ' ' A' ' 45' ' ' PHE . 61.9 mt -88.35 -178.03 5.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.928 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.624 HG13 ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -160.68 -168.43 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.819 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.624 ' N ' HG13 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -48.56 -45.51 37.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.836 0.351 . . . . 0.0 111.134 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.533 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -156.94 60.64 0.52 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.647 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.44 -77.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.37 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.567 HG21 ' HA3' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -166.19 -31.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.446 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.3 p -46.85 -55.41 8.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.646 0.26 . . . . 0.0 111.441 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.57 -14.32 62.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.777 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -90.5 -30.97 16.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.09 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.505 HG22 ' CD2' ' A' ' 22' ' ' PHE . 14.8 p -86.54 -29.19 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.495 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.9 pttt -48.93 -28.5 3.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.132 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.8 -34.88 69.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.66 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.4 tt -89.96 -18.89 25.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.037 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.505 ' CD2' HG22 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -71.12 -17.09 62.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.236 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.2 p -90.13 -26.23 20.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.438 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -87.4 -47.77 8.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.345 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.57 -11.25 10.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.63 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.9 -22.94 37.05 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.641 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.58 35.17 14.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.81 0.338 . . . . 0.0 110.86 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.404 ' HA ' ' HG2' ' A' ' 50' ' ' MET . 14.9 p -76.81 141.79 15.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.119 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -77.31 -44.79 28.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.96 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -174.7 145.87 0.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.014 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.457 HG22 HG13 ' A' ' 48' ' ' VAL . 23.0 t -127.09 140.95 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.908 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.94 106.59 2.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.071 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.534 HD22 ' HA3' ' A' ' 46' ' ' GLY . 4.7 mt -85.91 175.16 8.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.634 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.732 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.5 pp -107.9 154.53 8.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.22 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.424 ' CE1' ' HG3' ' A' ' 42' ' ' PRO . 83.2 m-85 -140.43 -176.21 4.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.92 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -84.93 -179.6 7.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.934 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -112.09 32.97 5.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -157.79 -54.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.037 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.01 5.65 20.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.415 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 57.85 29.68 17.9 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.839 0.352 . . . . 0.0 110.957 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -76.27 113.96 33.36 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.867 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.424 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 52.8 Cg_exo -52.91 121.73 9.82 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.452 2.101 . . . . 0.0 112.27 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.557 ' HB2' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -54.65 -41.09 69.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.05 37.79 0.11 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.978 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.765 ' C ' HD12 ' A' ' 9' ' ' LEU . 31.6 p90 -178.95 165.83 1.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.982 0.42 . . . . 0.0 111.215 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.534 ' HA3' HD22 ' A' ' 33' ' ' LEU . . . -146.91 -167.69 13.2 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.524 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 3' ' ' ASN . 0.1 OUTLIER -139.56 136.59 34.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.85 0.357 . . . . 0.0 111.021 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.457 HG13 HG22 ' A' ' 31' ' ' VAL . 45.1 t -129.03 136.09 60.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.899 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -105.21 113.13 26.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.885 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.404 ' HG2' ' HA ' ' A' ' 28' ' ' VAL . 0.5 OUTLIER -150.38 152.03 33.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.919 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.52 173.06 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.718 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.69 -152.54 0.06 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.376 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 67.49 -68.69 0.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.209 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.2 m -67.63 -28.62 67.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.235 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.813 ' O ' HD12 ' A' ' 59' ' ' ILE . 30.2 t -58.16 -25.05 25.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.401 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.2 p -72.22 -50.47 27.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.136 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -83.24 -26.11 31.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.296 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -56.55 -42.65 78.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.494 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.813 HD12 ' O ' ' A' ' 55' ' ' VAL . 2.8 mp -90.39 -12.15 9.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.281 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.08 -47.39 13.6 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -90.46 -21.47 21.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.687 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 80.3 mt -90.03 -69.6 0.71 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.737 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -49.51 124.38 9.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.321 -179.468 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -177.59 -49.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.857 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.02 -169.5 2.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.82 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -101.71 124.96 48.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.917 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.57 -173.16 4.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 8.5 mtp -72.13 66.09 0.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.746 ' HA2' HD11 ' A' ' 72' ' ' ILE . . . 59.32 28.94 65.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.509 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.36 -27.76 12.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.728 0.299 . . . . 0.0 110.968 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.532 HG23 ' H ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -135.57 -71.68 0.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.091 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.746 HD11 ' HA2' ' A' ' 69' ' ' GLY . 25.6 mt 59.78 159.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.8 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.47 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -81.78 74.02 8.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 110.789 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.43 HG22 ' N ' ' A' ' 75' ' ' THR . 11.0 p -90.13 155.23 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.43 ' N ' HG22 ' A' ' 74' ' ' VAL . 5.4 t -167.47 152.65 7.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.93 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -68.5 124.78 24.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.911 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.477 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.143 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 tpp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.798 0.333 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -127.75 -177.65 4.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -122.58 153.74 38.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.2 mt -131.56 123.3 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.173 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.499 ' CE2' ' CD2' ' A' ' 45' ' ' PHE . 29.2 t80 -108.84 115.54 30.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.659 HG13 HD11 ' A' ' 9' ' ' LEU . 11.2 p -124.08 124.17 68.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.156 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.15 -170.17 29.55 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.535 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 59.05 40.89 21.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.917 0.389 . . . . 0.0 110.945 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.659 HD11 HG13 ' A' ' 6' ' ' VAL . 65.1 mt -98.45 -178.14 3.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.623 HG13 ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -172.85 -168.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.743 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.623 ' N ' HG13 ' A' ' 10' ' ' VAL . 29.5 t80 -50.29 -47.95 55.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.827 0.346 . . . . 0.0 111.128 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.518 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.8 p -143.35 55.14 1.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.675 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.91 -72.98 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.196 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -165.44 -41.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.056 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.15 -49.33 66.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.065 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -67.05 -15.59 63.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.718 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -90.41 -36.39 14.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.981 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 p -90.07 -23.44 6.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.66 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 42.3 pttt -52.58 -34.33 50.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.762 0.315 . . . . 0.0 111.209 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -65.18 -34.45 78.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.723 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 tp -89.86 -26.69 20.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.74 -23.19 27.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.166 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.6 t -82.91 -29.78 28.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.987 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -90.1 -21.54 22.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -112.82 -30.96 6.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.284 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -117.94 -1.39 16.95 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.113 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.3 pttt 44.92 43.77 7.38 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.85 0.357 . . . . 0.0 111.337 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.9 p -54.67 150.94 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.228 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -91.8 -51.24 5.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.039 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -139.46 158.04 44.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.022 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.0 t -151.48 98.19 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.977 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.84 166.48 11.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.002 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.528 HD23 ' HA3' ' A' ' 46' ' ' GLY . 19.4 mt -140.68 175.09 9.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.843 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.857 HD11 ' HA3' ' A' ' 44' ' ' GLY . 2.4 pp -119.51 -178.79 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.083 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -130.22 -179.13 5.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.054 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -20.29 55.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.17 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.09 36.05 2.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.902 0.382 . . . . 0.0 110.746 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -175.19 -40.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.743 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.3 -10.21 17.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.266 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 mptt 66.66 31.47 7.66 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.86 0.362 . . . . 0.0 110.686 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -111.82 131.04 22.61 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.22 111.17 0.6 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.467 2.112 . . . . 0.0 112.294 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -176.63 127.23 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.918 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.857 ' HA3' HD11 ' A' ' 34' ' ' ILE . . . 142.52 -79.09 0.27 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.617 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.618 ' C ' HD12 ' A' ' 9' ' ' LEU . 50.3 p90 -168.01 -176.64 3.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.811 0.338 . . . . 0.0 111.032 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.528 ' HA3' HD23 ' A' ' 33' ' ' LEU . . . -143.68 169.25 26.09 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.539 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.09 131.35 47.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.802 0.334 . . . . 0.0 111.001 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.8 t -126.26 145.19 34.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.963 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -114.4 114.45 25.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 29.6 mtm -141.83 169.5 17.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -78.48 154.29 30.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -72.01 93.3 1.37 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.904 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -173.43 -49.41 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.466 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.14 -15.34 31.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.994 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.905 ' O ' HD12 ' A' ' 59' ' ' ILE . 21.7 t -66.68 -39.51 83.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.825 0.345 . . . . 0.0 111.179 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.726 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -75.12 -24.67 58.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.216 -179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.26 -42.95 10.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.759 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.701 ' HB1' HD12 ' A' ' 62' ' ' LEU . . . -58.86 -67.78 0.33 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.905 HD12 ' O ' ' A' ' 55' ' ' VAL . 3.7 mt -56.53 -29.4 29.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.144 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.726 ' HB2' ' O ' ' A' ' 56' ' ' SER . . . -57.75 -57.55 12.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.69 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -90.25 -26.08 20.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.646 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.701 HD12 ' HB1' ' A' ' 58' ' ' ALA . 84.4 mt -75.21 -72.9 0.27 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.81 0.338 . . . . 0.0 111.488 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.623 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -50.9 135.67 23.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.346 -179.398 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -178.12 -67.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.761 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.76 -172.16 2.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.811 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.51 99.2 8.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.964 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.18 -172.52 2.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.842 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 23.9 mtt -100.22 36.42 1.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.66 32.7 1.4 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.505 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.12 -37.95 3.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.825 0.345 . . . . 0.0 110.953 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -140.56 -55.69 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.872 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.485 HG21 ' CG2' ' A' ' 6' ' ' VAL . 1.5 mt 59.79 160.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.991 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.462 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -88.39 59.32 5.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.762 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.446 HG22 ' N ' ' A' ' 75' ' ' THR . 14.3 p -79.72 156.75 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.224 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.446 ' N ' HG22 ' A' ' 74' ' ' VAL . 10.0 t -178.46 144.98 0.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.903 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.36 114.61 6.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.497 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.069 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.818 0.342 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.21 161.28 13.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.718 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 3.6 m-80 -100.96 102.09 13.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.405 ' O ' ' CD1' ' A' ' 47' ' ' PHE . 29.6 mt -72.42 141.08 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.095 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.75 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 76.0 t80 -112.24 138.36 49.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.807 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.497 HG22 HD21 ' A' ' 9' ' ' LEU . 11.2 p -147.79 129.14 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.285 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.08 -175.79 25.49 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.329 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 58.45 37.83 25.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.816 0.341 . . . . 0.0 110.806 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.497 HD21 HG22 ' A' ' 6' ' ' VAL . 3.4 mm? -87.98 159.63 18.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.033 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.646 HG13 ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -154.03 -167.41 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.78 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.646 ' N ' HG13 ' A' ' 10' ' ' VAL . 80.0 m-85 -49.5 -46.09 47.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.833 0.349 . . . . 0.0 111.088 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.514 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.3 m -157.18 57.64 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.778 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.419 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -62.04 -52.01 65.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.259 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.447 ' OG1' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -177.61 -36.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.099 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.5 m -51.34 -51.88 50.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.223 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.86 -14.87 63.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.787 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -90.54 -36.27 14.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.089 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.413 HG22 ' CD1' ' A' ' 22' ' ' PHE . 10.7 p -86.23 -24.77 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.625 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -53.16 -32.04 45.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.889 0.376 . . . . 0.0 111.072 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.37 -39.28 94.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.632 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.3 tt -83.14 -31.23 27.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.705 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.413 ' CD1' HG22 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -61.2 -28.27 69.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.928 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.27 -26.9 26.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.088 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -85.36 -25.44 27.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.137 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -111.47 -29.57 7.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.195 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -114.15 -24.65 4.42 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.807 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.87 46.53 3.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.861 0.362 . . . . 0.0 110.776 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 49' ' ' GLU . 10.1 p -52.02 147.4 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.295 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -73.81 -50.26 21.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.919 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -154.67 157.92 38.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.972 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.406 HG22 HG13 ' A' ' 48' ' ' VAL . 23.4 t -152.76 124.08 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.082 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -160.02 -178.6 7.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.981 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 34.0 mt -122.78 160.01 26.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.851 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.87 HD12 ' O ' ' A' ' 35' ' ' TYR . 2.5 pp -81.63 -22.11 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.516 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.87 ' O ' HD12 ' A' ' 34' ' ' ILE . 21.2 m-85 58.83 171.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.008 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -59.94 160.44 7.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.68 40.53 1.22 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.969 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -170.82 -44.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.763 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.98 -17.97 18.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.186 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp 64.12 33.17 12.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.894 0.378 . . . . 0.0 110.9 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.4 150.42 37.98 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.763 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.42 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 63.5 Cg_exo -51.45 99.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.581 2.188 . . . . 0.0 112.3 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.81 129.4 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 127.9 -76.45 0.4 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.643 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.636 ' CE2' HG21 ' A' ' 34' ' ' ILE . 24.4 p90 -176.09 171.61 2.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.754 0.312 . . . . 0.0 110.913 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.93 171.01 21.9 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.479 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.406 ' CE1' ' HB3' ' A' ' 3' ' ' ASN . 2.7 m-85 -134.38 145.52 49.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.836 0.351 . . . . 0.0 110.87 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.406 HG13 HG22 ' A' ' 31' ' ' VAL . 22.8 t -131.59 97.47 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.092 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.43 ' O ' HG23 ' A' ' 28' ' ' VAL . 68.1 tt0 -68.3 86.91 0.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.973 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.7 mtp -125.42 179.6 5.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.905 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.82 ' O ' HG23 ' A' ' 55' ' ' VAL . 2.4 mt-30 -67.89 173.84 4.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.02 -36.94 48.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.968 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -64.3 -36.04 82.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.02 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.7 t -71.03 -30.27 66.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.033 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.875 ' O ' HD12 ' A' ' 59' ' ' ILE . 25.8 t -66.82 -36.37 77.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.267 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.715 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 42.9 t -77.87 -24.99 48.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.214 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.25 -44.9 9.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.753 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.486 ' HB1' HD12 ' A' ' 62' ' ' LEU . . . -57.48 -68.39 0.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.965 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.875 HD12 ' O ' ' A' ' 55' ' ' VAL . 4.3 mt -54.85 -31.1 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.073 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 56' ' ' SER . . . -56.34 -59.8 4.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.602 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -90.32 -11.48 40.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.106 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.486 HD12 ' HB1' ' A' ' 58' ' ' ALA . 63.6 mt -89.93 -75.08 0.46 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.641 0.258 . . . . 0.0 111.623 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.603 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -52.72 150.33 5.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.035 0.445 . . . . 0.0 111.246 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -178.58 -40.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.847 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -162.85 -169.48 2.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.781 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -107.13 93.55 4.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.818 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.09 -176.28 2.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 15.0 mtm -94.16 46.44 1.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.81 32.99 4.86 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.494 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -113.77 -30.01 6.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.758 0.313 . . . . 0.0 111.152 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 t -152.37 -45.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.013 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 73' ' ' ARG . 20.3 mt 61.6 161.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.796 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.472 ' N ' HG22 ' A' ' 72' ' ' ILE . 4.0 mtm180 -94.25 43.38 1.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.984 0.421 . . . . 0.0 111.011 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.535 HG13 ' HB3' ' A' ' 63' ' ' ASP . 9.2 p -61.81 147.51 11.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.981 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.1 t -158.76 171.83 19.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.918 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -85.03 121.07 27.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.785 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.75 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.162 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttt . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.847 0.356 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.13 -175.33 5.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.886 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -123.12 105.63 10.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.877 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.725 HD11 ' HB2' ' A' ' 50' ' ' MET . 6.6 mt -65.16 145.44 13.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.987 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.731 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 4.7 t80 -125.13 115.65 20.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.922 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.459 ' CG2' HG21 ' A' ' 72' ' ' ILE . 11.6 p -109.66 141.52 24.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.951 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -120.93 62.92 0.5 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.582 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.555 ' HB3' HG23 ' A' ' 72' ' ' ILE . 16.1 t30 -177.5 62.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.875 0.369 . . . . 0.0 110.636 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.586 ' CD1' HD22 ' A' ' 33' ' ' LEU . 8.2 mt -109.73 161.61 15.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.061 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.563 ' N ' ' HB2' ' A' ' 13' ' ' ALA . 14.5 p -178.96 161.46 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.723 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.511 ' N ' HG22 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -47.23 -27.99 1.73 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.328 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 88.2 p -120.28 30.12 7.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.14 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.563 ' HB2' ' N ' ' A' ' 10' ' ' VAL . . . -68.69 -31.42 70.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.235 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.567 ' O ' HG12 ' A' ' 18' ' ' VAL . 1.3 m 90.61 5.64 0.1 Allowed 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.721 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.584 ' HA ' HG12 ' A' ' 18' ' ' VAL . 2.6 m -70.93 -52.74 18.17 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.927 -179.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.78 -18.6 62.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.449 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.43 -39.17 12.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.978 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 15' ' ' SER . 13.9 p -81.87 -24.58 9.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.687 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -51.3 -37.05 45.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.802 0.334 . . . . 0.0 111.031 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.16 -32.59 70.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.007 0.432 . . . . 0.0 110.542 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.3 tt -83.6 -31.01 26.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.563 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -20.79 61.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.935 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.3 t -83.1 -29.24 28.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.954 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -81.64 -22.11 37.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.124 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -112.12 -31.64 6.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.149 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.59 -23.96 4.21 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.926 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? 62.48 50.14 3.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.858 0.361 . . . . 0.0 110.838 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.608 HG21 HG22 ' A' ' 31' ' ' VAL . 9.9 p -55.64 146.68 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.169 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -93.8 -31.05 14.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.968 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -150.71 145.85 26.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.107 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.608 HG22 HG21 ' A' ' 28' ' ' VAL . 24.7 t -147.1 106.43 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.772 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.62 ' C ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -136.24 155.7 49.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.186 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.62 HD23 ' C ' ' A' ' 32' ' ' LYS . 1.0 OUTLIER -116.94 155.17 29.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.58 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.866 HG21 ' CE2' ' A' ' 45' ' ' PHE . 2.6 pp -82.85 177.29 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.034 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.407 ' CG ' ' O ' ' A' ' 34' ' ' ILE . 70.7 m-85 -157.02 167.55 30.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.33 156.88 22.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.5 38.57 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.941 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -159.97 -45.29 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.927 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p -106.95 -16.27 14.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.206 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.7 mttp 62.39 37.25 13.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.915 0.388 . . . . 0.0 110.965 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 32.2 mttp -113.32 139.01 22.66 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.809 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 41' ' ' LYS . 53.0 Cg_exo -54.95 118.88 5.64 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.445 2.097 . . . . 0.0 112.402 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -70.2 -64.55 0.87 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.3 50.29 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.413 -0.898 . . . . 0.0 112.987 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.866 ' CE2' HG21 ' A' ' 34' ' ' ILE . 27.8 p90 -178.04 153.38 0.8 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.013 0.435 . . . . 0.0 111.081 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.61 -164.73 11.42 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.571 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -140.78 144.96 35.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.85 0.357 . . . . 0.0 111.169 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.64 HG12 ' HG3' ' A' ' 50' ' ' MET . 45.9 t -141.97 115.61 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.867 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.65 101.52 13.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.02 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.725 ' HB2' HD11 ' A' ' 4' ' ' ILE . 29.8 mtm -130.58 154.86 47.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.918 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.926 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -63.76 149.45 46.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.892 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.21 -31.72 63.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.088 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -63.25 -34.71 78.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.006 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 9.5 t -90.0 -39.25 13.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.985 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.926 HG23 ' O ' ' A' ' 51' ' ' GLN . 21.4 t -54.82 -47.81 74.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.372 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.7 m -52.15 -64.02 0.95 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.19 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -26.83 67.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.004 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.559 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -63.94 -39.53 94.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.267 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.526 ' O ' HG22 ' A' ' 59' ' ' ILE . 5.4 mt -90.12 -7.28 10.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.303 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.7 -44.95 9.67 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.97 -25.0 19.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.451 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 66.0 mt -90.11 -74.23 0.49 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.901 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.473 ' CB ' HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -50.96 142.1 12.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.932 0.396 . . . . 0.0 111.295 -179.395 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -178.83 -38.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.871 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -159.72 -175.05 4.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -104.35 108.66 20.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -124.71 -168.61 1.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.948 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.2 mmt -95.04 44.46 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.82 32.61 6.14 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.499 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.95 -34.62 6.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.83 0.347 . . . . 0.0 110.964 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.62 -53.93 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.992 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.555 HG23 ' HB3' ' A' ' 8' ' ' ASN . 29.3 mt 59.92 159.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.019 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.479 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -87.41 61.18 6.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.831 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.484 ' O ' HG23 ' A' ' 59' ' ' ILE . 11.4 p -72.82 140.64 17.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.096 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.9 t -164.27 150.91 11.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.868 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -70.33 127.35 32.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.731 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.103 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.822 0.344 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -114.4 -178.53 3.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.866 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.649 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 3.7 m-80 -110.73 142.5 42.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.556 HD11 ' HB2' ' A' ' 50' ' ' MET . 2.2 mt -118.85 120.08 62.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.609 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 3.5 t80 -102.17 123.54 46.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.004 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.562 ' HB ' HG23 ' A' ' 74' ' ' VAL . 11.2 p -128.47 129.04 68.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.024 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -110.67 -168.84 19.31 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.51 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.38 33.68 23.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.751 0.31 . . . . 0.0 110.9 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.74 HD13 HD13 ' A' ' 33' ' ' LEU . 18.3 mt -85.97 -178.72 6.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.964 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.598 HG22 ' H ' ' A' ' 11' ' ' TYR . 2.5 p -163.98 174.42 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.824 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.598 ' H ' HG22 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -43.19 -45.56 5.66 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.75 0.31 . . . . 0.0 111.563 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.576 ' H ' HG13 ' A' ' 10' ' ' VAL . 8.9 t -140.78 61.94 1.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.888 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.7 ' O ' HG23 ' A' ' 14' ' ' THR . . . -68.13 -78.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.327 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 13' ' ' ALA . 0.4 OUTLIER -177.43 -32.24 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.312 -179.746 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.9 t -47.27 -54.95 9.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.76 0.314 . . . . 0.0 111.521 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -14.47 61.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.851 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -90.68 -27.95 18.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.274 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -90.14 -20.69 6.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.842 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.801 ' HB2' HG11 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -49.36 -28.01 4.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.778 0.323 . . . . 0.0 111.236 -179.74 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -72.35 -32.14 66.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.82 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.6 tt -90.01 -30.26 17.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.955 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.85 -22.91 40.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.7 t -76.51 -31.93 57.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.985 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -90.19 -10.67 43.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.42 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.52 -37.77 5.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.645 0.26 . . . . 0.0 111.157 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.529 ' HA3' ' HE1' ' A' ' 50' ' ' MET . . . -127.38 -5.65 5.48 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.516 -0.85 . . . . 0.0 113.265 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp 61.33 47.54 6.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.872 0.367 . . . . 0.0 110.938 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 49' ' ' GLU . 11.6 p -53.97 116.05 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.188 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -59.77 -39.9 86.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.887 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -160.08 158.76 30.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.819 HG23 HG22 ' A' ' 48' ' ' VAL . 10.2 p -155.22 127.88 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.035 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.3 mtpt -160.04 123.23 3.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.973 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.74 HD13 HD13 ' A' ' 9' ' ' LEU . 9.0 mt -84.68 -169.04 2.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.572 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.762 HD13 ' HB2' ' A' ' 43' ' ' LYS . 1.7 pp -111.93 155.18 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.902 0.382 . . . . 0.0 111.233 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -157.22 169.66 24.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.741 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.61 131.5 34.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -84.1 56.4 3.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.921 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 179.2 -40.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.795 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 p -111.88 -19.82 12.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.203 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.1 tttt 68.92 25.82 5.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.778 0.323 . . . . 0.0 110.904 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -90.73 121.3 68.37 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.831 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.3 125.81 20.27 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.408 2.072 . . . . 0.0 112.337 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.762 ' HB2' HD13 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -63.58 -35.47 80.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.745 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 130.11 32.64 0.53 Allowed Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.119 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.722 ' C ' HD12 ' A' ' 9' ' ' LEU . 27.8 p90 -178.49 -176.96 0.52 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.992 0.425 . . . . 0.0 111.223 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.527 ' HA3' HD22 ' A' ' 33' ' ' LEU . . . -161.97 -171.72 28.44 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.453 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.463 ' CE1' ' CD2' ' A' ' 5' ' ' TYR . 1.7 m-85 -144.8 141.17 28.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.938 0.399 . . . . 0.0 111.075 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.819 HG22 HG23 ' A' ' 31' ' ' VAL . 40.6 t -130.24 150.11 34.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.932 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.581 ' O ' HG23 ' A' ' 28' ' ' VAL . 1.4 tt0 -111.49 109.95 20.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.93 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.556 ' HB2' HD11 ' A' ' 4' ' ' ILE . 40.4 mtp -143.6 177.68 8.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.863 ' O ' HG23 ' A' ' 55' ' ' VAL . 39.7 mt-30 -71.22 159.27 34.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -67.07 -30.77 70.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.824 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -75.9 -31.81 59.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.908 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.4 m -74.69 -29.46 61.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.063 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.863 HG23 ' O ' ' A' ' 51' ' ' GLN . 21.6 t -65.12 -37.31 79.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.276 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.681 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 10.2 t -74.91 -24.39 58.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.09 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.21 -42.68 10.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.663 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.646 ' HB1' HD12 ' A' ' 62' ' ' LEU . . . -58.82 -67.99 0.31 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.818 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.863 HD12 ' O ' ' A' ' 55' ' ' VAL . 3.3 mt -54.88 -30.57 23.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.056 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.681 ' HB2' ' O ' ' A' ' 56' ' ' SER . . . -57.04 -59.44 5.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.366 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.15 -9.14 49.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.904 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.646 HD12 ' HB1' ' A' ' 58' ' ' ALA . 71.5 mt -90.09 -74.95 0.47 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.838 0.351 . . . . 0.0 111.336 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.506 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -56.67 152.4 12.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.134 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.561 ' O ' HG23 ' A' ' 65' ' ' THR . 1.0 OUTLIER -178.57 -40.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.775 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 64' ' ' ASN . 0.6 OUTLIER -166.43 -178.28 4.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.873 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.0 p-10 -98.14 102.81 14.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.843 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.22 -168.83 1.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.939 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 1.5 mmt -93.46 46.93 1.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.876 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.37 37.49 6.2 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.546 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.1 tpp85 -116.14 -42.36 3.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.837 0.351 . . . . 0.0 110.92 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.98 -48.77 1.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.914 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.454 HG22 ' N ' ' A' ' 73' ' ' ARG . 9.3 mt 59.27 163.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.999 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.454 ' N ' HG22 ' A' ' 72' ' ' ILE . 2.2 mtt180 -94.07 47.64 1.22 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.019 0.437 . . . . 0.0 110.74 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.562 HG23 ' HB ' ' A' ' 6' ' ' VAL . 12.6 p -62.0 144.29 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.095 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.3 t -149.27 175.88 11.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.986 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.69 133.07 35.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.967 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.649 ' HB3' ' HB3' ' A' ' 3' ' ' ASN . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.131 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.842 0.353 . . . . 0.0 111.137 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.615 ' HB2' HG21 ' A' ' 55' ' ' VAL . 3.7 mmt180 -94.2 -8.57 38.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.503 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.5 m120 54.1 103.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.219 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.84 HG12 HG13 ' A' ' 55' ' ' VAL . 6.3 mt -94.42 158.51 2.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.219 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.49 ' N ' HG22 ' A' ' 4' ' ' ILE . 37.3 t80 -139.79 143.47 36.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.682 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.71 ' CG1' HD11 ' A' ' 9' ' ' LEU . 9.9 p -142.52 146.63 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.268 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -130.29 -174.37 13.67 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.322 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 t30 56.01 33.18 21.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.931 0.396 . . . . 0.0 110.994 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.71 HD11 ' CG1' ' A' ' 6' ' ' VAL . 64.2 mt -89.43 99.91 12.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.096 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.755 HG13 ' H ' ' A' ' 12' ' ' SER . 2.7 p -63.33 176.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.642 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.637 ' H ' HG22 ' A' ' 10' ' ' VAL . 17.6 m-85 -41.54 -35.35 0.7 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.865 0.364 . . . . 0.0 111.419 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.755 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.2 p -157.26 67.47 0.52 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.571 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 14' ' ' THR . . . -71.62 -65.4 0.76 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.405 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -179.12 -24.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.578 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.612 ' OG ' HD13 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -46.07 -57.91 4.06 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.747 0.308 . . . . 0.0 111.509 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.61 ' HB3' HD11 ' A' ' 33' ' ' LEU . 4.0 pt-20 -66.49 -13.3 60.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.817 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -90.54 -28.3 18.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.291 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 15' ' ' SER . 11.9 p -87.07 -24.49 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.754 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.7 -27.67 12.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.744 0.307 . . . . 0.0 111.171 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -33.1 70.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.764 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.4 tt -88.9 -30.85 18.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.809 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -26.04 62.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.016 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.44 -24.17 24.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.237 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -88.66 -24.38 22.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.265 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -111.47 -30.68 7.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.225 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -117.62 -17.56 5.55 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.575 -0.822 . . . . 0.0 113.067 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm 61.98 43.98 8.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.944 0.402 . . . . 0.0 110.715 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 49' ' ' GLU . 12.0 p -46.36 139.54 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.459 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -89.3 -39.1 13.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.835 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -139.29 149.19 43.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.955 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.729 HG23 HG22 ' A' ' 48' ' ' VAL . 13.2 p -172.11 120.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.063 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -157.11 167.3 30.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.949 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.61 HD11 ' HB3' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -128.61 160.26 32.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.683 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.486 HD13 ' HB3' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -94.33 170.48 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.054 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 42' ' ' PRO . 49.1 m-85 -138.77 -174.23 3.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.009 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -101.55 -178.48 3.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -120.28 31.75 6.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.67 -58.25 0.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.876 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.03 -1.08 27.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.403 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt 60.2 36.21 20.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.88 0.371 . . . . 0.0 110.883 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -112.99 152.02 44.59 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.822 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 53.4 Cg_exo -52.37 135.25 53.79 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.581 2.187 . . . . 0.0 112.282 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.486 ' HB3' HD13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -69.75 -69.18 0.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.794 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.41 37.59 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.898 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.457 ' CE2' HG12 ' A' ' 34' ' ' ILE . 38.3 p90 -179.9 152.88 0.49 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.987 0.423 . . . . 0.0 111.124 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.48 ' HA3' HD23 ' A' ' 33' ' ' LEU . . . -145.28 -169.99 13.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.389 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.445 ' CZ ' ' CB ' ' A' ' 77' ' ' ALA . 1.9 t80 -133.13 156.3 47.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.884 0.373 . . . . 0.0 111.057 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.729 HG22 HG23 ' A' ' 31' ' ' VAL . 24.1 t -149.16 130.45 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.972 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.667 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -110.57 116.17 30.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.02 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.433 ' HG2' HG23 ' A' ' 28' ' ' VAL . 2.5 mtm -140.63 156.21 46.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.916 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.05 151.73 18.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.971 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -77.24 95.03 4.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.931 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -174.91 -53.44 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.261 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 1.8 m -90.02 -16.15 30.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.981 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.84 HG13 HG12 ' A' ' 4' ' ' ILE . 26.0 t -61.09 -43.87 97.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.832 0.348 . . . . 0.0 111.277 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.6 m -56.82 -54.22 48.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.165 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -74.98 -26.47 59.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.106 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -57.61 -39.36 76.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.338 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.694 HD12 ' O ' ' A' ' 55' ' ' VAL . 3.2 mt -90.29 -8.94 10.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.181 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.51 -48.75 10.67 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.65 -19.11 24.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.785 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.525 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 83.3 mt -89.97 -75.12 0.46 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.93 147.42 15.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.842 0.353 . . . . 0.0 111.041 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -176.6 -41.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.941 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.4 ' OG1' HG21 ' A' ' 71' ' ' THR . 0.7 OUTLIER -154.62 -177.66 6.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -103.57 97.45 7.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.16 -169.33 1.46 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 16.9 ptm -98.38 31.57 2.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.92 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.09 33.55 1.49 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.474 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.77 -54.06 2.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.786 0.327 . . . . 0.0 110.883 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.4 HG21 ' OG1' ' A' ' 65' ' ' THR . 1.1 t -119.73 -49.76 2.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.889 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 73' ' ' ARG . 24.8 mt 60.15 159.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.212 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.481 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -90.71 51.6 2.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.819 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.558 ' O ' HG23 ' A' ' 59' ' ' ILE . 11.0 p -67.18 125.51 24.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.072 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.5 t -141.9 160.22 40.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.02 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.418 ' HG3' HD13 ' A' ' 59' ' ' ILE . 52.0 mt-10 -59.82 140.88 56.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.875 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.445 ' CB ' ' CZ ' ' A' ' 47' ' ' PHE . . . . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.095 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mtp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.845 0.355 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -99.16 175.45 5.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.959 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.401 ' HB3' ' CE2' ' A' ' 47' ' ' PHE . 22.0 m-20 -122.07 120.13 33.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.862 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.66 HG12 HG13 ' A' ' 55' ' ' VAL . 1.8 mp -111.21 132.61 59.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.122 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.776 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 6.4 t80 -107.2 142.85 36.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.476 HG13 HD11 ' A' ' 9' ' ' LEU . 7.5 p -143.98 121.01 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.99 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.448 ' HA2' ' CD1' ' A' ' 45' ' ' PHE . . . -104.79 -169.53 24.38 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.767 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 63.46 29.66 15.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.715 0.293 . . . . 0.0 110.948 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.532 HD22 ' HB2' ' A' ' 15' ' ' SER . 32.0 mt -101.24 159.8 14.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.919 0.39 . . . . 0.0 111.124 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.648 HG13 ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -155.07 -166.8 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.666 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.648 ' N ' HG13 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -48.77 -44.95 39.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.878 0.371 . . . . 0.0 111.051 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.509 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -144.06 49.04 1.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.593 179.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.8 -76.1 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.359 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.583 HG21 ' CA ' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -164.59 -37.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.304 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.532 ' HB2' HD22 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -48.94 -52.96 21.81 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.798 0.332 . . . . 0.0 111.36 -179.754 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -65.43 -15.96 63.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.751 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -90.59 -36.92 14.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.073 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.9 p -90.04 -22.35 6.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.669 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 pttp -50.0 -29.48 8.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.799 0.333 . . . . 0.0 111.101 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -68.22 -35.69 78.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.66 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.3 tp -87.03 -30.36 21.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.899 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.15 -24.48 54.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.116 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.2 m -82.38 -25.9 33.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.158 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -90.02 -24.48 21.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.216 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -110.43 -30.9 7.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.156 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -112.06 -22.24 5.99 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.775 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp 62.98 45.07 5.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.944 0.402 . . . . 0.0 110.901 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.0 p -54.14 153.07 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.107 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -97.26 -36.37 10.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.015 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -166.15 140.87 4.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.124 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t -124.71 119.44 56.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.732 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -123.44 163.14 21.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.024 0.44 . . . . 0.0 111.26 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 mt -141.51 161.29 38.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.397 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.553 HD11 ' HA3' ' A' ' 44' ' ' GLY . 2.5 pp -123.62 155.41 30.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.981 0.419 . . . . 0.0 111.29 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.478 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.7 m-85 -94.36 -165.58 1.34 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.92 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -73.66 -8.53 56.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.332 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 66.42 29.57 9.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.896 0.379 . . . . 0.0 110.743 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -165.61 -44.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.615 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 p -97.48 -13.71 21.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.184 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.29 25.94 2.77 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.803 0.335 . . . . 0.0 110.982 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -102.53 123.62 42.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.7 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.53 107.49 1.63 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.38 2.053 . . . . 0.0 112.101 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.618 ' HB3' HG23 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -176.32 42.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.29 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.553 ' HA3' HD11 ' A' ' 34' ' ' ILE . . . -132.05 42.02 1.43 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.619 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.448 ' CD1' ' HA2' ' A' ' 7' ' ' GLY . 0.9 OUTLIER 73.94 161.49 0.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.851 0.358 . . . . 0.0 111.033 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.94 -173.84 13.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.582 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 48' ' ' VAL . 46.0 t80 -128.34 159.32 35.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.761 0.315 . . . . 0.0 110.919 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.451 ' N ' ' CD1' ' A' ' 47' ' ' PHE . 31.7 t -144.81 127.7 10.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.06 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -105.3 113.33 26.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.931 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.518 ' HE2' HD13 ' A' ' 4' ' ' ILE . 35.4 mtm -142.26 147.87 37.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.6 155.83 14.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.881 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.07 95.18 4.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.037 0.446 . . . . 0.0 110.906 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -176.36 -49.37 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.263 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 5.1 m -90.02 -21.73 22.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.916 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.717 ' O ' HD12 ' A' ' 59' ' ' ILE . 21.5 t -60.61 -31.62 49.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.379 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.0 m -60.98 -53.93 51.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.243 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.63 -22.93 27.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.292 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -55.47 -41.48 73.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.432 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.717 HD12 ' O ' ' A' ' 55' ' ' VAL . 3.3 mp -90.32 -21.22 6.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.911 0.386 . . . . 0.0 111.301 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.13 -55.38 25.77 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.44 -14.3 33.13 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 51.0 mt -90.05 -75.27 0.46 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.943 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.458 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -55.52 150.7 11.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.07 0.462 . . . . 0.0 111.406 -179.114 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 175.1 -36.62 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.715 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.39 -173.89 3.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.81 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.5 96.68 6.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.955 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.426 ' CD2' ' HB2' ' A' ' 70' ' ' ARG . 0.6 OUTLIER -121.71 169.07 11.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 24.2 mmm -80.51 65.05 5.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.953 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.583 ' CA ' HG21 ' A' ' 14' ' ' THR . . . 82.69 31.02 30.92 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.607 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.426 ' HB2' ' CD2' ' A' ' 67' ' ' PHE . 1.5 tmm_? -111.0 -30.1 7.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.793 0.33 . . . . 0.0 111.081 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 t -153.02 -51.09 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.942 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.498 HG22 ' N ' ' A' ' 73' ' ' ARG . 20.1 mt 64.65 160.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.033 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.498 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -92.4 48.68 1.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.875 0.369 . . . . 0.0 110.913 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 74' ' ' VAL . 12.0 p -72.17 114.58 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.182 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.6 t -135.25 153.85 51.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.042 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -57.13 131.62 50.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.776 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.312 -0.851 . . . . 0.0 111.077 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ptp . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.822 0.344 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.94 -6.11 22.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.496 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.5 t30 59.03 114.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.055 0.455 . . . . 0.0 110.993 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.561 HG12 HG13 ' A' ' 55' ' ' VAL . 23.7 mt -103.31 127.84 56.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.117 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -110.94 126.97 55.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.844 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.48 ' HB ' HG23 ' A' ' 74' ' ' VAL . 11.1 p -135.03 154.02 35.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.122 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.411 ' N ' HG22 ' A' ' 6' ' ' VAL . . . -127.7 -166.11 12.01 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.394 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 58.98 31.43 21.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.757 0.313 . . . . 0.0 110.787 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.65 HD13 HD21 ' A' ' 33' ' ' LEU . 26.4 mt -93.9 -179.39 4.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.953 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.644 HG13 ' N ' ' A' ' 11' ' ' TYR . 0.6 OUTLIER -170.32 -165.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.697 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.644 ' N ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -46.3 -40.55 11.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.95 0.405 . . . . 0.0 111.269 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.485 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.8 m -163.72 52.66 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.67 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.515 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -66.24 -46.89 75.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.307 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.597 HG21 ' HA3' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -177.65 -32.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.416 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.7 p -47.55 -55.09 9.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.779 0.323 . . . . 0.0 111.429 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.01 -12.78 61.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.949 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -90.77 -39.06 12.61 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.204 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -77.2 -27.93 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.865 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.9 ptmm? -53.36 -28.52 29.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.779 0.323 . . . . 0.0 110.992 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -70.94 -35.36 72.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.576 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.7 tp -90.03 -27.27 19.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.721 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.87 -28.09 47.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.938 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.03 -24.27 47.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.97 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -90.12 -34.27 15.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.773 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -60.82 -41.51 95.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.746 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.07 27.27 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.577 -0.82 . . . . 0.0 113.045 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 57.01 110.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.909 0.385 . . . . 0.0 111.193 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.512 HG23 ' HG2' ' A' ' 50' ' ' MET . 10.8 p -96.37 131.33 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -59.18 -43.6 92.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.971 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -171.46 166.48 6.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.953 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 31' ' ' VAL . 11.2 p -146.59 123.4 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.03 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -132.53 174.48 10.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.121 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.65 HD21 HD13 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -143.8 158.98 43.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.757 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.874 HG21 ' CE2' ' A' ' 45' ' ' PHE . 2.5 pp -85.18 -178.91 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.14 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -158.17 168.91 25.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -86.71 152.15 22.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.951 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -96.94 41.36 1.11 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.878 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -162.56 -44.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.799 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.22 -11.12 15.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.262 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.71 30.65 16.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.821 0.343 . . . . 0.0 110.85 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.403 ' HG3' ' N ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -107.76 141.76 23.77 Favored Pre-proline 0 N--CA 1.451 -0.395 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.118 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.403 ' N ' ' HG3' ' A' ' 41' ' ' LYS . 37.4 Cg_endo -65.66 115.82 3.6 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.522 2.148 . . . . 0.0 112.332 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -56.69 -67.77 0.28 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.018 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.23 52.61 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.817 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.874 ' CE2' HG21 ' A' ' 34' ' ' ILE . 29.4 p90 -177.94 142.5 0.29 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.917 0.389 . . . . 0.0 111.061 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -134.86 -167.07 11.31 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.474 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.99 150.08 40.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.79 0.329 . . . . 0.0 110.934 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.6 t -133.2 152.31 35.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.003 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -117.45 105.14 11.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.929 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.512 ' HG2' HG23 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -140.72 144.26 35.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.848 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.1 pm0 -55.66 146.53 20.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.089 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -69.32 93.39 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.948 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -172.81 -49.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.431 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.23 -19.91 23.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.952 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.561 HG13 HG12 ' A' ' 4' ' ' ILE . 20.0 t -58.99 -48.24 87.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.845 0.355 . . . . 0.0 111.229 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.618 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 1.6 t -62.58 -23.73 67.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.035 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -90.2 -35.03 15.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.598 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.625 ' HB1' HD12 ' A' ' 62' ' ' LEU . . . -62.78 -65.61 0.66 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.751 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.664 HG23 ' HB3' ' A' ' 63' ' ' ASP . 3.9 mt -58.22 -29.56 37.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.005 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 56' ' ' SER . . . -57.32 -56.87 16.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.711 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -90.23 -25.98 20.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.708 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.625 HD12 ' HB1' ' A' ' 58' ' ' ALA . 84.2 mt -76.02 -72.14 0.34 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.763 0.316 . . . . 0.0 111.312 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.664 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -53.42 140.6 27.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.269 -179.443 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -178.19 -39.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.956 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.57 -169.73 1.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.849 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -106.68 119.92 40.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -147.51 -175.95 5.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.82 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.67 49.41 1.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.017 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.597 ' HA3' HG21 ' A' ' 14' ' ' THR . . . 97.59 35.18 5.26 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.627 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.97 -30.44 7.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.7 0.286 . . . . 0.0 111.001 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.2 t -155.27 -52.03 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.075 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.476 HG22 ' N ' ' A' ' 73' ' ' ARG . 21.9 mt 60.76 159.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.031 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.476 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -89.11 53.88 2.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.841 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.482 HG22 ' N ' ' A' ' 75' ' ' THR . 12.3 p -73.92 159.32 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.05 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.594 ' HA ' HG21 ' A' ' 59' ' ' ILE . 9.1 t -161.15 179.05 8.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.897 0.38 . . . . 0.0 110.957 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.421 ' OE1' HD13 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -107.82 108.76 20.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.962 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.184 -0.912 . . . . 0.0 111.049 179.998 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.861 0.362 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.07 171.23 9.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.029 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -113.2 166.32 11.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.681 HD11 ' HB2' ' A' ' 50' ' ' MET . 3.0 mp -132.59 125.32 52.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.033 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.664 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 14.7 t80 -99.05 124.05 43.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.012 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.658 HG13 HD21 ' A' ' 9' ' ' LEU . 9.5 p -131.14 142.6 43.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.961 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -136.59 179.81 17.52 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.535 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 62.89 30.6 16.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.785 0.326 . . . . 0.0 110.96 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.658 HD21 HG13 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -123.09 -177.51 3.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.045 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.765 HG12 ' HB2' ' A' ' 13' ' ' ALA . 0.4 OUTLIER -139.59 -169.57 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.767 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.616 ' N ' HG13 ' A' ' 10' ' ' VAL . 4.8 t80 -57.05 -52.25 66.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.806 0.336 . . . . 0.0 110.949 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.463 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.8 t -126.45 54.04 1.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.975 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.765 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -88.71 -54.93 3.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.111 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.537 HG21 ' CA ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -161.65 -41.96 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.079 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.3 t -54.46 -48.59 71.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.058 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -69.36 -14.36 62.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.757 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -90.45 -37.52 13.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.084 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 p -83.7 -28.2 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.583 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.446 ' HB2' HG21 ' A' ' 31' ' ' VAL . 3.7 pttp -53.3 -34.38 57.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.789 0.328 . . . . 0.0 110.983 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.07 -38.36 90.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.752 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.9 tt -86.28 -28.79 23.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.79 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.27 -26.16 62.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.974 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.62 -26.83 55.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.077 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -90.06 -12.8 37.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.489 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -109.04 -36.82 5.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.645 0.26 . . . . 0.0 111.24 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.8 10.27 4.55 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.066 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.6 pttp 43.07 54.78 4.78 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.837 0.351 . . . . 0.0 111.454 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.9 p -47.11 131.56 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.368 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -60.19 -57.43 12.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.894 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -156.65 165.21 36.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.002 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.561 HG13 HG22 ' A' ' 48' ' ' VAL . 21.6 t -141.63 114.49 4.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.005 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -119.02 151.94 37.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.024 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mt -130.76 149.36 52.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.755 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.963 HG21 ' CE2' ' A' ' 45' ' ' PHE . 2.7 pp -72.69 -175.14 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.983 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.434 ' N ' HD12 ' A' ' 34' ' ' ILE . 20.6 m-85 -149.14 -176.2 5.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.999 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.402 ' CB ' ' HE3' ' A' ' 43' ' ' LYS . 4.7 t0 -80.83 -168.52 1.81 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.826 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -120.61 35.97 4.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.817 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -163.97 -59.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.964 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.37 -4.94 28.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.387 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.93 35.98 13.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.843 0.354 . . . . 0.0 110.901 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -77.25 116.28 56.27 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.417 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 32.0 Cg_exo -61.27 114.77 2.35 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.54 2.16 . . . . 0.0 112.311 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.738 ' O ' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -177.61 137.03 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.976 0.417 . . . . 0.0 110.971 179.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.32 -72.09 0.48 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.633 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.963 ' CE2' HG21 ' A' ' 34' ' ' ILE . 1.7 p90 -152.25 -177.8 6.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.764 0.316 . . . . 0.0 110.851 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -154.59 -170.56 20.51 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.587 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.36 135.25 13.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.841 0.353 . . . . 0.0 110.92 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.561 HG22 HG13 ' A' ' 31' ' ' VAL . 39.8 t -123.98 156.7 31.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.015 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.464 ' N ' HG12 ' A' ' 48' ' ' VAL . 64.4 tt0 -119.74 112.18 18.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.871 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.681 ' HB2' HD11 ' A' ' 4' ' ' ILE . 21.9 mtp -144.96 168.97 18.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.956 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.405 ' O ' HG23 ' A' ' 55' ' ' VAL . 4.8 mm100 -71.85 160.53 32.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.824 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -82.04 59.38 4.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.76 -46.67 0.45 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.739 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 1.0 OUTLIER -90.02 -20.08 23.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.041 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.915 ' O ' HD12 ' A' ' 59' ' ' ILE . 42.9 t -64.7 -41.52 92.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.819 0.343 . . . . 0.0 111.166 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.4 m -57.71 -47.69 81.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.162 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -82.8 -28.32 30.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.118 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.51 ' O ' HD12 ' A' ' 62' ' ' LEU . . . -58.4 -41.22 84.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.329 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.915 HD12 ' O ' ' A' ' 55' ' ' VAL . 2.8 mp -90.32 -24.4 5.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.96 0.41 . . . . 0.0 111.166 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.37 -52.16 62.88 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.45 -19.1 24.27 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 58' ' ' ALA . 75.8 mt -90.02 -71.21 0.63 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.615 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -46.37 136.0 7.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.559 -179.333 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.467 ' O ' HG23 ' A' ' 65' ' ' THR . 62.1 t30 -177.18 -48.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.784 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 64' ' ' ASN . 0.4 OUTLIER -163.94 -175.15 3.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.968 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -91.0 113.62 25.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.941 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -130.25 -171.69 2.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.09 51.53 2.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.537 ' CA ' HG21 ' A' ' 14' ' ' THR . . . 83.88 38.07 10.85 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.465 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.44 -51.53 2.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.348 . . . . 0.0 110.987 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.79 -53.89 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.48 HG22 ' H ' ' A' ' 73' ' ' ARG . 5.0 mt 57.73 166.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.913 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.48 ' H ' HG22 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -91.1 48.84 1.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.902 0.382 . . . . 0.0 110.836 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.518 HG13 HG23 ' A' ' 59' ' ' ILE . 10.1 p -66.89 156.03 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.162 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.567 ' HA ' HG21 ' A' ' 59' ' ' ILE . 2.5 t -166.66 157.94 12.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.65 127.93 34.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.249 -0.882 . . . . 0.0 111.093 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.885 0.374 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -88.44 175.19 7.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 4.7 m-20 -118.55 129.88 55.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.868 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.806 HD12 ' HB ' ' A' ' 48' ' ' VAL . 30.6 mt -97.03 152.93 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.164 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.401 ' HB3' HG23 ' A' ' 75' ' ' THR . 90.7 t80 -130.18 103.58 6.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.812 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.677 HG13 HD23 ' A' ' 9' ' ' LEU . 10.6 p -113.56 116.97 54.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.164 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.1 -175.11 30.38 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.336 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.3 26.67 10.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.673 0.273 . . . . 0.0 111.323 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.775 HD21 ' N ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -102.76 -171.91 2.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.92 0.39 . . . . 0.0 111.17 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.705 HG13 ' H ' ' A' ' 12' ' ' SER . 6.7 p -164.49 170.55 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.469 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.564 ' H ' HG22 ' A' ' 10' ' ' VAL . 8.7 t80 -40.05 -31.64 0.13 Allowed 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 111.971 0.359 . . . . 0.0 111.971 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.705 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -144.04 50.55 1.33 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.798 0.332 . . . . 0.0 111.197 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.677 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -78.58 -61.16 2.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.123 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.662 HG21 ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER 179.47 -36.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.123 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.93 -50.53 68.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.01 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -71.72 -12.66 61.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.669 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -90.71 -28.0 18.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.147 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.57 HG22 ' CD1' ' A' ' 22' ' ' PHE . 14.7 p -90.09 -24.2 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.833 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.602 ' HB2' HG21 ' A' ' 31' ' ' VAL . 3.3 pttp -48.95 -32.72 9.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.761 0.315 . . . . 0.0 111.207 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -66.1 -33.77 76.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.967 0.413 . . . . 0.0 110.479 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 21' ' ' LEU . 8.2 tt -88.87 -27.12 21.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.662 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.57 ' CD1' HG22 ' A' ' 18' ' ' VAL . 2.0 m-30 -53.82 -24.86 16.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.049 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.6 m -61.41 -37.94 85.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.831 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.408 ' HG3' ' N ' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -90.35 -29.1 18.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.941 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.408 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -69.94 -40.4 75.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.936 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.57 21.26 0.16 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.434 -0.888 . . . . 0.0 113.264 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.2 tttm 56.17 111.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.959 0.409 . . . . 0.0 111.316 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 28' ' ' VAL . 12.8 p -105.37 121.54 57.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.013 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -67.44 -53.17 31.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.976 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -158.35 159.95 36.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.977 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.602 HG21 ' HB2' ' A' ' 19' ' ' LYS . 27.3 t -127.93 130.45 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.973 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.65 145.97 51.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.028 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.471 HD23 ' CA ' ' A' ' 46' ' ' GLY . 34.6 mt -141.18 146.55 37.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.728 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.431 HG21 ' CE1' ' A' ' 45' ' ' PHE . 2.6 pp -82.22 175.65 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.161 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -134.01 175.69 9.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.003 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -75.2 166.39 23.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 mpp_? -105.24 36.61 2.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.911 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -174.18 -41.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.966 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.6 -10.54 19.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.332 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt 61.76 28.97 17.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.782 0.325 . . . . 0.0 110.834 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -105.95 137.05 19.24 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.706 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.25 109.46 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.43 2.087 . . . . 0.0 112.407 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.418 ' C ' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -155.01 109.68 2.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.993 179.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 148.54 -63.92 0.41 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.726 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.446 ' CA ' HD11 ' A' ' 9' ' ' LEU . 13.2 p90 -177.25 170.72 2.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.875 0.369 . . . . 0.0 111.05 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.775 ' N ' HD21 ' A' ' 9' ' ' LEU . . . -125.34 179.87 16.01 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.543 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -146.36 129.53 16.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.348 . . . . 0.0 110.917 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.806 ' HB ' HD12 ' A' ' 4' ' ' ILE . 33.3 t -122.46 148.67 26.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.045 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -117.69 104.76 11.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.927 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 32.0 mtp -138.09 159.73 41.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.7 158.51 34.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.722 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -68.24 93.31 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.096 0.474 . . . . 0.0 110.963 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -169.53 -60.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.999 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 t -90.3 -15.56 30.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.84 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.894 ' O ' HD12 ' A' ' 59' ' ' ILE . 25.5 t -68.68 -49.0 68.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.843 0.354 . . . . 0.0 111.173 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 0.6 OUTLIER -70.12 -22.36 63.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.157 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -90.28 -37.21 14.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 110.602 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.64 ' HB1' HD12 ' A' ' 62' ' ' LEU . . . -57.75 -65.05 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.86 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.894 HD12 ' O ' ' A' ' 55' ' ' VAL . 2.6 mp -58.01 -30.63 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.031 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 56' ' ' SER . . . -57.43 -55.9 28.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.678 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -90.48 -28.07 18.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.684 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.64 HD12 ' HB1' ' A' ' 58' ' ' ALA . 94.1 mt -74.87 -72.26 0.3 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.782 0.325 . . . . 0.0 111.398 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.64 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -53.25 138.93 30.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.16 -179.599 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -177.38 -46.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.891 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -158.22 -178.69 7.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.948 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -92.65 106.62 18.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.873 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.67 -164.87 1.0 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.743 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 3.1 mtm -96.86 34.93 1.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.784 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.662 ' O ' HG21 ' A' ' 14' ' ' THR . . . 105.0 31.03 4.57 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.513 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -112.45 -62.28 1.6 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.862 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.7 -50.14 3.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.843 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.496 HG22 ' H ' ' A' ' 73' ' ' ARG . 4.0 mt 56.37 167.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.15 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.496 ' H ' HG22 ' A' ' 72' ' ' ILE . 10.4 ttm105 -95.01 45.08 1.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.915 0.388 . . . . 0.0 110.637 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.487 HG22 ' N ' ' A' ' 75' ' ' THR . 12.4 p -65.57 159.29 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.236 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.626 ' HA ' HG21 ' A' ' 59' ' ' ILE . 9.1 t -157.8 -176.82 6.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.523 ' HG2' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -94.63 44.66 1.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.93 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 3' ' ' ASN . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.141 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mtm . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.839 0.352 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -107.81 172.52 6.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -111.18 129.68 55.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.545 HG12 HG13 ' A' ' 55' ' ' VAL . 21.2 mt -98.12 143.46 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.093 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.493 ' CE1' ' CD2' ' A' ' 45' ' ' PHE . 41.5 t80 -116.97 123.32 46.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.962 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.523 ' CG2' HG21 ' A' ' 72' ' ' ILE . 12.0 p -125.92 121.32 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.971 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -107.21 76.8 0.23 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.696 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.625 ' CB ' HG23 ' A' ' 72' ' ' ILE . 4.5 t30 -178.04 54.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.85 0.357 . . . . 0.0 110.758 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.775 HD22 ' HB2' ' A' ' 15' ' ' SER . 16.7 mt -128.73 -168.82 1.97 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.179 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.607 HG22 ' H ' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -178.55 -168.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.388 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.607 ' H ' HG22 ' A' ' 10' ' ' VAL . 35.5 m-85 -47.02 -41.76 17.03 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.859 0.361 . . . . 0.0 111.1 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.543 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.8 m -167.66 76.43 0.15 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.658 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.56 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -97.62 -63.3 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.547 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -163.61 -19.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.989 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.775 ' HB2' HD22 ' A' ' 9' ' ' LEU . 7.6 t -47.56 -59.16 3.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.821 0.343 . . . . 0.0 111.511 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -67.42 -11.73 58.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.88 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -90.36 -32.61 16.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.062 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.6 p -87.23 -25.96 6.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.748 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.517 ' HB2' HG11 ' A' ' 31' ' ' VAL . 22.2 pttp -55.62 -29.75 59.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.781 0.324 . . . . 0.0 111.036 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -67.71 -35.96 79.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.757 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.8 tt -85.01 -30.34 24.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.815 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -17.79 65.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.107 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.7 -24.28 41.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.257 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -88.3 -25.97 22.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.225 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -107.24 -32.37 7.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.231 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -114.46 -25.27 4.1 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.806 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.99 53.47 2.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.039 0.447 . . . . 0.0 110.748 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.401 HG21 ' HB ' ' A' ' 31' ' ' VAL . 8.4 p -57.34 143.63 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.195 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -100.92 -40.12 7.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.875 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -138.59 126.13 21.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.906 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.517 HG11 ' HB2' ' A' ' 19' ' ' LYS . 11.1 p -146.47 131.73 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.087 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.4 170.08 7.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 10' ' ' VAL . 23.2 mt -96.63 154.29 17.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.816 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.607 HD11 ' HB3' ' A' ' 43' ' ' LYS . 2.6 pp -92.82 175.74 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.095 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -144.85 171.89 13.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.44 160.32 24.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.932 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.39 30.82 4.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.963 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -144.46 -57.41 0.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.43 -5.5 25.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.276 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 63.4 34.2 13.14 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.968 0.413 . . . . 0.0 110.934 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -110.72 143.17 27.67 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.831 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.47 133.66 54.3 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.532 2.155 . . . . 0.0 112.257 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.607 ' HB3' HD11 ' A' ' 34' ' ' ILE . 7.9 tptp -79.51 -69.02 0.61 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.848 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.99 45.07 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.532 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.493 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 27.0 p90 -177.75 169.31 2.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.904 0.383 . . . . 0.0 110.947 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.89 178.93 19.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.481 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -128.73 136.77 51.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.756 0.312 . . . . 0.0 110.915 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.513 HG22 HG23 ' A' ' 31' ' ' VAL . 23.8 t -127.74 141.62 45.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.093 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.26 113.83 25.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.7 mtp -145.96 -179.78 6.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.823 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.833 ' O ' HG23 ' A' ' 55' ' ' VAL . 15.0 tt0 -61.15 152.02 29.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.834 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -69.12 -32.6 72.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.016 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -77.13 -29.73 54.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.039 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.6 m -73.86 -32.42 63.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.015 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 51' ' ' GLN . 21.5 t -56.74 -49.18 79.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.309 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 m -53.16 -62.49 1.62 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.07 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -63.02 -29.65 70.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.997 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -66.57 -40.09 88.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.413 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.718 HG23 ' HB3' ' A' ' 63' ' ' ASP . 8.0 mt -90.12 -24.08 5.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.978 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.99 -52.8 63.47 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -90.47 -23.48 20.97 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 78.6 mt -85.39 -75.01 0.38 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.717 0.294 . . . . 0.0 111.702 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.718 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -52.46 134.04 34.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.875 0.369 . . . . 0.0 111.254 -179.439 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 179.1 -38.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.844 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.61 -165.8 2.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.768 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -119.92 96.95 5.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.921 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.2 -165.54 1.03 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.831 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 4.3 mmt -97.1 36.19 1.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.052 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.37 28.12 3.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.576 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -110.76 -31.15 7.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.815 0.341 . . . . 0.0 110.968 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.469 HG23 ' H ' ' A' ' 72' ' ' ILE . 0.6 OUTLIER -140.82 -56.38 0.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.949 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.625 HG23 ' CB ' ' A' ' 8' ' ' ASN . 18.0 mt 59.97 159.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.052 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.476 ' N ' HG22 ' A' ' 72' ' ' ILE . 5.7 ttt85 -89.29 53.64 2.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.776 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 75' ' ' THR . 12.1 p -74.57 156.81 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.21 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.457 ' N ' HG22 ' A' ' 74' ' ' VAL . 5.0 t -178.12 147.89 0.47 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.806 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -61.7 128.72 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.3 -0.857 . . . . 0.0 111.156 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpp? . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.813 0.339 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.765 ' HB2' HG21 ' A' ' 55' ' ' VAL . 8.4 mmt-85 -118.62 151.99 36.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.854 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.439 ' HB3' ' CE1' ' A' ' 47' ' ' PHE . 26.4 m-20 -89.72 115.74 27.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.694 HG23 HD11 ' A' ' 59' ' ' ILE . 10.5 mt -87.27 127.01 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.134 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -99.62 123.05 43.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.837 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.678 HG13 HD11 ' A' ' 9' ' ' LEU . 12.0 p -121.65 127.21 75.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.096 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.439 ' HA2' ' CD1' ' A' ' 45' ' ' PHE . . . -105.88 -171.98 23.51 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.414 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 59.48 30.49 20.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.809 0.337 . . . . 0.0 110.955 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.742 HD22 ' HB2' ' A' ' 15' ' ' SER . 48.7 mt -82.83 166.72 18.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.982 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.82 HG12 ' HB2' ' A' ' 13' ' ' ALA . 0.8 OUTLIER -162.23 -174.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.796 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.625 ' H ' HG22 ' A' ' 10' ' ' VAL . 6.9 m-85 -46.73 -52.99 12.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.95 0.405 . . . . 0.0 111.159 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.454 ' H ' HG13 ' A' ' 10' ' ' VAL . 2.9 m -154.07 75.05 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.61 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.82 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -94.95 -56.72 2.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.429 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.627 HG21 ' CA ' ' A' ' 69' ' ' GLY . 1.5 m -165.5 -34.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.465 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.742 ' HB2' HD22 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -47.27 -54.4 11.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.715 0.293 . . . . 0.0 111.451 -179.658 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -68.13 -13.08 61.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.96 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -90.62 -43.4 10.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.136 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -79.23 -30.79 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.683 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -52.43 -27.53 16.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.801 0.334 . . . . 0.0 111.15 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -71.95 -37.74 69.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.811 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.1 tp -88.38 -28.44 20.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.89 -21.67 44.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.163 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.459 ' HA ' HG12 ' A' ' 28' ' ' VAL . 85.8 p -84.57 -27.62 27.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.093 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -89.98 -34.2 16.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.289 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -105.21 -30.23 9.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.271 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.4 -14.95 22.66 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.895 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.75 35.01 24.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.85 0.357 . . . . 0.0 110.86 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 23' ' ' SER . 11.0 p -50.69 143.31 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.336 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -91.26 -34.46 14.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.927 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -167.79 158.18 10.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.918 0.39 . . . . 0.0 111.193 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.466 HG13 HG22 ' A' ' 48' ' ' VAL . 21.3 t -143.48 150.34 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.898 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.437 ' C ' HD23 ' A' ' 33' ' ' LEU . 18.0 ttpt -169.64 151.76 4.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.933 0.397 . . . . 0.0 111.288 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.526 HD22 HD13 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -134.95 -177.27 4.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.329 179.762 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.574 HD11 ' HA3' ' A' ' 44' ' ' GLY . 1.8 pp -129.57 179.83 3.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.821 0.343 . . . . 0.0 111.189 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -139.71 -168.59 2.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.952 -179.651 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.77 -20.67 36.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.513 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.29 26.44 4.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.922 0.392 . . . . 0.0 110.81 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -156.44 -46.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.414 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.07 0.54 25.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.96 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.9 mttm 63.98 38.95 8.34 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.93 0.395 . . . . 0.0 111.044 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 42' ' ' PRO . 12.5 mtmm -100.96 100.79 13.76 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.573 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.444 ' HD2' ' CZ ' ' A' ' 11' ' ' TYR . 33.3 Cg_endo -64.8 107.1 0.84 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.354 2.036 . . . . 0.0 112.216 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.5 37.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.195 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.574 ' HA3' HD11 ' A' ' 34' ' ' ILE . . . -129.25 32.64 3.2 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.473 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.477 ' C ' HD12 ' A' ' 9' ' ' LEU . 0.5 OUTLIER 72.41 166.05 0.3 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.888 0.375 . . . . 0.0 110.905 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.651 ' N ' HD12 ' A' ' 9' ' ' LEU . . . -140.31 -162.36 9.08 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.482 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.439 ' CE1' ' HB3' ' A' ' 3' ' ' ASN . 0.3 OUTLIER -139.81 160.91 38.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 0.0 111.039 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.466 HG22 HG13 ' A' ' 31' ' ' VAL . 32.7 t -147.91 142.22 19.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.955 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -107.75 114.58 28.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.584 ' HB2' HD11 ' A' ' 4' ' ' ILE . 21.4 mtm -145.54 -178.12 5.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.887 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -75.85 150.65 37.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 -179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -61.18 -36.96 81.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -63.47 -31.05 72.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.016 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.41 -35.42 21.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.987 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 51' ' ' GLN . 40.7 t -57.69 -30.82 38.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.28 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.563 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -85.39 -23.43 27.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.269 -179.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -90.21 -41.45 11.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.888 0.375 . . . . 0.0 110.84 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.555 ' HB1' HD12 ' A' ' 62' ' ' LEU . . . -58.34 -66.43 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.949 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.862 HD12 ' O ' ' A' ' 55' ' ' VAL . 3.6 mt -58.07 -21.81 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.277 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 56' ' ' SER . . . -68.66 -54.3 17.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.584 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.19 -29.97 17.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.479 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.555 HD12 ' HB1' ' A' ' 58' ' ' ALA . 92.9 mt -73.2 -74.24 0.18 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.241 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.524 ' CB ' HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -57.0 135.86 56.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.055 -179.78 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 t30 179.51 -38.78 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.789 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.422 ' OG1' HG21 ' A' ' 71' ' ' THR . 0.5 OUTLIER -159.49 -177.51 6.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.788 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.21 111.4 23.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.988 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -131.71 -171.07 2.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.947 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 21.5 mtp -93.12 45.68 1.18 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.627 ' CA ' HG21 ' A' ' 14' ' ' THR . . . 97.98 39.5 3.8 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.516 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.08 -39.68 2.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.697 0.284 . . . . 0.0 111.075 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.422 HG21 ' OG1' ' A' ' 65' ' ' THR . 0.1 OUTLIER -135.37 -48.86 0.72 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.244 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.623 HG22 ' H ' ' A' ' 73' ' ' ARG . 1.9 mt 55.26 174.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.637 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.623 ' H ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -104.78 66.16 0.77 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.969 0.414 . . . . 0.0 111.022 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.524 HG12 ' CB ' ' A' ' 63' ' ' ASP . 14.7 p -83.25 156.98 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.0 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.453 ' N ' HG22 ' A' ' 74' ' ' VAL . 5.4 t -167.31 142.12 3.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.964 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.484 ' HB3' HG12 ' A' ' 55' ' ' VAL . 18.0 pt-20 -69.61 134.12 48.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.949 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.044 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.413 ' HG2' ' CE1' ' A' ' 29' ' ' PHE . 4.8 mtm . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.783 0.325 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -96.48 167.0 11.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.938 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -115.68 106.42 13.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.817 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.6 mt -76.76 128.76 37.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.201 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.526 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 50.1 t80 -108.54 122.21 46.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.749 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.713 HG13 HD11 ' A' ' 9' ' ' LEU . 10.9 p -132.49 145.92 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.228 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.34 -165.33 11.78 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.408 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 55.04 34.62 22.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.76 0.314 . . . . 0.0 111.039 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.713 HD11 HG13 ' A' ' 6' ' ' VAL . 28.6 mt -106.68 128.49 54.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.968 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.62 HG13 ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -89.71 -168.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.797 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.62 ' N ' HG13 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -49.7 -47.47 50.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.788 0.328 . . . . 0.0 111.04 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.528 ' H ' HG13 ' A' ' 10' ' ' VAL . 1.4 t -145.76 58.79 1.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.706 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.636 ' O ' HG23 ' A' ' 14' ' ' THR . . . -59.31 -52.87 63.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.266 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER 176.03 -32.21 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.102 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.49 -54.15 19.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.323 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -64.83 -15.4 61.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.898 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -90.49 -34.09 15.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.201 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 p -90.12 -21.79 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.858 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.519 ' HB2' HG11 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -48.86 -28.43 3.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.748 0.308 . . . . 0.0 111.142 -179.822 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -71.77 -33.25 68.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.748 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.8 tt -88.9 -32.13 17.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.809 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.35 -23.46 64.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.988 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.6 m -80.91 -23.06 39.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.076 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.06 -37.52 14.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.111 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -101.7 -31.16 10.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.093 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.22 -24.79 9.32 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.655 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.0 tttt 63.88 36.99 9.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 0.0 110.899 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 49' ' ' GLU . 11.8 p -61.01 131.98 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.034 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.413 ' CE1' ' HG2' ' A' ' 1' ' ' MET . 74.8 m-85 -74.33 -41.92 60.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -150.85 148.32 28.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.825 HG23 HG22 ' A' ' 48' ' ' VAL . 11.0 p -162.95 130.24 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.975 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.99 161.46 4.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.884 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mt -100.83 173.75 6.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.921 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.611 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.4 pp -112.32 161.26 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.156 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.401 ' CD2' ' HB3' ' A' ' 42' ' ' PRO . 12.4 m-85 -145.34 -174.32 4.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.18 132.0 44.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.97 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -92.14 50.71 1.68 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.791 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -171.65 -42.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.51 -20.52 18.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.08 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.8 mmtp 67.78 44.68 1.56 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.914 0.388 . . . . 0.0 110.934 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -136.56 141.81 36.89 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.924 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.439 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 66.4 Cg_endo -73.88 134.1 19.36 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.52 2.146 . . . . 0.0 112.268 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.9 mmmt -63.8 -66.83 0.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.847 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.06 44.65 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.64 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.425 ' CE2' HG12 ' A' ' 34' ' ' ILE . 33.2 p90 -177.75 154.47 0.94 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.802 0.334 . . . . 0.0 110.986 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.12 -164.37 9.88 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.451 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -146.15 137.48 24.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.819 0.342 . . . . 0.0 110.908 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.825 HG22 HG23 ' A' ' 31' ' ' VAL . 33.7 t -122.52 111.89 32.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.998 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.604 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.8 OUTLIER -80.37 103.86 10.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.957 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.6 mtm -142.81 152.96 42.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.608 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -63.74 178.86 0.55 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.89 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.72 -159.0 0.08 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.45 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 66.05 -71.58 0.09 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.16 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.3 m -61.29 -30.99 70.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.039 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 51' ' ' GLN . 35.4 t -63.73 -44.78 98.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.181 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -67.14 -25.4 66.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.177 -179.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -90.16 -38.08 13.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.931 0.396 . . . . 0.0 110.727 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.712 ' HB1' HD12 ' A' ' 62' ' ' LEU . . . -58.41 -64.51 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.895 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.572 HG23 ' HB3' ' A' ' 63' ' ' ASP . 6.5 mt -58.13 -26.65 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.204 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 56' ' ' SER . . . -63.78 -53.91 43.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.713 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -90.33 -33.98 15.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.886 0.374 . . . . 0.0 111.428 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.712 HD12 ' HB1' ' A' ' 58' ' ' ALA . 83.6 mt -72.01 -70.79 0.31 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.38 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.572 ' HB3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -54.91 134.59 48.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.18 -179.583 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -179.98 -67.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.904 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.58 -174.02 2.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -103.86 105.29 15.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.043 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -123.22 -174.75 3.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.813 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 8.5 ptt? -96.02 36.83 1.27 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.991 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.28 36.76 1.17 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.55 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.38 -40.42 2.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.727 0.299 . . . . 0.0 110.976 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.445 HG23 ' H ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -134.02 -60.99 0.8 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.859 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.505 HD13 HD21 ' A' ' 9' ' ' LEU . 26.9 mt 59.76 159.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.012 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.491 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -83.88 58.69 4.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.926 0.394 . . . . 0.0 110.748 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.473 HG22 ' N ' ' A' ' 75' ' ' THR . 13.8 p -75.37 158.11 5.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.185 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.473 ' N ' HG22 ' A' ' 74' ' ' VAL . 9.9 t -174.15 153.94 2.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.803 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -76.54 124.02 26.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.526 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.022 179.994 . . . . . . . . 1 1 . 1 stop_ save_